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8UMMART
Four ts mutants of RS virus, two from the subgroup A/wild-type 
strain A2 (ts A p  ts A2)and two from the subgroup B/wild-type strain 
RSN-2 (ts N1( ts N19 >, representing different complementation groups, 
were studied.
Mutant ts A} (complementation group A) was found to be 
restricted at a late stage of infection at 39°C. The degree of 
growth restriction was directly related to the length of incubation 
of ts A1-infected cultures at 39°C, implying that the spread of 
infection (by cell-to-cell fusion) was affected. The SDS-PAGE 
profile of radiolabelled ts A} intracellular viral proteins at 39°C 
revealed a significant reduction in the amount of the Fj polypeptide 
(the large subunit of the fusion protein), followed by a slightly 
less severe decrease of the matrix (M) protein. The cleaved but 
undissociated fusion (F^ 2> protein of ts Aj migrated more slowly 
than its wild-type counterpart on SDS-PAGE. Characterization of ts+ 
revertants revealed varying degrees of reversion to wild-type levels 
of growth at 39°C, but no coordinate restoration of the ts phenotype 
and of the ts Aj F^ 2 waa observed. This suggested that the mutation 
affecting Fj 2 mobility in ts Aj could be compensated by secondary 
mutations in the same (F) or in another gene, or that the tsA^ lesion 
is located in a different viral protein with which the F protein 
forms a complex during the virus cycle.
Mutant ts A2 (complementation group B) was found to exhibit 
temperature-sensitive synthesis of the G glycoprotein which mediates 
RS virus attachment to host cells. Examination of the G-processing 
pathway showed that synthesis of the major p50 precursor was 
unaffected but further maturation to fully glycosylated G was 
defective at 39°C. Mutant ts A2 also exhibited defective proteolytic 
cleavage of the F0 precursor into Fj and F2 subunits (a processing 
step required for creation of a fusion-active F protein) at both 
temperatures. This could explain the previously reported variability 
in plaque phenotype and growth of ts A2 under permissive conditions 
in different cell types, since the proteolytic activation of the 
fusion protein is host-dependent.
Mutant ts Nj (complementation group D) possessed an M protein 
which disappeared from the soluble cytoplasmic fraction of infected 
cells soon after its synthesis at 39°C. The ts Nj M protein was also 
partially unstable at 33°C and exhibited slightly decreassd SDS-PAGE 
mobility. The M protein of ts* revertants was stable at 39°C, 
correlating the defect in M-stability with the ts I»i phenotype. The 
M proteins of three ts+ revertants exhibited the slower mobility of 
the ts Nj M protein, suggesting that they were pseudorevertants. The 
P protein of ts Nj (and its ts* revertants) also migrated more slowly 
than the wild-type RSN-2 P protein. Sequence analysis and in vitro 
expression of a ts N^ P cDNA clone showed that the aberrant P 
mobility was due to a single amino acid change (Asn -* Asp at position 217).
Mutant ts N^9 (complementation group E) was completely 
restricted at 39°C, indicative of a ts defect at an early stage of 
infection. The ts Nj9 P protein lacked an epitope recognized by 
anti-P MAb 3-5. The P proteins of ts* revertants, which exhibited 
wild-type growth at 39°C, had this epitope restored, confirming that 
loss of the P-epitope was correlated with the ts phenotype. Sequence 
determination of P cDNA clones, produced from RSN-2, ts N29 and ts* 
revertant P mRNA by reverse transcription and PCR amplification, 
identified a single amino acid difference (Gly -* Ser at position 172) 
in the ts N^9 P protein. In vitro expression of the sequenced P cDNA 
clones and immunoprécipitation of the respective P proteins with MAb 
3-5 showed that presence of the Gly^72 residue was required for MAb- 
binding. This residue was contained within a C-terminal domain of 
the P protein which could be independently expressed by internal 
initiation of in vitro translation at AUG14 3.
xvi

1. INTRODUCTION
Respiratory syncytial (RS) virus is a pleomorphic enveloped 
virus which replicates in the cytoplasm of infected cells and whose 
genome is an unsegmented, linear, single-atranded RNA molecule of 
negative sense (i.e., with sequence complementary to that of the 
viral mRNAs). RS virua is classified in the genus Pneumovirum of the 
family P aramyxov iridam.
Among the negative-strand RNA viruses [class V in the 
classification of Baltimore (1971)] three families possess segmented 
RNA genomes (Orthomyxoviridam, Arenaviridae and Bunyaviridaa) and 
three families, the Rhmbdoviridmm, Paramyxoviridaa and Flloviridaa, 
have non-segmented genomes. Recently, a proposal has been submitted 
to the International Committee on Viral Taxonomy to classify the 
three latter families together as the order Mononeoavirales (C. R. 
Pringle, personal communication).
Several studies of the Paramyxoviridas and Rhabdoviridaa have 
suggested their evolutionary relationship. The resemblance in the 
molecular organisation of their genomes (Fig. 1), the similarities in 
the existence and placement of transcriptional signals, intergenic 
and extracistronic sequences, and in the strategy of genome 
expression and, finally, the significant homology shared by their 
catalytic L polymerase proteins strongly support the notion of a 
common ancestry and conservation of an archetypal mechanism of 
transcriptional regulation (Olasier et ml., 1977; Leppert et ml.,
1979; Blumberg et ml., 1984; Gupta and Kingsbury, 1984; Morgan and 
Rakestraw, 1986; Collins et ml., 1987; Kolakofsky and Roux, 1987; 
Yusoff et ml., 1987; Feldhaus and Lesnaw, 1988; Galinski et ml.,
1988; Tordo et ml., 1988; Poch et ml., 1990). Blumberg et ml.
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Fiamr« 1. Gene order of nonaegaented negativ« atrand RNA viruses 
(adapted fron Pringle, 1987a).
EHABDOVIBIDAE PARAMYXOVIRIDAE
LYSSA-
VIRUS
VESICULO­
VIRUS
MORBILLI­
VIRUS
PARAMYXO­
VIRUS
PNEUMO­
VIRUS
HNV/RV* vsv* MV° NDV/rf [ SV5 ]
Sendai/
HPIV-3*
RS
virus
3* 3* 3' 3* 3* 3’
Pr Pr - - - - Pr Pr Pr
NS 1C
NS IB
N N ---- NP NP NP N
*1 NS/7K --- P/C P/C[V] P/C P
m 2 M --- - M M M M
1A
r°
o
«■ H ----
*o
(SH)
HNo -
*o
///
--HN-/
/  Fo//
M2 (22K)
NV
L L --- L L L L
5’ 5* 5' 5 ' 5’ 5'
a HNV I Haematopoietic necrosis virus, RVt Ravies virus 
b VSV i Vesicular stomatitis virus
c MV t Measles virus
d NDV i Newcastle disease virus, SV5: Simian virus 5 
* HPIV—3i Human parainfluenza virus type 3
Pr i promoter site; NS > non-structural; NV : non-virion 
HNn and F0 denote precursor proteins; Functionally analogous gene products 
b«twMn the two families ar* indicated by dashed lines.
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(1988) have hypothesized an evolutionary pathway leading from the 
rhabdovirus VSV to the paramyxovirus group in the order t VSV -* NDV -» 
Sendai virue -• Measles virus, in parallel with a narrowing of the 
host range of these viruses during evolution.
Within this context, and in view of the extensive information 
which presently exists for the rhabdovirus system, the first part of 
this introduction is a brief description of the major features of the 
prototype vesiculovirus Vesicular stomatitis virus (of the 
Rhmbdoviridmm family). The variations of this general scheme which 
are present in the Pmrmmyxoviridas are then discussed in the second 
part. Respiratory syncytial virus, being the specific interest of 
this study, is presented separately. Finally, the aims of the work 
undertaken in this thesis will be described. (The Flloviridmm 
Marburg and Bbola viruses have been excluded from consideration on 
account of the limited characterization of these viruses that has so 
far been carried out).
1A. RHABPOVIRP8BS « VSV
Vesicular stomatitis virus (VSV), the prototype member of the 
family Rhmbdoviridmm, is a bullet-shaped virus that infects a wide 
range of animal cells and is a mild pathogen of cattle. Barly in 
infection the negative-stranded genome (mol. mass 4 x 10® daltons) is 
sequentially and discontinuously transcribed by a virally encoded 
RNA-dependent RMA polymerase which is packaged in the virion 
(Baltimore et ml., 1970; Abraham and Banerjee, 1976; Iverson and 
Rose, 1981). This first biosynthetic step, called "primary 
transcription", produces six species of plus-sense transcripts; a 
short "leader" RNA molecule complementary to the exact 3* end of the
3
genome (Colonno and Banerjee, 1976) and fiva cappad and 
polyadanylatad mRNAa which coda for tha fiva viral structural 
protains L, NS, N, M and G (Both at al., 1975). Accumulation of 
sufficiant amounts of nawly synthesized protains causas tha viral 
polymerase to switch from tha transcriptive to tha replicative mode 
of RNA synthesis. Tha process of genome replication is absolutely 
dependant upon concurrent protein synthesis (Herts and Levine, 1973) 
Davis and Herts, 1982) and involves the synthesis of a full-length, 
plus-sense replicative intermediate (anti-genome) which acts as a 
template for progeny negative-stranded genome production. Genome 
replication provides the templates for secondary transcription which 
leads to amplified synthesis of all viral proteins needed for 
subsequent virus assembly. Maturation and virion egress finally 
occur by budding through regions of the host cell membrane modified 
by the insertion of the G glycoprotein which mediates attachment to 
new host cell receptors. Vesicular stomatitis virus has been the 
subject of thorough research over the past 20 years and so the 
following description of the VSV proteins and RNA synthetic processes 
focuses on the most important- and more recent- information.
1A.1 N PROTBIM
The N (nucleocapsid) protein is the most abundant intracellular 
viral polypeptide, tightly encapsidating genomic RNA to form the 
active template for transcription and replication referred to as 
ribonucleoprotein (RNP) core. The stoichiometry of 1,285 N protein 
oiolecules per nucleocapsid (Thomas et ai., 1985) suggests that 
approximately 9 nucleotides are enwrapped by each N protein monomer
in the intact virion. This value correlates well with the minimum
RNA oligomer aise protected by N protein from RNase A digestion in 
vitro (Masters and Banerjee, 1988b), as well as the length of the 
conserved, 5'-proximal leader sequence which bas been suggested as 
the nucléation site for initiation of nucleocapsid assembly (see 
Section 1A.7).
The discovery of plus- and minus-strand leader RMAs in VSV- 
infected celle and the démonstration that these vers encapsidated by 
N protein (Blumberg and Kolakofeky, 1981), coupled with the 
requiraoent of the réplication process for concurrent protein 
synthesis (Hertz and Levine, 1973), has led to the hypothesis that 
the switch from the transcriptive to the réplicative mode of RNA 
synthesis is modulated, at least in part, by the availability of 
free, soluble cytoplasmic N protein (Leppert et al., 1979; Blumberg 
et al., 1981 ). Several subséquent in vivo and in vitro studies of 
VSV réplication hâve firmly supported this hypothesis (Patton et al., 
1984a,b; Arnheiter et al., 1985; Peluso and Noyer, 1988). The 
central réplicative function of the N protein is additionally lmplied 
by the replication-negative phenotype of ts N-protein sautants 
(Combard et al., 1977; Knipe et al., 1977a; Marks et al., 198S).
More recent data, however, suggest that the NS protein (section 
1A.2) plays an auxiliary rôle in réplication by maintaining N protein 
in a repiication-competent State. When N protein is présent at high 
concentrations in vivo and in vitro (in the absence of other viral 
proteins) it has the tendency to self-aggregate, forming a high Mr 
complex that does not support réplication (Sprague et al., 1983;
Davis et al., 1986; Peluso, 1988). Furthermore N and NS proteins 
form multiple complexes bot h in vivo and in vitro (Bell et al., 1984; • 
Davis et al., 1986; Masters and Banerjee, 1988a) and two of these 
complexes, with NiNS molar ratios of 2il and ltl, are prédominant
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under condition« of optimal in vitro replication (Howard et ml.,
1987; Peluso, 1988; Howard and Hertz, 1989). These observations have 
suggested that complex formation between the N and NS proteins may 
prevent the concentration-dependent aggregation of the N protein. In 
agreement with this model, Masters and Banerjee (1988b) have shown 
that formation of N-NS complexes abolished the non-specific binding 
of nascent N protein to any available RNA species in vitro, implying 
that the NS protein might also confer the sequence-specificity 
required for initiation of VSV encapsidation in vivo. Interestingly, 
N-binding by the NS protein in the two types of complexes formed in 
vitro, i.e. with NtNS ratios of 2tl and 1 1 1, resembled the two types 
of N-binding by two anti-N MAbs in vivo (Arnheiter et ml., 1985).
For example, one of the anti-N MAbs which inhibited in vivo 
replication, bound only to free N protein, similarly to NS binding of 
N in the 1<1 complex (Masters and Banerjee, 1988a). More recently, 
the ltl N:NS complex has been reported to be essential for supporting 
in vitro DI genome RNA replication and DI nucleocapsid assembly (La 
Perla and Peluso, 1989).
The precise roles of the different types of N-NS complexes have 
not yet been elucidated, but both types could be involved in the 
replication process, since - as suggested by Lazzarini et ml. (1981) 
and Blumberg et ml. (1983) - initial binding of N protein to the 
nascent leader would need to be sequence-specific, whereas subsequent 
assembly would be assured by cooperative protein-protein 
interactions. In view of the fact that NS protein has been shown to 
bind to a site 16-30 nucleotides downstream of the 3' end of the 
genome (Keene et ml., 1981) and that the proposed leader nucleation 
site is contained within the first 14-18 nucleotides (Blumberg et 
ml., 1983) it is possible that the equimolar N-NS cosiplex might be
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functional in tha initiation of «neapsidation, which would require NS 
protein for its sequence-specificity (Masters and Banerjee, 1988b). 
Complexes of higher N-NS stoichiometry, where NS binding would 
primarily maintain high concentrations of N protein in a soluble 
form, might be functional in the continuation of nucleocapsid 
assembly.
ft riwna
The NS (non-structural) protein of VSV is a phosphoprotein of 
approximately 30 Kd (Oallione et ml., 1981; Gill and Baner jee, 1985). 
Barly studies showed that both L (the putative polymerase) and NS 
proteins were required for efficient transcription in vitro, 
indicating that NS protein is a vital component of the transcriptase 
(Emerson and Yu, 1975). Analysis of ts NS-protein mutants (Evans et 
ml., 1979; Lesnaw et ml., 1979) suggested that NS protein was also 
involved in the replication process (see Section 1A.1). The NS 
protein is thought to be the promoter-recognising component of the 
viral polymerase complex (Keene et ml., 1981; Isaac and Keene, 1982; 
Williams et ml., 1988). In addition, stoichiometric amounts of NS 
protein are required for the extension of initiated RNA transcripts 
(De and Banerjee, 1985). This elongation function is thought to be 
carried out by temporary displacement of nucleocapaid-bound N protein 
in order to facilitate movement of the polymerase on the template 
(Hudson et ml., 1986; Banerjee, 1987a).
Phosphorylation of NS in vivo seems to be an early 
modification, occurring during or insnediately after its synthesis 
(Moyer and Summers, 1974). The extent of NS phosphorylation has been 
shown to regulate both its ability to bind to viral RNP cores
functional in tha initiation of encapsidation, which would require NS 
protain for its saquanca-spacificity (Mastars and Banarjaa, 1988b). 
Complaxas of higher N-NS stoichiometry, whara NS binding would 
primarily maintain high concantrations of N protain in a solubla 
form, might ba functional in tha continuation of nuclaocapsid 
assembly.
1A.2,”  « O « »
Tha NS (non-structural) protain of VSV is a phosphoprotein of 
approximately 30 Kd (Oalliona at ml., 1981; Gill and Banarjaa, 1985). 
Xarly studies showed that both L (tha putative polymerase) and NS 
protains ware required for efficient transcription in vitro, 
indicating that NS protain is a vital component of tha transcriptase 
(Emerson and Yu, 1975). Analysis of ts NS-protein mutants (Xvans at 
ml., 1979; Lasnaw at ml., 1979) suggested that NS protain wan also 
involved in tha replication process (see Section 1A.1). Tha NS 
protain is thought to ba the promoter-recognizing component of tha 
viral polymerase complex (Keane at ml., 1981; Isaac and Keane, 1982; 
Williams at ml., 1988). In addition, stoichiometric amounts of NS 
protain are required for tha extension of initiated RNA transcripts 
(Da and Banarjaa, 1985). This elongation function is thought to ba 
carried out by temporary displacement of nucleocapsid-bound N protain 
in order to facilitate movement of tha polymerase on tha template 
(Hudson at ml., 1986; Banerjee, 1987a).
Phosphorylation of NS in vivo seams to be an early 
modification, occurring during or immadiataly after its synthesis 
(Hoyer and Sunmers, 1974). The extent of NS phosphorylation has been 
shown to regulate both its ability to bind to viral RNP cores
(Clinton at ml., 1978b) and ita ability to stimulate in vitro 
transcription (Kingsford and Emerson, 1980; Hsu at ml., 1982). Tha 
protain exists in diffarantly phoaphorylatad Corns, NSI and NSII, 
which can ba saparatad by DEAS-cellulose chromatography (Kingsford 
and laaraon, 1980). Both forms can ba furthar saparatad into two 
subspacias, NSI and NS2, which ara rasolvabla by gal alactrophorasis 
(Clinton at ml., 1979; Hsu at ml., 1982; Mastars and Banarjaa, 1986). 
Tha two subspacias ara thought to reprasant two diffmrant 
conformational statas of tha protain, on tha basis of thair ralativa 
migration in uraa-polyacrylamida gals, thair contrasting 
sensitivities to phosphatasa treatment and thair differential 
recognition by viral and cellular kinases in vitro (Mnrnell and 
Summers, 1984; Mastars and Banarjaa, 1986). Tha NSI form contains 
tha constitutively phosphorylated residues within tha H-terminal 
domain of tha protain and can ba furthar phosphorylatad by callular 
kinasas in vitro, wharaas tha NS2 form has additional phosphorylatad 
rasiduas and can ba convartad into NSI by in vitro phosphatasa action 
(Hsu and Kingsbury, 1985; Marnall and Summers, 1984; Ball and Pravac,
1985). Tha NS2 form is preferentially phosphorylatad in vitro in tha 
presence of N/RNA template by tha L-associated protain kinase (sea 
Section 1A.5).
Comparison of tha NS protain sequences of tha Indiana and New 
Jersey VSV serotypes revealed only a 32% overall amino acid homology 
(Gill and Banarjaa, 1985). Tha region of highest homology was 
located at tha basic carboxy-terminal region of tha protain (90% 
identity). Despite thair sequence divergence, tha NS proteins 
exhibit remarkably similar hydropathicity profiles; indicating that • 
protein function is maintained through conservation of structure 
(Masters and Banerjee, 1987). eighteen potential phosphorylation
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gitas (Ser or Thr) a n  conserved batwaan tha NS proteins of tha two 
serotypes, fiva of which ara locatad within tha otharwisa 
nonhomologous N-tarminal domain which contains tha constitutivaly 
phoaphorylatad rasiduas (Raa and Blliott, 1986a; Hudson at ai.,
1986). This domain is also highly nagativaly chargad and its acidic 
natura is thought to hindar proportional SDS binding, causing tha 
abarrant (slowar) migration of tha protain in SDS-PAGB (Galliona at 
a1 1981; Marnall and Suamars, 1984; Ball and Pravac, 1985; Raa and 
Blliott, 1986b; Chattopadhay and Banarjaa, 1987b).
A sacond, small protain of 7 Kd has baan datactad among tha in 
vitro translation products of NS mRNA, which comigratad with a 
protain praaant in traca amounts in vivo (Harman, 1986). This 
polypaptida was shown to ba darivad by intarnal initiation of 
translation, in tha same reading frame as that for tha NS protain, 
from tha 3*-proximal one-third of tha NS mRNA. No function has yat 
baan assigned to this small protain.
Bxpression of truncated NS proteins in vitro and examination of 
thair ability to bind to N/RNA template and L protain during VSV 
transcription-reconstitution in vitro has defined three functional NS 
domains t domain X, which is tha highly acidic N-tarminal half of tha 
protain, domain XX, a region batwaan rasiduas 213-247 which is 
assantial for transcription and domain III, tha C-terminal 28 amino 
acids, which is not directly involved in transcription but mediates 
strong binding of NS to tha N/RNA template (Gill at al., 1986). The 
putative L-binding region (domain XX) contained two conserved and one 
variable serine rasiduas. Substitution of either invariant sarina 
negated L-mediated phosphorylation of tha other residua, suggesting ,
l
. that tha two serines act cooperatively with respact to tha L-kinase 
site. However tha overall structure of tha entire dosiain XX was
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Important for binding of L protein, ae its deletion resulted in a 
transcriptionally inactive NS protein. Based on these observations, 
Chattopadhay and Banerjee (1987a) suggested that domain IX is the 
site of interaction between NS and L proteins and, during 
transcription, site-specific phosphorylation of the two coneerved 
serines within domain II by the L-aesociated kinase promotes tight 
binding of L to the NS and the N/RNA template. Domain III may 
atabilise binding of NS to the template by its interaction with 
domain II, whereas the acidic domain I might traneiently displace N 
protein from the template to enable elongation of initiated RNA 
chains.
Consistent with this model is the observation that the function 
of domain I can be partially replaced by the similarly charged 
protein /3-tubulin in vitro and that the requirements for domain I and 
domains II and III for optimal in vitro transcription are 
stoichiometric and catalytic, respectively (Chattopadhay and 
Banerjee, 1987b). Theee findings collectively indicate that the 
highly acidic domain I ia primarily involved in electrostatic 
interactions, while the other two domains interact directly with L 
protein and N/RNA template in a sequence-specific manner.
Furthermore, the catalytic requirement for domain III, its basic 
nature and its high degree of conservation between otherwise 
divergent NS proteins suggest this region ae the likely candidate for 
the promoter-binding property of the NS protein.
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1A.3 M PROTEIN
Tha M (matrix) protain of VSV la tha most abundant protain of 
tha virion (Thomas at ml., 1985) and it is thought to hava a pivotal 
rola in virus saturation by forming a bridga batwaan tha cytoplasmic 
RNP particlas and tha siambrana anvalopa (Dubovi and Wagner, 1977; 
Schnitsar and Lodish, 1979). This view is supportsd by 
charactarization of ts M-protein mutants, which ara dafactiva in 
virion production and ralaasa at tha rastrictiva temperaturs (Knipa 
at ml., 1977b; Kennedy-Morrow and Lasnaw, 1984; reviewed by Pal and 
Wagnar, 1987). Tha M protain is highly basic (pi 9.1; Carroll and 
Wagnar, 1979) and can ba reconstituted as a peripheral mambrane 
protain with vesicles containing acidic phospholipids (Sakowski at 
ml., 1981). In addition to its association with tha lipid bilayar, M 
protain is electrostatically bound to RNP cores, prooioting their 
condensation into a tightly coiled helix (Newcomb and Brown, 1981; Da 
at ml., 1982) . Synthesis of tha N protain has bean suggastad to ba 
tha rate-limiting step in virus assembly (Knipa at ml., 1977c; Weiss 
and Bennet, 1980). Reidler at ml. (1981) hava reported that tha 
arrival of M at tha membrane decreases the lateral mobility of tha 
already inserted O protain and suggested that formation of tha 
immobile M-O complexes at tha membrane is tha rate-limiting step in 
virion assembly.
As a result of its strong interaction with RNP cores tha N 
protain functions as an endogenous inhibitor of VSV transcription 
(Clinton at ml., 1978a; Carroll and Wagnar, 1979; Da at ml., 1982;
i
Pal at ml., 1985b). Tha electrostatic nature of this association is 
suggastad by its preservation after detergent-disruption of virions
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In low ionic strength buffers and the fact that the transcription- 
inhibitory activity of M can be reversed in vitro by polyanionic 
cosqpounds or by high ionic strength buffers (tfilson and Lenard, 1981; 
De et ml., 1982; Pinney and Emerson, 1982b). Inhibition of 
transcription by the M protein seems to occur at the level of RNA 
chain elongation, presumably to allow preparation of transcribing RNP 
templates for subsequent packaging (Pinney and Emerson, 1982b). This 
activity appears to be important in regulation of transcription in 
vivo, since ts M-protein mutants exhibit the phenomenon of 
hypertranscription at the restrictive temperature (Clinton et ml., 
1978a; Martinet et ml., 1979). Sequencing of the M gene of the ts 
mutants and ts+ revertants and site-directed mutagenesis of wt- and 
ts mutant-M clones have shown that transcription-inhibition is not 
itself a ts function (Morita et ml., 1987; Li et ml., 1988). The 
unusually high rate of reversion of the tsM mutants, due to many 
intragenic pseudoreversions, suggested that the protein functions in 
a highly folded conformation, with most of its residues participating 
in formation of its functional state (Gopalakrishna and Lenard, 1985; 
Morita et ml., 1987; Pringle, 1987b). Characterisation of the 
epitopes of anti-M MAbs and studies with synthetic M-oligopeptides 
have suggested that the trypsin-resistant C-terminal portion of the 
protein is responsible for the interaction with the lipid bilayer, 
whereas the transcription-inhibitory activity, could be located - at 
least partially - in the highly basic N-terminal domain (Pal et ml., 
1985a,b; Ogden et ml., 1986; Shipley et ml., 1988).
The M protein is found phosphorylated in vivo, however to a 
minor degree relative to that of the NS protein (Meyer and Summers, • 
1974; Clinton et ml., 1978b). Virions also contain protein kinase 
activities which lead to further phosphorylation of M protein in
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vitro (Clinton ot al., 1979; Witt and Summers, 1980). Recently it 
has been reported that the majority of virion M protein is not 
phoephorylated and that the virion-associated M-kinase is highly 
specific for the X protein in vitro, phosphorylâting one or more of 
three serine residues within the M-terminal domain (Beckes et al., 
1989). The importance of this modification in a minority of M 
molecules is currently unknown. Witt et al. (1981) have suggested 
that M protein phosphorylation might bm a requirement of the virus 
uncoating process at the start of infection.
W A V i -M.
The G protein of VSV ie an integral membrane glycoprotein which 
forme the characteristic virion spikes and is also responsible for 
virus adsorption onto host cells. Synthesis of the 511 amino acid- 
long polypeptide backbone of the G ie carried out on membrane-bound 
polysomes and insertion into microsomal membranes, via an amino­
terminal signal peptide, begins when approximately 80 residues have 
been synthesised. The nascent polypeptide chain is then extruded 
into the lumen of the RXR, where it is coordinately glycosylated in 
two distinct steps (Rothman and Lodish, 1977; Rothman et al., 1978; 
Kats and Lodish, 1979). The growing polypeptide ie finally anchored 
in the BR membrane via a 20 amino acid-long hydrophobic region which 
serves as a 'stop-transfer* signal, leaving the carboxy-terminal 29 
amino acids exposed to the cytoplasmic side of the membrane (Knipe et 
al., 1977c; Chatis and Morrison, 1979; Rose and Gallione, 1981). The 
glycopolypeptide is then transferred to the Golgi apparatus and 
finally to the plasma membrane, with the carbohydrate-containing 
portion oriented extracellularly (Rothman et al., 1978; Kats and
Lodiah, 1979). Intracellular transport of tha G protain la beliavad 
to occur via clathrin-coated vasiclas in two succassiva stages 
(Rothman and Fine, 1980). Tha protein seams to be randomly 
distributed in tha plana of tha plasma membrane until tha time of 
virus budding, whan its lateral mobility is decreased by interaction 
with tha matrix protein (Raidlar at ml., 1981; Jacobs and Penhoet,
1982).
Shortly before the protein leaves the SR it is acylated by 
addition of one molecule of palmitic acid, probably by esterification 
of the single cysteine residue within the first 14 amino acids of the 
cytoplasmic domain (Rose et al., 1984). This modification does not 
appear to be a universal requirement for transport, since it is 
absent from the G protein of VSV New Jersey serotype and elimination 
of the esterification site does not prevent cell surface expression 
of the protein. Fatty acylation may affect the long-term stability 
of G in the membrane or might play a role in virus budding (Rose at 
ml., 1984; reviewed by Pal and Nagner, 1987 and Rose and Dorns, 1988). 
A soluble form of the G protein (Ga) has been identified in the 
culture medium of VSV-infected cells, which was lacking the 
cytoplasmic and transmambrane domains (Irving and Gosh, 1982).
Studies with a ts G-protein mutant (ts 045) demonstrated the presence 
of Gs also intracellularly and suggested that this form might be 
generated by proteolytic cleavage in the RRR (Chen and Huang, 1986).
The importance of N-linked glycosylation for proper transport 
was indicated in early studies with tunicamycin, where a differential 
requirasient for carbohydrate was observed in two different wild-type 
strains of the Indiana serotype (Leavitt at ml., 1977; Gibson at ml., 
1979). Analysis of ts G-protein mutants and revertants suggested 
that the protein sequence itself determined the extent of
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carbohydrate requirement for intracellular transport (Chatia and 
Morrison, 1981; Kotwal at ml., 1986). Examination of tha G amino 
acid sequences of the two wild-type strains led to the hypothesis 
that the hydrophilic oligosaccharides play an indirect role in 
transport by maintaining the proper folding state of the protein 
(Gallione and Rose, 1985). This hypothesis has been confirmed by 
studies on the efficiency of transport of site-directed mutant G 
proteins, which had amino acid substitutions near or at the normal 
glycosylation sites or new glycoaylation sites introduced in place of 
the normal ones (Machamer at ml., 1985; Machamer and Rose, 1988a,b; 
Pitta at ml., 1989).
The cytoplasmic C-terminal domain has been suggested as an 
important signal for rapid and efficient transport of the G protein 
from the RR (Rose and Bergmann, 1983). This domain is highly basic 
and shows conservation of charge distribution between the two VSV 
serotypes (Gallione and Rose, 1983). The hydrophobic transmambrane 
domain is among the least conserved regions of the protein, however 
its length appears to be critical for proper cell surface transport 
(Adams and Ross, 1985). In addition, it has been suggested that 
formation of G protein trimers might be a prerequisite for maturation 
of the G from the RER (Krais and Lodish, 1986). Non-covalently 
associated trimers are formed in the ER from newly synthesised G 
monomers with a t*j of approximately 6 -8 minutes after synthesis (Doms 
at ml., 1987). Characterisation of this process using deletion 
mutants of the G protein has shown that trimer formation is largely 
dependent on correct folding of the G ectodomain but, while it might 
be required for transport, the intact cytoplasmic domain is also 
necessary to fulfil independent structural requirements, perhaps by 
inducing clustering of the protein at sites of transport vesicle
formation (Puddington at ai., 1986) Dona at al., 1988; Criaa at al., 
1989).
1A.S «■ tioniM
Tha L (large) protain ia prasumad to ba tha catalytic aubunit 
of tha viral polymaraaa complex. Tha low abundance of L protain in 
viral RNP coraa (50 molaculaa par genome; Thomaa et al., 1985) 
implies ita catalytic function. Tha L protein appaara to poaaeaa tha 
nuclaotida polymerisation activity of tha polymaraaa complex, ainca 
it can initiate RUA chaina, but addition of tha NS aubunit ia 
required for tranacript elongation (Da and Banerjee, 1984). Tha 
requirement for L and NS proteins, for optimal transcription in 
vitro, ia catalytic and stoichiooietric, respectively (Da and 
Banerjee, 1985). Indeed the ratio of the two subunita in the complex 
appears to be critical for efficient RNA synthesis in vivo, since 
over-production of either protein in vivo (from recombinant 
expression vectors) has adverse effects on VSV replication and 
complementation of their respective ts mutants (Schubert at al.,
1985; Gill at al., 1986).
Tha large sisa of the L protein (241 ADa; Schubert at al.,
1984) suggests that L is a multifunctional protein, possessing the 
enzymatic activities of capping, méthylation and polyadenylation of 
VSV transcripts, a view supported by functional analyses of ts L- 
protein mutants and of host range (hr) mutants (Horikami and Noyer, 
1982; Horikami at al., 1984; Hunt at al., 1984, 1988; Harcyk at al., 
1988). The intragenic complementation between ts L-protein mutants • 
of the New Jersey serotype is probably a reflection of the
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multifunctional nature of tha L protein (Bella lele and Emeraon
1982; Ongradi at a1., 1985).
The L genes of the two VSV serotypes exhibit only 65% 
nucleotide homology but overall functional similarity. Six regions 
of strong amino acid identity (85-96%) are observed (Feldhaus and 
Lesnaw, 1988), two of which are also conserved in the more distantly 
related paramyxoviruses NDV and Sendai virus (Galinski at ml., 1988; 
see also page 46). An evolutionary relationship between the two 
families was also suggested by comparison of their G(HN)-L intergenic 
regions.
The L protein has been shown to possess the virion-associated 
protein kinase activity which specifically phoephorylates serine 
residues within domain II of the NS protein in vitro (SAnchez et ml., 
1985; Chattopadhay and Banerjee, 1987a). A recent search for 
sequence similarities between rhabdoviral L proteins and known or 
putative protein kinases has identified two blocks of L sequence 
which show distant, but statistically important, homology to the 
catalytic domain of two different subfamilies of tyrosine kinases 
(McClure and Perrault, 1989). The two L regions exhibit less 
similarity between them than with the corresponding kinase subfamily, 
so it appears that the L protein possessee two protein kinase-like 
domains. Interestingly, both subfamilies (PDGFR and Abl) bear the 
closest sequence similarity of all tyrosine kinases to the Ser/Thr 
specificity class. The evolutionary significance of these 
observations and the correlation with the serine-kinase activity of 
the L protein have yet to be defined.
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ua yty —  amsumai
An Important aspect of the mode of VSV transcription is the 
phenomenon of sequential synthesis of the five mRNAs which was first 
established, together with the VSV gene order, by UV transcriptional 
mapping studies (Abraham and Banerjee, 1976; Ball and White, 1976).
The UV target size of any individual gene was found to be independent 
of its physical sise but very close to the sum of the target sires of 
the preceding genes on the genome. Since the order of UV-sensitivity 
reflected the order of the genes within a single transcriptional 
unit, the sequential VSV mRNA synthesis corresponds to the gene order 
of VSV (Fig. 1). A similar polar affect was seen in the molar yields 
of individual mRMAs, suggestive of a discontinuous mode of 
transcription (Villareal at ml., 1976). The non-equimolar mRNA 
synthesis was shown to be caused by a significant pause (attenuation) 
of the polymerase complex at each intergenic junction, such that the 
molar abundance of each mRNA is regulated by the location of its gene 
on the genomic map (Iverson and Rose, 1981). Since the viral mRNAs 
are translated with similar efficiencies, attenuation of sequential 
transcription results in a corresponding gradient of viral protein 
accumulation and has been suggested to be the principal means by 
which the virus regulates protein synthesis during its growth cycle 
(Banerjee, 1987a).
Reconstituted in vitro VSV transcription is tightly coupled to 
capping, methylation and polyadenylation of the nascent RNA species. 
The mechanism of cap formation differs from that of the host cell in • 
that both the a- and ^-phosphates of the blocking OTP are retained in 
the triphosphate S'-5' linkage (Banerjse, 1980). Two distinct
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MthyltranifuiM activities exist in vitro in purified VSV viriona 
which give rise to a dimethylated cap : 7mGpppAmp (Testa and 
Banerjee, 1977). The capping reaction seems to occur after 
initiation of mRNA synthesis and it has been suggested that a minimum 
sise limit must be attained before capping takes place (Chanda and 
Baner jee, 1981; Schubert at al., 1982). The in vitro synthesised 
mRNAs contain approximately 200 A residues at their 3' end, of which 
only 7 appear to be specified by U residues in the genomic template, 
indicating that reiterative copying ("chattering”) of this (U)7  
stretch - which is conserved at all gene termini - is the likeliest 
mechanism for poly(A) addition (Rose, 1980; Schubert et al., 1980). 
Identification of polycistronic transcripts covalently linked by long 
poly(A) tracts has confirmed that polyadenylation is a 
transcriptional event, in contrast to the post-transcriptional 
polyadenylation of cellular mRNAs (Herman et al., 1978; Emerson and 
Schubert, 1987a). The tight association between the in vitro 
transcription and RNA modification reactions, the inability of 
exogenous RNAs to act as substrates for these modifications, the 
interdependence of methylation and polyadenylation, and the unique 
cap structure of VSV mRMAs collectively suggest that the viral 
polymerase cosiplex carries out these functions (see also Section 
1A.5).
Two models have been proposed for VSV transcription. The 
earlier model of precursor RNA cleavage, originally suggested by 
Colonno and Banerjee (1976), is currently thought unlikely since no 
evidence of processing has been obtained in vitro. The second model 
proposed that the polymerase initiates transcription at the 3* end of , 
the genome but stops at each intergenic boundary and that re­
initiation is required for transcription of the downstream genes
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(Banarjaa at al., 1977). Thla "stop-etart" modal haa baan aupported
by numerous subsequent studles (ravlawad by Banarjaa, 1987b; Bmarson,
1987) but, at praaant, thara ara two variationa concarning tha alta 
of polymaraaa antry. Tha flrst auggaata that thara la a aingla 
promotar (polymaraaa antry alta) at tha extreoie 3' and of tha ganocna 
and that tha polymaraaa molaculaa can raach lntarnal Inltlatlon altaa 
only aftar tha tranacrlptlon of tha upatraam ganan, and ao aaquantlal 
aynthaala la obllgatory (Bmeraon, 1982). Tha aacond varlatlon 
auggaata that thara ara alao lntarnal promotar altaa at aach gana- 
atart whara lndapandant, almultanaoua lnltlatlona occur but 
alongatlon and complatlon of tha lnltlatad apaclaa dapand on tha 
prior tranacrlptlon of tha 3'-proxlmal ganas (Testa at al., 1980a). 
Internally lnltlatad gene-speclflc ollgonuclaotldea have baan 
detectad in vi tro, but lt has not baan posslble to chasa thaaa 
transcripta lnto matura RKAs (Chanda and Banarjaa, 1981; Laxsarlnl at 
al., 1982; Plnney and Bmarson, 1982a). A hypothesls raconclllng tha 
two confllctlng variationa of tha modal has racantly baan proponed In 
whlch tha catalytlc aubunlt of tha polymaraaa (I. protaln) la alao 
located at lntarnal promotar altas on tha viral ganóme (múltipla 
antry) followed by prafarantlal antry of tha structural aubunlt NS at 
tha 3' and and Inltlatlon of leader RNA aynthaala (Banarjaa, 1987b). 
Accordlng to thla hypothesls aaquantlal mRNA aynthaala would be dua 
to incraaslng requlrement for NS protaln ln ordar for tha polymaraaa 
to transcribe 3'-dlstal ganas and tha observad attanuatlon would 
reflact tha tima requlred for accumulatlon of aufflclent NS protaln 
at aach gana junctlon (Banarjaa, 1987a).
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1A.7 V8V OKNOMB REPLICATION
Unlike the transcription phase in the VSV growth cycle, the 
replication phase has not been studied as extensively. However, the 
recent developoient of in vitro replication systems (reviewed by Hertz 
et ml., 1987a) has enabled the analysis of the roles and requirements 
of viral proteins in the replication process. The absolute 
requirement for N protein and the auxiliary role of the NS protein 
during replication have been discussed in Section 1A.1.
According to the replication model proposed by Blumberg et ml. 
(1981, 1983), binding of N protein to the nucleocapsid (NC) assembly 
site on the nascent leader RNA suppresses termination downstream of 
the leader, promoting readthrough at'the leader-N gene junction. 
Similar antitermination at the other downstream intergenic regions 
would result in synthesis of a full-length, positive-strand RNP 
(antigenome). The MC assembly signal is thought to be a five times 
repeated A residue in every third position within a S'-proximal 
leader region of 18 nucleotides, whose complement is highly 
homologous at the 3* ends of genomes and antigenomes (Oiorgi et ml., 
1983a). This region also contains an invariant hexamer (3'-UUUGGU- 
5') which may be involved in the initiation of RNA synthesis due to 
its proximity to the putative polymerase binding site (see Sections 
1A.1 and 1A.2). The duplication of this hexamer at the 3' end of the 
antigenome, but not the genome, has been considered as an explanation 
for the observed enhanced rate of minus-strand leader synthesis 
(Leppert and Kolakofsky, 1980) and the preponderance of negative- 
strand RNPs at late times in infection (Simonson et ml., 1979). In 
contrast, the (♦) and (-) leader termination sequences are relatively
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Im i  homologous, perhaps reflecting the flexibility of the polymerase 
to ignore stop signals during replication (Keene at ml., 1980; Oiorgi 
et ml., 1983a).
In fact, readthrough transcripts, or full-length antigenomes, 
can be synthesised under certain conditions in vitro in the absence 
of concurrent protein synthesis (Testa et ml., 1980b; Herman and 
Lassarini, 1981). These data, by implying that changes in the 
template-associated proteins may regulate the transition from 
specific termination to readthrough synthesis, are consistent with 
the properties of the polR class of mutants. These mutants 
efficiently readthrough the leader termination sequence under 
standard conditions of in vitro transcription, without concurrent 
leader assembly (Perrault et ml., 1983). This "replication-like” 
phenotype is due to an alteration of the template-bound N protein, 
caused by a single amino acid substitution (Helfman and Perrault,
1988). Characterisation of the polR mutants has led Perrault et ml. 
(1983, 1984) to propose a replication model in which preexisting 
assesibled RNP templates (and not assembly on nascent leaders) 
determine whether readthrough of the leader termination site will 
occur. According to this model, wild type virus packages RNPs whose 
structure will lead to transcription upon uncoating whereas the 
switch from this "transcription RHP" to "replication RNP" might be 
achieved by modification of a few H-protein subunits at selected 
sites along the genome, presumably those sequences which act as stop 
signals; subsequent packaging would be carried out on the growing 
readthrough RNA transcript. The NS protein - and possibly host cell 
factors, known to be involved in VSV replication - .-have been 
suggested as candidates for the putative N modifying function.
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IB. THB PARAMYXOVIRUSES
The family Pmrmnyxoviridmm consists of antigenically 
heterogenous, snvslopsd negative strand RHA viruses, primarily 
asaociatsd with rsspiratory disease in mammals and birds (Table 1). 
The family is subdivided into three genera on the basis of the 
properties of their attachment proteinst i) P mr mmyxov iru • (HN 
protein), ii) Morbillivirum (H protein), iii) Pneumovirus (G 
protein). All three proteins are class II integral membrane 
glycoproteina, but the morbillivirua H protein is only a 
haemagglutinin and lacks the neuraminidase activity of the 
paramyxovirus HN protein (see below), while the pneumovirus G protein 
may possess neither activity. The genome organisation of the first 
two genera is similar whereas that of Pnmumovirum is considerably 
different, mainly in the existence of additional genea (Fig. 1). On 
the basis of immunological relationships Sendai virus is more closely 
related to HPIV-3 and mumps (Orvell at ml., 1986) and SV5 is 
similarly related to HPIV-2 (Goswami and Russell, 1982). Norrby et 
ml. (1985) have suggested that rinderpest virus is the common 
ancestor of the two other morbilliviruses, measles virus and CDV.
The sequence homologies between functionally analogous paramyxovirus 
proteins and their implications for the evolutionary relationships 
between the three genera, and with the rhabdoviruses, are discussed 
in Section IB.4.
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IB. M B
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may poaeeea neither activity. The genosie organisation of the firat 
two genera ia aimilar whereaa that of Pnauaovi.ru* ia conaiderably 
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between the three genera, and with the rhabdoviruses, are discussed 
in Section IB.4.
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Tabi» 1 Paramvxoviridae i t— !»'■■■ hosts and disease potential,
(adapted from Pringle, 1987a).
Serotype Primary hoat (virus) Associated disease
i) Genus Paramyxovirus
Parainfluenza type 1 Man URTI*
Mouse (Sendai) Inapparent, 
latent in mice
Parainfluenza type 2 Man URTX
Monkey (SVS) URTI
Dog (SV5) URTI
Parainfluenza type 3 Man URTI, laryngitis.
(HPIV-3) bronchiolitis and 
pneumonia in children
Mumps virus Man Parotitis
Avian parainfluenza- Chicken Inapparent to lethal
virus type 1 (MOV*) neurotropic
ii) Genus Morbillivirua
Measles virus Man URTI, rash, otitis 
media, rarely 
(1/1,000,000) SSPE
Canins distemper 
virus (CDV)
Dog URTI, skin eruptions, 
old dog encephalitis
Phocine distemper 
virus
Seals URTI
Rinderpest virus Cattle, Sheep, 
Goats, Pigs
Mucosal lesion,
diarrhoea,
bronchopneumonia
Peste des petits
ruminants
Sheep, Goats Mucosal disease, 
diarrhoea
iii) Genus Pneumovirus
Respiratory
syncytial virus 
(RS virus)
Man
Cattle, Sheep, 
Goats
URTI, bronchiolitis 
and pneumonia in 
infants, otitis media 
URTI, pneumonia, 
bronchiolitis in 
calves
Murine pneumonia Mouse, Syrian Inapparent, latent
virus (PVM) Hamster, 
Cotton Rats
in mice
TRTV° Turkeys URTI
----w------------------- 1---
*URTI I Upper Respiratory Tract Illness 
*HDV I Newcastle Disease Virus 
CTRTV t Turkey Rhinotracheitis Virus
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The nucleocapid (NP) protein of paramyxoviruses aervaa to 
•neapsidata genomic RNA and to confer helical symmetry to the 
nucleocapsid core. Tightly sneapsidatsd ganoma RNA is not accessible 
to RNass digestion and is sufficiently flexible to undergo salt- 
dependent reversible conformational changes without rendering the RNA 
susceptible to enzymatic degradation (Hsggsness at Ml., 1980, 1981). 
Unlike the VSV (and RS virus) N protein, the NP proteins of Sendai 
virus and HPIV-3 have a net negative charge at neutral pH and are 
also found in two phosphorylated forms which coexist with the non- 
phosphorylated protein (Hsu and Kingsbury, 1982) wechsler at Ml.,
1985; Sineher at Ml., 1986). The NP proteins of NDV (which is 
similarly phosphorylated) and Sendai virus, isolated from virions, 
exhibit electrophoretic heterogeneity duo to intrachain disulphide 
bonding, which may reflect requirements for conformationally distinct 
species of NP during nucleocapsid assembly (Smith and Hightower,
1981). Trypsin digestion of purified Sendai nucleocapsids removes a 
C-terminal fragment from bound NP protein, suggesting that the N- 
terminal region of NP is the part of ths molecule which contacts the 
viral RNA, probably on the ribose-phosphate backbone (Heggsness et 
Ml., 1981; Kolakofsky and Roux, 1987). Consistent with ths RNA- 
binding function, the N-tsrminal region of Sendai and HPIV-3 NP 
proteins has a relatively higher content of basic residues (Morgan et 
Ml., 1984; Jambou et Ml., 1986). In contrast, the trypsin-sensitive, 
hydrophilic C-tsrminal domain is mainly acidic and,also contains ths , 
majority of the phosphorylated residues (Hsu and Kingsbury, 1982). 
Morgan et Ml. (1984) have suggested that the overall
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electronegativity of this region may enable HP molecules to interact 
electrostatically with baeic M protein and mediate attachment of 
nucleocapsida to the viral envelope. The exposure of the NP 
carboxyterminus on the surface of the nucleocapeid is further 
indicated by its highly immunogenic nature (Oill et ml., 1988).
The matrix (M) proteins of paramyxoviruses carry a significant 
net positive charge at neutral pH and have very basic pis, except for 
the K proteins of SV5 and RS virus. The intracellular M protein of 
Sendai virus has been found in a phosphorylated form in nearly 
equimolar amounts to non-phosphorylated M (Lamb and Choppin, 1977), 
whereas phosphorylated M was a minor intracellular form of total M 
protein in HPIV-3 (Weehaler et ml., 1985); no phosphorylation of 
measles M protein has been detected (Nong et ml., 1987) and 
phosphorylated NDV M protein was mainly observed in virions -(Smith 
and Hightower, 1981). The significance of M-phosphorylation is not 
known but its variation among paramyxoviruses would imply that it is 
not a universal functional requirement.
The paramyxovirus M protein is thought to play an important 
role in virus assembly and maturation. In vitro mixing experiments 
showed that Sendai virus glycoproteins associate with nucleocapsids 
only in the presence of M protein (Yoshida et ml., 1976). The 
association of M protein with nucleocapsids has been demonstrated 
under low ionic strength conditions of virus fractionation (McSharry 
et ml., 1975; Shimizu and Ishida, 1975) and by formation of NP-M 
heterodimers upon chemical cross-linking of virions (Markwell and 
Fox, 1980). The H protein of Sendai virus is involved in virus 
budding since a ts M-protein mutant failed to assemble into virions , 
at the restrictive temperature (Yoshida et ml., 1979). Analysis of 
ts M-protein mutants of NDV suggested the existence of a specific M-F
interaction on tha cytoplasmic face of thm membrane (Peeplea and 
Bratt, 1984). In vitro reassembly of purified Sendai M protain 
results in fonsation of sheath-like ordered structures which resemble 
the ordered array of virus particles observed In vivo beneath the 
inner membrane leaflet, suggesting that this highly ordered 
arrangement of M protein siolecules provides specific recognition 
sites for the nucleocapeids (Heggeness at al., 1982). The important 
role of M protein in virus maturation is emphasised by the 
establishment of persistent non-lytic Sendai virua infections under 
conditions of M protein instability (Roux and Waldvogel, 1982) and by 
the characteristic features of the persistent measles virus infection 
of the central nervous system. This type of infection does not 
produce infectious virus and progresaively leads to a rare, fatal 
degenerative disease called subacute sclerosing panencephalitis 
(SSPB). Several studies have correlated a variety of defects in the 
expression, antigenicity or stability of the M protein with 
maintenance of the persistent state of infection in SSPB patients 
(Bacsko et al., 1986; Cattaneo at al., 1986; Sheppard et al., 1986; 
Ogura et al., 1987).
Aa shown in Pig. 1, the genome of the paramyxovirus SV5 
contains an additional gene between the F and HN genes, which encodes 
a small hydrophobic (SH) polypeptide (Hiebert et al., 1985a). The SH 
protein has a C-terminal ectodomain of only 5 amino acids, an 
extensively hydrophobic transmembrane region of 23 residues and a 
cytoplasmic N-terminal domain of 16 amino acids (Hiebert et al.,
1988). The absence of glycosylation sites and of an antigenically 
significant ectodomain suggests that the functional SH domain may be , 
the highly charged N-terminal region, perhaps by participating in 
virion assembly (Hiebert et al., 1988).
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Like the glycoproteins of other enveloped viruses, the
paramyxovirus glycoproteins (F and HN/H/G) form spike-like 
projections on the surface of the virion. They are functionally 
similar to the surface glycoproteins of influenza virus and, on this 
basis, the family was originally classified as myxoviruses. The HN 
protein contains both haemagglutinin (receptor-binding) and 
neuraminidase (receptor-destroying) activities (Scheid et al., 1972; 
Scheid and Choppin, 1974). The association of both activities on a 
single molecule contrasts with the separate existence of these 
activities in two distinct influenza glycoproteins. However the 
paramyxovirus HN proteins share the membrane orientation of the 
influenza neuraminidase (NA) by being anchored in the viral envelope 
near their amino-termini (Blumberg et al., 1985a; Hiebert et al., 
1985b; Elango et al., 1986a; Jorgensen et al., 1987; Waxham et al., 
1988). Since the HN protein mediates virus attachment to sialic 
acid-containing host cell receptors, destruction of theee receptors 
by the neuraminidase might promote efficient viral spread by 
preventing aggregation of progeny virions (Choppin and Scheid, 1980). 
Blumberg et al. (1985a) have proposed that the part of the HN 
molecule responsible for neuraminidase activity shares a common 
ancestor with influenza NA, while Jorgensen et al. (1987) observed 
that the putative sialic acid-binding region in the neuraminidase 
site had a sheet-loop structure similar to that of influenza NA. 
Several observations from ts mutant analysis, immunological and 
chemical studies have euggested that the receptor-binding and 
neuraminidase activities might be located on different sites of the 
molecule (Fortner, 1981; Merz et al., 1981; Smith and Hightower,
1982, 1983; Peeples et al., 1983).
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Penetration of paramyxoviruses into the host cell occurs by
fusion of the viral envelope with the host cell membrane at neutral
pH, a process mediated by the F glycoprotein. The protein is
synthesized as an inactive precursor (F0) which is post-
translationally cleaved by a host trypsin or trypsin-like protease
into two subunits, T1 and F2 , which remain covalently linked by a
single disulphide bond (Scheid and Choppin, 1977). The cleavage
produces a fusion-active F protein and generates a new N-terminus on
the *i subunit, which is very hydrophobic, a characteristic highly
conserved among paramyxoviruses (Hsu at ml., 1981; Hsu and Choppin,
1984; Patterson et ml., 1984; Richardson at ml., 1986; Spriggs et
ml., 1986). These features of the Fj N-terminus have been suggested
to reflect a requirement for fusion activity and have implicated this
region in a direct hydrophobic interaction with the lipid bilayer of
the target membrane (reviewed by Choppin and Scheid, 1980). This
hypothesis has been supported by the inability of Sendai virions
containing uncleaved Fq to fuse with phospholipid vesicles (Hsu et
8
ml., 1983) and by the demonstration that synthetic oligopeptides, 
with similar amino acid sequencss to that of the Fj N-terminus, 
specifically inhibit virus-induced fusion by competition for receptor 
sites on the target membrane (Richardson et ml., 1980; Richardson and 
Choppin, 1983). The ability of the F^ N-termimus to interact 
directly with cell membranes was confirmed by its ability to function 
as a membrane anchorage domain in hybrid proteins (Paterson and Lamb, 
1987). These authors also suggested that the internal position of 
this region in the Fq precursor prsvents its function as a stop- 
transfer signal during translocation in intracsllular membranes. In 
agreement with this notion, enzymatic cleavage of Fq appears to occur
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either in trans-Golgi membranes or soon after its exit from the Golgi 
complex (Morrison et ml., 1985).
Membrane fusion is also an important mechanism for the spread 
of paramyxovirus infection through cell-to-cell fusion. Since 
cleavage of the precursor is mediated by a host cell enzyme, the F 
protein is a major determinant of the host range, tissue tropism and 
pathogenicity of paramyxoviruses (reviewed by Pringle, 1987a). This 
is best illustrated by the protease activation (pa) mutants of Sendai 
virus, isolated by Scheid and Choppin (1976). The F0 protein of 
these mutants can be activated by a range of proteases which do not 
activate wild type Sendai virus, but not all of them retain the wild 
type enzyme specificity and consequently fail to multiply in the wild 
type host tissue. Sequencing of the F mRNA from pa mutants has 
revealed one or two amino acid changes near or at the cleavage site 
which account for the change in specificity (Hsu et ml., 1987).
* H i»J.S AMP EXPRESSION OF THE P/C OEMS
A striking and unusual feature of the P gene of most 
paramyxoviruses is the translation of multiple protein products from 
the corresponding mRNA. The P protein is a nucleocapsid-associated 
phosphoprotein which, similarly to the vsv NS phosphoprotein, 
participates in RNA synthesis (see following section). The 
additional proteins are generally known as C proteins and are 
considered to be non-structural. On the basis of the strategy for 
expression of their non-structural proteins the Pmrmmyxovlridmm can 
be divided into three groups t i) One or more non-structural C 
proteins are encoded by a second, overlapping open reading frame 
(ORF) in the P mRNA in Sendai virus (Giorgi et ml., 1983b; Curran et
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ml., 1986), HPIV—3 (Luk at ml., 1986; Spriggs and Collins, 1986a), 
maaslas virus (Bellini at ml., 1985) and canine distemper virus 
(Barrett et ml., 1985), 11) translation of non-structural, C-like 
proteins occurs by internal initiation in I b u i u  ORF as that used 
for the P protein in Mumps virus (Takeuchi et ml., 1988; Blango et 
ml., 1989) and Newcastle disease virus (McGinnes et ml., 1988), 111) 
non-structural proteins are encoded by separate oenes in RS virus 
(Collins et ml., 1985b; Huang et ml., 1985).
In HPIV-3 and measles virus, where a single C protein has been 
identified, the start of the C ORF is located very close to that of 
the P ORF on the 5* end of the bicistronic mRNA (10-20 nucleotides 
downstream), suggesting that translation of the C ORF is possible due 
to inefficient utilisation of the upstream suboptimal p start codon, 
according to the 'leaky scanning' hypothesis (Bellini et ml., 1985; 
Spriggs and Collins, 1986a).
The overlapping C ORF in Sendai virus has been shown to encode 
at least three proteins in vitro, C, C' and Y (Curran and Kolakofaky, 
1987). All three proteins are also detected in vivo, with the C 
protein being five times more abundant than either the P or C* 
proteins. Using site-directed and deletion mutagenesis of the P/C 
gene, Curran and Kolakofsky (1988a) and Gupta and Patwardhan (1988) 
demonstrated that the initiation codon for the C ORF was upstream of 
the one used for the P ORF and, more surprisingly, that it was an ACG 
instead of the usual ATG. However, this ACG was located in an 
otherwise favourable context for initiation and was thus able to 
function efficiently in translation of the C' protein. The start 
codons for the P, C and Y proteins were identified'further downstream ■ 
in increasingly more favourable contexts for initiation and this 
arrangsment was considered to explain the relative molar abundance of
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these proteins In vivo, on the basis of the scanning model (Kozak, 
1986p;Curran and Kolakofsky, 1988a). Although the scanning model has 
been consistent with the above observations, other data suggest the 
possibility of direct ribosomal binding at internal mRNA sites. 
Alkhatib et ml. (1988) found that the level of measles C protein 
expression was unaffected by the presence or absence of an efficient 
upstream P initiation codon. Similarly, McOinnes et ml. (1988) 
observed translational initiation from internal ATO triplets which 
were in a suboptimal context, despite the presence of the upstream 
optimal start codon for the NDV P protein. Thus it seems that, in
v^
addition to the generally accepted context effects, other features 
might influence the efficiency of initiation, such as the secondary 
structure of the mRNA, as originally suggested by Oupta and Kingsbury 
(1985a) and Shioda et ml. (1986) and recently shorn by Kozak (1989a).
The paramyxovirus SV5 employs a unique strategy for expression 
of the structural P and non-structural V proteins by transcribing two 
mRNAs from the P gene (Thomas at ml., 1988). The two proteins are 
amino-coterminal and are translated from the same 5' -proximal ATO but 
addition of two nontemplated O residues creates the P mRNA, by 
causing a switch from the 0 reading frame to the +1 reading frame at 
a downstream site. Thomas et ml. (1988) suggested that the 
nontemplated residues are added to the P mRNA by reiterative copying 
of four C residues by the viral polymerase, in a manner similar to 
the one proposed for mRNA polyadenylation (see Section 1A.6). This 
was supported by the fact that the sequence preceding the four C 
residues resembled the putative polyadenylation signal of the SV5 
genes.
a
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The function« of tha paramyxoviral non-atructural protaina ara 
aa yat undetermined. Tha C protaina of Sendai virua, HPIV-3 and 
meaalaa virua are strongly baaic, with an eatimated pi of 9-10 
(Spriggs and Collina, 1986a). Tha Sendai and HPIV-3 C proteins share 
a higher degree of homology at their C-terminal regions (58%) which 
are derived from the N-terminal portion of the P mRNA (in the +1 
ORF), where there is lesa homology for the respective P proteins 
(30%; Luk et ml., 1986; Galinski et ml., 1986). In addition, there 
are several positions within the C ORF of meaales virus where a 
single point mutation could generate a stop codon for the C protein, 
without affecting the amino acid sequence of the P protein (Bellini 
et ml., 1985). These data indirectly suggest an important role for 
the C protein, since there appears to be selective pressure for 
maintenance of its expression. Immunofluorescent antibody staining 
of measles virus-infected cells showed that the C and N proteins 
colocalised in perinuclear inclusions, suggesting that the C protein 
might be involved in RNA synthesis (Bellini et ml., 1985). A later 
study of measles virus-infected cells and cells expressing the C 
protein from a recombinant adenovirus vector identified C protein- 
immunofluorescence in bright inclusion bodies, as well as in a more 
diffuse staining pattern, but this intracellular localisation of the 
C protein was found to be unaffected by the presence or absence of 
other viral proteins (Alkhatib et ml., 1988). Similar studies with 
Sendai virus-infected cells revealed that the C and C' proteins had a 
uniform intracellular distribution and were found in both 
nucleocapsid-associated and free cytoplasmic forms, suggesting an 
indirect role in RNA synthesis, possibly in nucleocapsid assembly 
(Portner et ml., 1986). In the same study, failure of anti-C
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antibodiea to inhibit viral transcription was reported, consistent 
with the non-structural status of the C proteins.
An interesting feature of the SV5 V protein is the presence of 
a cysteine-rich domain within its C-terminal region which resembles 
the consensus sequence for a metal-binding domain, generally thought 
to be a regulatory element in protein interactions (Thomas et al., 
1988). These authors also predicted the existence of proteins with a 
similar cysteine-rich region, which could be translated from one (of 
the possible three) reading frame of the P gene in NDV, measles, 
mumps, HPIV—3 and Sendai viruses. Recently, these putative "V" 
proteins have in fact been identified in measlea virus (Cattaneo et 
al., 1989) and Sendai virus (Vidal and Kolakofsky, 1989).
Furthermore, a small protein, called X, has been found in Sendai 
virus-infected cells, which represented the C-terminal 95 amino acids 
of the P protein and was shown to arise from scanning-independent 
internal initiation of translation in the P ORP (Curran et al., 1986; 
Curran and Kolakofsky, 1987, 1988b). Clearly, the paramyxovirus P/C 
gene is a complex genetic unit, whose pattern of expreasion enhances 
the coding potential of their genomes.
»T? Ttm m  ffnnBffu
The gene order of paramyxovirus genosies and their mode of 
transcription ««ere deduced by UV-mapping studies, which showed that 
individual genes ««ere contained in a single transcriptional unit and 
that the respective mRNAs ««ere synthesized sequentially (Glazier et 
al., 1977; Collins et al., 1980). The majority of^paramyxovirus 
genomic sequences are encoded into mRNA and protein (93.6% in Sendai 
virus; Shioda et al., 1986). The remaining sequences (extracistronic
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and intergenic ragions), together with the untranslated 5' and 3' 
terminal mRNA sequences, are thought to contain important signals for 
the polymerase, according to the "stop-start" model of transcription 
(see Section 1A.6).
The intergenic trinucleotide 3'-GAA (similar to the VSV 
intergenic 3'-GA dinucleotide) is conserved in most gene junctions of 
Sendai virus, HPIV-3 and measles virus (Gupta and Kingsbury, 1984; 
Richardson at ml., 1985; Spriggs and Collins, 1986b). It is present 
immediately downstream of the L gene-end sequence in Sendai, measles 
and HDV, suggesting that it may be part of the transcription 
termination signal (Shioda et ml., 1986; Yusoff et ml., 1987; Crowley 
at ml., 1988). The transcription start sequences of Sendai virus 
genes are almost identical to those of HPIV-3 and highly homologous 
to those of NOV, and the mRNAs of all three viruses initiate with an 
A residue, which contributes only its a-phosphate to the cap 
structure (Gupta and Kingsbury, 1984; Ishida et ml., 1986; Spriggs 
and Collins, 1986b; Kolakofsky and Roux, 1987). However, the mRNA 
start signals show minor variations between different genes of the 
same virus which, together with the variations in certain intergenic 
regions (notably the leader-NP junction) might regulate the 
transcription of specific genes by affecting the rate of re­
initiation by the polymerase (Blumberg et ml., 1984; Shioda et ml., 
1986; Millar et ml., 1986). The common terminal sequence 3'- 
AUUCUUUUUG—5 • of Sendai virus genes is thought to be the termination- 
polyadenylation signal, which contains the stretch of U residues that 
is thought to cause "chattering* transcription by the polymerase 
(Gupta and Kingsbury, 1982; Shioda et ml., 1983, 1986). A different 
tetranucleotide precedes the polyadenylation signal in measles virus 
and CDV which, however, is absent from the end of their M genes
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(Rosenblatt et ml., 1985a). In HPIV-3 the 3' termini of the NP and P 
mRNAs are identical to those of Sendai virus, but the 3' end of the M 
mRNA contains an 8-nucleotide insertion precisely before the site of 
poly(A) addition, a fact which is believed to explain the greater 
accumulation of the M-F bicistronic transcript observed in vivo, by 
causing increased readthrough transcription at the M-F junction 
(Spriggs and Collins, 1986b; Sinchez mt ml., 1986; Luk et ml., 1987; 
Spriggs et ml., 1987). The paramyxovirus bicistronic trancripts, 
unlike those of VSV (see Section 1A.6), do not contain intervening 
polyadenylate sequences (Wilde and Morrison, 1984; Gupta and 
Kingsbury, 1985b; Collins et ml., 1986; Wong and Hirano, 1987). 
Bicistronic readthrough RMAs are generally thought to be by-products 
of the sequential mode of transcription, however all NDV bicistronic 
transcripts were found associated with polysomes in vivo, implying 
that they could function as mRNAs (Wilde and Morrison, 1984). 
Expression of cDNA clones of a measles P-M bicistronic transcript in 
COS cells resulted in synthesis only of the P protein (from the 
upstream cistron) but not of the M protein (from the downstream 
cistron), suggesting that such species might partially contribute to 
regulation of expression in vivo (Wong and Hirano, 1987). This would 
be consistent with results obtained from one case of SSPE, where a 
large accumulation of the P-M bicistronic RNA correlated with absence 
of M protein from the infected tissue (Baczko et ml., 1986).
By analogy to the rhabdovirus system, the L and P proteins are 
thought to be the catalytic and structural components of the 
paramyxovirus RNA polymerase. Purified Sendai virions contain 
approximately 30 molecules of L and 300 molecules ef P per genome 
(Lamb et ml., 1976). Hamaguchi et ml. (1983) showed that both L and 
P proteins are required for efficient reconstitution of NDV
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transcription in vitro. Furthermore, ts mutants of NDV with lesions 
in their L or P proteins are defective, to varying extents, in 
primary transcription at the nonpermissive temperature (Samson et 
ai., 1981; Peeples and Bratt, 1982a; Peeples et al., 1982). The X. 
and P proteins were found to colocalize in clusters along Sendai 
intracellular nucleocapsids, presumably reflecting functional 
association of these proteins during RNA synthesis, although there 
were some clusters of P molecules free of L protein (Portner et al., 
1988). The distribution of P protein seems to depend on the 
functional state of the nucleocapsids, since virion nucleocapsids, 
which are transcriptionally inactive, have a uniform distribution of 
P protein (Portner and Murti, 1986). The virion P proteins of Sendai 
virus and NDV exist as monomers, as well as disulphide-linked trimers 
and are found in multiple phosphorylated forms in virions and in 
infected cells (Chambers and Samson, 1980; Markwell and Fox, 1980; 
Smith and Hightower, 1981). Hightower et al. (1984) identified an 
additional phosphorylated form of NDV P protein which was abundant in 
infected cells but absent from virions. The major phosphorylation 
sites of the Sendai P protein have been located to the N-terminal 
region of the molecule, which is exposed at the surface of the 
nucleocapsid and can be enzymatically removed without a concomitant 
effect on viral mRNA synthesis (Chinchar and Portner, 1981a; Hsu and 
Kingsbury, 1982). The C-terminal protease-resistant fragment (SP), 
which remains associated with the nucleocapsid, retains the 
disulphide-linked trimeric structure and apparently contains the 
active P domain(s) involved in mRNA synthesis, since anti-SP MAbs 
inhibit nucleocapsid transcription in vitro (Chinckar and Portner, 
1981b; Deshpande and Portner, 1985). The carboxy-terminus of the 
Sendai P protein has been observed to mediate binding of P to
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nucleocapsids under conditions of in vitro nucleocapsid assembly, 
although formation of disulphide bonds was not necessary to initiate 
binding, suggesting that the trimeric P structure might be 
specifically associated with transcription requirements (Ryan and 
Kingsbury, 1988). This C-terminal P domain appears to be highly 
antigenic (consistent with its hydrophilic nature) and more basic 
than the entire P molecule, consistent with its association with the 
acidic nucleocapsid cores (Chinchar and Portner, 1981b; Desphande and 
Portner, 1985; Ryan and Kingsbury, 1988; Vidal et al., 1988). Thus 
the Sendai virus P protein, like its rhabdovirus counterpart NS 
protein (see Section 1A.2), could be divided into an acidic and 
phosphorylated N—terminal domain, which is not directly involved in 
transcription and a C-terminal, more basic domain, which is required 
for transcription and binding to nucleocapsids.
The VSV replication model, according to which the switch to 
replicative RNA synthesis is modulated by the availability of 
unassembled N protein, appears to be true also for the 
paramyxoviruses. By comparing the in vitro transcription products of 
two Sendai virus strains, Vidal and Kolakofsky (1989) observed a high 
readthrough frequency in one of the strains, similarly to the VSV 
polR mutants. These authors proposed a modified model for both VSV 
and Sendai virus, in which concurrent assembly on nascent leader is 
not only required for readthrough synthesis but also for the 
elongation of the readthrough transcripts. Leader encapsidation 
would permit efficient readthrough throughout the genome, regardless 
of a basal level of readthrough synthesis which occurs in the absence 
of assembly. Vidal and Kolakofsky (1989) also suggested that 
exchange or modification of polymerase subunits and/or template 
components at gene junctions may be involved in the switch, since
1
(
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after the leader-NP junction, two types of polymerases could be 
distinguished : transcriptases, which have reinitiated at this 
junction and replicasea, which readthrough the junction independent 
of assembly. Although the intracellular levels of replication- 
competent NP protein are still considered to be the rate-determining 
step in both viruses, there appear to be differences in the way the 
nucleocapsid protein is maintained in an unassembled form. Baker and 
Moyer (1988) found that purified Sendai NP protein was a soluble 
monomer under the conditions used for in vitro RNA synthesis (whereas 
VSV N would self-assemble) and that it could not alone initiate 
encapsidation. However the Sendai NP protein was not observed to 
form stable complexes with the P phosphoprotein, suggesting that the 
C and C' proteins, which colocalise with nucleocapsids in infected 
cells (see Section 1B.2), might be involved in the initiation of 
nucleocapsid assembly (Baker and Moyer, 1988).
18.4 EVOLCTIOMARY RELATIONSHIPS
Alignment and comparison of amino acid sequences within protein 
families can provide an insight to the functional organisation of 
these proteins, since identification of areas of localised sequence 
homology may signify important structural and/or functional features. 
Additionally, the degree of conservation of functionally significant 
protein domains among different viruses can be used as an estimate of 
their evolutionary relatedness and of their relative distance from a 
hypothetical common ancestor.
The overall identity between the respective aucleocapsid and 
matrix proteins of several paramyxoviruses and VSV is shown in Table 
2. The NP proteins of Sendai virus and HPIV-3 are clearly closely
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Table 2 Relationships of the NP and M proteins of several non-segmented 
negative strand RNA viruses.
Identity (%) Degree of homology (S.D.)a
HPIV-3 NP protein versus*
Sendai virus NP 58.8 59.8
Measles virus NP 21.2 19.7
CDV NP 20.9 9.5
RS virus N 11.5 1.2
VSV N 10.2 -0.7
HPIV-3 M protein versus0
Sendai virus M 61 89
Measles virus M 34 39
CDV M 32 35
RS virus M 10 0.8
VSV M 12 0.5
“ S.O. = standard deviation. Alignments were scored using the matrix of 
Dayhoff according to which scores of 3 S.D. or greater indicate an authentic 
relationship between functionally analogous proteins (Barker and Dayhoff, 
1982).
b The data were taken from Jambou at al. (1986). 
c The comparison was taken from Spriggs et al. (1987)
Table 3. Relationships of the P, HN and F proteins of non-segmented negative 
strand RNA viruses.
Identity (%) Degree of homology (S.D.)a
HPIV-3 P protein versus*
Sendai virus P 24.6 30.3
Measles virus P 15.8 4. S
CDV P 11.5 2.8
RS virus P 12.7 1.4
HPIV-3 HN protein versus*1
Sendai virus HN 45 72.7
SV5 HN 19 20.4
Measles virus H 15.3 4.6
RS virus G 12.3 -0.9
h pi v-3 y p m v l n  vyrgug0
Sendai virus F 41.1 37.5
SV5 F 25.3 15.7
RS virus F 19.2 8.5
VSV G 14.5 1.4
a S.D. » standard deviation; see footnote a of Table 2.
The data were taken from Spriggs and Collins (1986a) 
c The data were taken from Spriggs et al. (1986)
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related and within the NP sequence there are two regiona that show an 
even higher level of identity! the N-terminal domain (70%) and a 
central region of approximately 200 residues (80%; Jambou et ml.,
1986; Sánchez et ml., 1986). In contrast, the C-terminal domain (the 
last 100 amino acids) shows much lower homology (20%), although there 
is overall conservation of its acidic character, consistent with the 
proposed function of this domain in protein interactions during virus 
maturation (see Section 1B.1). The strongly conserved middle region 
is predominantly hydrophobic, suggesting that it may be involved in 
non-covalent interactions with neighbouring NP molecules during 
nucleocapsid assembly (Morgan et ml., 1984; Jambou et ml., 1986).
The same asymmetric pattern of identity is observed between the NP 
proteins of the two morbilliviruses, which share 66% homology in 
their N-terminal regions, 88% in their central domains and only 
little homology in the last 107 residues (Rosenblatt et ml., 1985b).
The close relatedness of Sendai virus and HPIV-3 is also 
evident in the high level of homology shared by their M proteins.
The matrix proteins of the two morbilliviruses are likewise strongly 
conserved (76% identity; Bellini et ml., 1986). Comparison of the 
homology levels for the NP and M proteins (Table 2) and those 
observed for the remaining genes of Sendai virus, HPIV-3, measles 
virus and CDV (Table 3) shows that the M protein is the most highly 
conserved polypeptide among these four paramyxoviruses (Spriggs and 
Collins, 1986a; Galinski et ml., 1987; Spriggs et ml., 1987). This 
is emphasized by the fact that 25% of the amino acid residues are 
identical in all four protein sequences, while the highest 
conservation is observed in the C-terminal third of the protein (Luk ■ 
et ml., 1987). Within this region there is a stretch of hydrophobic 
amino acids, predicted to form a 0-sheet between two flanking a-
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helical regions, which has been suggested as a possible site of 
interaction with the lipid bilayer (Bellini at ml., 1986). This is 
in contrast with the structure of the region of the VSV M protein 
which has been proposed to approach the host cell membrane and which 
does not contain a significantly long hydrophobic domain and appears 
largely devoid of any predicted secondary structure (Ogden et ml.,
1986). Thus, despite the conservation of the strongly basic nature 
of the matrix protein in rhabdo- and paramyxo-viruses, which probably 
reflects the universal requirement for attachment of the acidic 
nucleocapsids to the viral envelope, the regions of the M protein 
which are involved in interactions with the cell membrane and/or with 
adjacent M molecules during virion assembly seem to be different, as 
is additionally suggested by the considerable difference in their 
respective biochemical properties (McCreedy et ml., 1990). The NDV M 
protein is only 17% homologous to the Sendai M protein and shows the 
least homology in the C-terminal region, although there is some 
conservation of glycine and proline residues, as well as good 
conservation of paired basic residues, which are a general 
characteristic of paramyxovirus M proteins (Chambers et ml., 1986; 
McGinnes and Morrison, 1987). In contrast to the high degree of M 
protein homology, the P proteins of Sendai and measles viruses, HPIV- 
3 and CDV show considerable sequence divergence (Table 3). The 
highest homology between the Sendai and HPIV-3 P proteins is observed 
in their C-terminal regions (the nucleocapsid-associated domain, see 
Section IB.3). Despite the low level of sequence homology the 
hydropathic profiles of these two proteins are quite similar, 
reminiscent of the situation observed in the case ef the NS proteins • 
of the two VSV serotypes (Luk et ml., 1986; Galinski et ml., 1986; 
Spriggs and Collins, 1986a). There is a similar level of homology
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(approximately 25%) between the NDV and mumps P proteins, but no 
detectable homology between either of these two and the P proteins of 
Sendai, HPIV-3 or the two morbilliviruses (McGinnes et ml., 1988; 
Elango et ml., 1989). However, the cysteine-rich region of the 
recently identified "V" proteins is more highly conserved between all 
of these paramyxoviruses than their respective P proteins (Thomas et 
ml., 1988; Cattaneo et ml., 1989).
The homologies among the paramyxovirus HN proteins (Table 3) 
are consistent with the pattern of evolutionary relatedness emerging 
from the above mentioned comparisons of other genes. The overall 
identity of the Sendai and HPIV-3 HN proteins is fairly high and 
there are regions of even greater sequence conservation (Elango et 
ml., 1986a). The HN protein of NDV is more closely related to that 
of SV5 (32% identity) and mumps (30.6%) than to the Sendai HN protein 
(23%; Millar et ml., 1986; Waxham et ml., 1988). However, there is 
absolute conservation of 10 cysteine residues in all of these HN 
proteins which indicates a requirement for stabilization of a 
tertiary or quaternary structure, since the Sendai and NDV HN 
proteins are known to exist as disulphide-linked homo-oligomers on 
the cell surface (Markwell and Pox, 1980; Jorgensen et ml., 1987).
Comparison of paramyxovirus F protein sequences (Table 3) shows 
that there is increased relationship between otherwise distantly 
related members of the family. Statistical analysis of sequence 
homologies has indicated that the F proteins of Sendai and RS viruses 
and SV5 are members of a single gene family and likely to have arisen 
from a common ancestor (Kolakofsky et ml., 1987). The most strongly 
conserved region between different paramyxovirus F^proteins is the 
"fusion peptide" at the F^ N-terminus (see Section 1B.1) but there is 
also high conservation of the number and location of cysteine
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residue*, suggestive of conformational similarities (McGinnes and 
Morrison, 1986; Richardson at ml., 1986; Spriggs et ml., 1986).
Apart from the need to maintain the disulphide bridge between the 
and F2 subunits, conservation of Cys residues might be also important 
for fusion activity, as indicated by the existence of epitopes to 
syncytium-inhibiting MAbs within the cysteine-rich region of the F^ 
subunit of Sendai virus (Portner et ml., 1987), measles virus (Hull 
et ml., 1987), HPIV-3 (Coelingh and Tierney, 1989) and NDV (Toyoda et 
ml., 1988; Neyt et ml., 1989). Another important determinant of F 
activity appears to be the sequence preceding the site of Fq 
cleavage, which is responsible for producing the active F^ N- 
terminus. It has been observed that the number of basic residues at 
this site correlates with efficiency of cleavage In vivo s the SV5 Fq 
sequence contains 5 tandem Arg residues and is readily cleaved 
(Paterson ec ml., 1984), the HPIV-3 F0 contains an intervening Thr 
among the basic residues in this site which results in inefficient Fq 
cleavage in certain cell lines (Spriggs et ml., 1986) and Sendai Fq 
contains only a single arginine, leading to absence of cleavage in 
most tissue culture cell types (Hsu and Choppin, 1984).
Comparison of L protein sequences (Table 4) reveals an 
important level of localized homology between different non-segmented 
negative strand RNA viruses. Significantly, the conserved protein 
regions shown in Table 4 follow one another in the same sequence 
order in all four I. proteins compared, suggesting a direct 
evolutionary relationship. The separation of these blocks of 
significant sequence homology by variable regions of low sequence 
conservation suggests the existence of autonomous functional domains 
that have been concatenated to form the multifunctional L protein 
molecule of non-segmented negative strand RNA viruses (Blumberg et
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ml., 1988; Tordo at ml., 1988; Poch at ml., 1990). These peptide* 
are located in the N-terminal half of the protein, whereas the C- 
terminal third of the L sequences is their most variable reqion 
(Galinski et ml., 1988; Feldhaus and Lesnaw, 1988). This asymmetric 
pattern of sequence conservation may denote the presence of RNA 
polymerization and modification activities in the homologous regions 
of the N-terminal portion, while the variable carboxyterminus may be 
involved in interactions with the highly divergent structural subunit 
of the polymerase complex, P (or VSV NS) protein (Yusoff et al.,
1987).
On the basis of the aforementioned homologies the 
paramyxoviruses could be divided into four groups of closely related 
members : a) Sendai virus and HPIV-3, which share strongly conserved 
genomic features and gene products [Kolakofsky and Roux (1987) have 
suggested that Sendai might be the same virus as HPIV-1], b) measles 
virus and CDV, which represent an homologous pair equivalent to the 
Sendai/HPIV-3 pair (however all four viruses show significant 
homology in their genetic maps, intergenic sequences and some gene 
products), c) NDV, SV5 and mumps, which are more distantly related to 
the viruses mentioned above in terms of genomic organization, protein 
sequences and strategy of expression of non-structural polypeptides 
and <#) the pneumoviruses, which appear to be the most distant members 
of the group and where significant homology with the paramyxovirus 
family is found only in the fusion glycoprotein (and in the partial 
alignment of their genomic maps).
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1C. PNEUMOVIRUSES , RS VIRUS
Human respiratory syncytial (RS) virus, first isolated in 1957, 
is ths most important causs of acuta respiratory illness during 
infancy and is associated predominantly with pneumonia and 
bronchiolitis in infants under one year of age (McIntosh and Chanock,
1985). RS virus replicates efficiently in enucleate cells (Follett 
et ml., 1975), does not shut off host cell metabolism (Levine et ml., 
1977) and more than 90% of RS viral infectivity remains cell- 
associated (Peeples and Levine, 1980). RS virus strains can be 
classified into two (or possibly three) distinct subgroups, A and B 
(or Bj and B2 ), on the basis of differences in reactivity with 
monoclonal antibodies to several viral proteins but mainly the G and 
P proteins (Mufson et ml., 1985; Gimenez et ml., 1986; Akerlind et 
ml., 1988). Comparison of subgroup A and B protein sequences has 
shown that the G is the least conserved RS virus protein (Johnson et 
ml., 1987). Comparison of the degree of conservation of protein­
coding sequences with that of intergenic and non-coding genomic 
sequences suggests that the two RS virus subgroups are at an early 
stage of divergent evolution (Johnson and Collins, 1988a, 1989).
1C.1 OBMOME OROAMIIATIOM
The genome of RS virus is a single negative-sense RNA strand of 
approximately 15,000 nucleotides (Huang and Hertz, 1982). It is 
transcribed almost in its entirety in vivo to generate 10 major mRNA 1 
species, each encoding for a single virus-specific protein (Fig. 2).
The polypeptide coding assignments have been made by in vitro
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translation of each mRNA isolated by gel electrophoresis or by 
hybridization-selection with cDNA clones (Huang and Hertz, 1983; 
Venkatesan et ml., 1983; Collins et ml., 1984a). Analysis of the UV- 
transcriptional inactivation kinetics and sequencing of genomic RNA 
and of polycistronic readthrough transcripts have determined the 3' -» 
5' gene order of the RS virus genome and established the colinearity 
of the physical and transcriptional maps, suggesting the presence of 
a single promoter at the 3' end of the genome (Collins and Hertz,
1983; Dickens et ml., 1984; Collins et ml., 1986).
Similarly to other paramyxoviruses, all RS virus genes contain 
terminal sequences which are thought to function as signals during 
sequential transcription. The highly conserved mRNA start signal,
5'-GGGGCAAAU-3*, resembles the Sendai virus mRNA start signal in 
length and sequence, whereas the mRNA end signal differs in length, 
sequence and position from that of Sendai virus (Collins et ml.,
1984b; Collins and Hertz, 1985b). The 3' terminal regions contain 
the important oligo(U) tract (the polyadenylation signal) but the 
number of U residues is variable among RS virus genes (Collins and 
Hertz, 1985a,c; Collins et ml., 1985, 1986). As in other 
paramyxoviruses, the RS virus polycistronic transcripts do not 
contain intervening poly(A) sequences, however RS virus is notable 
for the lack of length and sequence conservation in the intergenic 
regions, a phenomenon which appears to exist only in one other 
paramyxovirus, SV5 (Paterson et ml., 1984; Collins and Hertz,
1985b,c; Collins et ml., 1985, 1986; Hiebert et ml., 1985a). The RS 
virus intergenic sequences range in length from a single nucleotide 
(for the N-P junction) to 52 nucleotides (for the 6-F junction) and 
this variation has been suggested to be a mechanism for obtaining 
differing degrees of transcriptional attenuation (Collins et ml..
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1986). The length of the lntergenic regions is similar between RS
virus strains of the two subgroups and exactly conserved in some 
junctions. However, overall the intergenic sequences, together with 
the noncoding gene sequences, are much less conserved between the 
subgroups compared to the transcriptional signals and the protein­
coding regions (Johnson and Collins, 1988a, 1989).
An interesting and unique situation has been observed at the 
last (22K-L) gene junction. The two genes are not separated by an 
intergenic sequence but, instead, the L-mRNA start signal is located 
within the 3* non-coding region of the 22K mRNA, resulting in an 
overlapping sequence of 68 nucleotides (Collins et el., 1987). The 
presence of the 22K gene-end sequence downstream of the L-mRNA start 
signal appears to function as a site-specific attenuator of L-gene 
transcription and suggests that transcriptional readthrough is the 
only mechanism for synthesis of the full-size L mRNA. The 
possibility of existence of a second promoter upstream of the L gene 
has been considered unlikely in view of the sequence divergence of 
this region between the two subgroups (Johnson and Collins, 1988a). 
The fact that the L-mRNA start signal differs from the RS virus 
consensus sequence by two nucleotides and the almost exact 
conservation of the overlapping 22K-L region between the subgroups 
(Collins et al., 1987) Johnson and Collins, 1988a) implies that the L 
start signal might be able to function independently of adjoining 
gene-end and intergenic regions, albeit less efficiently, in 
producing the least abundant L-mRNA transcript.
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19-f iL m m a a a
The RS virus-specific polypeptides and virion structural 
proteins have been identified by gel electrophoresis of actinomycin 
D-treated infected cells and by imnunoprecipitation with specific 
antisera (Cash et ml., 1979; Dubovi, 1982; Fernie and Gerin, 1982; 
Walsh and Hruska, 1983). Two RS virus polypeptides, IB and 1C, are 
considered to be non-structural (Huang and Wertz, 1983; Huang et ml., 
1985). RS virus is the only paramyxovirus that encodes non- 
structural polypeptides from separate genes, which are furthermore 
placed in a unique position in the 3' -»5* gene order, where they 
precede the N protein-gene in being promoter-proximal (Fig. 1 and 2). 
The length of the promoter-proximal genomic region in RS virus (i.e.
1C, IB, N and P genes) is similar to that of paramyxoviruses (i.e. NP 
and P/C genes), as the RS virus N and P genes are smaller than their 
paramyxovirus counterparts (Satake et ml., 1984; Collins et ml.,
1985) and it has been speculated that the proteins encoded by the 3'- 
proximal genes may have analogous functional domains that have become 
distributed among different numbers of protein products (Collins et 
ml., 1986).
The IB (11 Kd) and 1C (14 Kd) proteins have net charges of +6 
and -1, respectively, at neutral pH and are not detectably modified 
post-translationally (Dubovi, 1982; Collins et ml., 1984a; Blango et 
ml., 1985; Collins and Wertz, 1985b). Their functions are presently 
unknown, although the basic nature of the IB protein suggests that it 
may be involved in RNA interactions (Collins and Wertz, 1985b). The , 
RS virus nucleocapsid protein N (ca 42 Kd) differs from the 
paramyxovirus NP protein - and resembles the VSV N protein - in that
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it la rich in basic amino acids and not found in phosphorylatsd forms 
(Cash et a1., 1979; Elango and Venkatesan, 1983; Collins •£ al.,
1985; Lambert et al., 1988). The N protein is the most highly 
conserved RS virus protein between the two subgroups (96% identity; 
Johnson and Collins, 1989). However, Hard et al. (1984) observed 
antigenic variation in a hydrophilic region of the N protein, which 
is exposed on the surface of intact nucleocapsids.
The P protein is relatively acidic (estimated pi of 5.8) and 
highly phosphorylated (Cash et al., 1979; Satake et al., 1984; 
Lambden, 1985; Lambert et al., 1988). Similarly to the paramyxovirus 
P and VSV NS proteins, it is found associated with nucleocapsids and, 
by analogy to the latter viruses, thought to be involved in genome 
transcription (Runner and Pringle, 1976; Huang et al., 1985). The P 
protein exhibits characteristic apparent mobility and antigenic 
differences between strains of the two subgroups, despite an overall 
90% identity between subgroup A- and B-P protein sequences (Mufson et 
al., 1985; NSrrby et al., 1986a; Gimenez et al., 1986; Morgan et al., 
1987; Akerlind et al., 1988; Johnson and Collins, 1990).
The M and 22K proteins are two non-glycosylated, membrane- 
associated polypeptides (Gruber and Levine, 1983; Huang et al.,
1985). The M protein (ca 27 Kd) is moderately hydrophobic, 
consistent with its association with the lipid bilayer and thought to 
have an analogous maturation function to the paramyxovirus matrix 
protein, although it is considerably less basic (Satake and 
Venkatesan, 1984). The 22K protein has no counterpart among the 
Paramyxoviridae and is the most basic RS virus protein (Dubovi, 1982; 
Huang et al., 1985; Collins and Hertz, 1985c). The protein is 
relatively hydrophilic but contains three moderately hydrophobic 
regions which could be involved in membrane interactions (Collins and
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Wertz, 1985c). The precise function(s) of the 22K protein is 
unknown, however the similarities in its location and properties with 
the paramyxovirus and RS virus matrix proteins suggest that it might 
be involved in virus maturation (Huang et ml., 1985; Klango et ml., 
1985). Routledge et ml. (1987a) observed that a small proportion of 
the 22K protein molecules could be located on the surface of infected 
cells at late stages of infection, whereas the majority remained 
intracellular and co-localised with the N and P proteins, suggesting 
a function of binding to viral nucleocapsids. The 22K protein 
exhibits strain-specific variations in apparent mobility and 
subgroup-specific antigenic differences (Nttrrby et ml., 1986a; Morgan 
et ml., 1987; Routledge et ml., 1987b). The major form of the 
protein (Mr 23-24Kd) migrates faster under non-reducing conditions 
(Mr 20-21Kd) and under the latter conditions a second form of ca 19Kd 
(22Ka) is also observed, which is thought to be a conformational 
variant generated by formation or rearrangement of disulphide bonds 
during sample preparation (Routledge et ml., 1987b; Fig. 3A). When 
infected cells are immediately disrupted in non-reducing SDS-PAGE 
sample buffer the 22Ka band becomes the major form of the 22K protein 
and a second, faster migrating band appears (22Kb; Fig. 3A).
Routledge et ml. (1987b) have suggested that the 22Kb form is an 
artifactual conformational variant (due to disulphide-bond formation 
after denaturation in non-reducing sample buffer) since its 
appearance can be prevented by treatment with iodoacetamide.
However, two minor 22K-specific bands of ca 24Kd and 21Kd can be 
observed in addition to the major 23Kd band under reducing conditions 
(Routledge et ml., 1987b; Fig. 3B), suggesting that different 
conformational 22K forms may exist in infected cells (Routledge et 
ml., 1987a,b).
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Figure 3. Multiple electrophoretic forms of the 22K protein. In part A 
(panel I), BS-C-1 cells were infected with the subtype A/wild-type strains 
RSS-2 (lanes S) and A2 (lanes A), or with the subtype B/wild-type strain 
RSN-2 (lanes N) and labelled with (3 5SJmethionine. Infected-cell lysates 
were immunoprecipitated with polyclonal anti-RS virus serum, samples were 
solubilized in lx SDS-PAGE buffer in the presence or absence of 0- 
mercaptoethanol (reducing and non-reducing, respectively) and analyzed on a 
6-15% linear gradient gel. The major form of the 22K protein migrates with 
an Mr of approximately 23K under reducing conditions, but faster (Mr ca. 
20K) under non-reducing conditions, in agreement with published data 
(Routledge et al., 1987b). In panel II, virus-infected cells were lysed 
with NP40 (in PBS-PMSF solution) on ice and imnediately disrupted in lx 
non-reducing SDS-PAGE buffer, analyzed by 10% SDS-PAGE and transferred onto 
nitrocellulose, followed by staining of the blot with anti-22K MAb 5H5 and 
anti-P MAb 3-5. Part B shows the electrophoretic heterogeneity of the 22K 
protein under reducing conditions. In panel I, virus-infected cells 
(labelled with (3 5S)methionine) were lysed and immunoprecipitated with 
anti-22K MAb C3142, solubilized in lx reducing sample buffer and analyzed 
on a 6-15% linear gradient gel. In panel II, infected-cell lysates were 
immunoprecipitated with anti-22K MAb C3142 or with polyclonal anti-RS virus 
serum, solubilized in 3x reducing sample buffer and analyzed by 10% SDS- 
PAGE (lane UI contains a mock-infected cell extract). After Western 
transfer, the blot was stained with anti-22K MAb 5H5 and anti-P MAb 3-5.
Two minor, 22K-specific bands of ca. 24K and 21K can also be observed, as 
previously described (Routledge et al., 1987b).
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Th« IA protein of RS virua resembles the SH protein of SV5 in 
being a small polypeptide (64 aa), rich in hydrophobic residuea 
(Collins and Wertz, 1985a). It accumulates as four structurally 
distinct species in infected cells, two of which are glycosylated 
(16K, Fig. 4 and 22-35K, Fig. 10) and incorporated into the viral 
membrane, with the carboxyterminus located extracellularly (Olmsted 
and Collins, 1989). The unmodified form of the 1A protein (7.5 Kd) 
is also detected at the cell surface, whereas the fourth species (4.8 
Kd) is intracellular and thought to originate by translational 
initiation at the second AUG codon in the 1A sequence. The 1A 
protein appears to be important for the stimulation of humoral
55a
immunity during RS virus infection since a naturally occurring B-cell 
epitope has been identified in its extracellular (C-terminal) domain 
(Nicholas et al., 1988).
The fusion glycoprotein of RS virus (F) is synthesized as an 
inactive precursor protein (F0), which is cleaved by a host protease 
to yield the two disulphide-linked subunits Fj and (Fig. 4). In 
addition to the strong hydrophobicity of the newly created N-tenninus 
of the Fj subunit ("fusion peptide"), a further similarity with other 
paramyxoviruses is the sequence Phe-X-Gly at the exact F^ 
aminoterminus (Collins et al., 1984b; Elango et al., 1985). The RS 
virus F0 protein, like the SV5 F0 protein, contains a highly 
cleavable activation site (a stretch of basic residues t Lys-Lys-Arg- 
Lys-Arg-Arg) and appears to be cleaved intracellularly, at a late 
Golgi stage or soon after its exit from the Golgi stack (Collins et 
al., 198¿b; Fernie et al., 1985; Gruber and Levine, 1985b; Olmsted 
and Collins, 1989). The F protein is the major neutralization 
antigen of RS virus and most neutralizing MAbs are also fusion- 
inhibiting, emphasizing the importance of cell-to-cell fusion for 
virus spread (Walsh and Hruska, 1983; Walsh et al., 1985, 1986; 
Anderson et al., 1988). Inoculation of susceptible animal hosts with 
vaccinia-RS virus F-gene recombinants was found to stimulate almost 
complete resistance to subsequent RS virus replication in the lower 
respiratory tract (Olmsted et al., 1986; Wertz et al., 1987bl The F 
proteins of the two RS virus subgroups exhibit high degree of 
sequence conservation, although there are strain-specific mobility 
differences (Fig. 4) and some epitopic variation (Mufson et al.,
198S; Nttrrby et al., 1986a; Baybutt and Pringle, 1987; Johnson and 
Collins, 1988b). Two highly conserved neutralization epitopes (which 
appear to be linear) have recently been mapped to the aminoterminal
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The envelope glycoproteins of RS virus. Virus-infected
cells, incubated at 33°C and labelled with [^H]glucosamine, were 
immunoprecipitated with an anti-F MAb (panel A), an anti-G MAb (panel 
B) or with polyclonal anti-RS virus serum (panel C). The previously 
reported (Ndrrby et al., 1986a) subgroup mobility difference in the 
Fj and ?2 subunits between wild-type strains RSS-2 (subgroup A) and 
RSN-2 (subgroup B) is shown in panel A. The G-precursor forms Ga 
(p50) and Gb (p45) are indicated in panel B and the G form 
synthesized in the presence of tunicamycin (GTM), demonstrating the 
extensive O-linked glycosylation of this protein (Satake et al.,
1985; Hertz et al., 1989) is shown in panel C. In the same panel, 
the 16K partially glycosylated 1A protein species (Olmsted and 
Collins, 1989) can be seen as well. Both the F and 1A proteins 
contain tunicamycin-sensitive carbohydrates (i.e. W-linked) and do 
not incorporate [3H]glucosamine in the presence of the drug, hence 
they are absent from the tunicamycin-treated sample (+). The protein 
molecular weight standards (BRL), seen in panel B, are the following 
polypeptides: lysozyme (Mr 14,300), ^-lactoglobulin (Mr 18,400), a- 
chymotrypsinogen (Mr 25,700), ovalbumin (Mr 46,000), bovine serum 
albumin (Mr 68,000), phosphorylase b (Mr 97,000) and myosin H-chain 
(Mr 200,000). [The Mr 's indicated in the figure are expressed in 
kilodaltons].
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Flour« 4. The envelope glycoproteine of RS virus. Virus-infected 
cells, incubated at 33°C and labelled with [3H]glucosamine, were 
immunoprecipitated with an anti-F MAb (panel A), an anti-G MAb (panel 
B) or with polyclonal anti-RS virus serum (panel C). The previously 
reported (NOrrby et al., 1986a) subgroup mobility difference in the 
and ?2 subunits between wild-type strains RSS-2 (subgroup A) and 
RSN-2 (subgroup B) is shown in panel A. The G-precursor forms Ga 
(p50) and Gb (p45) are indicated in panel B and the G form 
synthesized in the presence of tunicamycin (GTM), demonstrating the 
extensive 0-1inked glycosylation of this protein (Satake et al.,
1985; Wertz et al., 1989) is shown in panel C. In the same panel, 
the 16K partially glycosylated 1A protein species (Olmsted and 
Collins, 1989) can be seen as well. Both the F and 1A proteins 
contain tunicamycin-sensitive carbohydrates (i.e. W-linked) and do 
not incorporate [3H]glucosamine in the presence of the drug, hence 
they are absent from the tunicamycin-treated sample (+). The protein 
molecular weight standards (BRL), seen in panel B, are the following 
polypeptides: lysozyme (Mc 14,300), ^-lactoglobulin (Mr 18,400), a- 
chymotrypsinogen (Mr 25,700), ovalbumin (Mr 46,000), bovine serum 
albumin (Mr 68,000), phosphorylase b (Mr 97,000) and myosin H-chain 
(Mr 200,000). (The Mr 's indicated in the figure are expressed in 
kilodaltons].
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third of the subunit, contained between the 'fusion peptide* and 
the cysteine-rich region in the middle of the Fj subunit (Trudel et 
ml., 1987; L6pez et ml., 1990).
The G protein is the attachment glycoprotein of RS virus (Walsh 
et ml., 1984d;Levine et ml., 1987). It does not possess 
haemagglutinin or neuraminidase activities but resembles the 
paramyxovirus HN protein in its membrane orientation, i.e. it has an 
extracellular C-terminus and an N-terminal membrane anchor region 
(Satake et ml., 1985; Wertz et ml., 1985). Two exceptional features 
of the RS virus G protein are i) the existence of O-linked 
oligosaccharides ii) the extensive glycosylation of the polypeptide 
backbone. The fully glycosylated G protein migrates with an Mr of 
84-90K (depending on cell type and virus strain), of which cm 33K can 
be attributed to the polypeptide moiety while the remainder is due to 
carbohydrate addition (Lambert and Pons, 1983; Gruber and Levine, 
1985b; Satake et ml., 1985). The majority of G oligosaccharides is 
found O-linked on Ser and Thr residues (which together account for 
30% of the G protein sequence) and most of these residues are located 
in the C-terminal ectodomain (Wertz et ml., 1985; Lambert, 1988;
Wertz et ml., 1989). The high [Ser + Thr] content is one of the few 
conserved features between the G proteins of the two subgroups, 
whereas the potential W-linked glycosylation sites (which have a 
relatively minor contribution to the size of mature G) are variable 
among strains and the protein sequences show extensive divergence 
(53% identity), especially in the G ectodomain (Johnson et ml., 1987; 
Cristina et ml., 1990). Inhibition of either W— or O-linked 
glycosylation of the A2 strain - G protein has no effect on 
intracellular transport and cell surface expression of the G (Satake 
et ml., 1985; Wertz et ml., 1989). The necessary signals for
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efficient membrane insertion and translocation to the surface appear 
to be mainly contained in the cytoplasmic and transmembrane domains, 
which exhibit 81% and 86% identity, respectively (Vijaya et ml.,
1988; Olmsted et ml., 1989).
Major antigenic differences exist between the subgroup A and B 
G glycoproteins, as well as between those of different strains of 
subgroup B, which is subdivided into groups Bj and Bj on the basis of 
reactivity with certain anti-G MAbs (Mufson et il., 1985; Orvell et 
ml., 1987; Akerlind et ml., 1988). However, monospecific anti-G sera 
show a small degree of cross-subgroup neutralisation (Walsh et ml.,
1987), which has been suggested to correlate with a highly conserved 
cysteine-rich region in the G ectodomain (Johnson et ml., 1987).
As a result of the two types of stepwise glycosylation, 
partially modified intermediate forms of the G can be detected in 
infected cells (Fig. 4). The p4S (Gb) intermediate is thought to 
represent the polypeptide chain with the cotranslationally added N- 
1inked, high-mannose oligosaccharides in the RER (Fernie et ml.,
1985; Gruber and Levine, 1985a,b; Routledge et ml., 1986; Werts et 
ml., 1989). The p50 (Ga) form is also a major precursor and shares 
antigenic sites with the mature G molecule (Routledge et ml., 1986) 
but it is not clear whether this form arises from post-translational 
processing of W-linked side-chains, some of which is known to occur 
in the late ER compartment (Rose and Dorns, 1988), or from further 
modification in the Golgi (Olmsted et ml., 1989; Wertz et ml., 1989). 
In the presence of monensin, a carboxylic ionophore which inhibits 
medial and trans-Golgi functions (Tartakoff, 1983), the G protein 
migrates as a diffuse collection of bands in the Mf range of 46-50K ■
(Gruber and Levine, 1985a; Satake et ml., 1985). In the presence of 
tunicamycin, the G migrates slightly fastsr than the fully
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glycosylated form (Fig. 4), with an Mr of 70-82K (depending on virus 
strain) which correlates with the absence of W-linked - but presence 
of 0 - 1  inked - oligosaccharides (Fernie ef of. ., 1985; Lambert,
1988).
The RS virus 6 protein is the only class II viral glycoprotein 
that has, so far, been reported to exist in a soluble form (Ga). The 
Ge protein is shed into infected-culture fluids before the appearance 
of progeny virions and, like the VSV G8 protein, seems to be 
generated by proteolytic cleavage of the cytoplasmic and 
transmembrane domains (Hendricks at al., 1988). This cleavage 
involves two specific sites in the G protein sequence, resulting in 
the loss of the N-terminal 65 or 74 amino acids, but the cellular 
location and mechanism of Ga production are not known.
1C.3 IMMUNITY. T8 MUTANTS AND VACCINES
The nature of the immune response to RS virus infection is not 
well understood. Neutralizing antibody seems to be only partially 
effective since repeated RS virus infection is a common phenomenon 
and not until the third infection is an appreciable reduction in 
severity of RS virus disease observed (Hall, 1980). Re-infection 
with RS virus may be necessary to elicit substantial immunity since 
there is a pattern of gradually increasing levels of serum antibody 
with successive infections (Stott and Taylor, 1985). Both serum and 
secretory antibodies are produced upon RS virus infection whereas 
cytotoxic T cells appear to be important for virus clearance and 
recovery (McIntosh and Chanock, 1985; Stott and Taylor, 1985). The 
two RS virus subgroups are known to co-circulate within the same 
community (Hendry et ml., 1986; Mufson at ml., 1988) and cross-
59
reactive, RS virua-apecific murine cytotoxic T cells (Tc) have been 
identified, which probably recognize a conaerved internal viral 
antigen, perhaps the N protein (Bangham and Askonas, 1986; Pringle, 
1987a). However, Pemberton at al. (1987) reported that vaccinia-RS 
virus N recombinants induced low levels of N-specific Tc cells in 
mice, while vaccinia-RS virus F recombinants induced much higher 
levels of F-specific Tc cells, which nonetheless appeared to be 
subgroup-specific; thus the target of naturally produced cross- 
reactive Tc cells remains unknown. In the same study, poor Tc cell 
recognition of the G and 1A glycoproteins was observed, consistent 
with the fact that both proteins are important for the introduction 
of humoral immunity (Elango at al., 1986b; Nicholas st al., 1988).
RS virus readily infects infants, despite the presence of maternal 
antibodies. Although passively administered MAbs to certain 
epitopes of the F and G proteins conferred protection to RS virus 
infection in animal hosts (Taylor at al., 1984; Walsh st al., 1984b), 
it was found that passively transferred hyperimmune anti-RS virus 
serum suppressed the antibody response to the two glycoproteins 
(expressed from recombinant vaccinia-RS virus vectors) in cotton rats 
(Murphy at al., 1988). It is possible that the levels and/or the 
nature of maternally derived antibodies determine the degree of 
protection against severe RS virus disease in infants (Stott and 
Taylor, 1985).
Induced temperature-sensitive mutants of RS virus have been 
isolated from the A2 wild-type strain, after treatment with 5- 
fluorouridine and S-fluorouracil, and from the RSN-2 and RSS-2 
strains, after treatment with 5-fluorouracil (Gharpure et al., 1969; ,
Faulkner et al., 1976; McKay et al., 1988). One mutant from the A2 
wild-type (ts A7) was isolated after exposure to EMS
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(ethylmethanesulphonate; Wright at ai., 1973). Tha ta mutants of tha 
A2 and RSN-2 strains have been classified into 8 complementation 
groups (Table 5). Groups B and C ara unique to the A2 strain and 
groups O, E, F and G are represented only by RSN-2 ts mutants (Wright 
at ai., 1973; Gimenez and Pringle, 1978; Pringle at ml., 1981). This 
fact may be due to differences in the inherent mutability of each 
strain and/or the different cell types used for ts mutant isolation.
A small number of complementing heterozygotes, but no recombinants, 
was detected among the progeny of mixed infections with the tsl and 
ts2 mutants of the A2 strain (Wright at ml., 1973). Preliminary 
characterization of representative ts mutants from the 8 
complementation groups - by immunofluorescence and SDS-PAGE (Pringle 
at ml., 1981) - has defined three distinct phenotypic groups (Table
5 ) .
In contrast to the VSV ts mutants, where definitive correlation 
of the complementation groups of both serotypes with specific protein 
defects has been made (reviewed by Pringle, 1987b), the gene 
assignment of paramyxovirus ts mutants is less advanced due to a 
variety of technical problems, mainly concerning the lower 
multiplicities of infection and the resulting difficulty in 
establishing reliable criteria of complementation (Bratt and 
Hightower, 1977; Gimenez and Pringle, 1978). Of the 7 
complementation groups of Sendai virus ts mutants isolated by Portner 
et ml. (1974), 6 had RNA-negative phenotypes at 38°C and one of these 
(group D) appeared to involve a lesion in a nucleocapsid-asaociated 
protein (Portner, 1977), whereas the single RNA-positive mutant 
(group G) was assigned to the HN gene (Portner et ml., 1974; 1975; ■
l
Portner, 1981). Among the 6 complementation groups of ts mutants of 
NDV isolated by Tsipis and Bratt (1976), two had RNA-negative
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Tabla 5. Complementation groups and phenotypic characteristics of 
RS virus ts mutants*
Mutant* Complementation group Phenotype at 39°C
ts N17 B' negative (early
ts N19 E function defect)
ts Aj A amount of surface
ts A7 C antigen reduced
ts Nj D (maturation defect)
ts N6 G generally
ts N20 F impaired
ts A2 B synthesis
* compiled from data of Pringle et ai. (1981).
* The designation N indicates derivation from the RSN-2 (subgroup B) 
strain and designation A from the A2 (subgroup A) strain of RS virus.
Table 6 . Gene assignment of the complementation groups of 
Newcastle disease virus.
Group RNA
phenotype 
at 41.8°C
Assignment Supporting data
A negative L -High frequency of isolation*
-UV-tar get size for complementation* 
-Defective in primary transcription0 
-No rescue by nc mutantad
B, C, BC positive HN Defective in HN functions*
D positive M M mobility difference^
E negative P -UV-target size for complementation* 
-Defective in secondary transcription1 
-Complemented by nc mutants**
A Tsipis and Bratt (1976).
£ Peeples and Bratt (1982a).
£ Peeples et ai. (1982).
d nc « non-cytopathic mutants, deficient in L protein accumulation;
Madansky and Bratt (1981a,b). .
£ Peeples and Bratt (1982b); Peeples et al. (1983).
£ Peeples and Bratt (1984).
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phenotypes at 41.8°C while three RNA-positive groups (B, C and BC) 
have been aasigned to the HN gene (Table 6 ). The low level of 
complementation between the group B and group C mutants of NDV has 
been attributed to intracistronic complementation (Peeples et al.,
1983), which may be due to the dual function of the paramyxovirus HN 
protein and the existence of HN dimers in NDV virions (Smith and 
Hightower, 1981). Prior to the work described in the following 
sections, no assignments had been made for any of the eight 
complementation groups of RS virus. However group B', whose ts 
mutants are isolated with the highest frequency, was tentatively 
assigned to the L gene (C. R. Pringle, personal communication), by 
analogy with VSV (Pringle, 1982) and NDV (Table 6 ).
Two ts mutants of the A2 strain (ts Aj and ts Aj) have been 
tested as potential live vaccines, following the failure of trials 
with a formal in-inactivated (killed) RS virus vaccine and a cold- 
adapted strain (reviewed by Stott and Taylor, 1985). The ts Aj 
mutant did not produce any symptoms when administered intranasally to 
adult volunteers, was genetically stable and induced resistance to 
subsequent challenge with wild-type virus (Wright et al., 1971). 
However, when ts A^ was inoculated into infants and children, a 
proportion of genetically altered (revertant) viruses was recovered 
and some seronegative children developed mild symptoms of disease 
(Kim et al., 1973). These revertants emerged late in infection and 
in most cases represented incomplete reversion to the wild-type 
phenotype (Hodes et al., 1974). In an attempt to produce a more 
defective virus, Richardson et al. (1977) isolated second-stage 
mutant clones, after exposure of ts Aj to nitrosoguanidine (N6 ). No ■ 
revertants ««ere detected in passages of the NG clones but they were 
found to be over-attenuated in vivo (Belshe et al., 1978).
63
Similarly, triala with ta A2 showed that thia mutant waa poorly 
infactioua in both adulta and children when adminiatered intranaaally 
(Wright et al., 1982), thua both ta mutanta were abandoned aa 
possible vaccinea. A more auitable candidate may be a second-stage 
ta mutant (ta IB) of the RSS-2 atrain (which waa derived entirely in 
human diploid cella) which haa recently been teated in adult 
volunteera with promiaing resulta (McKay et al., 1988).
IP. AIMS AMP DEVELOPMENT OF THE PROJECT
The main objective of the present study was to obtain gene 
assignments for as many of the eight complementation groups of RS 
virus as possible. In order to achieve this, identification of the 
ts gene product in each group was performed by immunoprecipitation 
and SPS-PAGE analysis of RS virua-specific polypeptide synthesis in 
cells infected with representative ts mutants and their respective 
ts+ revertants. Investigation of the nature of temperature-sensitive 
defects detected by this procedure was then carried out, by studying 
the synthesis, stability, post-translational processing and 
antigenicity of the ts polypeptides. This allowed correlation of 
structural alterations with particular ts phenotypes, indicative of 
the function(s) of the affected polypeptides during the virus 
replicative cycle. These approaches identified candidate genes for 
sequence analysis and for definition of structure/function 
relationships in RS virus proteins.
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2*. MATERIALS
2A.1 CELL AMD VIRUS CULTURES
BS-C-1 cells and RS virus strains A2, RSS-2 and RSN-2 (wild-type and 
ts mutants) were obtained from Professor C. R. Pringle.
The A2 wild-type and its ts mutants (ts Alf ts A2) were originally 
obtained from Dr. R. Chanock (NIH, Maryland, USA). Wild-types RSN-2 
and RSS—2 were originally isolated in Newcastle and obtained from 
Professor R Gardner (University of Newcastle). Mutants ts N^ and ts 
n19 were isolated from wild-type strain RSN-2 by Faulkner et al. (1976). 
Culture media, trypsin, versene, agar, neutral red, amino acid- and 
antibiotic-solutions, PBS and double-distilled, sterile H20 were 
provided by the Virus group media preparation laboratory.
Crystal violet stain
7.5 gr crystal violet in 500 ml ethanol, diluted 1 in 40 with 
water for use.
E/FCS-2 medium
GMEM 1 litre
FCS 20 ml
Glutamine (200 mM) 20 ml
Antibiotics 2 ml
Olutaraldehvde-fixing solution 
Glutaraldehyde (50%) 4 ml
PBS 200 ml
Overlay agar
2 X  GMEM 100 ml
FCS 2 ml
Antibiotics 1 ml
Noble agar (1.8%) 100 ml
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The agar was melted In a boiling water bath, allowed to cool and 
combined with the supplemented medium. Mixtures were maintained at 
46°C until used.
Overlay agar with neutral red
Prepared by addition of 5 ml of neutral red solution (0.1 % 
w/v) to 200 ml of overlay agar.
Vetsene
0.02% EOTA (disodium salt) and 0.002% phenol red in phosphate 
buffered saline pH 7.4 (PBS; see page 6 8).
Foetal calf serum was obtained from Gibco BRL (Gaithesburg, U.S.A.) 
and tissue-culture plasticware from Northumbria Biologicals 
(Northumberland, U.K.). Crystal violet was from Sigma (St. Louis, 
U.S.A.) and glutaraldehyde from BDH (Poole, U.K.).
2A.2 ANALYSIS OF VIRAL PROTEINS
All chemicals mentioned in this and subsequent sections were obtained 
from BDH (unless otherwise stated) and were of AnalaR grade. 
Radioisotopes for protein labelling, the fluorographic agent
TMAmplify , biotinylated anti-mouse Zg, biotinylated peroxidase- 
streptavidin complex and nitrocellulose (Hybond-C) were purchased 
from Amersham International pic. Staphylococcus aureus V8 protease, 
protein Mr markers and aprotinin «rare obtained from Sigma and R e ­
labelled protein markers from BRL. X-ray films were from Fuji Photo 
Film Co. (Japan) and rabbit reticulocyte lysate translation kits from 
NRN Research Products (Boston, U.S.A.).
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The majority of MAbs used in immunoprécipitations was a kind gift 
from Drs. E. Nôrrby and C. Orvell (Karolinska Institute, Stockholm, 
Sweden). Anti-P MAbs 3-5 and 4-14 were generously provided by 
Dr. B. Gimenez (University of Aberdeen). Anti-22K MAbs ICI3 and 5H5 
were obtained from Dr. G. Toms (University of Newcastle upon Tyne) 
and MAb C3142 from Dr. E. Stott (IAH, Compton Laboratory). Finally, 
polyclonal bovine anti-human anti-RS serum was provided by Drs. Stott
and Taylor (IAH, Compton Laboratory).
Buffer for immunoprécipitation of in vitro translations ÎIVT1
Tris-HCl (pH 7.6) 50 mM
EDTA (pH 8.0) 5 mM
Sodium chloride 0.15 M
NP-40 0.05* (v/v)
In vitro translation premlx 
[3 5S]-méthionine (15 pCi/pl) 4.0 pl •
Potassium acetate (IM) 2 .0  pl
Magnésium acetate (32.5 mM) 0.5 ill
RNasin (14 U/pl) 1 .0  pi
translation cocktail 5.5 pi
Stock solutions of the two salts and the translation cocktail were 
supplied as part of the NEN translation kit. Human placental 
ribonucléase inhibitor (RNasin) was obtained from BRL.
Gel fixing solution (Fixer)
Methanol 50«
Acetic acid 7*
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Methionine-free GMBH
2 * GMEM without Leu, Val, Met, NaHC03 500 ml
Leucine (200 mM) 10 ml
Valine (200 mM) 10 ml
Glutamine (200 mM) 20 ml
Sodium hydrogen carbonate (5% w/v) 20 ml
Antibiotics 5 ml
Distilled water to 1 litre
PhenvlroethvlBulfonvl fluoride (PMSF-1
Working stock solutions of 100 mM PMSF in ethanol were prepared and 
stored at 4°C. When mentioned in conjunction with buffers, PMSF was 
added inmediately before use to a final concentration of 1 mM.
Phosphate buffered saline (PBS. pH 7.4)
Potassium chloride 0 .2  gr
Sodium chloride 8.18 gr
Potassium dihydrogen orthophosphate 0 .2  gr
di-sodium hydrogen orthophosphate 1.15 gr
Distilled H20 
PBS-T
PBS as above containing 0.1% v/v of Tween 20.
1 litre
Poncvau S
One gr of Ponceau S (Sigma) in 1% acetic acid.
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Preparation of Immunoprecipitln (IMP!
Immunoprecipitin (formalin-fixed Staph, aureus A cells, BRL) was 
pelleted at 10,000 g for 2 minutes. The storage buffer was discarded 
and the pellet was resuspended in the buffer used for 
immunoprécipitation of viral polypeptides (IVT or RIP buffer). IMP 
solutions were stored at 4°C.
PIP W flSE
Tris-HCl (pH 7.4) 0.01 M
Sodium chloride 0.15 M
Sodium deoxycholate 1% (w/v)
Triton X-100 1* (v/v)
SDS 0 .1* (w/v)
SDS—PAGE sample buffer (3x concentrate) 
Tris-HCl (pH 6.7) 0.15 M
Glycerol 30* (v/v)
^-mercaptoethanol 15* (v/v)
SDS 6* (w/v)
Bromophenol blue 0.15 mg/ml
SDS—PAGE non-reducing sample buffer 
Tris-HCl (pH 6.7) 0.05 M
Glycerol 10* (v/v)
SDS 2* (w/v)
Bromophenol blue - 0.05 mg/ml •
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SDS-PAGE running buffer
Trizma baa«
Glycine
SDS
Distilled H20
6 gr 
4 gr 
1 gr
to 1 litre
SPS-polvacrvlamide gradient gela
Solution Amounts used in
6% gel 15% gel Stacking gel
Acrylamide-bis (30%)* 4.8 ml 12 ml 5 ml
Tris-HCl (1M, pH 8.9) 9.0 ml 9 ml
Tris-HCl (1M, pH 6.7) 3.75 ml
Distilled H20 9.81 ml 0.36 ml 20.7 ml
Glycerol 2.4 ml
SDS (10%) 0.24 ml 0.24 ml 0.3 ml
Ammonium persulphate (10%) 0.15 ml 0.075 ml 0.25 ml
TEMED 10 /il 10 /il 12 /il
* 28.5% acrylamide-1 .5% bisacrylamide 
SDS-polvacrvlamide/sucrose gels
Solution Amounts used in
resolving gel
Acrylamide-bis (40% A-l.08% B) 12.5 ml
Ax4 buffer (pH 8.9) 12.5 ml
Distilled H20 8.2 ml
Sucrose 25 g
Ammonium persulphate (2%) 1 ml
TIMED 15 /il
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The Ax4 buffer contained l.SM Trie-HCl (pH 8.9) and 0.4« (*r/v) SDS. The
gel solution was vigorously stirred, until the sucrose dissolved, and 
degassed prior to pouring.
SDS-polvacrvlamide single-concentration gala
Solution Amounts used in resolving
10« gel 12.5« gel 15« gel
Acrylamide—bis (30«)* 10 ml 20 ml 24 ml
Distilled H20 13.32 ml 9.32 ml 5.32 ml
Tris-HCl (pH 8.9) 18 ml 18 ml 18 ml
SDS (10«) 0.48 ml 0.48 ml 0.48 ml
Ammonium persulphate (10«) 0 .2  ml 0 .2  ml 0 .2  ml
TEMED 20 fil 20 til 20 fil
* See page 90 for acrylamide:bis ratios 
SDS-polvacrvlamide peptide-mapping 15% qelfl
Solution Amounts used for
Resolving gel Stacking gel
Acrylamide—bie (30«)* 35 ml 2.5 ml
Tris-HCl (IM, pH 8.9) 28 ml
Tris-HCl (IM, pH 6.7) 3.75 ml
Distilled H20 5.6 ml 8.45 ml
SDS (10«) 0.7 ml 0.15 ml
Ammonium persulphate (10«) 0.7 ml 0.15 ml
TEMED 20 fil 6 Ail
* 29.25« acrylamide-0.75« bisacrylamide
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stackina-qel buffer
Tri*-HCl (pH 6.7) 0.125 M
SDS 0.1« (w/v)
TynlcfltnYSlD
Working stocks of 0.5 mg/ml in 50« ethanol were prepared and stored 
at -20°C. Whenever tunicamycin was used in conjunction with protein­
labelling experiments, it was added to B/FCS-2 culture medium to a 
final concentration of 2-3 ¿ig/ml immediately after adsorption of the 
virus inoculum.
Western transfer buffer 
Trisma base 
Glycine 
Methanol 
Distilled H20
Western blot-blocking solution
5 gr of powdered skimmed milk (Marvel; Cadburys) in 100 ml of 
PBS. Diluted to 1« (w/v) with PBS.
Western blot-colour development 
HRP colour development reagent 60 mg
(4-Chloro-1-napthoi)
Methanol 20 ml
The solution was mixed immediately before use with 100 ml of PBS, to 
which 60 /il of hydrogen peroxide had just been added.
1 2 .1 2 gr 
57.6 gr 
800 ml 
to 4 litres
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HRP colour development reagent was obtained from Bio-Rad Laboratories 
(Richmond, U.S.A.), TEMED and PMSF were purchased from Sigma, 
tunicamycin from Boehringer Manheim (West Germany), acrylamide 
(electrophoresis grade) from Fisons (Loughborough, U.K.) and 
bisacrylamide from Kodak Chemicals Ltd (Liverpool, U.K.). Ultrapure 
ammonium persulphate was from Pharmacia (Uppsala, Sweden).
2A.3 RMA HYBRIP11ATIOW
Agarose-formaldehyde gels
agarose (type II medium EEO) 3 gr
RNA running buffer (lOx) (cf. pg. 76) 25 ml
double-distilled H2O 183.3 ml
The solution was boiled to melt the agarose, allowed to cool to 60°C 
and mixed with 41.75 ml of 38% formaldehyde solution prior to 
casting.
Chloroform
Whenever "chloroform'' is mentioned throughout the text it denotes a 
mixture of chloroform-isoamylalcohol at 24 to 1 (v/v).
Deionization of formamide
10 ml of formamide were mixed with 2 gr of a mixed-bed, ion-exchange 
resin (Bio-Rad AG501-X8) and incubated at room temperature, with 
constant agitation, until the pH became neutral. It was then stored 
in small aliquots at -20°C, in tightly capped tubes.
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Denhardt's solution ISOx concentrate»
Bovina serum albumin (Pentax fraction V) 1% (w/v)
Polyvinylpyrrolidone (PVP) 1% (w/v)
Ficoll 1* (w/v)
The solution was filter-sterilized with a disposable Nalgene filter
and stored at -20°c.
Dlthiothreltol (DTT)
Working stock solutions of 1M were prepared by dissolving 0.31 gr of 
DTT in 2 ml of 0.01 M sodium acetate (pH 5.2). Solutions were 
filter-sterilized and stored at -20°C.
BPTft (diapdlvm salt) Qt aplgtion (Na2-gPT*. P» Q.O)
The solution was prepared by dissolving 93.05 gr of the disodium salt 
of EDTA in 400 ml of water. To aid solubilization of this salt, 
approximately 9 gr of NaOH pellets were also added (Maniatis et Ml., 
1982). The solution was finally adjusted to pH 8.0 by addition of 
approximately 0.5 ml of IN NaOH.
rormatntde sample buffer
deionized formamide 0.3 ml
RNA running buffer (lOx) (cf. pg. 76) 0.06 ml
formaldehyde (38%) 0.12 ml
Hybridisation hullMX.
Formamide 50% (v/v)
Denhardt's solution 5x
Standard saline citrate (cf. pg. 76) 3x
denatured salmon sperm DNA 100 pg/ml
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Isotonic Ivi» buffar
Tria-HCl (pH 7.4) 0.05 M
Sodium chloride 0.15 M
NP-40 0.6« (v/v)
Nick tranalatlon buffer (lOx concentrate)
Tris-HCl (pH 7.6) 500 mM
Magnesium chloride 50 mM
Dithiothreitol 10 mM
Phenol equilibration buffer (pH 7.51 
Tria-HCl (pH 7.5)
Sodium chloride 
Na2~EDTA (pH 8.0)
Preparation of phenol 
Redistilled phenol aliquots were removed from 4°C, allowed to warm to 
ambient temperature and melted at 68°C. Once phenol had liquified it 
waa extracted several times with an equal volume of phenol 
equilibration buffer, until the pH of the aqueous phase was higher 
than 7.6. The phenolic phase was stored in an equal volume of phenol 
equilibration buffer, in the dark, at 4°C.
Phenol-chloroform
Phenol prepared as above but also mixed with an equal volume of 
chloroform prior to storage in phenol equilibration buffer.
10 mM 
300 mM 
1 mM
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RNA loading buffer (pH 7.8>
Glycerol 50% (v/v)
RNA running buffer (cf. pg. 76) 50% (v/v)
Bromophenol blue 0.4 % (w/v)
RNA running buffer
HEPES 200 mM (47.7 g/lt)
EDTA 10 mM (3.73 g/lt)
The pH wae adjusted to 7.8 with concentrated NaOH solution. 
Sephadex G50 columns
Sephadex G50 medium (Pharmacia) 10 gr
TE buffer (pH 8.0) (cf. pg. 77) 150 ml
The solution was mixed thoroughly and allowed to stand at room 
temperature overnight. Sephadex G50 columns were prepared in 
disposable 5-ml borosilicate glass pipettes plugged with sterile 
glass wool. Prior to application of samples, the columns were washed 
with several column-volumes of TE (pH 8.0).
Standard saline citrate (SSC)
Sodium chloride 0.15 M
Tri-sodium citrate 0.015 M
Sodium acetate
Working stock solutions of 3M were prepared by dissolving 408.1 gr of 
sodium acetate in 800 ml H2O. The pH was adjusted to 5.2 with 
glacial acetic acid and the volume made to 1 litre with HjO.
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TE buffar pH 7.5 pH 8.0
10 mH Tris-HCl pH 7.5 pH 8.0
1 mM Na2-EDTA pH 8.0 pH 8.0
Agarose, dithiothreitol, salmon sperm DNA, deoxyribonucleotides and 
the reagents for Denhardt's solution were all purchased from Sigma. 
All solutions used with RNA samples were made in double-distilled H20 
and sterilized by autoclaving. Escherichia coli DNA polymerase I and 
[a-3 2P]dCTP were obtained from Amersham and DNase I from Worthington 
Biochemicals.
2A.4 RECOMBINANT DNA TECHNIQUES 
Agarose gel electrophoresis
Agarose gels of various concentrations were prepared by mixing the 
appropriate amount of agarose with the desired volume of TBE running 
buffer. Solutions were boiled until agarose had dissolved and cast 
as described in Maniatis et al. (1982).
Alkallne-SDS solution
Sodium hydroxide 0.2 N
SDS 1« (w/v)
The solution was prepared immediately before use.
77
AmpiciUln
Working stocka of 100 mg/ml ampicillin in distilled H20 were prepared 
filter-sterilized and stored at 4°C. Ampicillin was added to 
bacterial cultures to a final concentration of 100 ¿ig/ml.
Cesium chloride solution
Cesium chloride 26 gr
TE buffer (pH 7.5) 20 ml
The solution was made immediately before use and the entire volume 
was mixed with resuspended DNA pellet from one 500 ml-bacterial 
culture.
Chloramphenicol
Working stocks of 100 mg per ml were prepared in ethanol and kept at 
-20°C until use.
DNA loading buffer 
Glycerol
TBE running buffer (cf. pg. 80)
Bromophenol blue
1 g<?pg9pvim<?-g-qftl»ct9gl<ae (IPIS)
Stock solutions of 100 mM were prepared by dissolving 60 mg IPTG in 
2.5 ml of H20. Solutions were filter-sterilized and stored at 4°C.
50% (v/v) 
50% (v/v) 
0.4% (w/v)
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Ligation buffer
Tris-HCl (pH 7.5) 660 mM
Magnesium chloride 66 mM
Dithiothreitol 100 mM
Lvaozvme buffer
Glucose 50 mM
Tris-HCl (pH 8.0) 25 mM
EDTA 10 mM
oThe solution was autoclaved at 10 lb/in for 15 minutes and stored at
4°C.
L-broth (Lurla-Bertani medium1
Bactotryptone IO gr
Yeast extract 5 gr
Sodium chloride 10 gr
h2o to 1 litre
L-aaar
As above, containing 1.5% bactoagar. The solution was autoclaved and 
allowed to cool to 60°C before addition of ampicillin, IPTG and X-gal 
(see page 80).
Pa£fl»»Um ag«tatq (5M. PH 4t9)
Potassium acetate (5M) 60 ml
Glacial acetic acid 11.5 ml
Distilled H20 28.5 ml
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The resulting solution is 3M with respect to potassium and 5M with 
respect to acetate.
Soerroidine-HCl
Working stock solutions of 100 mM were prepared by dissolving 50.92 
mg of spermidine-HCl in 2 ml double-distilled H2O. Solutions were 
filter-sterilized and stored at -20°C.
TBE running buffer (lOx; pH 8.4)
Trizma base 108 gr
Boric acid 55 gr
Na2-EDTA (0.5M, pH 8.0) 40 ml
Distilled H20 to 1 litre
X-aal (5-broroo-4-chloro-3-indolvl-fl-D-oalactoside 
Working stocks of 20 mg/ml of X-gal were prepared in 
dimethylformamide and stored in the dark at -20°C.
Ampicillin, chloramphenicol, ethidium bromide, gelatin, lysozyme and 
spermidine-HCl were obtained from Sigma. The enzymes T4 DNA ligase, 
pancreatic DNase I (RNase-free) and Klenow polymerase were purchased 
from Amersham while SP6 and T7 RNA polymerases were from BRL. FPLC 
pure T3 RNA polymerase was purchased from Pharmacia. Taq polymerase 
was obtained from Perkin Elmer Cetus (Norwalk, U.S.A.) and AMV 
reverse transcriptase from Life Sciences Inc. (St. Petersburg,
U.S.A.).
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Restriction enzymes, with accompanying reaction buffers, were 
obtained from Amersham and BRL. Calf intestinal alkaline phosphatase 
was from Boehringer Manheim (West Germany) and ultrapure dNTP and 
rNTP solutions (100 mM) from Pharmacia. Gel photographs were taken 
with Polaroid-Type 55 films. Falcon tubes were from Becton- 
Dickinson. Reagents for bacterial culture media were from Difco 
(Detroit, U.S.A.) and Oxoid Ltd. (Basingstoke, U.K.). IPTG and X-gal 
were obtained from Bachem Inc. (California, U.S.A.). The 
transcription vector pGEM-1 was obtained from Promega Biotec. 
(Madison, U.S.A.) and vectors pTZ18/19 from Pharmacia. Bluescribe(+) 
vector was from Vector Cloning Systems (San Diego, U.S.A.). Finally, 
E. coli strain TG2 was provided by Dr. A. Easton and strain G119 by 
Dr. H. Baybutt.
2A.5 DMA SBQUEMCIMO
Extension mix (5x concentrate) 
dCTP, dGTP and dTTP each at 7.5 /jM.
Diluted 1 in 5 with H20 immediately prior to use.
Formamide-dve mix 
Deonized formamide 
EDTA
Bromophenol blue 
Xylene cyanol
95* (v/v)
20 mM
0.05% (w/v) 
0.05% (w/v)
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seguaneIna buffer (5x>
Tria-HCl (pH 7.5) 200 mM
Sodium chloride 250 mM
Magnesium chloride 50 mM
Sequencing gel solution
Acrylamide 5.7 gr
Bisacrylamide 0.3 gr
Urea 48 gr
TBB buffer (lOx) 10 ml
h 2o 35 ml
The solution was made to 100 ml with HjO, once chemicals were 
completely dissolved, and filtered through a type 1 Whatman paper.
Prior to pouring 0.5 ml of 10% (w/v) ammonium persulphate and 50 pi 
of TKMED were added.
Termination dldeoxvnucleotlde-mixes 
At 300 pM ddATP, 25 pM dATP and 
250 pH each of dCTP, dTTP, dGTP
Ct 100 pM ddCTP, 25 pM dCTP and 
250 pM each of dATP, dTTP, dGTP
Gt 150 pM ddGTP, 25 pM dGTP and 
250 pM each of dATP, dTTP, dCTP
Tt 500 pM ddTTP, 25 pM dTTP and , •
250 pM each of dATP, dGTP, dCTP
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a n  myUwB
Bactotryptone 16 gr
Yeast extract 10 gr
Sodium chloride 5 gr
Distilled H20 to 1 litre
T«?p asm
Bactotryptone 10 gr
Sodium chloride 8 gr
Bactoagar 6 gr
Distilled H20 to 1 litre
All sequencing chemicals and Klenow fragment of DNA polymerase I were 
obtained from Pharmacia and were FPLC-pure. Urea was purchased from 
Fisons and [<*35S]-dATP from Amersham. M13-specific primers were 
kindly provided by Mr. J. Barr. M13 vectors mplB and mpl9 were 
obtained from Miss M. Major and Or. P. Cane, respectively. P gene- 
specific primers were prepared by Mrs. G. Scott using an Applied 
Biosystems 380B DNA synthesizer.
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2B. METHODS
2B.1 CELL CULTURE AMD VIRUS PROPAOATIO*
2B.1.1__Cell culture
BS-C-1 cells were grown in 1.5-litre roller bottles in E/FCS-2 medium 
at 37°C and passaged at 3 to 4 day-intervals. Cells were washed with 
20 ml of versene twice and once with 20 ml of trypsin/versene (1 in 
5, v/v). A small amount of the latter was left in the roller bottles 
for further incubation at 37°C, until all cells became detached from 
the glass surface. The cell suspension was then diluted with E/FCS-2 
and one-tenth aliquots were pipetted into new bottles.
2B.1.2 Preparation of virus stocks
Confluent monolayers of BS-C-1 cells in 25cm2-tissue culture flasks 
were inoculated with 0.4 ml virus each (stock titres ranged from 1 x 
105 to 5 x 106 pfu/ml), placed at 33°C for one hour to allow 
adsorption of the inoculum, supplemented with 5 ml of E/FCS-2 and 
incubated at 33°C for two to seven days, until most of the cells were 
involved in fusion events. Wild-type virus was occasionally passaged 
at 37°C. Infected cells were harvested by immediate freezing at 
-70°C.
2B.1.3__Viral infectivitv assay
Ten-fold serial dilutions of virus, in E/FCS-2, were inoculated onto 
duplicate monolayers of BS-C-1 cells in 12-well tissue culture 
clusters. After a one hour-adsorption at 33°C the monolayers were
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covered with overlay agar and incubated at 33°C and 39°C in CO 2“ 
gassed and humidified incubators for S days. The cells were then 
fixed for 4 hours with 1% glutaraldehyde, the overlay agar was 
removed and monolayers were stained with crystal violet for 2-3 
minutes. Excess stain was washed off and darkly stained foci 
("plaques") were counted under a low power microscope.
2B.1.4 Isolation of wild-type and revertant clones
Dilutions 10°, 10_1 and 10~^ of the mutant virus were inoculated onto 
BS-C-2 cells in SO mM Petri dishes (0.2 ml per dish). After 
adsorption at 33°C for one hour the monolayers were covered with 
overlay agar and incubated for 7 days at 39°C. A second overlay 
agar, containing the vital dye neutral red, was then applied, 
followed by incubation at 33°C in the dark, for more than 4 hours.
Ts+ plaques were clearly marked under microscope and material from 
well-separated plaques was collected by a Pasteur pipette and 
aspirated onto BS-C-1 cells in tissue culture flasks. Subsequent to 
adsorption, 5 ml of prewarmed E/FCS-2 were added per flask and 
infected cells were incubated at 39°C until cpe was evident. Virus 
recovered from this passage was tested for temperature resistance by 
plaque assay at 33°C and 39°C. Clones with a yield difference of ten 
fold or less between the two temperatures were considered as 
revertants. This plaque-purification method was also used for 
maintenance of the ts mutants, by their re-selection from ts virus 
stocks when spontaneous revertants had arisen in them during 
consecutive passages at 33°C. Ts virus-infected menolayers in Petri ■ 
dishes were incubated for 5 days at 33°C. After staining and
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microscopic observation, plaque isolates were grown at 33°C and 
assayed for temperature sensitivity at 33° and 39°C.
2B.2 ANALYSIS OF VIRAL PROTEINS
2B.2.la In vivo labelling with f35S1-methionine
BS-C-1 cells were seeded into screw-capped tissue culture tubes
2(which had one side flattened to provide a 5.5 cm surface area for 
monolayer cultivation). Once confluent, replicate monolayers were 
inoculated with virus (m.o.i. approximately 1 pfu/cell). After a 1 
hour adsorption at 33°C the inoculum was removed and infected 
monolayers were supplemented with 6 ml of prewarmed E/FCS-2 and 
incubated at 33°C (humidified incubator) and 39°C (completely 
immersed in a water bath, where the temperature was maintained at 39 
+ 0.2 °C). Viral growth was monitored daily by microscopic 
observation of cultures maintained at 33°C. Prior to development of 
extensive cpe the culture medium was replaced with 6 ml of prewarmed 
GMEM lacking methionine and PCS. After one hour incubation at the 
respective temperatures - to enable depletion of methionine from 
intracellular pools - this medium was discarded and cultures were 
incubated overnight in 0.5 ml of prewarmed methionine - and 7CS-free 
medium which contained 30-40 pCi/ml of (3 5S]-methionine (specific 
activity! > 800 Ci/mmol).
2B.2.lb__In vivo labelling with r3Hl-glucosamine
Labelling of viral glycoproteins with tritiated glucosamine was 
performed as described above in 2B.2.1a with the exception that pre-
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incubation in methionine and FCS-free medium waa omitted and 
monolayers were directly labelled with 0.5 ml of E/FCS-2 containing 
100-150 ¿iCi/ml [3H]-glucosamine (specific activity: 20-40 Ci/mmol) 
for 18 to 20 hours.
2B.2.2__Pulse-chase labelling
Confluent monolayers of BS-C-1 cells in culture tubes were infected 
with virus and maintained in 6 ml E/FCS-2 at 33° and 39°C. When 
viral cpe was extensive, the maintenance medium was replaced with 
methionine-free GMEM, for three hours. The medium was then discarded 
and monolayers were incubated in 0.3 ml of prewarmed methionine-free 
GMEM containing 150 pCi/ml (35S)methionine, at the respective 
temperatures. The length of this "pulse” step was 10 minutes, after 
which the pulse medium was removed and residual label washed off 
twice with ice-cold methionine-free GMEM supplemented with L- 
methionine at an approximate concentration 2 0 0 times larger than 
normal. At this point one culture from each incubation temperature 
was removed onto ice for separate treatment; these served as control 
samples, i.e. as the zero time of chase. The remaining cultures were 
overlaid with 0.5 ml of prewarmed washing medium and incubated 
further at 33°C and 39°C for varying lengths of time.
When [3H]leucine (specific activity: 40-70 Ci/mmol) was used 
for labelling, prelabelling incubation was in GMEM lacking leucine, 
pulse-labelling was for IS minutes and subsequent washes were done in 
leucine-free GMEM supplemented with 50 times the normal concentration
of leucine
2B.2.3__PulSg-ghEP? *hd temperature 9hift-\iP
This method is a pulse-chase experiment which combines the "chase" 
step with a shift-up to the restrictive temperature (whereas prior 
viral growth and pulse-labelling are carried out under permissive 
conditions). Briefly, virus-infected BS-C-1 monolayers were 
incubated at 33°C until most of the cells exhibited viral cpe. The 
culture medium was then replaced with methionine-free GMEM for a 
further 3 hour incubation, after which pulse-labelling with 
[35S]methionine took place at 33°C for 10 minutes. The labelling 
medium was removed and washed off as described in 2B.2.2. At this 
point one culture was removed onto ice (ZERO TIME CONTROL) and 
another was incubated in 0i5 ml of waehing medium (prewarmed at 33°C) 
at 33°C for the entire chase period (FINAL TIME CONTROL). The 
remaining cultures were overlaid with 39°-prewarmed washing medium 
and shifted to a 39°C water bath from which they were subsequently 
removed at predetermined intervals.
2b . 2 .4a__iBHwnqpgreipitatipn qf intracellular yiral prqtqin»
Radiolabelled virus-infected monolayers were scraped into suspension 
with glass beads. Cells were collected as a pellet after a 30 
seconds centrifugation in an Eppendorf microfuge (10,000 g). 
Supernatant culture fluids were kept for separate treatment.
Residual culture medium was washed off by resuspension of the cell 
pellet in 1 ml of ice-cold PBS/PMSF. Cells were collected by a 1 
minute centrifugation and the washing step repeated once more. The 
final cell pellet was resuspended in 100 pi of PBS/PMSF and the cells
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lysed by addition of NP-40 detergent (final amount of 2« (v/v), for 
half an hour on ice. Cellular debris was removed by centrifugation 
for 1 minute. The supernatants were precleared by incubation with 50 
pi of freshly-prepared immunoprecipitin (IMP) and 10 pi of PCS, for 
half an hour on ice. This preclearing step reduces non-specific 
background by removal of the more predominant cellular proteins in 
the lysate. After removal of the staphylococci by centrifugation, 
supernatants were reacted with 4-10 pi of polyclonal anti-RS virus 
antiserum or specific MAbs, for more than 4 hours at +4°C. Samples 
were then incubated with IMP, at an IMPtantibody volume ratio of 10 
to 1, on ice for 30 minutes. Immune complexes were pelleted and 
washed three times with cold washing buffer (0.5 M Licl and 0.1 M 
Tris-Cl pH 8.5). The final pellets were resuspended in SDS-PAGE 
sample buffer and stored at -20°C. Before electrophoresis, samples 
««ere boiled for 2-3 minutes and clarified from the bacteria by a 1 
minute centrifugation.
2B.2.4b__I(npmn<?Preclpitation °t Yiral 9tryctural proteins
Released virus particles in supernatant culture fluids (obtained as 
described in 2B.2.4a) »«ere concentrated by incubation with a one- 
fifth volume of 36 percent PEG-6000 at +4°C overnight. Subsequently 
samples ««ere centrifuged for 15 minutes and dissociation of PEG- 
precipitated viral particles was achieved by resuspension of the 
resulting pellet in 50 pi ice-cold RIP/PMSF on ice for 30 minutes. 
Thereafter samples ««ere treated as described for cell lysates in 
2B.2.4a. ' <
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2B.2.5 Polyacrylamide gel electrophoresis (gPS-pAgg)
The discontinuous system of Laemmli (1970) was used. The resolving 
gel contained either a 6-15% linear polyacrylamide gradient or a 
uniform concentration of 10%, 12.5% or 15% polyacrylamide. Gel 
solutions were prepared as described in MATERIALS (pages 70 and 71) 
using a 30% stock solution of acrylamide/bisacrylamide at a w/w ratio 
of 28.5 to 1.5 for gradient and 10% single concentration gels, 29.25 
to 0.75 for 12.5% gels and 175 to 1 for 15% gels (Collins et ml.,
1984a). For single concentration gels the solution was poured 
directly inside the assembled gel plates (250 x 220 mm with 1.5 mm 
spacers). For gradient gels the two solutions were poured separately 
into a gradient former (BRL) and, as they were being mixed, 
introduced gradually into the assembled gel plates via a peristaltic 
pump (Pharmacia). A 5% stacking gel was applied on top of the 
resolving gel once this had set. Gels were run at a constant current 
of 10-15 mA until the dye front had reached the bottom of the gel.
2B.2.6 Fluorooraphv and autoradiography
Gels were fixed with two changes of fixer for more than 3 hours. 
Fluorography was carried out by gentle shaking of fixed gels in 
Amplify™ for 15-30 minutes. Gels were then dried onto a 3 MM 
Whatman paper under vacuum for one and a half hours (BIO-RAD gel 
drier) and exposed to pre-flashed X-ray film at -70°C.
Autoradiography (used to detect bands for partial proteolysis) was ■ 
performed by drying gels immediately after electrophoresis and 
exposure to non-preflashed film.
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Inclusion of a radiolabelled Mr markers track in each gel
enabled determination of the Mr's of viral polypeptides. A standard
curve was produced by plotting the log10Mr of the markers versus
their respective relative migration (Rf). Application of the Rf of
each viral protein on this curve allowed calculation of its Mr.
Quantitation of protein profiles was performed by laser
densitometer scanning of fluorograms using the Ultrascan XL laser
densitometer (Pharmacia LKB). Densitometric data were analysed by a
TMcompatible software program (Pharmacia Gelscan XL version 2.0). 
Protein peak areas (absorbance units x millimetres) were used as a 
measurement of incorporation of radioactivity into protein bands as 
previously described (Lambert et al., 1988). All the quantitations 
based on data obtained by densitometer scanning of different 
fluorograms were not corrected for length of exposure to X-ray film 
or for the possibility of non-linear correlation between band density 
and length of gel exposure to X-ray film.
2B.2.7__partial Protrelvti«
The procedure of Cleveland et al. (1977) was used. Bands of interest 
were excised from the dried gel using its superimposed autoradiogram 
as indicator of their positions. Gel slices were rehydrated in 
stacking gel buffer for 30 minutes and placed into the wells of a 
second gel which consisted of a 15% single concentration resolving 
gel (A to B of the stock was 29.25 to 0.75) and a 5cm-long stacking 
gel. Bach slice was overlaid with 20 pi of 20 percent (v/v) glycerol 
in stacking gel buffer, on top of which the required amount of S. 
aureus V8 protease was applied in 10 pi of stacking gel buffer 
containing 10 percent glycerol and 0.15 mg bromophenol blue per ml. 
Gels were electrophoresed at 40 mA until the dye front had reached 
two-thirds of the distance of the stacking gel. The power was then 
turned off for 30 minutes to allow enzymatic cleavage to occur.
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Subsequently gels were re-electrophoresed at 15 mA until the dye 
front had reached the bottom.
2B.2.8__western blotting
The electrophoretic transfer of viral proteins onto nitrocellulose 
was performed according to Towbin et al. (1979). Both 
immunoprecipitated and total cell lysates were used. For preparation 
of the latter, infected cells - grown in culture tubes - were scraped 
into 1 ml of cold PBS/PMSF, the cell pellet collected and washed once 
more and finally lysed with 2% NP-40 in PBS/PMSF on ice for 15 
minutes. After removal of cellular debris by centrifugation, 
supernatants were mixed with an equal volume of 3x SDS-PAGE sample 
buffer (or of 2x non-reducing buffer) and stored at -20°C. One half 
of the total cell sample was loaded per well onto 10% SDS- 
polyacrylamide gels.
After electrophoresis gels were equilibrated in transfer buffer 
for 30 minutes and then laid on pre-wetted 3MM Whatman paper, resting 
on a fibre pad which was placed on the bottom half of a gel holder of 
the Trans-blot™ apparatus (BIO-RAO). A piece of nitrocellulose (21 
x 16 cm), pre-soaked in transfer buffer, was applied tightly onto the 
gel. Assembly was completed by placing another pre-wetted filter
paper on top of the nitrocellulose and a second fibre pad on top of
TMthe paper. The gel holder was inserted into the Trans-blot tank, 
which had been filled with transfer buffer, with the nitrocellulose 
towards the anode. Transfer took place at a constant voltage of 70V 
for 3 hours. The gel holders were then taken out ef the tank, opened • 
and the nitrocellulose sheets stained for 5 minutes in Ponceau S and 
destained in distilled H2O until the standards became apparent.
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Thair positions were then marked with a pencil and destaining 
continued until most of the stain was removed.
Blots were then incubated in 5% blocking solution overnight, at 
room temperature, to allow blocking of non-specific binding sites. 
Blots were next washed five times (5 minutes each wash) in PBS-T and 
incubated with antibody, diluted 1i100 to 1:250 (depending on MAb 
titre) in 5% blocking solution and held for 3 hours at ambient 
temperature. Unbound antibody was washed off with 5 changes of PBS-T 
and blots were incubated with biotinylated second antibody (anti­
mouse Ig), diluted 1:500 in 1% blocking solution for one hour. After 
another 5 washes in PBS-T, blots were incubated with biotinylated 
peroxidase-streptavidin complex, diluted 1:300 in 1% blocking 
solution, for 30 minutes. Blots were finally washed 3 times in PBS-T 
and rinsed twice in PBS alone (to remove residual detergent), prior 
to colour development. When protein bands appeared, blots were 
removed from the development solution and allowed to dry.
29-1,9__Hi yjtfç transition
Total cytoplasmic RNA from infected or uninfected cells (up to 10 pg) 
or in vitro—produced uncapped RNA transcripts (150-300 ng) were 
translated in a nuclease-treated rabbit reticulocyte lysate (NEN).
Each 25 /il reaction contained 2 pi of RNA sample ( in double- 
distilled, sterile HjO), 13 pi "premix" and 10 pi of reticulocyte 
lysate. Incubation was at 30°C for 2 hours, after which 25 pi of 3x 
SDS—PAGE sample buffer were added to each sample, followed by storage 
at -20°C. If immunoprécipitation was required, each sample was •
diluted with 150 pi of ice-cold IVT buffer (Herman, 1986) containing 
2 mM PMSF and 1.2 units of aprotinin per ml. Polyclonal anti-RS
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waa carried out as described in 2B.2.4a, with IVT buffer used as the
washing buffer.
2B.3 RMA HYBRIDISATION
2B.3.1 Preparation of intracellular viral RNA
The method used for RNA extraction was based on that of Kumar and 
Lindberg (1972) as modified by Dr. A. Easton (personal
communication). Confluent BS-C-1 monolayers in tissue-culture flasks 
were infected in duplicate with virus and maintained at 33°C and 
39°C. When viral cpe became evident in the cultures of 33°C (usually 
48 hours post-infection), cells were scraped into suspension and 
pelleted at 3,000 g for 5 minutes at 4°C (MSE Chilspin). Cells were 
lysed by resuspension in isotonic lysis buffer (aided by passage 
through a 21-gauge syringe needle) and incubation on ice for 15 
minutes. Cell debris were removed by centrifugation at 3,000 g for 5 
minutes at 4°C. Supernatant cell lysates were immediately mixed with 
an equal volume of phenol-chloroform and de-proteinized with vigorous 
shaking, followed by centrifugation at 4,000 g for 5 minutes. The 
aqueous phase was re-extracted with phenol-chloroform and finally 
with chloroform alone, to completely remove phenol. RNA was 
precipitated by addition to the final aqueous layer of ethanol 
(volume of ethanol added » three times the volume of the aqueous 
layer), and sodium acetate (pH 5.2) to a final concentration of 0.3 M, 
overnight at -20°C. Ethanol-precipitates were centrifuged at 4,000 g 
for 20 minutes and RNA pellets were washed in 70 percent ethanol, 
dried in a vacuum dessicator and resuspended in double-distilled, 
sterile H2O. Quantitation of RNA yields was carried out
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spectrophotometrically by measurement of the absorbance at 260 nm 
(LKB Spectrophotometre) and substitution for A in the formula: 
concentration of RNA » A x  40 pg/ml x (sample dilution) - 1
2B.3.2__RNA gel electrophoresis
RNA was electrophoresed in 1.2% agarose-2M formaldehyde gels, based 
on the method described by Maniatis et ml. (1982), using a somewhat 
modified protocol (Or. H. N. Baybutt, personal communication). 
Oenaturation of RNA before electrophoresis was achieved by addition 
of 23 pi of formamide-sample buffer to 4 pi of RNA (up to 20 pg) and 
heating at 60°C for 10 minutes, after which samples were quenched on 
ice. Once chilled, 4 pi of RNA loading buffer were added per tube 
and samples «rare loaded onto horizontal, 20cm-long gels, prepared as 
described on page 73. Gels were electrophoresed, completely 
submerged in sterile running buffer, at 100 volts until the dye front 
had migrated t»«-thirds of the gel distance.
2B.3.3__Northern transfer and pre-hvbridization
After electrophoresis RNA gels were soaked in several washes of 
double-distilled H2O for 20 minutes, to remove the formaldehyde, and 
were laid onto a damp 3MM Whatman paper which was supported by a pair 
of glass plates, placed in a large tray filled with transfer buffer 
(20x SSC)• The 3MM paper was covering the glass plates such that the 
four edges were in contact with the transfer buffer. A
nitrocellulose sheet, which had been soaked in transfer buffer for 5- 1 
10 minutes prior to use, was firmly placed on top of the gel and 
further arrangement of 3MM papers, towels and a weight on top of the
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nitrocellulose was carried out as described by Maniatis et ml. (1982) 
for Southern blotting. Transfer took place overnight.
Nitrocellulose filters were subsequently recovered and baked between 
two sheets of 3MM paper, under vacuum, at 80°C for more than two 
hours. Filters were then incubated, inside heat-sealed bags, in 
excess hybridization buffer at 42°C, with gentle shaking, for more 
than 5 hours, to achieve blocking of non-specific nitrocellulose 
binding sites.
2B.3.4 RNA dot-blots
RNA samples, prepared from virus-infected cells as described in 
2B.3.1, were diluted with an equal volume of 20x SSC, boiled for 2 
minutes and quenched on ice. A nitrocellulose sheet, pre-soaked in
20x SSC, was assembled inside a multiwell filtration manifold (Hybri- 
*PMdot , BRL), through which the RNA samples were applied onto the 
nitrocellulose. Once the sample volume was absorbed (by use of a 
water-suction pump), the loading wells were rinsed once with 20x SSC, 
the nitrocellulose was removed and baked between two 3MM sheets under 
vacuum, at 80°C, for more than two hours. Prehybridization was 
performed by incubation of the filters in hybridization buffer at 
42°C, for 5-18 hours.
2B.3.5__Preparation of radiolabelled probeB
32[ P ]-labelled, gene-specific probes were prepared by nick 
translation of cDNA clones of the RS virus N, P and M genes (all •
obtained from the A2 strain and kindly provided by Dr. G. Hertz, 
Alabama, U.S.A.). All three clones had PstI sites at both termini.
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acquired by homo polymer tailing and insertion into the Pat I site of
plasmid pBR322 (except in the case of the P clone. Bee below). The N 
cDNA clone contained the entire N gene sequence. The P cDNA clone 
represented a portion of the P gene starting from the internal PstI 
site, thus lacking the first 231 nucleotides (corresponding to the 5' 
terminal P mRNA sequence). The M cDNA clone represented a fragment 
(of approximately 500 bp) of the full clone, corresponding to the 3' 
proximal region of the M mRNA. The cDNA inserts were excised from 
recombinant plasmids by PstI digestion and isolated from agarose gels 
by the "freeze-thaw” method described in section 2B.4.3.
A typical nick translation reaction contained approximately 1
32fjq of cDNA, 10 pCt of [a— P ] -dCTP, 5 mM of the remaining dNTPs and 
100 ng/ml BSA (final concentrations) in nick-translation buffer and 
10 fil distilled H2O. Following addition of 1 pi of DNase (freshly 
diluted to 1 ng per fil from a stock solution) and 1 fil of E. coli DNA 
polymerase I (2-8 units par pi), reactions were incubated at 12°C for 
90 minutes.
Reactions were terminated by addition of 100 pi TB (pH 7.5), in 
simultaneous preparation for the later separation of nick-translated 
products from unincorporated dNTPs by column chromatography.
Sephadex G-50 columns were prepared as described on page 76, 
following the protocol of Maniatis et al. (1982). Fifteen column 
fractions were collected from each probe and radioactivity was 
measured in a liquid scintillation counter (LKB) directly by Cerenkov 
counting. Fractions comprising the leading peak of radioactivity 
were pooled and stored at -20°C. Before use, double-stranded probes 
were denatured by boiling for 2 minutes and quenched on ice.
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2B.3.6__Probe hybridization and washing
After blocking of the filters, bags were opened and prehybridization 
buffer was discarded. Filters were placed in new plastic bags and a 
small amount of fresh buffer was added (just enough to cover the 
filter surface). Denatured probes on ice were mixed with 0.5 ml of 
hybridization buffer and added to the buffer covering the filters. 
After being sealed, bags were gently squeezed and inverted to ensure 
thorough mixing of the probe. Hybridization took place overnight 
(16-22 hours) at 42°C with constant agitation.
Following hybridization, filters were washed twice, for 20 
minutes each wash, in a large volume of 2x SSC and 0.1 percent SDS, 
at room temperature. Filters were then washed twice, for 45 minutes 
each wash, in prewanned O.lx SSC and 0.1 percent SDS at 42°C. For 
autoradiography, filters were placed on sheets of 3MM Whatman paper, 
covered with plastic film and exposed to pre-flashed X-ray film at 
—70°C.
28.4 RECOMBINANT DMA TECHNIQUES
2B-4tl__Production of cDNA by reverse transcription and PCR
cDNA clones of the RS virus P gene were produced by first-strand 
synthesis with reverse transcription of viral mRNA, followed by 
second-strand synthesis and subsequent amplification of the cDNA with 
the Polymerase chain reaction (PCR). The method used for PCR- 
amplification was based on that of Saiki et al. (1988), with several 
modifications introduced in order to incorporate the requirements of
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the preceding reverse transcription step in the same reaction 
conditions (Dr. M. A. McCrae, personal communication).
Reactions were assembled on ice and contained 5 to 25 pg total 
cellular RNA from virus-infected cells (obtained as outlined in 
2B.3.1), P-gene-specific 5' and 3* primers at 1 pH each (see section 
3.4A for sequences), 30 mM Tris-HCl (pH 8.3), 50 mM KC1, 4.3 mM 
MgCl2, 480 pH of each dNTP, 320 pM DTT and 320 pg per ml gelatin in a 
final volume of 100 pi. Ten units of AMV reverse transcriptase were 
added and reactions were incubated for 70 minutes at 42°C. One unit 
of Thermua aquatxcus DNA polymerase (Tag) was then added per 
reaction, samples were overlaid with 30 pi of liquid paraffin, to 
prevent condensation and incubated sequentially at 94°C for 2 minutes 
(denaturation), 55°C for 2 minutes (annealing) and 72°C for 5 minutes 
(extension).
Thermal cycling was performed in a programmable heat block 
(Techne) and the amplification cycle was repeated 35 to 40 times. 
After the last cycle samples were incubated for an additional 5 to 10 
minutes at 70-72°C to ensure completion of the final extension step. 
The efficiency of amplification was assessed by electrophoresing 15 
pl-aliquots from the reactions in a 1% agarose mini-gel.
2B-4r?__Further treatment of PCR products
Once thermal cycling was complete, overlaying paraffin was removed 
and amplified cDNA was recovered by phenol-chloroform extraction of 
the reaction mixtures. Reactions were diluted to 1 5 0  pi with double- 
distilled HzO and vigorously mixed with 1 5 0  pi of phenol-chloroform. 
After centrifugation for 2 minutes at 1 0 , 0 0 0  g the o r g a n i c  phase was 
re-extracted with 1 5 0  pi double-distilled H2 0 .  The two aqueous
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phases were pooled and re-extracted with 300 pi of phenol-chloroform, 
followed by two chloroform extractions, to remove traces of phenol 
and paraffin. The final aqueous phases were precipitated overnight 
at -20°C in 2.5 volumes of ethanol and 0.3 M sodium acetate (pH 5.2).
2B.4.3 Preparation of PCR products for cloning
Ethanol-precipitated DNA was pelleted at 10,000 g for 15 minutes, 
washed in 70 percent ethanol, dried in a vacuum dessicator and 
solubilized in double-distilled H20. Possible remaining single- 
stranded overhangs (due to incomplete extension by Tag) were filled 
in with Klenow polymerase in 50 pl-reactions containing PCR-cDNA, 200 
pH of each dNTP, nick translation buffer and 5 units of E. coli 
Klenow fragment of DNA polymerase X. After incubation at 37°C for 30 
minutes, PCR products were purified from 1% agarose mini-gels by the 
"freeze-thaw" method (Dr. P. Chambers, personal communication), a 
modification of the "freeze-squeeze" method of Thuring et al. (1975). 
Gel fragments containing the DNA bands were excised with a scalpel 
blade and placed in Eppendorf tubes which were immediately frozen in 
an ethanol-dry ice bath. Samples were thawed for 3 minutes at 37°C, 
vortexed and re-frozen for 3 minutes. After thawing sample liquids 
were removed to separate tubes, 200 pi double-distilled H2C> were 
added to the gel "slices" and the freeze/thaw/vortex cycle was 
repeated at least twice more. Final sample liquids were pooled with 
the initial ones and phenol-extracted three times, followed by one 
chloroform extraction and ethanol precipitation of the aqueous phases 
as explained in 2B.4.2. After washing and drying,-DNA pellets were . 
resuspended in 20 pi H20.
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2B.4.4__Ligation
Purified cDNAb , being blunt at both ends, were inserted into the Smal 
site of the multiple cloning site of the Bluescribe(+) vector. 
Digestion of the vector with Smal was carried out at 30°C for 1 hour 
in buffer supplied with the enzyme. Ligation reactions contained the 
entire PCR-cDNA, 50 to 70 ng of linearized vector, 60 pM ATP and 5 to 
10 units of T4 DNA ligase, in ligation buffer and water, to a final 
volume of 50 pi. Reactions were incubated overnight at 14°C and used 
directly for transformation.
2B.4.5__TC4hg format j.on
Competent bacteria for transformation were prepared by the calcium 
chloride procedure (Maniatie at al., 1982) with minor modifications 
(Dr. A. Easton, personal communication). Fifty ml of L-broth were 
inoculated with 1 ml of a TG2 overnight culture and bacteria were 
grown by shaking at 37°C, until the O.D.550 was approximately 0.4 
(usually 90 minutes). The culture was then chilled on ice for half 
an hour. Bacteria were pelleted at 4,000 g for 5 minutes at 4°C and 
gently resuspended in 20 ml of freshly made, ice-cold 0.1 M MgClj* 
Bacteria were immediately pelleted again at 4,000 g for 5 minutes at 
4°C and resuspended in 2 ml of ice-cold freshly prepared 0.1 M CaCl2 • 
Bacteria were competent for transformation after subsequent 
incubation on ice for at least 1 hour (and up to 24 hours).
Transformation was carried out by mixing 100 pi of competent 
bacteria with DNA (25 pi of ligation reactions) in'Falcon tubes and 
incubation on ice for 30 minutes. Bacteria were heat-shocked for 2 
minutes at 42°C and returned to ice for half an hour. Bacteria were
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then grown at 37°C (in 1 ml L-broth per tube) for 1 hour, to allow 
expression of ampicillin resistance. Portions of transformed 
bacteria were spread onto selective L-agar plates, containing 100 pg 
per ml of ampicillin and also X-gal (20 pg per ml) and 80 pM IPTG 
which permit chromogenic selection of recombinants. Once the liquid 
had been absorbed, plates were inverted and incubated overnight at 
37°C.
2B.4.6 Analysis of recombinant clones
Identification of positive clones was performed by restriction 
mapping of recombinant plasmid DNA, prepared by the small-scale 
alkaline lysis method of Maniatis et al. (1982). Bacterial colonies,
chosen as recombinants on the basis of their white colour, were 
inoculated into 2 ml of L-broth, supplemented with ampicillin at 100 
pg per ml, and grown at 37°C overnight. One and a half ml of culture 
were centrifuged for 2 minutes at 10,000 g while the remainder was 
stored at 4°C. Bacterial pellets were resuspended in 100 p 1 of 
lysozyme buffer in which the cell walls were disrupted by addition of 
0.4 percent lysozyme (w/v) and incubation at room temperature for 5 
minutes. Bacterial cells were then lysed for 5 minutes on ice by 
addition of 200 pi of alkaline-SDS solution. Finally 150 pi of ice- 
cold 5M potassium acetate (pH 4.8) were added for a further 5 minute 
incubation on ice.
Bacterial debris were removed by centrifugation for 5 minutes 
at 10,000 g and supernatants were extracted with phenol-chloroform 
with vigorous mixing and separation of phaseB at 10,000 g for 2 
minutes. Final supernatants were precipitated with 2 volumes of 
ethanol for 15 minutes at room temperature and centrifuged for 15
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minutes. Pellets were washed in 70 percent ethanol, dried and 
resuspended in 40 fjl of TE (pH 7.5) containing 40 )jg per ml of 
ribonuclease A. Digestion with restriction endonucleases was carried 
out in 20 fil reactions containing 0.5 to 2 ¿ig of plasmid DNA and 1 jil 
of the desired enzyme (usually 5 to 10 units) in the appropriate 
buffer, at the recommended temperature for 1 hour. Double digestions 
were performed simultaneously, if ionic requirements were the same 
for both enzymes, or sequentially, starting with digestion at the 
lower salt concentration and supplementing the required NaCl for the 
second digestion.
Portions of the digests were mixed with 3 to 5 jil of loading 
buffer and analysed on agarose gels which were electrophoresed 
submerged in TBE buffer containing 0.5 fjg per ml of ethidium bromide. 
Gels were viewed and photographed on a UV-light transilluminator.
Size estimation of restriction fragments was achieved by co­
electrophoresis of DNA size standards (1 kb-ladder from BRL) . Once 
confirmed as positive, recombinant colonies were stored in L-broth 
(with ampicillin) and 40 percent of sterile glycerol at -20°C, in 1 
ml aliquots.
2B.4.7__Subclonlnq into different vectors
Large quantities of pure plasmid DNA, required for further cloning 
and analysis, were obtained by plasmid amplification and purification 
from cesium chloride gradients (Maniatis et al., 1982). Overnight 
bacterial cultures were prepared from glycerol stocks of recombinant 
colonies. One ml-portions were sub-cultured in 50'ml L-broth (with 
100 fjg per ml of ampicillin) until the O.D.55Q had reached 0.6. This 
late log-phase culture was divided into two 2-litre flasks containing
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500 ml of L-broth (plus ampicillin) and incubated at 37°C for 6 
hours. Chloramphenicol was then added (at 100 pg per ml) and 
incubation continued overnight. Bacteria were harvested by 
centrifugation at 3,000 g for 20 minutes at 4°C. Pellets from 500 ml 
cultures were resuspended in 10 ml of lysozyme solution, containing 5 
mg per ml of lysozyme and incubated for 5 minutes at room 
temperature. Alkaline lysis was carried out by addition of 20 ml of 
alkaline-SDS solution and incubation on ice for 10 minutes, followed 
by addition of 15 ml of ice-cold 5M potassium acetate (pH 4.8) for a 
further 10 minutes on ice.
Bacterial lysates were transferred to Oakridge tubes and 
centrifuged in a Beckman fixed-angle rotor at 15,000 rpm for 30 
minutes at 4°C. Supernatants were transferred, in 18 ml-aliquots, 
into Corex tubes and precipitated with 0.6 volumes of iso-propanol at 
room temperature for 20 minutes. Samples were centrifuged at 15,000 
rpm for 30 minutes at 20°C, in a Beckman fixed-angle rotor. Pellets 
were washed in 70 percent ethanol, briefly dried and resuspended in a 
total volume of 6 ml of TE (pH 7.5). Samples were then mixed with 
CsCl solution (page 78) and 0.5 ml of ethidium bromide (10 mg per ml) 
and transferred to centrifuge tubes. The remainder of the tubes was 
filled with light paraffin oil, tubes were heat-sealed and 
centrifuged in a Beckman vertical type-50 rotor at 45,000 rpm for 17 
hours at 20°C. The plasmid DNA band (visible in ordinary light) was 
collected through a hypodermic needle and extracted 4 to 5 times with 
an equal volume of iso-amylalcohol, to remove the ethidium bromide. 
The final aqueous phase was dialysed against three changes of 5 
litres of TE (pH 8.0) at room temperature, for 1 hour each time, to 
remove the CsCl. DNA solutions were precipitated with 2 volumes of
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ethanol and 0.3 M NaCl at -20°C overnight. Plasmid DNA was collected 
by centrifugation at 4,000 g for 15 minutes, washed in 70 percent 
ethanol, dried and resuspended in distilled H2O. For estimation of 
plaBmid yields and purity of preparations, the absorbance of sample 
dilutions was measured at 260 nm and 280 run (LKB spectrophotometre) 
and calculations made as described in Maniatis at al. (1982).
For subcloning cDNA inserts, cesium chloride-purified DNA was 
doubly digested with the appropriate enzymes and desired fragments 
were gel-purified by freeze-thawing (see Section 2B.4.3). For 
subcloning the Bcll-PstI fragment from the A2-PcDNA, the recombinant 
plasmid was firstly transformed into the dam and dcm E. coli strain 
G119 because of the known inability of Bell to restrict methylated 
substrates (Maniatis et al., 1982). Vectors were restricted 
accordingly, to give identical— or compatible-cohesive ends to the 
ones generated by recombinant plasmid digestion and dephosphorylated 
by addition of 2 to 5 units of calf-intestinal alkaline phosphatase 
to digestions, after the first 30 minutes of incubation. Linearized 
vector DNA was recovered by phenol-chloroform extraction of 
digestion-reactions, followed by ethanol precipitation (as described 
in 2B.4.2). Ligations were carried out as outlined in Section 
2B.4.4, between 0.5 to 0.8 ^9 of fragment cDNA and 0.3 to 0.5 pg of 
vector DNA, for 4 to 8 hours at ambient temperature.
2B.4 .8__Jn vitro RNA synthesis
Viral cDNA clones were in vitro transcribed from adjacent 
bacteriophage promoters according to the method of'Melton et al. 
(1984). DNA templates were prepared by restriction of recombinant 
plasmids at a site (or sites) downstream of the 3* end of inserts.
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using endonucleases which did not generate a 3 ’ overhang.
Restriction reactions were extracted with an equal volume of phenol- 
chloroform and linearized templates were recovered by ethanol 
precipitation. Small aliquots were electrophoresed on agarose mini­
gels to ensure that linearization of template was complete.
In vitro transcription reactions were assembled at room 
temperature and contained 100 pg per pi of linearized plasmid DNA, 40 
mM Tris-HCl (pH 7.5), 6 mM MgCl2, 2 mM spermidine-HCl, 10 mM DTT, 100 
fig per ml BSA, 500 fiM each of ATP, UTP, rCTP, rGTP, 1.5 units per fi 1 
of human placental ribonuclease inhibitor and 1 to 2 units per fi 1 of 
the appropriate bacteriophage RNA polymerase, in a final volume of 50 
to 100 pi. After incubation for 1 hour at 40°C, a fresh aliquot of 
RNA polymerase was added (1 unit per pi) and incubation continued at 
40°C for another hour. When RNA synthesis was complete DNA templates 
were removed by addition of ribonuclease-free pancreatic 
deoxyribonuclease (final concentration of 20 pg per ml) and 
incubation at 37°C for 10 minutes. Reaction mixtures were then 
diluted with sterile H20 and extracted twice with phenol-chloroform 
and once with chloroform. Run-off RNA transcripts were collected by 
two rounds of overnight precipitation in 3 volumes of ethanol and 0.3 
M sodium acetate (pH 5.2) at -20°C. RNA was pelleted at 10,000 g for 
15 minutes, washed in 70 percent ethanol, dried and resuspended in 
sterile H20. Quantitation of yields was carried out 
spectrophotometrically (see Section 2B.3.1). Suitable aliquots of 
RNA solutions were used for in vitro translation as described in 
Section 2B.2.9.
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2B.5.1 SubcXoninq into M13
P cDNA inserts were excised from recombinant Bluescribe vectors by 
double digestion with BamHI and SmaI or EcoRI, isolated from agarose 
mini-gels by freeze-thawing and ligated into similarly digested 
double-stranded (replicative form) M13mpl8 and mpl9 vectors. For 
subcloning the internal B i n d 1-AvalI P fragment, the Avail 5' 
overhang was made blunt with Klenow polymerase and the fragment was 
ligated into HincII-cut mpl8 and Smal-cut mpl9.
Half the ligation reaction was mixed with 150 pi competent TG2 
in Falcon tubes and incubated on ice for 30-45 minutes. After being 
heat-shocked for 2 minutes at 42°C, the bacteria-DNA mixture was 
returned to ice for another 30 minutes. Meanwhile, 20 pi of 100 mM 
IPTG and 30 pi of 2 percent X-gal were added to each of 3 ml-aliquots 
of top agar, which were kept molten at 46°C. Prior to addition of 
transformed bacteria, ISO pi of an early log-phase TG2 culture were 
added per tube and 3 ml-aliquots of top agar (plus X-gal, IPTG and 
"lawn” bacteria) were mixed with 10, 25 or 50 pi portions of 
transformed bacteria and poured onto prewarmed L-agar plates. After 
15 minutes at ambient temperature, to allow setting of the top agar, 
plates were inverted and incubated at 37°C overnight.
2B. 5.2__Preparation of single-stranded M13
2B.5 PNA SEQUENCING
Recombinant M13 plaques were picked and grown in 3 ml 2YT medium, 
containing a 3:50 dilution of an overnight culture of bacteria, for 6 
hours at 37°C, with vigorous shaking to provide good aeration. 
Subsequently, 1.5 ml of this culture were centrifuged at 10,000 g for
107
\
2 minutes twice, to remove all the bacteria and 1 . 2  ml of supernatant 
were mixed with 0.3 ml of 2.5 M NaCl-20 percent PEG and incubated for 
15 minutes at room temperature. PEG-precipitated M13 virions were 
collected by centrifugation for 5 min, followed by another 
centrifugation for 2 min, to ensure complete removal of residual 
traces of PEG-solution. Pellets were then resuspended in 120 ¿¿1 of 
TE (pH 8.0) and de-proteinized with 50 pi of phenol. Residual phenol 
in the aqueous phase was extracted with 50 pi of chloroform. After 
centrifugation for 2 min, the final supernatants were precipitated 
with 2.5 volumes of ice-cold 95° ethanol and 0.3 M sodium acetate (pH 
5.2), in an ethanol-dry ice bath, for 20-30 minutes. Single-stranded 
M13 ONA was collected by centrifugation for 15 minutes as a pellet, 
which was then washed in 70 percent ethanol and dried in a vacuum 
dessicator. Pellets were finally resuspended in 30 pi of TE (pH 
8.0) .
2B.5.3 Sequencing reactions
The method of dideoxynucleotide chain-termination of Sanger et al. 
(1977) was used, following the "extended DNA sequencing” protocol 
suggested by BRL (BRL Focus, Vol. 9, 1987). The procedure comprises 
three stages:
i) template-primer annealing,
ii) labelling-extension,
iii) chain-termination.
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For the first step, approximately 1 pg of single-stranded 
template was mixed with 3ng of M13-specific primer (universal 17mer 
primer or "LAC" primer) in sequencing buffer and distilled, sterile 
H^O in a final volume of 10 pi. The mixtures were wanned at 65°C for 
10 minutes (in a forced hot-air incubator) and allowed to cool slowly 
to room temperature for 20 minutes, for annealing to occur. During 
this time, 2.S pi of each termination mix were aliquoted in 0.5 ml 
Eppendorf tubes labelled accordingly A, G, C, T (for the respective 
ddNTP in the mix), in sets of four for each template. Upon 
completion of the annealing period, labelling-extension was carried 
out by addition to the annealed templates of extension mix, 10 pCi of 
[a-35S]dATP, 2 units of Klenow polymerase and water to a final volume 
of 16 pi. Following a 5 minute-incubation at room temperature, 3.5 
pl-aliquots of each reaction were mixed with each of the four 
termination mixes and incubated for 5 minutes at 37°C. Finally, 4 pi 
of formamide-dye mix were added per tube and samples were stored at 
-20°C. Prior to electrophoresis, samples were heated at 95°C for 2-3 
minutes and quenched on ice.
2B.5.4 Sequencing gel electrophoresis
40 cm-long sequencing gels were cast using either standard, 0.4 mm, 
flat spacers or 0.4-1.2 mm, wedge spacers (BRL). The use of field 
gradient (wedge) gels improved overall resolution by increasing the 
number of oligonucleotides that could be read in a single lane. Gel 
solutions, prepared as described on page 82, were pipetted inside the • 
gel plates and 0.4 mm-wide sharkstooth combs (BRL) were inserted to 
provide 12.7 mm loading wells. Gels were pre-electrophoresed for 30
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minutes at a constant power of 80 Watts and, after sample loading, 
for 4 to 8 hours, depending on the part of the sequence which was of 
interest. Gels were then fixed for 40 minutes in 10 percent acetic 
acid and dried onto a 3MM Whatman paper, at 80°C under vacuum, for 
one hour (flat gels) or one and a half hours (wedge gels), followed 
by exposure to X-ray film at room temperature.
no
RESULTS
AND
DISCUSSION
3.1 T» MUTANT A i
3.IA RESULTS
Intracellular polypeptide synthesis. The electrophoretic profiles of 
[35S]-labelled, RS virus-specific proteins synthesized in cells infected 
with the wild-type A2 and two of its ts mutants isolated by Gharpure et 
al. (1969), ts Aj and ts A2 , are shown in Fig. 5. An interesting 
observation is that the A2 wild-type P protein appears to migrate as a 
double band (lanes 1 and 2). This phenomenon has also been observed by 
other workers (Huang and Wertz, 1983; Gimenez et al., 1984; Morgan et 
al., 1987) and the P-specificity of both bands has been confirmed by 
immunoprécipitation with anti-P specific MAbs (Fig. 6) . In Fig. 68 it 
can also be observed that two other wild-type strains, RSS-2 and RSN-2; 
have a single P protein band. A band migrating ahead of the P 
(indicated by circles in Fig. 5 and 6A) has been found to be of cellular 
origin by comparison of immunoprecipitates from virus-infected and mock- 
infected cells (Fig. 7). Surprisingly, the three ts mutants derived 
from the A2 wild-type (Fig. 5, 6A and 7B) exhibit a single P protein 
band. A possible explanation for this difference could lie in the 
actual wild-type stock used for mutagenesis and the number of passages 
since carried out in different laboratories. Several wild-type A2 
clones grown from individual plaque isolates, obtained from the wild- 
type stock originally provided from the laboratory of Dr. R. M. Chanock, 
also had a double P band (Fig. 8). However, in view of the fact that 
the single P band is apparent in mutants of three different 
complementation groups, this difference is unlikely to be specifically, 
involved in their ts phenotypes.
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figure 5 . Immunoprécipitation of viral polypeptides with polyclonal 
anti-RS virus serum from lysates of cell cultures infected with the 
A2 wild-type (lanes 1 and 2), the ts mutant A2 (lanes 3 and 4) and 
the ts mutant Aj (lane 5). Duplicate infected cultures were 
maintained at 33°C (lanes 1 and 3) and 39°C (lanes 2, 4 and 5). 
Immunoprecipitated proteins were analyzed in a 6-15% linear 
polyacrylamide-SDS gradient gel. Pbrk represents a breakdown product 
of the P protein. The band indicated by circles is a cellular 
protein as explained in the text.
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Figure 6.
(A) Difference in the P polypeptide between the wild-type A2 (lane 
3) and its ts mutants, ts (lane 1) and ts A2 (lane 2). The 
polypeptides were immunoprecipitated with an anti-P monoclonal 
antibody from lyBates of infected BS-C-1 monolayers, maintained 
at 33°C. The observed co-precipitation of the N protein is 
characteristic of all anti-P MAb immunoprécipitations and 
arises from the strong interaction between these two proteins, 
as previously reported (Gimenez et al., 1984; Mufson et al., 
1985). The band indicated by circles is a cellular protein as 
explained in the text.
(B) Variability of P protein mobility between RS virus strains. 
PEG-precipitated viruB particles of the wild-types RSN-2 (lanes 
2, 7, 10), RSS-2 (lanes 3, 6, 8) and A2 (lanes 4, 5, 9), 
produced at 33°C, were lyBed in RIP buffer, immunoprecipitated 
with three anti-P monoclonal antibodies and analyzed by SDS- 
PAGE (6-15% linear gradient gel). Lane 1 ("RS") contains the 
RSN-2 virion polypeptides immunoprecipitated by polyclonal 
anti-RS virus serum. Lane M contains the Mr protein markers, 
whose indicated molecular weight is expressed in kilodaltons.
Figure 7.
(A) Virus-specific polypeptides of three wild-type strains of RS 
virus. Cells infected with RSS-2, RSN-2 or A2 wild-type virus 
and uninfected cells (UI), incubated at 33°C, untreated (-) or 
treated with tunicamycin (+), were labelled with
[35S]methionine, lysed and immunoprecipitated with polyclonal 
anti-RS virus serum. The band indicated by circles is of 
cellular origin. The P breakdown product (Pbrk) is indicated 
in the appropriate lanes by arrows. The band indicated by the 
bold arrow, which is more intense in the tunicamycin-treated 
samples, could be the unglycosylated 23K fragment of the Fj 
subunit shown in Figure 12. The F 2 subunit is visible only in 
the untreated lysate of A2-infected cells.
(B) Immunoprécipitation of virus-specific polypeptides from the ' 
wild-type A2 and its three ts mutants. Cells infected with ts 
Aj (lane 1), ts Aj (lane 2), ts A7 (lanes 3 and 4), wild-type 
A2 (lanes 6 and 7), wild-types RSS-2 (lanes 8 and 9) and RSN-2
(lane 10) and maintained at 33°C (lanes 1, 2, 3, 6, 8, 10) and
o 3539 C (lanes 4-, 7, 9) were labelled with [ SJmethionine and
immunoprecipitated with polyclonal anti-RS virus serum. The
band indicated by circles is a cellular contaminant as deduced
by comparison of infected and uninfected (lane 5) cell lysates.
M A b  A c A d  tsAj
figure 8. Migration of the P protein of wild-type A2 as a doublet 
band. Wild-type A2 virus plaqueB were picked and propagated in 
BS-C-1 cells as described in Methods (Section 2B.1.4). Three wild- 
type viruB clones (Ab, Ac, Ad), representing different plaque 
isolates, were immunoprecipitated from infected-cell lysates with an 
anti-P MAb. The similarly immunoprecipitated profile of ts Aj^ - 
infected cells is included for comparison of the P protein mobility. 
Lane M contains the Mr protein markers, whose sizes are indicated in 
kilodaltons.
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The polypeptide profile of ts Aj-infected cultures at 39°C (Fig. 5, lane 
5 ) revealed an overall decrease in the amounts of viral proteins at the 
restrictive temperature, in comparison to the profiles of the wild-type 
(lanes 1 and 2) and the mutant ts A2 (lanes 3 and 4). In subsequent 
experiments with ts A^, shown in Fig. 9, the reduction of labelled 
polypeptides at 39°C was observed to occur to variable extents. In 
order to quantitate the polypeptide profiles, densitométrie scanning of 
fluorograms and analysis of the data were carried out as described in 
Methods (Section 2B.2.6). Comparison of the relative accumulation of 
viral polypeptides (i.e. 39°/33° ratio) in the ts A^ and wild-type A2 
profiles of Fig. 9A reveals a marked reduction of the F  ^ and M proteins 
and a less pronounced decrease of the nucleocapsid-associated N and P 
proteins (Table 7). The variability in the extent of restriction of ts 
Aj at 39°C between different experiments (Fig. 5 and 9) can be 
demonstrated by comparison of the amounts of viral proteins present in 
the corresponding profiles (Table 8). The experiments shown in Fig. 5 
and 9A differ with respect to the length of incubation of infected 
monolayers before labelling was carried out, which was at one day post­
infection for Fig. 5 and at two days post-infection for Fig. 9A. The 
length of this post-infection incubation of cultures before the addition 
of label varied from one to three days, depending on the input 
multiplicity of infection, because an appreciable level of viral epe 
(monitored by microscopic observation of 33°C-cultures only) was 
required for efficient labelling of viral polypeptides. In order to 
compensate for possible variations in the degree of label incorporation 
and in the number of cells used for immunoprécipitation between 
different experiments, the data in Table 8 are presented as the ratios, 
of the three major intracellular labelled species N, M and Fj.
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The polypeptide profile of ts Aj-infected cultures at 39°C (Fig. 5, lane 
5 ) revealed an overall decrease in the amountB of viral proteins at the 
restrictive temperature, in comparison to the profiles of the wild-type 
(lanes 1 and 2) and the mutant ts A2 (lanes 3 and 4). In subsequent 
experiments with ts A1# shown in Fig. 9, the reduction of labelled 
polypeptides at 39°C was observed to occur to variable extents. In 
order to quantitate the polypeptide profiles, densitométrie scanning of 
fluorograms and analysis of the data were carried out as described in 
Methods (Section 2B.2.6). Comparison of the relative accumulation of 
viral polypeptides (i.e. 39°/33° ratio) in the ts Aj^  and wild-type A2 
profiles of Fig. 9A reveals a marked reduction of the F^ and M proteins 
and a less pronounced decrease of the nucleocapsid-associated N and P 
proteins (Table 7). The variability in the extent of restriction of ts 
A} at 39°C between different experiments (Fig. 5 and 9) can be 
demonstrated by comparison of the amounts of viral proteins present in 
the corresponding profiles (Table 8). The experiments shown in Fig. 5 
and 9A differ with respect to the length of incubation of infected 
monolayers before labelling was carried out, which was at one day post­
infection for Fig. 5 and at two days post-infection for Fig. 9A. The 
length of this post-infection incubation of cultures before the addition 
of label varied from one to three days, depending on the input 
multiplicity of infection, because an appreciable level of viral epe 
(monitored by microscopic observation of 33°C-cultures only) was 
required for efficient labelling of viral polypeptides. In order to 
compensate for possible variations in the degree of label incorporation 
and in the number of cells used for immunoprécipitation between 
different experiments, the data in Table 8 are presented as the ratios, 
of the three major intracellular labelled species N, M and F^.
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Figure 9. Temperature-sensitive restriction of polypeptide synthesis
in ts Aj. Duplicate BS-C-1 monolayers, infected with the wild-type 
A2 (lanes 1, 2) or the ts mutant A^ (lanes 3, 4), were incubated at 
33°C (lanes 1, 3) and 39°C (lanes 2, 4) for two or three days post­
infection (panel A and B, respectively). Cultures were then labelled 
with ( ] methionine, lysed and immunoprecipitated with polyclonal 
anti-RS virus serum. The positions of the viral polypeptides are 
indicated in panel A. The F0 precursor, faintly observed in panel A, 
is indicated also in panel B. The band denoted as 1C/1B probably 
corresponds to the two non-structural RS virus polypeptides which are 
not resolvable in this gel system (6-15% linear polyacrylamide 
gradient), as explained in Section 3.3a. The positions of the Mr 
markers are indicated by bars (for sizes see Fig. 6 and 7).
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Table 7 . Comparison of viral polypeptide synthesis in cells infected 
with wild-type A2 or mutant ts »j at 33° and 39°C.
Protein Relative accumulation Relative yield
ts Ax wt A2 ts A^/wt
F1 7 92 8N 58 70 83
P 65 66 98
M 8 68 12
Relative accumulation = (protein peak area at 39°C/protein peak
area at 33°C) x 100
Relative yield = (relative accumulation in ts Aj/relative 
accumulation in wt A2) x 100
Densitometric data (in this and subsequent tables) not corrected 
for length of gel exposure or for possible non-linearity of band 
densities with respect to length of exposure to X-ray film.
Table 8. Restriction of ts Aj^  viral polypeptides at 39°C.
Protein area 
ratio
39c>ca 39c’c* Relative reduction0
wt A2 ts A} wt A2 ts Ax 39°Ca 39°C*
M/Ki 1 . 1 0 1.07 0.64 1.02 102 63
N/Fi 0.83 4.56 0.57 6.79 18 8
N/M 0.75 4.23 0.65 6.63 18 10
values from labelling at one day post-infection.
values from labelling at two days post-infection.
Relative reduction = (protein ratio in wild-type/protein
ratio in ts Aj) x 100.
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These data confirmed the visual observation that the length of the 
pre-labelling incubation period was directly related to the degree of 
restriction in ts Aj-polypeptide abundance at 39°C. This observation 
corresponds to previous findings of Schnitzer et al. (1976) who reported 
that the variability in growth restriction of ts A} at 39°C was a direct 
and linear function of the input inoculum. Furthermore, Schnitzer et 
al. (1976) observed by immunofluorescence that the early stages of 
infection and antigen production by ts Aj^  were unaffected at 39°C at 24 
hours post-infection but prolonged incubations did not increase the 
percentage of antigen-presenting cells, suggesting that the mutant had a 
te defect which affected the spread of infection. The data presented in 
Tables 7 and 8 are consistent with this interpretation since the 
greatest reduction is observed in the Fj membrane glycopolypeptide which 
mediates cell-to-cell fusion [the F2 subunit is poorly labelled by [35S] 
methionine, due to its low methionine content, and is usually 
undetectable under these labelling conditions].
F protein synthesis. In view of the importance of fusion-from-within 
for RS virus spread in monolayer cultures, the synthesis of the fusion 
(F) glycoprotein of ts A^ was examined in more detail. Radiolabelling 
of the glycoproteins of ts Aj with [3H]glucosamine revealed an apparent 
absence of the F  ^and F2 subunits from the mutant profile at 39°C, 
whereas the G glycoprotein was unaffected (Fig. 10). The minor band 
indicated by arrow in Fig. 10A is one of the multiple forms of the 1A 
protein. This protein has recently been shown to undergo stepwise 
glycosylation and the 16K form seen in Fig. 10A has been reported to be 
a precursor of the more heavily glycosylated, mature form of the 1A , 
protein (Olmsted and Collins, 1989). Both forms can be readily observed 
after [3H ]glucosamine-labelling and immunoprécipitation with a 1A-
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figure 1 0.
(A) Glycoproteins of wild-type A2 and ts Aj. Duplicate BS-C-1 
monolayers, infected with A2 (lanes 1 and 2) or the mutant ts 
Aj (lanes 3 and 4) and maintained at 33°C (lanes 1, 3) and 39°C 
(lanes 2, 4) for two days post-infection, were labelled with
[3H]-glucosamine and immunoprecipitated with polyclonal anti-RS 
virus serum. The faint band indicated by the arrow corresponds 
to the 16K lA-specific band shown in panel B.
(B) The 1A glycoprotein of RS virus. Cells infected with the 
subgroup A strains RSS-2 (lane 1), A2 (lane 2) or the subgroup 
B strain RSN-2 (lane 3) were labelled with (3H]-glucosamine and 
immunoprecipitated with anti-lA-CT serum. This serum was 
raised against a synthetic peptide corresponding to the 
carboxyterminal region of a subgroup A strain-lA protein (and 
kindly provided by Dr. P. Collins). The serum is thus subgroup 
A-specific, as the C-terminal region of the 1A protein is 
highly variable between the subgroups (Dr. P. Cane, personal 
communication). The 16K band is the partially modified 
precursor of the fully glycosylated 22-35 K species (Olmsted 
and Collins, 1989). The small variation between the observed 
and reported sizes of these bands (the reported Mr of the 
precursor is 13-15 K, that of the mature 1A glycoprotein 21- 
30K) is probably due to different conditions of gel 
electrophoresis and/or differences in glycosylation between 
different host cell types.
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specific anti-(COOH)peptide serum (kindly provided by Dr. P. Collins), 
under which conditions the final glycosylation 1A product migrates as a 
diffuse, heterodisperse band in the size range of 22-35K (Fig. 10B) .
The failure to detect F^ and F2 bands by [3H]glucosamine­
labelling, when synthesis of the Fj polypeptide can be detected by [35S] 
methionine-labelling (Fig. 5), could be due to absence of glycosylation 
of these polypeptides at 39°C. However the ts Aj Fj^  band seen in Fig. 5 
possessed the apparent mobility of the glycosylated polypeptide. 
Furthermore, the ts A^ F0 precursor synthesized at 39°C (Fig. 11) 
migrated as the fully glycosylated 67K protein in pulse-chase 
experiments. Thus the inability to detect the Fj and F2 subunits by 
oligosaccharide labelling could be a consequence of the different 
sensitivities of the two labelling procedures combined with the 
significant reduction in the amounts of viral polypeptides detected in 
ts Aj-infected cultures at 39°C.
The pulse-chase experiment in Fig. 11 (panel A) shows that the 
polypeptides synthesized in tB A^-infected cells at 39°C during the 10 
minutes-pulse period were stable throughout the subsequent 5 hours-chase 
incubation, in agreement with the observation that ts A^ is able to 
persist in infected cells at the restrictive temperature, albeit in a 
non-infectious state (Schnitzer et ai., 1976). Proteolytic cleavage of 
the F0 precursor to its constituent Fj and F2 subunits can also be 
observed to occur during the chase at 39°C, to similar extents as at 
33°C in both the mutant and wild-type infections (panel A and B, 
respectively), making unlikely the possibility of a ts defect at this 
level of processing. In fact, none of the results described so far 
would support unequivocally the suggestion of Schnitzer et al. (1976) , 
that the fusion protein of ts A^ was the site of its ts lesion.
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Figure 11. Kinetics of F0 cleavage in ts Aj- or wild-type A2- 
infected cells. Duplicate monolayers of ts Aj-infected cells (panel 
A) or wild-type A2-infected cells (panel B), maintained at 33° and 
39°C, were briefly labelled (10 minutes) with [^5S)methionine (pulse, 
lanes P) and chased in medium containing an excess of non-radioactive 
methionine. The minutes of chase are indicated on top of the 
respective lanes. The two final chase samples of ts A^ were 
collected at 4 and 5 hours (4h and 5h, respectively). Samples were 
immunoprecipitated with polyclonal anti-RS virus serum and analyzed 
on 6-15% linear gradient gels. The band indicated by circles is the 
cellular protein seen in Figure 7. The bands indicated by an arrow 
are two closely migrating degradation products of the and P 
proteins, seen in Figure 12 and 5, respectively. [The decreased 
intensity of all labelled proteins in the samples of 90 min and 150 
min in panel A is due to loss of part of the labelled cultures during 
harvesting). The Mr 's of the protein markers are indicated in 
kilodaltons.
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However, supporting evidence to that effect was obtained when monoclonal 
antibodies were used to detect the F proteins of ts A^ and wild-type A2.
[35S]-labelled F protein from ts Aj-infected cells (maintained at 
33°C) was inwnunoprecipitated with a number of specific anti-F MAbs and 
was found to react positively with all of them (a representative 
experiment is shown in Fig. 12). One of the anti-F MAbs used in the 
experiment of Fig. 12 (anti-F 7C2, a gift from Dr. M. Trudel), has been 
shown to bind to a highly conserved neutralization epitope which is 
contained in the amino-terminal third of the Fj subunit (Trudel et al., 
1987). Preliminary experiments with the A2 wild-type showed that some 
of these MAbs could react with F protein on Western blots but only when 
the F protein was undissociated, suggesting that they might recognize 
non-contiguous epitopes on both subunits. Undissociated, cleaved F 
protein can be obtained by omission of /)-mercaptoethanol from the sample 
buffer and is hereafter designated as F1>2, in order to distinguish it 
from the uncleaved F0 precursor ("pulse-form") of the protein which is 
obtained in the presence of the reducing agent because proteolytic 
cleavage into Fj and F2 occurs progressively during the chase (i.e. F1>2 
is the non-reduced form of the chase F protein).
When the undissociated Fj (2 protein from ts Aj was examined in 
Western blots it was found that, as in immunoprécipitations, the protein 
still reacted positively with the anti-F MAbs but, significantly, there 
was a mobility difference between the Fj^ 2 protein of ts A^ and wild- 
type A2 (Fig. 13). In fact, both proteins appeared to migrate more 
slowly than the corresponding F0 molecules (67K) previously observed in 
the pulse-chase experiments of Fig. 11, although a less intensely 
stained band could occasionally be detected within^this size range (as, 
indicated in the ts Aj lane of Fig. 13 and the A2 wild-type lane of Fig. 
16). This phenomenon became more obvious by immunoprécipitations of
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obtained in the presence of the reducing agent because proteolytic 
cleavage into F^ and F2 occurs progressively during the chase (i.e. F1>2 
is the non-reduced form of the chase F protein).
When the undissociated F1 /2 protein from ts Aj was examined in 
Western blots it was found that, as in immunoprécipitations, the protein 
still reacted positively with the anti-F MAbs but, significantly, there 
was a mobility difference between the F 1>2 protein of ts Aj and wild- 
type A2 (Fig. 13). In fact, both proteins appeared to migrate more 
slowly than the corresponding F0 molecules (67K) previously observed in 
the pulse-chase experiments of Fig. 11, although a less intensely 
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Figure 12. Immunoprecipitation of infected-cell lysates with anti-F 
MAbs. [^5SJmethionine-labelled monolayers, infected with the A2 
wild-type (lanes 1, 6, 7, 10, 14), ts mutant A2 (lanes 3, 4, 9, 12) 
or ts mutant A^ (lanes 2, 5, 8, 11, 13) and maintained at 33°C, were 
lysed and immunoprecipitated with a panel of anti-F MAbs, indicated 
in the figure above the respective lanes (for specificity of MAb 7C2, 
see text). In addition to the specific co-precipitation of the F2 
subunit (faintly observed due to poor methionine incorporation in 
this polypeptide), there is some (probably) non-specific 
precipitation of the N and M proteins, perhaps due to insufficient 
washing of the immunoprecipitates. The 23K band represents a 
nonglycosylated proteolytic fragment of the F^ subunit which has been 
described previously (Norrby et al., 1986).
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Fioure 13. Staining of the F1>2 protein on Western blots with anti-F 
MAbs. Cells infected with the wild-type A2 or the ts mutant Alf 
maintained at 33°C, were immunoprecipitated with polyclonal anti-RS 
virus serum. Samples were resuspended in lx non—reducing SDS-PAGE 
buffer, analyzed by 10% PAGE and transferred onto nitrocellulose. 
After staining with Ponceau S, the filter was divided into duplicate 
strips which were then stained with anti-F MAb F^ or anti—F MAb Fg. 
The positions of the Mr protein markers are indicated on the left. 
Also indicated by the arrow is the faster migrating form of the F1>2  
protein mentioned in the text.
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[35S]-labelled-Fl f 2 protein (Fig. 14) where the major band of the non- 
reduced form was seen to migrate above the 68K size marker, followed by 
a more rapidly migrating diffuse smear between the 60-70 kilodaltons 
range. This slower F mobility under non-reducing conditions could arise 
from inter-molecular disulphide bonding between the F and another viral 
protein, of the kind that has recently been observed to exist between 
the F and G proteins (Arumugham et al., 1989). The mobility of the non- 
reduced F band was considerably faster than the Mr of 200K suggested for 
such F-G complexes. Nonetheless the possibility was examined by dual 
staining of Western blots with anti-F and anti-G MAbs (Fig. 15).
Staining with an anti-G MAb revealed the p50 major G precursor (see 
Introduction, Fig. 4) and a fainter band very close to the beginning of 
the gel. This high Mr band has been previously suggested to represent a 
dimeric G aggregate (Lambert, 1988). However, the F^f2 band was only 
observed by addition of the anti-F MAb.
The possibility of an F complex with the 22K polypeptide, another 
RS virus membrane protein known to contain cysteine residues potentially 
involved in formation of disulphide bonds, was also considered, as the 
observed F mobility would be more appropriate for such a complex. As 
shown in Fig. 16A, the anti-22K MAb 1C13 binds only to the 22K protein, 
in contrast to double staining by anti-22K and anti-F MAbs when presence 
of the ^1,2 band is clearly demonstrated. The absence of the 22K band 
from the RSN-2 profile is due to the subgroup A-specificity of this 
anti-22K MAb (Routledge et al., 1987b), providing further evidence that 
the observed F band is not complexed with the 22K protein. The absence 
of electrophoretic variants of the 22K protein in these blots is 
probably due to the fact that samples were immunoprecipitated with • 
polyclonal anti-RS virus serum prior to electrophoresis and Western 
transfer (under these conditions only the major 22K band is efficiently
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Figure 14. Immunoprécipitation of the ?i/2 protein. Cells infected 
with the wild-types RSN-2 (lane 2) or A2 (lanes 3, 5, 7, 9, 12), or 
the ts mutant A1 (lanes 4, 6, 8, 10, 11) and uninfected cells (lane 
1), maintained at 33°C, were labelled with [^S] methionine and 
immunoprecipitated with a panel of anti-F MAbs (indicated in the 
figure, on top of the respective lanes). The samples were boiled for 
2 minutes in lx SDS-PAGE buffer lacking /3-mercaptoethanol and 
analyzed on a 10% polyacrylamide gel. The observed co-precipitation 
of the N protein is probably non-specific, as noticed previously 
(Gruber and Levine, 1985b). The positions of the Mr protein markers 
are indicated on the left.
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Figure 15. MAb-staining of RS viral proteins in Western blots
Cells infected with the wild-type A2 or the ts mutant Aj and 
maintained at 33°C were immunoprecipitated with Polyclonal anti-RS 
virus serum. The immunoprecipitates were solubilized in lx non­
reducing sample buffer, boiled for 2 min and analyzed by 10% SDS- 
PAGE. Following transfer of proteins onto nitrocellulose, the filter 
was stained briefly with Ponceau S and divided into duplicate strips 
which, after further treatment (as described in Methods) were stained 
with the anti-G MAb a793 and the anti-F MAb F5 (provided by 
Drs. Norrby and Orvell) or with the anti-G MAb L9 (a gift from 
Dr. E. Walsh) and the anti-P MAb 3-5 (obtained from Dr. B. Gimenez). 
The position of the presumptive G aggregate (Lambert, 1988) is 
indicated (Gagg). Only the top band of the A2 P triplet (see Fig.
17) is visible,since the anti-P MAb was used at a high dilution,and 
the top band is the more abundant of the three under these 
conditions.
128
A2*A,'
M M  -Go(p30)
- P
stained, see also Fig. 3). The retarded migration of the FSN-2 F1>2 
protein compared to the A2 protein (when these were expected to 
comigrate) was consistently observed in immunoprécipitations as well 
(Fig. 16B) and the possible reasons for this difference are discussed in 
Section 3. IB. The overall conclusion from the Western blot analysis 
would thus be that the band stained specifically by the anti-F MAbs 
under non-reducing conditions is the authentic ^x,2 protein.
Although it is possible that the apparent mobility difference 
between the reduced Fc and the non-reduced F^>2 protein forms could be 
due to the different gel system used for resolution (the pulse-chase 
profiles were obtained on 6-15% linear gradient gels) it is also 
possible that the retention of the inter- and intra-subunit S-S bridges 
in the non-reduced form could somehow effect the migration rate of the 
molecule. The second possibility could also explain why no mobility 
difference was observed when the dissociated F^ and F2 subunits of the 
wild-type A2 and mutant ts A^ were compared (Fig. 10A).
Characterization of t«+ revertants. In order to investigate the 
significance of the mobility difference between the A2 and ts Aj Fj >2 
proteins and its relation to the ts A^ phenotype, a series of 
spontaneous ts+ revertants was isolated from the mutant as described in 
Methods, Section 2B.1.4. The electrophoretic profiles of [35S )-labelled 
viral proteins from wild-type-, mutant- or ts+ virus-infected cells 
(maintained at 33°C) are shown in Fig. 17. The samples were resuspended 
in buffer lacking ^-mercaptoethanol to enable detection of the 
undissociated F1(2 protein. Examination of the revertant profiles in 
Fig. 17A revealed the existence of two types of revertants : ts+ clones 
89/A/ll and 89/A/20 seemed to possess an F^/2 protein with wild-type
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* Figure 16.
(A) MAb-Btaining of Western blots. Cells Infected with the wild- 
types RSN-2 or A2 and maintained at 33°C were 
immunoprecipitated with polyclonal anti-RS virus serum.
Samples were resuspended in lx non-reducing SDS-PAGE buffer and 
analyzed by 10% SDS-PAGE. After transfer to nitrocellulose, 
duplicate strips of the filter were stained with anti-22K MAb 
1C13, specific for subgroup A strains (kindly provided by
Dr. G. Toms), or with anti-22K MAb 1C13 and anti-F MAb F4 (a 
gift from Dr. K. Orvell). The more rapidly migrating form of 
the protein in the A2 lane is indicated by the arrow. The
positions of the Mr standards are indicated on the right.
(B) F mobility difference between RSN-2, ts A^ and A2. BS-C-1 
cultures were infected with the wild-type RSN-2 (RN), the wild- 
type A2 or the ts mutant Aj and incubated at 33°C. Following 
labelling with [35S]methionine, infected cultures were lysed 
and immunoprecipitated with polyclonal anti-RS virus serum 
(POL) or anti-F MAbs (F2, F4), resuspended in lx non-reducing 
sample buffer and analyzed by 10% SDS-PAGE. In addition to the 
Fl,2 tobility difference, the P and M proteins of RSN-2 can be 
observed to migrate faster than the corresponding A2 proteins, 
in agreement with previous findings (Mufson et al., 1985; 
Gimenez et al., 1986).
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mobility, whereas ts+ clones 89/A/4, 89/A/16 and 89/A/17 contained an 
F^ 2 protein showing the mobility of their patent mutant ts Aj.
The altered appearance of the wild-type A2 P protein is also 
noticeable, since it is resolved as three bands under non-reducing 
conditions (indicated by arrows), in contrast to the single P band of ts 
A^ and its ts+ revertants. The P-specificity of all three bands of the 
wild-type was confirmed by their ability to bind to the anti-P MAb 3-5 
on Western blots (Fig. 17B) . It is interesting to note that the top 
band of the P triplet in the wild-type comigrates with the single P 
protein band of ts Alf suggesting that the difference in P apparent 
mobility seen previously (for example. Fig. 5) is variable according to 
the composition of the sample buffer used. As the P protein lacks 
cysteine residues (Satake et al., 1984), the appearance of three bands 
in place of the P doublet previously observed with the A2 wild-type is 
probably a consequence of the lower SDS content of the non-reducing 
sample buffer (2% (w/v) instead of 6% in the 3x reducing buffer], as 
will be discussed in greater detail in Results Section 3.4.
In contrast, the absence of ^-mercaptoethanol appears to be 
responsible for the resolution of the M protein in two bands (Fig. 17A) . 
Although confirmation of their M-specificity with anti-M MAbs was not 
carried out, the M protein sequence contains five cysteine residues 
(Satake and Venkatesan, 1984) and its apparent mobility could be 
affected by the absence of the reducing agent, in a manner similar to 
that observed with the 22K protein (see Introduction, Fig. 3). This is 
supported by the fact that both bands migrate faster than the previously 
seen reduced form of the M protein (i.e. below, rather than above, the 
25.7K Mr marker) and the presence of two bands could reflect variation, 
in post-lysis generation and/or rearrangement of intrachain disulphide 
bonds. Gruber and Levine (1983) have also observed two M protein bands
Figure 17.
(A) The Fif2 protein of ts A^ and several ts+ revertants. Cells 
infected with the wild-type A2, the ts mutant A^ or ts+ 
revertants (89/A/4, 11, 16, 17, 20), and maintained at 33°C, 
were labelled with [^5S¡methionine and immunoprecipitated with 
polyclonal anti-RS virus serum. Samples were resuspended in lx 
SDS-PAGE buffer lacking /9-mercaptoethanol and analyzed by 10% 
SDS—PAGE. The resolution of the M protein as two bands and of 
the wild-type A2 P protein as three bands is denoted by arrows. 
The band seen immediately below the N protein band is a 
breakdown product of the N protein, as previously reported 
(CaBh et al., 1979).
(S) P-specificity of the three bands seen in wild-type A2. Cells 
infected with A2 or ts Aj.and maintained at 33°C,were 
immunoprecipitated by anti-RS virus polyclonal serum, 
resuspended in lx non-reducing SDS-PAGE buffer and analyzed by 
10% SDS-PAGE. Following Western transfer to nitrocellulose, 
the filter was stained with anti-P MAb 3-5.
132
under non-reducing conditions and a similar phenomenon exiets for the M 
protein of the other Pneumovirus, murine pneumonia virus (Dr. R. Ling, 
personal communication).
Polypeptide synthesis in revertant-infected cells was also studied 
at 39°C (Fig. 18). The respective profiles indicated that there was 
variation in their degree of reversion to wild-type level of growth at 
the restrictive temperature, as had already been suggested by assay of 
the plaque-forming ability of each revertant at 39°C (Table 9). Thus 
the polypeptides of ts+ clones 89/A/4, 89/A/16 and 89/A/17 are present 
in significant quantities at 39°C, in contrast to the severely reduced 
profile of ts Aj. Revertant 89/A/20, however, shows an intermediate 
level of synthesis, possibly because this clone had only partially 
reverted to a ts+ state. The relative accumulation of viral 
polypeptides of the ts+ clones is presented in Table 10, in comparison 
to that of the ts A^ mutant and wild-type A2. The presence of the 
and F2 subunits in the profile of ts+ 89/A/16 at 33°C (lane 1), despite 
the solubilization of this sample in non-reducing buffer, is probably 
the consequence of diffusion of the reducing buffer from the adjacent 
lane containing the Mr markers (which were routinely resuspended in 3x 
reducing SDS-PAGE buffer). In addition, the M and 22K proteins (in lane 
1 ) have the increased mobility expected in the absence of reduction (see 
Fig. 17A and 3), however the diffusion of /3-mercaptoethanol from the 
adjoining markers track is sufficient to prevent the existence of the 
more highly disulphide-bonded form (i.e. the more rapidly migrating of 
the M and 22K double bands, which are seen in all the other lanes).
From Tables 9 and 10 it can be deduced that revertant clones of 
different phenotypes were isolated. A previous analysis of ts A^- ,
revertants had similarly reported a variety of ts+ phenotypes, i.e. some
figure 18. Polypeptide synthesis of ts Aj and its ts+ revertanta at 
33°C and 39°C. Duplicate BS-C-1 monolayers infected with the A2 
wild-type (lanes 7, 12), ts Ax (lanes 4, 10) or the ts+ revertants 
89/A/16 (lanes 1, 8), 89/A/17 (lanes 2, 9), 89/A/ll (lane 6), 89/A/4 
(lanes 3, 11) and 89/A/20 (lanes 5, 13), and maintained at 33°C 
(lanes 1-7) and 39°C (lanes 8-13), were labelled with [35S] 
methionine and immunoprecipitated with polyclonal anti-RSV serum. 
Samples were resuspended in lx non-reducing buffer and resolved by 
10% SDS—PAGE• Lane M contains the Mr protein markers (sizes 
indicated on the left). For explanation of the profile in lane 1 see 
text. The triplet P band of wild-type A2 is indicated by arrows in 
lane 12. The position of the more rapidly migrating form of the 
protein in tracks 2-13 (i.e. all except lane 1 where reduction of the 
Fi 2 protein has taken place) is indicated by circles.
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Table 9. Efficiency of plating of autant ta »¡ and ita ta+ 
revertants.
Virus clone Viral yield (pfu/ml) Efficiency of plating3
33°C 39°C
ts Aj 2.6 x 105 2.5 x 102 0.96 x 10- 3
wild-type A2 2.0 x 106 1.3 x 106 0.65
ts+ 89/A/4 7.7 x 105 5.7 x 105 0.74
ts+ 89/A/11 4.5 x 105 o»HXoCO 0.17
ts+ 89/A/16 5.5 x 104 5.0 x 104 0.90
ts+ 89/A/17 2 . 1  x 1 0 5 2 . 1  x 105 1 .00
ts+ 89/A/20 6.5 x 105 7.2 x 104 0 . 1 1
aEfficiency of plating • viral yield at 39°C/viral yield at 33°C
Table 10. Conparison of viral protein ayntheaia by wt A2, ta Aj and 
ta+ A1 clones at 33° and 39°C.
Protein Relative accumulation3
ts Ax ts+ A/20 ts+ A/17 ts+ A/4 wt A2
M 4 33 88 165 168
P 19 47 187 140 193
N 39 60 231 129 134
Fl,2 3 15 75 83 170
aRelative accumulation = (protein peak area at 39°a/protein peak
area at 33°C) x 100.
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\revertants resembled wild-type virus whereas others retained some degree 
of temperature-sensitivity (Schnitzer et al., 1976).
One of the revertants possessing an Fj 2 protein with the ts Aj 
mobility (89/A/16) was further analyzed by pulse-chase experiments in 
order to compare the mobility of its F0 protein to that of the wild- 
type. In the experiment shown in Fig. 19, the mobility difference 
previously observed for their respective F1 ( 2 proteins under non­
reducing conditions is non-existent for their FQ proteins under reducing 
conditions (because the Fc proteins of the two viruses are seen to 
comigrate). This observation is similar to the one made for the ts A^
F0 protein, which was not found to exhibit a mobility difference from 
the wild-type F0 protein (Fig. 9; Fig. 11, the estimation is based on 
the position of the wild type and ts Aj F0 proteins relative to the 68K 
Mr marker). Subsequently, the F0 proteins of the other revertants and 
ts Aj were compared directly with the wild-type FQ protein, by labelling 
infected cultures at 33°C for a Bhort pulse period. This was, however, 
long enough to detect some cleavage of F0 into Flf2' 90 that both forms 
could be detected simultaneously (Fig. 20). The fact that the F0 
proteins of the mutant and of all the revertants comigrate with the 
wild-type FQ protein (Fig. 19 and 20) suggests that the apparent 
mobility difference in their F j ^  proteins is not due to differences in 
glycosylation, since these would be observed in their F0 proteins as 
well. Furthermore, the amount of *"1 , 2 protein (in Fig. 20) detected in 
the non-reduced tracks (7-12) can be correlated with the degree of 
cleavage that has occurred during the 25 minute-pulse (as determined, 
visually, by the amount of F^ protein present in the reduced tracks 1 -6) 
suggesting that the shift to a higher Mr position may accompany the F0 i 
proteolytic cleavage. Interestingly, no labelled band which corresponds 
to the reduced FQ precursor can be observed under non-reducing
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Figure 19. Pulse-chase labelling of wild-type A2 and ts+ revertant 
89/A/16. Replicate cell cultures infected with A2 (panels A, C) or 
the ts+ revertant of ts Aj 89/A/16 (panels B, D), and incubated at 
33°C (panels A, B) and 39°C (panels C, D), were labelled with
O C( S]methionine for 10 minutes. Following removal of the label, one 
sample from each set of cultures was lysed and immunoprecipitated 
with polyclonal anti-RS serum (lanes 1). The remaining cultures were 
incubated further in medium containing "cold" methionine for 30 
minutes (lanes 2), 1 hour (lanes 3), 90 minutes (lanes 4) or 2 hours 
(lanes 5) before lysis and immunoprécipitation. Samples were 
resuspended in lx reducing sample buffer and resolved by 10% SDS- 
PAGE. [The difference in intensity of label observed between the 
panels does not reflect temperature-dependent differences but is due 
to miscalculation of the amount of labelling medium that each set of 
cultures received].
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figure 20. The F0 and Fjf2 proteins of ts Aj and its ts+ revertants. 
Duplicate BS-C-1 monolayers, infected with the wild-type A2 (lanes 4, 
lO), ts A^ (lanes 5, 9) or the ts+ revertants 89/A/20 (lanes 1, 7), 
89/A/17 (lanes 2, 8), 89/A/ll (lanes 3, 11) and 89/A/4 (lanes 6, 12) 
and incubated at 33°C, were labelled with [^5SJmethionine for 25 
minutes and immunoprecipitated with polyclonal anti-RS virus serum. 
One set of samples was resuspended in lx reducing buffer and the 
other in lx non-reducing PAGE buffer (indicated in the figure on top 
of the respective tracks). Proteins were resolved by 10% SDS-PAGE. 
The breakdown product of the N protein (Nbrk), seen previously in 
Figure 17A, and the two M protein bands under non-reducing conditions 
are indicated. The wild-type A2 P triplet band is present under 
both reducing and non-reducing conditions, since both buffers 
contained 2% SDS (i.e. lx). Panel B is a longer exposure of the 
fluorogram shown in panel A and is included in order to show the 
aggregated material not entering the resolving gel in the non-reduced 
tracks.
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conditions. However, a significant amount of labelled material can be 
seen to have remained close to the beginning of the resolving gel, as 
well as in the loading wells (Fig. 20B), suggesting the presence of 
aggregates. Formation of dimeric Fj >2 aggregates under non-reducing 
conditions has been previously observed (Lambert, 1988) and it is 
therefore possible that the F0 precursor undergoes similar aggregation.
Summary. Mutant ts A^ was found to exhibit a diminishing level of 
polypeptide synthesis with increasing exposure to 39°C. The cleaved but 
undissociated F 1>2 protein of ts Aj migrated more slowly than its wild- 
type counterpart. Characterization of spontaneous ts+ revertants 
revealed variation in the degree of reversion, however fully ts+ clones 
had an Fl f 2 protein of mutant mobility whereas partially ts+ clones had 
a wild-type mobility - Fl f 2 protein.
3. IB DISCUSSION
Intracellular Protein Synthesis. Mutant ts Aj was previously inferred 
to contain a ts lesion affecting a late stage of viral infection since 
in temperature shift-up experiments it required an incubation of at 
least 12-13 hours at the permissive temperature before infectious virus 
could be produced at 39°C (Belshe et al., 1977; Richardson et al.,
1977). As the latent ("eclipse") period of RS virus is approximately 12 
hours (Peeples and Levine, 1980), such a late lesion might indicate a 
defect in the spread of infection, at the level of membrane glycoprotein 
function, or - more specifically - in the "fusion factor" as suggested 
by Schnitzer et al. (1976), on the basis of multiplicity-enhanced growth 
of ts Aj at 39°C. A similar phenomenon was observed during the protein­
labelling experiments described here (Fig. 5 and 9), where the amounts
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of intracellular labelled polypeptides decreased with increasing times 
of incubation of ts Aj at 39°C prior to labelling, the F protein being 
the most affected polypeptide. Although the ts A^ F protein could not 
be labelled with [3H] glucosamine at 39°C (Fig. 7), the possibility of 
defective F glycosylation seems unlikely, as the ts A^ F0 precursor 
comigrated with that of wild-type A2 at 33°C (Fig. 9B and 20) and the ts 
A^ F0 protein synthesized at 33°C comigrated with F0 protein synthesized 
at 39°C (Fig. 11A). Additionally, no evidence of defective F0 cleavage 
or intracellular instability of the F protein was obtained.
Recently, a ts mutant of the paramyxovirus NDV has been described 
which exhibits impaired FQ cleavage at the restrictive temperature 
(Matsumura et al., 1990). This ts Fc protein was found to accumulate in 
the RER and was thus not transported to the site where cleavage occurs 
(i.e. the trans-Golgi membranes, see Introduction section 1B.1). Since 
cleavage of the RS virus F0 protein also occurs intracellularly at an 
equivalent maturation stage (Fernie et al., 1985; Gruber and Levine, 
1985a,b; Olmsted and Collins, 1989), the observation of F0 cleavage in 
ts Aj-infected cells at 39°C (Fig. 11A) implies that the protein is 
properly transported to the surface. However, the disproportionately 
large decrease (in comparison to the intracellular N and P proteins) of 
the ts Aj_, Pi'2 (or F1 and F2 ) protein observed after long labelling 
periods at 39°C indicates that the protein may be unstable after plasma 
membrane insertion and exposure to the cell surface. This is also 
suggested by the immunofluorescent staining experiments of Pringle et 
al. (1981), who observed a marked reduction of surface antigen at 39°C 
in ts A^-infected cells which exhibited near-normal intracellular
immunofluorescence. The slightly less severe reduetion of the M protein/
detected in ts Aj-infected cells at 39°C (Tables 7 and 8) is consistent 
with a long-term instability of the F protein, as the two proteins are
1 4 0
thought to specifically interact on the cytoplasmic side of the envelope 
(Peeples and Bratt, 1984). In the absence (or weakening) of such an 
association, the M protein may become less stable intracellularly. 
Indeed, decreased stability of the M protein’s association with the 
membrane in the absence of mature G protein (the acid pH-dependent 
fusion glycoprotein of VSV) has been observed with VSV tsG-protein 
mutants (Knipe et al., 1977b). The long-term stabilities of the ts A} F 
and M proteins at 39°C need to be studied by pulse-chase experiments 
where the chase period would be extended from 5 hours (when both are 
present in their pulse-labelled amounts to 18 hours (when the major 
reduction in their amounts is observed).
P mobility difference. The ts Aj F1>2 protein was found to exhibit a 
slower electrophoretic mobility than the wild-type protein (Fig. 13, 14 
and 15) whereas no mobility difference could be discerned in the 
uncleaved F0 precursor (Fig. 9b) or in the dissociated Fj and F2 
subunits (Fig. 10). Since the cleaved but undissociated F1>2 protein 
can only be obtained in the absence of ^-mercapthoethanol, whereas F0 
(pre-cleavage F) is observed in the presence of the reducing agent, this 
discrepancy may be due to the different sample buffers used. This was 
suggested by the fact that even the wild-type F1(2 protein migrated more 
slowly than the respective F0 protein (Fig. 11B and 14).
In the paramyxoviruses Sendai virus, HPIV-3 and Newcastle disease 
virus the F0 precursor migrates faster under non-reducing conditions, 
consistent with the existence of intrachain disulphide bonds, however 
the non-reduced Fl f 2 protein comigrates with the reduced F0 protein, 
despite the presence of interchain (and possibly intrachain) disulphide 
bridges, which would be expected to speed its migration relative to the 
reduced form (Hsu et al., 1981; Chatis and Morrison, 1982; McGinnes et 
al., 1985; Wechsler et al. 1985). The potential aggregation of the RS
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virus non-reduced F0 precursor and the slower mobility of the F ^ 2  
protein with respect to the reduced F0 form (Fig. 14, 18 and 20) 
indicate that the RS virus F protein differs from its paramyxovirus 
counterpart. The molecular organization of these F proteins, as deduced 
from their amino acid sequences, is consistent with this notion since 
the RS virus F sequence i) contains two cysteine residues in the F2 
subunit (thus both could be involved in the disulphide linkage between 
the two subunits), whereas in the other paramyxoviruses there is only 
one cysteine residue; ii) exhibits only partial conservation in the 
number and position of the cysteines in the F^ subunit, whereas there is 
almost exact conservation of this feature between Sendai virus, HPIV-3, 
SV5 and NDV; iii) contains the majority of potential glycosylation sites 
in the F2 subunit, whereas in the paramyxoviruses mentioned above most 
of these are located in the F^ subunit (Blumberg et al. , 1985b; McGinnes 
and Morrison, 1986; Spriggs et al., 1986; Johnson and Collins, 1988b). 
One or all of these features may explain the different electrophoretic 
behaviour of the reduced and non-reduced F0 and F].f2 proteins of RS 
virus.
Interestingly, the non-reduced F1#2 protein of the paramyxovirus 
NDV has been observed to migrate faster than the reduced F0 protein 
under strongly denaturing conditions (6M urea and 4% SDS), suggesting 
that upon efficient denaturation the mobility difference between these 
two forms is - as expected - primarily due to the presence of disulphide 
bonds in the non-reduced F j^ 2 protein (Morrison et al., 1985, 1987). 
Furthermore, for both NDV and Sendai virus, it has been reported that 
proteolytic cleavage induces a conformational change in the fusion 
protein, an aspect of which was the observed increase in detergent- , 
binding sites, presumably due to exposure of additional hydrophobic 
regions after cleavage (Hsu et al., 1981; Kohama et al., 1981). This
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change correlates with the increase of the hydrophobicity threshold of 
the fusion peptide, which becomes terminally - rather than internally - 
located after cleavage, thus being able to directly interact with target 
membranes (Paterson and Lamb, 1987; see also Introduction, section 
IB.1)• Since the fusion peptide of the RS virus Fj^ subunit i B  
comparably hydrophobic (Collins et al., 1984b; Spriggs et al., 1986), it 
would be possible to attribute the slower mobility of the F protein 
under non-reducing conditions to the post-cleavage exposure of the 
strongly hydrophobic fusion peptide, in view of the combined effect on 
mobility of the absence of reduction and the low detergent content of 
the lx non-reducing sample buffer (2% SDS) used throughout this study. 
The diffuse appearance of the F1>2 band under these conditions seen in 
immunoprécipitations (Fig. 14) and the occasional detection of a 
fainter, more rapidly migrating, discrete F band by immunoprécipitation 
and Western blotting (Fig. 13, 14, 16, 18) suggest microheterogeneity in 
F migration, perhaps due to different levels of SDS-binding (and 
potential rearrangement of S-S bonds), giving rise to a ladder of 
conformational variants.
The existence of some degree of conformation in the F1>2 bend is 
supported by the results shown in Figures 14 and 16, where the RSN-2 
Fi ,2 protein iB seen to migrate slower than the A2 protein, in contrast 
to their predicted equivalent positions, calculated by addition of the 
Mr 's of the respective subunits (for RSN-2 s 45-46K (Fj) + 21K (F2) * 
66-67K and for A2 : 47-48K (FjJ + 19K (F2) « 66-67K; see also Fig. 4 and 
7) - and in view of the exact conservation of all cysteine residues in 
the mature F protein between the two RS virus subgroups. However, 
solubilization under conditions achieving complete.dénaturation of the, 
Fl ,2 Protetn (such as urea) and perhaps treatment with the alkylating 
agent iodoacetamide (to prevent aberrant post-lysis disulphide bond
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formation) will be required to evaluate the relative contribution of the 
hydrophobic fusion peptide and the native disulphide bonds to the 
electrophoretic migration of the *"1 ,2 protein.
A similar hypothesis has been used to account for the mobility 
difference in the F^ subunit of the A2 (subgroup A) and 18537 (subgroup 
B) strains, which is unexpectedly large considering their high degree of 
amino acid identity. This phenomenon has been attributed to an indirect 
effect of the few existing amino acid differences on electrophoretic 
mobility, by alteration of protein conformation and/or detergent-binding 
properties (Johnson and Collins, 1988b). On the assumption, therefore, 
that the apparent mobility of the non-reduced F1>2 form is dependent on 
protein conformation, the observed mobility difference between the wild- 
type and mutant F1>2 proteins could be interpreted as the result of a ts 
mutation in the F protein of ts Aj which alters its conformation.
Analysis of ts* rsvertants. Genetic instability and reversion of ts Aj 
has been found previously to occur both in vivo and in vitro. Revertant 
viruses were first detected during vaccine trials with ts A^ in children 
(Kim et al., 1973), with only a small number of revertant isolates 
exhibiting complete loss of temperature-sensitivity (Hodes et al. ,
1974). Two types of revertants were isolated in the present study, 
exhibiting either complete or partial restoration of efficiency of 
plaquing at 39°C (Table 9). Electrophoretic analysis of these 
revertants showed that in ts+ clones with nearly wild-type profiles and 
efficiencies of plating at 39°C (Tables 9 and 10) the F1>2 mobility 
remained the same as in their mutant parent, whereas in ts+ clone 
89/A/20, with the lowest efficiency of plating at 39°C, the F1<2 protein 
had a wild-type-like mobility (Fig. 17). Therefore both types of 
revertants would seem to be the consequence of second-site mutations
144
because i) restoration of wild-type mobility does not coincide with 
complete restoration of wild-type plaquing efficiency ii) restoration of 
plaguing efficiency at 39°C (and therefore viral growth) is possible 
while the protein still exhibits the altered mutant mobility.
Different kinds of second-site reversion within the same gene 
(intragenic suppression) suggest the existence of an F-gene segment 
where several amino acid changes can be tolerated. This contrasts with 
the high degree of conservation between the F proteins of the two RS 
virus subgroups, especially in the membrane anchor region and the N- 
terminus of Fj subunit (Baybutt and Pringle, 1987; Johnson and Collins, 
1988b). However a region of relatively low sequence conservation has 
been identified in the F2 subunit, located between residues 111 to 129, 
which immediately precedes the protease cleavage region (residues 130- 
136). This hydrophilic region is predicted to have a prominent 
secondary structure and is possibly localised on the surface of the 
protein (Johnson and Collins, 1988b). It is thus conceivable that 
second-site mutations might occur within this less conserved segment, 
which could compensate the proposed ts Aj lesion.
In the absence of a strict correlation of reversion of the ts 
phenotype with fx,2 mobility however, it is possible that the ts 
mutation is located in a gene other than F. In that case, the altered F 
mobility in ts Aj could be a secondary phenotypic effect, perhaps due to 
its association with the ts gene product. According to this hypothesis 
partial reversion could be interpreted as a second mutation in the F 
component of the presumptive complex, which restores the mobility but 
not fully circumvents the ts defect. The *"1 , 2 band which exhibits 
altered mobility in ts A^ is unlikely to represent,a complex of the F , 
protein with either the G or the 22K membrane proteins in view of the 
Western blot analysis (Fig. 15 and 16). In addition, the amount of
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because i) restoration of wild-type mobility does not coincide with 
complete restoration of wild-type plaquing efficiency ii) restoration of 
plaquing efficiency at 39°C (and therefore viral growth) is possible 
while the F1>2 protein still exhibits the altered mutant mobility.
Different kinds of second-site reversion within the same gene 
(intragenic suppression) suggest the existence of an F-gene segment 
where several amino acid changes can be tolerated. This contrasts with 
the high degree of conservation between the F proteins of the two RS 
virus subgroups, especially in the membrane anchor region and the N— 
terminus of F^ subunit (Baybutt and Pringle, 1987; Johnson and Collins, 
1988b). However a region of relatively low sequence conservation has 
been identified in the F2 subunit, located between residues 111 to 129, 
which immediately precedes the protease cleavage region (residues 130- 
136). This hydrophilic region is predicted to have a prominent 
secondary structure and is possibly localised on the surface of the 
protein (Johnson and Collins, 1988b). It is thus conceivable that 
second-site mutations might occur within this less conserved segment, 
which could compensate the proposed ts Aj lesion.
In the absence of a strict correlation of reversion of the ts 
phenotype with F1>2 mobility however, it is possible that the ts Aj 
mutation is located in a gene other than F. In that case, the altered F 
mobility in ts A^ could be a secondary phenotypic effect, perhaps due to 
its association with the ts gene product. According to this hypothesis 
partial reversion could be interpreted as a second mutation in the F 
component of the presumptive complex, which restores the mobility but 
not fully circumvents the ts defect. The F^(2 band which exhibits 
altered mobility in ts A^ is unlikely to represent,a complex of the F , 
protein with either the G or the 22K membrane proteins in view of the 
Western blot analysis (Fig. 15 and 16). In addition, the amount of
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cleavage observed to take place during a short labelling period 
correlated well with the amount of higher mobility - ^1 , 2 protein seen 
in duplicate non-reduced samples (Fig. 20). However, in the light of a 
recent report that three of the four 1A protein forms can accumulate on 
the surface of intact infected cells (Olmsted and Collins, 1989), it is 
possible that a disulphide-linked complex between the F and any of these 
multiple 1A forms could be formed during transport to, or at, the 
membrane. Sequence analysis of the F gene of ts A^ and its revertants 
will be required to confirm the contribution of the F protein to the ts 
phenotype of mutants in complementation group A.
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3.2 Ts MUTANT An
3.2A. RESULTS
Mutant ts A2 belongs to the group of ts mutants isolated from 
the RS virus A2 wild-type strain by Gharpure et al. (1969). This 
mutant was later shown to be distinct from the other ts mutants of 
the A2 strain, because of its ability to form atypical, non- 
syncytial plaques at the permissive temperature (Wright et al.,
1973; Belshe et al., 1977). The non-syncytial cytopathology of ts 
Aj (in HEp-2 cells) was not observed in the BS-C-1 cell line which 
has been used throughout this study. Originally, 10 ts mutants of 
the RSN-2 strain, exhibiting the normal plaque morphology in BS-C-1 
cells, were classified together with ts A2 in complementation group 
B (Gimenez and Pringle, 1978). However more stringent 
complementation experiments have led to separate classification of 
these RSN-2 ts mutants (of which ts N17 is the prototype) in group 
B' (Pringle et al., 1981). Therefore ts A2 is currently the only 
mutant representing complementation group B.
Intracellular polypeptide synthesis. The polypeptides synthesized 
in cells infected with ts A2 or the wild-type A2 at the permissive 
and restrictive temperatures are shown in Fig. 21A. As already 
mentioned in Section 3.1A, all three ts mutants from the A2 strain 
(ts Aj, ts A2, ts A7) have a single P protein band, whereas the 
wild-type A2 P protein migrates as a doublet. Apart from this 
difference, the electrophoretic profiles are qualitatively identical 
at both temperatures (except for the presence at 33°C of an F- 
related band "Fx", see below). Quantitative comparison of the 
profiles (Table 11) shows that, in so far as the major [ 35S ]-labelled
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* figure 21.
(A) Viral polypeptide synthesis in ts A2-infected cells. Duplicate 
BS-C-1 monolayers were infected with the wild-type A2 (lanes
1.2) or mutant ts A2 (lanes 3,4) and incubated at 33°C (lanes
1.3) and 39°C (lanes 2,4). (35S)labelled-, RS virus-specific
proteins were resolved by SDS-PAGE (6-15* linear polyacrylamide 
gradient) after immunoprécipitation with polyclonal anti-RSV 
serum and solubilization in 3x sample buffer. Lane 5 contains 
RS virus polypeptides synthesized in ts A^—infected cells at 
39°C (this figure is a reproduction of Figure 5). The faint 
band observed in lane 3 and indicated as "Fx" is an F-specific 
polypeptide as discussed in the text. The band indicated by 
circles in lanes 3, 4, 5 is a cellular polypeptide (as shown 
previously in Figures 6 and 7).
(B) Viral polypeptide synthesis in ts Nj^-infected cells.
Duplicate BS-C-1 monolayers were infected with the wild-type 
RSN-2 (lanes 1,2), mutant ts N 17 (lanes 3,4) or two plaque- 
purified clones of mutant ts Ng (clone 6/1/2 in lanes 5 and 6, 
clone 6/1/3 in lanes 7 and 8), incubated at 33°C (lanes
1,3,5,7) and 39°C (lanes 2,4,6,8) and labelled with 
[33S )methionine. Samples were immunoprecipitated with 
polyclonal anti-RS virus serum and analyzed on a 6-15* linear 
gradient gel.
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Table 11 Relative accumulation* of intracellular polypeptides in 
wild-typo A2- and ts A2-infacted calls.
Polypeptide Wild-type A2 ts A2
N 60 55
P 195 120
N 65 90
*1 64 75
Table 12. Relative accumulation* of intracellular glycopolypeptides 
in wild-type A2- and ts Aj-infacted cells.
Polypeptide Wild-type A2 ts A2
*2 59 68
*1 74 56
p50 (Ga) 85 72
G 68 22
Relative accumulation = (protein peak area at 39°C/
protein peak area at 33°C) x 100
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polypeptides are concerned, the overall protein-synthesizing 
activity of ts A2 is not markedly impaired at 39°C. Considering the 
fact that virus adsorption, in this and all other experiments in 
this thesis, was carried out at the permissive temperature, prior to 
incubation and labelling at 39°C, this observation concurs with 
previous findings regarding the inability of the higher temperature 
to significantly restrict growth of ts A2 once adsorption had taken 
place at 32°C (Belshe et al., 1977). Thus, despite the variance of 
the plaque phenotype, the growth characteristics of ts A2 at 39°C 
are similar in HEp-2 and BS-C-1 cells. Comparison of the profiles 
of ts A2 and ts N17 at 39°C (Fig. 21A and B, respectively) supports 
the classification of the two mutants in separate complementation 
groups and extends the observations of Pringle et al. (1981), who 
reported absence of intracellular immunofluorescence in ts 
infected cells at 39°C (see also Introduction, Section 1C.3).
Synthesis of glycoproteins. Analysis of intracellular glycoprotein 
synthesis by ts A2 at 33°C and 39°C was also undertaken by 
immunoprécipitation of [^H]glucosamine—labelled proteins (Fig. 22A) •
In addition to the Fl, F2 and G glycoproteins, and the major G 
precursor species p50 (see also Fig. 4 in Introduction), the 
trailing end of the glycosylated, mature form (22-35 Kd) of the 1A 
protein is also faintly detectable (the glycosylated 1A forms have 
been shown in Fig. 10B). The G precursor bands are always observed 
in subgroup A viruses (such as the RSS-2 and A2 strains shown in 
Fig. 22A) to a variable degree, depending on the virus strain and 
the stage of viral growth at which labelling was initiated. A 
similar observation has been reported for the subgroup A/Long and A2 1 
strains by Routledge et al. (1986). Significantly, the intensity of 
the G protein band is markedly reduced at 39°C in the ts A2-
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Figure 32
(A) Synthesis of RS virus glycoproteins in ts A2~infected cells. 
Duplicate cell monolayers, infected with the subgroup A wild- 
type strains RSS-2 or A2, or the ts mutant A2, and mock- 
infected cultures (UI) were incubated at 33°C (lanes 33) and 
39°C (lanes 39) and labelled with [3H]glucosamine. Viral 
glycoproteins were immunoprecipitated with polyclonal anti-RSV 
serum and analyzed on a 6-15% linear gradient gel. The 1A form 
observed here is the trailing end of the heterodisperse 22-35K 
band shown previously in Figure 10.
(B) Viral glycoproteins in PEG-precipitated supernatants. The 
supernatant media from the [3H]glucosamine-labelled, virus- 
infected and mock-infected cultures shown in (A) were collected 
and mixed with 36% PEG. After overnight incubation at 4°C, 
PEG-precipitated material was collected by centrifugation, 
lysed in RIP buffer and immunoprecipitated with polyclonal 
anti-RSV serum. Lanes 3 and 9 contain samples from 33° and 
39°C, respectively. Lanes M in (A) and (B) contain the Mr 
protein markers.
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infection compared to the G protein present in the control infection 
of 33°C, whereas synthesis of the precursor species p50 seems to be 
restricted to the same relative level as that seen for the Fj and F2 
subunits (Table 12). On the other hand, analysis of PEG- 
precipitated supernatant medium from the infected cultures shown in 
panel A does not reveal an equivalent deficiency of mature G in ts 
A2 virions produced at 39°C (Fig. 22B).
PEG-precipitation of supernatant fluids from RS virus-infected 
cultures has previously been described as the most satisfactory 
method for concentration of RS virus particles (Wunner and Pringle, 
1976), thus this method has been routinely applied in the course of 
this study in order to obtain profiles of virion-associated 
proteins. PEG-precipitated material was assumed to represent shed 
virus particles, despite the inability to differentiate between 
intact virions and soluble macromolecules or protein released from 
disrupted cells. This assumption was based on the ability to 
reproducibly detect above background levels the full complement of 
structural polypeptides in immunoprecipitates of such material 
(examples are shown in Fig. 23). Specifically in Figure 22B, the 
presence of all three glycoproteins in the profile would suggest 
that the observed proteins were derived from virus particles.
However, in view of the heterogeneous migration of the G protein and 
the small mobility difference between the virion-associated and 
soluble forms of the G (6-9 K; Hendricks et al., 1988), it is 
possible that both forms are present in PEG-precipitated 
supernatants from infected cultures. Thus, G protein from such 
material would be more appropriately characterized as ,
"extracellular" G.
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' Figure 23. Immunoprécipitation of virion-associated polypeptides 
from PEG-precipitated supernatant media of RS virus-infected 
cultures.
(A) Cells infected with the wild-type A2, or mutant ts A2» were 
incubated at 33°C (lanes 3) and 39°C (lanes 9) and labelled 
with [35S¡methionine overnight. The culture supernatant media 
were clarified from cellular material by centrifugation at 
10,000g and mixed with 1/5 volume of 36% PEG. After overnight 
incubation at +4°C, PEG-precipitated particles were collected 
by centrifugation, lysed and immunoprecipitated with polyclonal 
anti-RS virus serum. Samples were analyzed on a 6-15% linear 
gradient gel.
(B) Cells infected with the wild-type A2 or ts A2 , and mock- 
infected cells (UI), were Incubated at 33°C and labelled with a 
mixture of [3H]leucine/[14C]-labelled protein hydrolysate, in 
order to obtain simultaneous detection of the RS virus 
structural polypeptides and of the G glycoprotein (which is 
poorly labelled with [ 35S]methionine). Treatment of the 
supernatant media from these cultures was performed as 
described in (A).
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The intracellular deficiency of mature G in ta A2~infected 
cells at 39°C was also observed by immunoprécipitation with two 
different anti-G MAbs (Fig. 24) and it did not appear to be the 
consequence of variation in the stage of post-translational 
processing at which labelling was carried out, since similar 
quantities of the p50 precursor were detected in ts A2~ and wild- 
type A2-infected cells. Figure 24B also shows the G mobility 
difference between the subgroup A/A2 strain and the subgroup B/RSN-2 
strain. This and other differences between the G proteins of 
strains A2 and RSN-2 are considered separately at the end of this 
section.
Pulse-chase experiments. To examine the maturation of the G protein 
in more detail, the kinetics of G synthesis was studied in ts A2- 
infected cells, pulse-labelled with [3H]leucine, chased and 
immunoprecipitated with anti-G MAb a793 (Fig. 25A). At 33°C the 
major precursor p50 can be seen throughout the duration of the 
chase, with mature G first apparent at 30 minutes after the end of 
the pulse, consistent with previous reports (Gruber and Levine, 1985 
a,b) and thereafter increases with time. [The decreased amount of 
label in the 90 minute-sample of 33°C is due to accidental loss of 
part of the sample during preparation). The major precursor is also 
efficiently labelled at 39°C, suggesting that G synthesis until this 
stage is unaffected at the restrictive temperature, but no 
corresponding maturation into fully-glycosylated G protein can be 
detected, for at least the first 90 minutes of chase. In contrast, 
a similar experiment with wild-type-infected cells (Fig. 26) shows 
that the major precursor p50 can be chased into mature G from 30 
minutes after the pulse onwards with equal efficiency at both
temperatures.
Figure 24.
(A) Synthesis of the G glycoprotein in RS virus-infected cells. 
Duplicate BS-C-1 monolayers, infected with the subgroup A wild- 
type strains RSS-2 and A2, or the mutants ts A2 , ts A7 and ts 
Aj, were incubated at 33°C (lanes 3) and 39°C (lanes 9) and 
labelled with [3H)glucosamine. G-specific glycopolypeptides 
were immunoprecipitated with the anti-G MAb III.2a (a gift from 
Dr. E. Stott). The two precursor forms p45 and p50 are not 
well separated, probably due to the existence of a ladder of 
intermediates between them (see Figure 4).
(B) Duplicate BS-C-1 monolayers infected with the subgroup B wild- 
type strain RSN-2, or the subgroup A wild-type A2 or ts A2, 
labelled with [3H]glucosamine and incubated at 33°C and 39°C, 
were immunoprecipitated with polyclonal anti-RS virus serum 
(lanes p) or with the anti-G MAb a793 (lanes m). The arrows 
indicate the presence of some uncleaved F0 in ts A2-infected 
cells at both temperatures. Lanes M in (A) and (B) contain the 
Mr protein markers.
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Figure 35.
(A) Kinetics of G-protein maturation in ts A2-infected cells. BS­
C-1 monolayers were infected with the mutant ts A2 » incubated 
at 33°C and 39°C, and labelled with [3H]leucine for 15 minutes. 
Following removal of the labelling medium, one culture from 
each temperature was lysed and immunoprecipitated with anti-G 
MAb a793 (lanes P). The remaining cultures were similarly 
treated after further incubation at the two temperatures for 
the times indicated in the figure (in minutes) on top of the 
respective tracks (2h = 2 hours). Samples were analyzed on a 
6-15% linear polyacrylamide gradient gel. The figure shows the 
major G-precursor species p50 and the gradual maturation of 
this species into G protein during the chase at 33°C. The 
presence of N and M protein bands in the profiles of 39°C is 
probably due to non-specific precipitation of these proteins.
(B) Immunoprécipitation with anti-G MAb a793. Cells infected with 
the wild-type RSN-2 (lane 1), the ts+ revertant (of ts N^) R2/3 
(lane 2), the wild-type A2 (lane 3) or the mutant ts A2 (lane 
4), were incubated at 33°C and labelled with [3H]leucine for 16 
hours. Samples were then immunoprecipitated with anti-G MAb 
a793 and analyzed by 10% SDS-PAGE. The positions of the two G- 
precursor species p45 and p50 are indicated. Lane M contains 
the Mr protein markers.
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Figure 26. Kinetics of G-synthesis in A2-infected cells. Replicate 
BS-C—1 monolayers were infected with the wild-type A2, incubated at 
33°C and 39°C, and labelled with a mixture of [3H]leucine/[3H]fucose 
(each at approximately 150 pCi/ml) for 15 minutes. Following removal 
of the labelling medium, one culture from each temperature was lysed 
and immunoprecipitated with the anti-G MAb a793 (lanes P). The 
remaining cultures were similarly treated after further incubation in 
medium supplemented with an excess of non-radioactive leucine and 
fucose, at the two temperatures, for the times shown on top of the 
respective tracks. The positions of the two G-precursor species p45 
(Gb) and p50 (Ga) are indicated. The presence of N and M protein 
bands in the profiles are probably due to non-specific precipitation 
as discussed in the text. [The disappearance of mature G protein 
from the infected-cell cytoplasm between 3-6 hours after labelling at 
39°C, when most of the mature G can be detected intracellularly at 6 
hours of chase at 33°C, could be due to earlier production and 
release into the supernatant medium of the soluble form of the G (Gs) 
at 39°C]• Lanes M contain the Mr protein markers.
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The presence of the N and M proteins in the profiles of Fig. 
25A and 26, despite the use of an anti-G MAb for immuno­
précipitation, is probably an artifact due to their intracellular 
abundance and their relatively high content of leucine (both 
approximately 10% as opposed to 6% for the G) and has also been 
previously reported (Gruber and Levine, 1985b). Coprecipitation of 
the N and M proteins by this anti-G MAb was also observed in 
immunoprécipitations of (^H)leucine-labelled infected cells at 33°C 
(Fig. 25B) after overnight labelling. Given the relative amounts of 
N and M proteins precipitated by the anti-G MAb and by polyclonal 
anti-RS serum (for example. Fig. 21A), their presence in the anti-G 
MAb profiles seems non-specific, probably reflecting residual (i.e., 
inefficiently washed) N and M protein in the immunoprecipitates.
Taken together the aforementioned data indicate that the 
defect in G protein maturation at 39°C is the underlying cause of 
the ts phenotype of mutant ts A2 . An unexpected additional result 
was obtained however by pulse-chase experiments with [”^S]methionine 
of cells infected with ts A2 (Fig. 27).
Comparison of the mutant and wild-type profiles (panels A and 
B, respectively) reveals a significant difference regarding the 
timing and extent of cleavage of the Fc precursor into its component 
subunits Fj and F2. In sharp contrast to the wild-type cleavage 
pattern, the ts A2 F0 protein was not detectably cleaved before 20— 
30 minutes of chase, and, even after its onset, the cleavage 
involved only a minority of molecules, with the bulk of F0 precursor 
remaining uncleaved by 2 hours of chase. Significantly, this 
considerably diminished rate of cleavage occurred^similarly at both 
the restrictive and permissive temperatures (the slightly increased 
cleavage observed at 39°C is probably due to the more intense
• *
figure 27. Kinetics of F0 cleavage in ts A2-infected cells.
Replicate BS-C-1 monolayers were infected with the mutant ts A2 
(panel A) or the wild-type A2 (panel B) and incubated at 33° and 
39°C. Following labelling of cultures for 10 minutes with 
(^^S]methionine, and removal of the labelling medium, one culture 
from each temperature was lysed and immunoprecipitated with 
polyclonal anti-RS virus serum (lanes p). The remaining cultures 
were similarly treated after further incubation at the two 
temperatures in medium containing excess non-radioactive methionine 
(chase). The minutes of chase are indicated on top of the respective 
tracks (panel B is a shorter exposure to X-ray film of the gel shown 
in Figure 11B). Samples were analyzed by 6-15% linear gradient gels. 
Lanes M contain the Mr protein markers (the numbers shown indicate 
molecular weight in kilodaltons).
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\labelling of the samples of 39°C, as indicated by their higher 
background levels compared to the samples of 33°C).
This finding was not anticipated since in longer (overnight) 
labelling experiments no deficiency of F^ and F2 subunits had been 
observed in ts A2 profiles (Fig. 21A, 22A), although occasionally 
some uncleaved FQ protein could also be detected (Fig. 24B). In 
addition, no difference in the immunoreactivity of the ts A2 F 
protein was observed, since it was efficiently immunoprecipitated by 
a panel of anti-F MAbs (Fig. 12, 28). Interestingly, a fainter band 
of an approximate Mr of 53-54K, which had previously been detected 
by polyclonal antiserum (Fig. 21A) in ts A2-infected cells, was also 
recognized by the anti-F MAbs, suggesting that it i B  F-related.
This band, designated as "Fx", was also found to be glycosylated by 
anti-F MAb immunoprécipitation of (3H]glucosamine-labelled infected 
cultures (Fig. 28B). Since this "Fx" band is present in small 
amounts after overnight labelling and was not observed during the 
pulse-chase experiment with ts A2 (Fig. 27A), it is possible that it 
arises from proteolytic degradation of the FQ precursor, due to its 
inefficient cleavage. However, the apparent stability of the F0 
protein (indicated by the ability to detect it after overnight 
labelling experiments) and the consistency in the Mr of the Fx band 
suggest that this "breakdown" occurs at a defined site which, 
despite its infrequent usage, is accessible to a proteolytic enzyme. 
O protein differences between wild-type strains. The G mobility 
difference between strains RSN-2 (subgroup B) and A2 (subgroup A), 
shown in Fig. 24B, is consistent with the previously recognized 
pattern of more slowly migrating G proteins being characteristic of 
subgroup A strains (Akerlind et al., 1988). Strain-specific 
variation in G mobility has also been found, thought to arise from
1 6 0
* figure 2 8.
(A) Xnununoprec ipitat ion of F-specific polypeptides in ts A2- 
infected cells. Replicate BS-C-1 monolayers infected with the 
wild-type A2 (lanes 1), ts A2 (lanes 2) or ts Ax (lanes 3), 
were incubated at 33°C and labelled with [ ^ SJmethionine. 
Samples were immunoprecipitated with the anti-F MAbs F4r F5, F7 
and F9 and analyzed by 10* SDS-PAGE. The arrows indicate the 
presence of an additional F-specific polypeptide (Fx) in ts A2- 
infected cell lysates. The 23K polypeptide is a breakdown 
product of the Fj subunit (as previously shown in Figure 12).
(B) F-specific glycosylated polypeptides in ts A2-infected cells. 
Duplicate BS-C-1 monolayers, infected with wild-types RSS-2 or 
A2, or mutant ts A2, were incubated at 33°C (lanes 3) and 39°C 
(lanes 9). Following labelling with [^H)glucosamine, samples 
were immunoprecipitated with an anti-F MAb, boiled in 3x 
reducing SDS-PAGE buffer and resolved on a 6-15* linear 
gradient gel. The arrows indicate the presence of some 
uncleaved F0 precursor and of the "Fx" polypeptide in ts A2- 
infected cells. Lanes M in (A) and (B) contain the Mr protein 
markers.
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sequence variability in the potential acceptor sites for N- and O- 
linked glycosylation (Routledge et al., 1986; Johnson et al., 1987). 
In addition to the mobility difference of the mature G protein, the 
difference in abundance (and mobility) of the G precursor species 
between RSN-2 and A2 is also noteworthy in Fig. 24B. Appreciable 
amounts of corresponding precursor forms of the RSN-2 G protein have 
not been consistently detected (Fig. 29A), in contrast to the 
situation with subgroup A strains A2 and RSS-2 (Fig. 22, 24, 29).
It should be mentioned that both anti-G MAbs used (a793 in Fig. 24B 
and L9 in Fig. 29A), although cross-reactive, have been raised 
against the G protein of the subgroup A/Long strain and react with 
the p50 precursor (Ga) of the A2 strain also in Western blots [Fig. 
15; anti-G MAb L9 also reacts with the polypeptide moiety of the A2 
G protein in Western blots (Wertz et al., 1989)]. Thus, the 
differing efficiency of immunoprécipitation of precursor forms in 
the A2 and RSN-2 strains may reflect differences in the 
immunoreactivity of the respective immature G proteins.
Walsh et al. (1987) have similarly not detected G-precursor 
species in another subgroup B virus (strain 18537) using an anti-G 
(Long) monospecific serum, although such species were detectable by 
the homologous anti-G(18537) serum. These observations indicate 
that the cross-subgroup-reactive antigenic determinants, already 
present in the Ga and Gb precursors of subgroup A strains and 
maintained during further processing, evolve in the course of G 
maturation in subgroup B strains, possibly as the result of post- 
translational modifications, and imply that conformational 
rearrangements may be involved in the G maturation process.
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Figure 29. G protein synthesis, in the presence or absence of tunicamycin, in 
a ✓RS virus strains of subgroups A and B. In panel A, cells infected with the 
subgroup A-strain A2 (lanes A) or with the subgroup B-strain RSN-2 (lanes N) 
and maintained at 33°C, were labelled with [3H]glucosamine, lysed and 
immunoprecipitated with the anti-G MAb L9 or the anti-G(Long) monospecific 
antiserum 1045 (both kindly provided by Dr. E. Walsh, Rochester, New York). 
Samples were analyzed by 10% SDS-PAGE. The positions of the two G-precursor 
species p45 and p50 (apparent only in the A tracks) are indicated.
In panel B, cells infected with the subgroup A-strains RSS-2 and A2, or 
with the subgroup B-strain RSN-2, were incubated at 33°C in the absence (lanes 
-) or presence (lanes + ) of tunicamycin (2 pg/ml, added to culture medium 
immediately after adsorption of the virus inoculum) and labelled with 
[ 3H )glucosamine. Samples were immunoprecipitated with polyclonal antiserum 
and analyzed on a 6-15% linear gradient gel. The position of the tunicamycin- 
resistant form of the G protein (GTM), present in extracts of cells infected 
with the subgroup A strains, is indicated. The 1A form seen in the untreated 
A2 sample is the 16K partially glycosylated form of the 1A protein (see also 
Figure 10). The presence of and F2 bands in the tunicamycin-treated, RSN- 
2-infected cell extract is probably due to "leaking" of labelled material from 
the adjoining track (this can also be observed to occur for the F2 band from 
the untreated RSS-2 sample) as discussed in the text. A similar experiment is 
shown in panel C, where cells infected with the three wild-type strains were 
labelled with [3H]glucosamine in the presence (+) or absence (-) of 2 pg/ml of 
tunicamycin in the culture medium. [The inability to detect a GTM form in the 
samples of panel C may be due to differences in the stage of infection at 
which labelling was initiated and/or in the concentration of label used (panel 
B : 150 pCi/ml, panel C : 100 ¿iCi/ml)].
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Tunicamycin-resistance. A further difference that has been observed
between subgroup A (A2 and RSS-2) and subgroup B (RSN-2) strains is 
the repeated inability to detect a tunicamycin-resistant form of the 
RSN-2 G protein (Fig. 29B and data not shown). The presence of F  ^
and F2 bands in the tunicamycin-treated RSN-2 sample is most likely 
due to ’leaking'* from the adjacent, intensely labelled untreated 
sample, since in other experiments with the same concentration of 
tunicamycin used (2 pg/ml) N-linked-glucosamine incorporation into 
F^ and F2 was completely inhibited (for example. Fig. 29C). Since 
the number of potential N-linked G-glycosylation sites is known to 
be variable between strains, the absence of a tunicamycin-resistant 
RSN-2 G protein could be due to inefficient labelling by (3HJgluco- 
samine of the O-linked glycosylation process alone. However, fully 
glycosylated RSN-2 G protein can be labelled by [3H]glucosamine 
almost as effectively as the A2 G protein (Fig. 24B, 29A) suggesting 
a similar final content of glucosamine. The significance of these 
findings is discussed in Section 3.2B.
Summary. Immunoprécipitation of viral proteins from ts A2~infected 
cells with polyclonal anti-RS serum and monoclonal anti-G antibodies 
has revealed a reduction of the intracellular amount of mature G 
protein at 39°C. Study of the kinetics of G-processing has shown 
normal synthesis of the major precursor species p50 in the mutant 
but lack of further processing into mature G at 39°C. Pulse-chase 
studies of overall protein synthesis in ts A2~infected cells have 
also revealed defective proteolytic cleavage of the F0 precursor at 
both temperatures.
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3.2B. DISCUSSION
O protein defect. The polypeptide profiles obtained from ts Aj- 
infected cells at 33° and 39°C (Fig. 21A) are in agreement with the 
hypothesis of Belshe et al. (1977) that ts Aj is defective in 
adsorption/penetration. Overall protein synthesis was not 
drastically reduced at 39°C once ts A¿ had adsorbed at the 
permissive temperature. In view of the fact that G is the 
glycoprotein mediating RS virus attachment to host cells (Levine et 
al., 1987), the decrease in the intracellular amount of ts A¿ G 
protein observed at 39°C (Fig. 22 and 24) is consistent with 
existence of a ts defect in this protein. The G protein deficiency 
affected only the final, full-size product and was not observed in 
the major G precursor species p50 (Ga), which could be detected in 
comparable amounts at 33°C and 39°C (Table 12). These results can 
be interpreted in two ways : either i) the G maturation process is 
significantly delayed after synthesis of the major precursor p50, 
possibly at the time of passage through the Golgi apparatus, en 
route to the plasma membrane or ii) the G protein follows the normal 
synthetic pathway intracellularly but, having reached the membrane, 
is then rapidly sequestered into virus particles and/or the culture 
medium. The pulse-chase experiment shown in Fig. 24A supports the 
first interpretation, since the major precursor was not observed to 
undergo further processing at 39°C at the times when this was 
clearly occurring at 33°C.
The p50 (Ga) precursor has recently been demonstrated to 
contain Endo H-resistant N-linked carbohydrates (Wertz et al.,
1989), indicating that it has reached the medial Golgi compartment 
(Dunphy and Rothman, 1985). Since core O-glycosylation takes place
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in the cis-Golgi cieternae (Roth, 1984), the Endo H-resiatance of
the pSO apeciea implies that the molecule contains O-linked 
carbohydrate, as has previously been shown for Herpesvirus 
glycoproteins (Johnson and Spear, 1983). Addition of O-linked N- 
acetylgalactosamine residues and W-acetylglucosamine-modification of 
N-linked oligosaccharides probably account for the mobility 
difference between the p50 (Ga) and p45 (Gb) precursor forms, since 
the latter represents the cotranslationally glycosylated G protein 
species in the RER (Lambert, 1988; Wertz et al., 1989). Therefore 
the observation of the p50 precursor in ts A2~infected cells at 39°C 
suggests that the delay in its maturation may arise from defective 
transport from the medial to the trans-Golgi cisternae where 
processing of the O-linked core carbohydrates occurs. Although the 
Endo H-resistance of the major G precursor was not assayed in the 
present experiments, several attempts to examine O-glycosylation 
separately, by dissociating it from N-glycosylation with the use of 
tunicamycin (as shown in Fig. 29B), were unsuccessful, even with 
wild-type infections, because it was found that incubation at 39°C, 
in the presence of the drug, destroyed the cell monolayer before 
viral growth was sufficiently advanced for effective radiolabelling 
(possibly due to the general inhibitory effect of tunicamycin on 
protein synthesis and the increased rate of host macromolecular 
synthesis at 39°C). However, the small amount of mature G in ts A2~ 
infected cells at 39°C and the normal abundance of extracellular G 
in the supernatant of such cultures could be taken as evidence of 
completed O-glycosylation of the ts A2 G protein at 39°C.
Furthermore, the ability of the A2 strain-G protein lacking either • 
N- or O-linked glycosylation to be expressed on the cell surface 
(Satake et al., 1985; Wertz et al., 1989) makes unlikely the
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possibility that defective core O-glycosylation is the cause of the 
delayed precursor maturation in ts A2.
Intracellular O transport. Little is known about the structural 
features required for the vectorial transport of class II (i.e. N- 
terminally anchored) membrane glycoproteins, in contrast to the 
detailed information available on class I glycoproteins (such as the 
VSV G, see Introduction, Section 1A.4). Recent studies with 
carboxy-terminally truncated RS virus G protein molecules have 
indicated that the conformation of the G ectodomain has little 
effect on transport (Vijaya et al., 1988; Olmsted et al., 1989). 
However, the retention of the membrane-proximal portion of the G 
ectodomain in those truncated mutants which were efficiently 
expressed on the surface indicates that this region may also have a 
role in transport, since the N-terminal domains which promote 
translocation are the first protein regions to be synthesized but 
their transport function will not be exhibited before the remainder 
of the protein has been released into the lumen of the RER. 
Furthermore, the absence of more processed intermediates between the 
p50 precursor and the mature G protein, coupled with the detection 
of the p50 as a major and stable precursor, and the event of late 
processing of this species (this study; Fernie et al., 1985; 
Routledge et al., 1986; Walsh et al., 1987; Wertz et al., 1989), 
suggest that there may be a natural pause in the G maturation 
pathway at the p50 stage, with further processing occurring rapidly 
such that only mature G can be observed thereafter. This pause may 
be due to conformational rearrangements similar to those necessary 
for creation of the cross-subgroup epitopes in the RSN-2 G protein 
(see below) and possibly explains the non-quantitative conversion of 
the pSO precursor into mature G protein during the pulse-chase
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experiments of Fig. 25A and 26, and the pulse-chase experiments of 
Routledge et al. (1986). Significantly, intermediates in the O- 
glycosylation process (not normally observed) have been identified 
under limiting galactose and W-acetylgalactosamine concentrations in 
the ldlD cell line (a mutant CHO line defective in formation of 
complex W-linked oligosaccharides and O-linked glycosylation), which 
suggests that processing of core O-linked oligosaccharides occurs in 
a predefined sequence (Wertz et al., 1989). Consequently, the 
putative rearrangement of the p50 precursor may reflect transition 
to a conformation that determines the order of further modification 
, of the O-linked sugars. The importance of local protein
conformation for defining accessibility to glycosyltransferases has 
been demonstrated previously for the VSV G protein (Rothman and 
Lodish,'1977; Rothman et al., 1978; Machamer and Rose, 1988b).
In view of these considerations, location of the ts A2 lesion 
in one of the critical N-terminal domains seems unlikely, since that 
would be expected to cause accumulation of the p45 precursor in the 
RER, whereas the p50 precursor, whose maturation is delayed in ts A2 
at 39°C, appears to be present in the Golgi complex. The pattern of 
ts A2 G protein synthesis observed at 39°C is consistent with a ts 
mutation disrupting the presumptive conformational rearrangement of 
the p50 precursor, thereby interfering with further processing and 
maturation. A conformational defect could also explain the 
leakiness of ts A2 at 39°C (Wright et al., 1973; Belshe et al.,
1977). This leakiness may account for both the small amount of 
mature G protein detected in ts A2-infected cells at 39°C (Fig. 22 
and 24) and the normal G content in virus particles formed at the • 
restrictive temperature. The detection of normal amounts of virion- 
G at 39°C is surprising in view of the delayed precursor maturation.
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Since only a minority of progeny virus is shed from RS virus-
infected cellB (Peeples and Levine, 1980), it appears that most of 
the "leaked” G molecules are incorporated into virions. Delayed 
maturation/transport may result in arrival of the G at the membrane 
at a time when most of the other viral components have been 
assembled, thus G is immediately packaged into virion structures. 
However, the methodology used here cannot distinguish between the 
virion-associated and soluble forms of the G protein, thus further 
analysis of the extracellular ts A2 G protein observed at 39°C will 
be required to resolve this issue.
Role of conformation. The possibility that conformational changes 
may arise during the G processing pathway is suggested by the 
inability to detect early intermediates in two subgroup B strains by 
cross-reactive, subgroup A-specific anti-G sera (Fig. 24B, 29A;
Walsh et al., 1987). These data, in conjunction with the apparent 
lack of O-glycosylation of the RSN-2 G protein in the presence of 
tunicamycin (Fig. 29B), are indicative of conformational differences 
between subgroup A and B G-precursor forms but, more importantly, 
they indicate that the conformation of the RSN-2 G protein lacking 
W-linked oligosaccharides is unstable and/or unable to follow the 
normal maturation pathway. This suggests therefore, that protein 
folding (in a portion of the G ectodomain) may be a requirement for 
intracellular transport, as proposed for the class I glycoproteins G 
of VSV (Gallione and Rose, 1985; Machamer and Rose, 1988a,b) and HA 
of influenza (Gething et al., 1986) and the class II HN glyco­
proteins of Sendai virus (Mottet et al., 1986a) and of measles virus 
(Sato et al., 1988). It is thus interesting that,all three 
potential N-linked acceptor sites in subgroup B strain 18537 are 
clustered in the membrane-proximal region of the G ectodomain
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(Johnson efc al., 1987) which, as discussed above, was part of the 
truncated G proteins that were efficiently transported to the cell 
membrane. However, it is also possible that, in the absence of W- 
linked glycosylation, the pattern of O-glycosylation may be altered 
depending on the amino acid sequence, which could result in 
differential efficiency of detection of this process with 
(3H]glucosamine in the highly divergent G proteins of subgroups A 
and B. In that case, amino acid- rather than sugar-labelling (e.g.
(^H]Threonine) will be a more suitable probe.
Further comparative studies of the effects of tunicamycin in
different subgroup A and B strains are needed to determine the/
efficiency of G protein transport and O-glycosylation in the absence 
of W-linked glycosylation. In addition, the potential W-linked 
carbohydrate requirement for transport of subgroup B G proteins 
could be studied in the ldlD cell line as recently described by 
Wertz et al. (1989). Identification of the site of the G mutation 
in ts A2 by nucleotide sequencing would also provide further insight 
to the structural requirements for transport of the RS virus G 
glycoprotein.
F0 cleavage defect. The conclusion from the above discussion that 
the ts phenotype of ts A2 is due to a lesion in the G glycoprotein 
differs from a previous suggestion by Belshe et al. (1977) that the 
ts A2 lesion affected the F glycoprotein, made on the basis of the 
altered cytopathology of ts A2 in HEp-2 cells. This phenotype was 
not observed in the BS-C-1 monolayers used here. A defect in the 
cleavage of the FQ precusor was observed which, however, was equally 
demonstrable at 33° and 39°C and, therefore, it was not a 
temperature-induced phenomenon. This defect was manifested 
primarily during kinetic (pulse-chase) studies (Fig. 27) and had
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little effect on the final amounts of and F2 present in ts A2- 
infected cells (Fig. 21A, 22A).
Since there was no evidence of an F protein alteration in 
either subunit mobility or antigenicity (Fig. 28), it is possible 
that the F defect (delayed precursor cleavage) is a secondary 
phenotypic effect of the ts mutation in the G protein (delayed 
precursor maturation). This would necessitate i) partial expression 
of the G defect at the permissive temperature and ii) temporal 
overlap of the glycosylation/maturation pathways of the two 
glycoproteins. The first assumption is not borne out by the 
observation of a wild-type pattern of G maturation in ts A2~infected 
cells at 33°C (compare Fig. 2SA and 26). Furthermore, several 
studies of the kinetics of maturation of the paramyxovirus F and HN 
glycoproteins have indicated that their respective rates of 
transport are inherently different, probably due to their inverse 
membrane orientation. Thus the C-terminally anchored F proteins of 
Sendai and measles viruses migrate to the cell surface at a 
considerably faster rate than the oppositely oriented HN proteins 
(Blumberg et al., 1985a; Mottet et al., 1986b; Sato et al., 1988). 
The detection of FQ cleavage in RS virus-infected cells (thought to 
begin at the trans-Golgi stage) during the 10-15 minute-pulse period 
(Fig. 27B) and the slow processing of the p50 precursor into fully 
glycosylated G - also occurring in the trans-Golgi compartment - at 
approximately 30 minutes after the pulse (Fig. 25A and 26) are in 
agreement with these reports and do not support the assumption of 
concurrent vectorial transport of the F and G glycoproteins.
Therefore it seems likely that the F0-cleavage defect is separate 
from the ts G-processing defect in mutant ts A2 •
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It is well established that cleavage-activation of the fusion 
protein of paramyxoviruses determines their infectivity, 
pathogenicity and tissue tropism since it is depende.it on a host- 
derived protease (reviewed by Choppin and Scheid, 1980). Thus the 
non-ts cleavage defect of the ts A2 Fo protein is the likeliest 
explanation for the variable cytopathology of the mutant observed in 
different cell types at the permissive temperature.
Sequence analysis of the connecting peptide (i.e. the exact C- 
terminus of the F2 subunit, preceding the cleavage site) in 
paramyxovirus F proteins has indicated that F0-cleavability depends 
on the presence of dibasic amino acid pairs and/or clustering of 
several basic residues at this site (Paterson et al., 1984; 
Richardson et al., 1986; Spriggs et al., 1986; Toyoda et a l . , 1987; 
Glickman et al., 1988). In addition, characterization of the FQ 
cleavage site in naturally occurring HPIV-3 variants (Coelingh and 
Winter, 1990) and in a pantropic Sendai virus variant (Tashiro et 
al., 1988), and deletion mutagenesis of the connecting peptide in 
the SV5 F0 protein (Paterson et al., 1989) have suggested that 
general structural features of the F protein are also important 
determinants of cleavability. Since the high efficiency of cleavage 
of the RS virus FQ protein correlates with presence of six 
consecutive basic residues in the connecting peptide (Collins et 
al., 1984b; Baybutt and Pringle, 1987), a mutation altering this 
highly basic character might diminish the susceptibility to 
cleavage. The delayed onset of FQ cleavage in ts A2-infected cells, 
as well as its reduced efficiency (Fig. 27A), suggest that the bulk 
of cleavage occurs at a later stage than that of the wild-type F0 
protein, presumably at the plasma membrane, given that cleavage is 
not necessary for cell surface expression of the paramyxovirus Fc
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(Garten et al., 1980; Hsu et al., 1987; Sato et al., 1988; Paterson 
et al., 1989). In that respect, it is tempting to speculate that 
the F-specific band (Fx) which migrates higher than the ts A2-Fl 
subunit (Fig. 28) arises from alternative cleavage of the F0 
precursor. Interestingly, cleavage at the sequence Arg-Ala-Arg-Arg 
(residues 106-109), which resembles the normal RS virus cleavage 
site (Lys-Lys)-Arg-Lys-Arg-Arg (residues 131-136) and also the 
sequence Arg-Thr-Lys-Arg (residues 106-109) of the HPIV-3 F0 
connecting peptide (Spriggs et al., 1986), would produce an 
“alternative" Fj subunit with an Mr increase of 7.2 kd (including 
the two glycosylation sites between residues 109 and 136), which is 
very close to the apparent size difference (ca 6k) between the Fj 
subunit and the Fx band of ts A2 (Fig. 28). The reduced amount of 
this "alternative" F^ subunit, compared to the normal one, could be 
due to the presence of the intervening uncharged alanine residue, 
similarly to the proposed effect of the intervening threonine in 
HPIV-3 (see Introduction, Section 1B.1) and/or the absence of the 
lysine pair which is present in the normal cleavage site. The 
possibility - and relative efficiency - of cleavage at the site of 
residues 106-109 could be studied by reciprocal site-directed 
mutagenesis (i.e. Lys in place of the intervening Ala in residues 
106-109 and Ala in place of Lys in residues 131-136), as well as by 
deletion of the lysine pair in order to evaluate its potential 
enhancing effect on cleavage. Sequence determination of the F gene 
in ts Aj would add to the current understanding of the requirements 
for efficient cleavage-activation of the paramyxovirus fusion 
protein. <•
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3.3A. RESULTS
3.3 Ts MUTANT M i
Intracellular and virion-associated proteins. Mutant ts N-j was 
isolated from the RSN-2 wild-type strain by Faulkner et al. (1976). 
Previous analysis of this mutant indicated that it possessed a 
maturation defect as well as an atypical P protein, which migrated 
more slowly than the wild-type P protein [Pringle et al., 1981; 
(mutant ts is designated as mutant ts1 in that reference)]. The 
polypeptides synthesized in ts N^-infected cells at 33° and 39°C are 
shown in Figure 30, where the aberrant mobility of the ts Nj-P 
protein can be observed. In addition to this alteration, the M 
polypeptide is absent (or considerably decreased) in the mutant 
profile at 39°C. In order to examine which of these two phenotypic 
changes was associated with the temperature-sensitivity of the 
mutant, a series of spontaneous ts+ revertants was subsequently 
isolated. The polypeptide profiles of two of these revertants are 
shown in Figure 31. The reduced amounts of all intracellular 
labelled proteins in the mutant profile at 39°C (lanes 4), in 
addition to the more severe reduction of the M protein band, was 
noticed in all subsequent experiments and this phenomenon seemed to 
be multiplicity-dependent, as the extent of reduction in labelled 
species directly correlated with the length of pre-labelling 
incubation of ts N^-infected cells at 39°C (for example, see Figure 
34). As already mentioned in connection with ts Aj (where a similar 
phenomenon is observed; Section 3.1A), cultures were incubated for 1- 
3 days post-infection at the two temperatures prior to labelling in 
order to amplify the original multiplicity of infection to the levels
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Figure 30. Viral polypeptide synthesis in ts Nj-infected cells. BS­
C-1 monolayers infected with the wild-type RSN-2 (Wt) or the mutant 
ts (N]_)# and mock-infected cells (UI), were labelled with 
[35S¡methionine and immunoprecipitated with polyclonal anti-RS virus 
serum. Samples were boiled in 3x SDS-PAGE reducing buffer and 
analyzed on a 6-15% linear polyacrylamide gradient gel. The P 
mobility difference between the wild-type and ts is indicated by 
the double bar. The arrow indicates the absence of M protein from 
the ts Nj profile at 39°C.
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Figure 31. Viral protein synthesis of ts+ revertants of mutant ts 
. BS-C-1 cells infected with the wild-type RSN-2 (lanes 1,2), ts 
(lanes 3,4) or ts+ revertants isolated from ts (lanes 5,6) were 
incubated at 33°C (lanes 1,3,5) and 39°C (lanes 2,4,6) and labelled 
with [35S)methionine. Infected-cell monolayers were lysed and 
immunoprecipitated with polyclonal anti—RS virus serum. Viral 
polypeptides were analyzed on 6-15% linear gradient polyacrylamide 
gels. The revertant shown in panel A is ts+ clone R2/3 and the 
revertant in panel B is ts+ clone R2/5. The decreased label 
intensity of the wild-type profiles (lanes 1,2) is probably due to 
the fact that labelling (and subsequent treatment) of these samples 
was not performed simultaneously with that of the mutant and 
revertant samples.
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V
\required for efficient label incorporation into virus-specific 
polypeptides.
The profiles of the two revertants in Figure 31 do not reveal 
any obvious reduction in the amount of labelled polypeptides at 39°C. 
Moreover, the P protein of the revertants migrates with the same 
mobility as that of their parent mutant ts Nj. The P protein of one 
revertant (R2/3) was also compared with the ts and wild-type P 
proteins by limited enzymatic cleavage. As shown in Figure 32 
several peptide fragments are produced by cleavage with 
Staphylococcus aureus V8 protease, as would be expected from the 
known specificity of this enzyme for acidic residues, which 
constitute 21% of the total residues of the P protein (Satake et al. ,
1984). In the lower enzyme concentration a fraction of undigested P 
is observed at the top of the gel, exhibiting the characteristic 
mobility difference. The fragments produced by cleavage of the 
revertant and mutant P proteins at both enzyme concentrations seem 
identical in mobility.
Comparison with the wild-type peptide profile (lane 3) shows 
that the same number of major fragments is produced in all viruses 
but only the two larger peptides can be seen to comigrate in the 
wild-type, ts and its ts+ revertant profiles (indicated by 
circles). The majority (denoted by x) exhibits a shift in mobility 
similar to the one that exists for the undigested proteins, i.e. the 
wild-type peptides always migrate faster than the equivalent 
revertant and mutant peptides. On the whole this pattern would 
suggest that the revertant P protein possesses the characteristics of 
the mutant P protein and maintains its difference from the wild-type • 
molecule. Conversely, a significant distinction between the mutant 
and the two revertants in Figure 31 is the presence of the M protein
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Figure 32. Limited enzymatic digestion of the P protein with Staph, 
aureus V8 protease. [35S]-labelled P protein, synthesized in cells 
infected with the wild-type RSN-2 (lanes 3), the mutant ts Nx (lanes 
2,5) or its ts+ revertant R2/3 (lanes 1,4), and the mutant ts 
(lane 7) or its ts+ revertant R3/6 (lane 6), was subjected to partial 
proteolysis (lanes +) according to the method of Cleveland et al. 
(1977). The P proteins in lanes 1 and 2 were treated with 0.2 pg of 
V8 protease, whereas the P proteins in all other lanes were treated 
with 0.05 pg of the enzyme (per sample) . Lane - in panel B contains 
an untreated wild-type (control) sample to mark the position of the 
undigested P protein. After a 30 minutes incubation period in the 
stacking gel, peptides were analyzed on a polyacrylamide-sucrose 
resolving gel. The two larger peptides which exhibit the same 
mobility in all tracks are indicated by circles. The wild-type 
peptides which exhibit the characteristic mobility difference of the 
undigested P molecules in ts Nj and its ts+ revertant R2/3 (in panel 
A) are indicated by x.
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\in the revertant profile at 39°C. Taken together, these observations 
suggest that reversion of the ts Nj phenotype correlates with 
presence/increased stability of the M protein at 39°C, thus 
indicating that mutant ts has a ts lesion affecting the M 
polypeptide. This conclusion is consistent with the previously 
suggested maturation defect (Pringle et al., 1981), since the M 
protein of paramyxoviruses is considered the major protein involved 
in maturation and virion assembly (see Introduction, Section 1B.1). 
This is also supported by analysis of structural polypeptides from 
PEG-precipitated virions of ts Nj (Figure 33), which reveals a 
severely reduced profile of virion-associated proteins in ts Nj- 
infected cultures at 39°C (lanes 4), in contrast to the wild-type and 
revertant profiles (lanes 2 and 6, respectively). The variable 
amounts of N protein in the ts tracks at 39°C could reflect 
minimal virion production or protein released into the medium during 
cell disruption. The profiles in Figure 33 indicate that very little 
- if any - mutant particle formation occure at 39°C, which could be a 
consequence of a primary maturation defect (absence of the M protein) 
and/or the reduced spread of infection (inferred by the multiplicity- 
dependent variability in the decreased profiles of intracellular 
labelled proteins of ts Nj at 39°C). It is also interesting to note 
the decreased amount of M protein in ts virions produced at 33°C, 
a phenomenon not observed in the wild-type or revertant particles 
(indicated by arrows in Figure 33).
Pulse-chase experiaents. To investigate the intracellular stability 
of the ts M protein, the kinetics of viral protein synthesis was 
studied by pulse-chase experiments in cells infected with ts N1# the , 
wild-type RSN-2 or the ts+ revertant R2/3. Figure 34 shows two 
different experiments with the mutant ts . In panel A, where all
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rigure 33. Virion-associated polypeptides of ts N^. Supernatant 
culture media from cells infected with the wild-type RSN-2 (lanes 
1,2), the mutant ts Nj (lanes 3,4) or ts+ revertants (lanes 5,6), and 
maintained at 33°C (lanes 1,3,5) and 39°C (lanes 2,4,6) were cleared 
from cellular material by centrifugation at 10,000g and mixed with 
1/5 volume of 36% PEG. After overnight incubation at 4°C, PEG- 
precipitates were lysed in RIP buffer and immunoprecipitated with 
polyclonal anti-RS virus serum. Viral polypeptides were analyzed on 
6-15% linear gradient gels. The ts+ revertants shown are s clone 
R2/7 (panel I), clone R2/3 (panel II) and clone R2/5 (panel III).
The arrows indicate the significantly reduced amount of M protein in 
PEG-precipitated supernatants from ts N^-infected cultures that have 
been maintained at the permissive temperature.
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the proteins can be observed, the M protein can only be detected at 
the end of the pulse whereas it is absent from the subsequent chase 
incubation at 39°C, i.e. from between 20 and 40 minutes following its 
synthesis onwards. In contrast, the wild-type profiles are virtually 
identical at both temperatures (Figure 35A). Furthermore, the 
revertant profile at 39°C (Figure 35B) is similar to that of the 
wild-type and different from that of ts in that the M protein is 
present throughout the chase (a small decrease of all labelled 
proteins can also be observed in the revertant at 39°C compared to 
its 33°C profile). Thus the status of the M protein at 39°C 
constitutes the major phenotypic effect associated with reversion to 
a ts+ phenotype and further supports the hypothesis of a ts lesion in 
this protein. These pulse-chase experiments also ascertained that 
synthesis of the M protein does take place at 39°C in ts N^-infected 
cells, suggesting that the defect arises post-translationally, 
perhaps through interference with the proper folding (functional 
conformation) of the protein.
The effect of incubation at the restrictive temperature on the 
intracellular stability of the matrix protein was examined in more 
detail by pulse-chase experiments which incorporated a shift-up to 
39°C during the chase period ("pulse-shift", see Methods, Section 
2B.2.3). In the experiment with mutant ts (Figure 36A), the M 
protein which is synthesized at 33°C during the 10 minute-pulse can 
be detected for the first 10 minutes after shift-up but is severely 
reduced and eventually disappears from the profile from 25 minutes 
after shift-up onwards. The gradual decrease of the detected M 
protein in this experiment is expressed in terms of its declining 
ratios to the N and P proteins in Table 13. In the ts+ revertant 
profile (Figure 36B), the M protein remains present throughout the 3
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rFigure 34. Kinetics of viral protein synthesis in ts N^-infected 
cells. Two different experiments are shown, which demonstrate the 
decreased efficiency of detection of ts viral polypeptides with 
increasing times of incubation at the restrictive temperature (prior 
to labelling). Replicate ts ^-infected monolayers incubated at 33° 
and 39°C for two days post-infection (panel A), or for three days 
post-infection (panel B), were labelled with ( ]methionine for 20
minutes (panel A) or 10 minutes (panel B). Lanes P contain cultures 
lysed and immunoprecipitated with polyclonal anti-RS virus serum 
immediately after the removal of label. The remaining cultures were 
similarly treated after a chase incubation in non-radioactive medium, 
for the times indicated at the top of the respective tracks. 
Immunoprecipitated polypeptides were analyzed on 6-15% linear 
polyacrylamide gradient gels. Lane M contains the Mr protein 
markers.
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Figura 35. Kinetics of viral polypeptide synthesis in cells infected 
with the wild-type RSN-2 or the ts+ revertant R2/3. Replicate BS-C-1 
monolayers infected with RSN-2 (panel A) or ts+ R2/3 (panel B) were 
incubated at 33° and 39°C and labelled with [^®S¡methionine for 10 
minutes. Following the removal of the labelling medium, cultures 
were lysed and immunoprecipitated with polyclonal anti-RS virus serum 
immediately (lanes P) or after further incubation at the respective 
temperatures in medium containing an excess of non-radioactive 
methionine (chase; the times are indicated on top of the respective 
tracks). Immunoprecipitates were analyzed on 6-15% linear gradient 
gels. The band indicated by circles is a cellular (BS-C-1) 
polypeptide. Pbrk is a breakdown fragment of the P protein. Lanes M 
contain the Mr protein markers.
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Figure 36. Temperature-induced instability of the ts Nj M protein. 
Replicate BS-C-1 monolayers, infected with the mutant ts N1 (panel A) 
or the ts+ revertant R2/3 (panel B) were incubated at 33°C and 
labelled for 10 minutes with [3 5S]methionine. After removal of the 
labelling medium, one set of cultures were lysed and 
immunoprecipitated with polyclonal anti-RS virus serum (lanes P).
The remaining cultures were similarly treated after further 
incubation in medium containing non-radioactive methionine (for the 
times indicated in the figure), following shift-up to the restrictive 
temperature (chase + 33° -* 39°C) or continued incubation at the 
permissive temperature for the duration of the chase (lanes 3)1 3 3 ). 
Samples were boiled in 3x reducing buffer and analyzed on 6-15% 
linear gradient gels. In panel A, two exposures of the same gel are 
shown s the short exposure (a) demonstrates the progressive cleavage 
of the F0 precursor into the and F2 subunits (the latter is not 
easily detectable due to its low content of methionine residues); the 
longer exposure (b) is included to show the virtual absence of the M 
protein band after incubation for 25 minutes at 39°C. The positions 
of the Mr protein markers are indicated on the left and their 
molecular weight given in kilodaltons.
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Table 13. Reduction of t» M protein during ahift-up to 39°C.
Protein Area 
Ratio
Pulse Shift-Up (39°C) Control
(33°C) 10 min 25 min 3 hr 3hr (3 3°C)
H/N 0.27 0.09 0.05 0 . 0 1 0.33
M/P 0.50 0 . 2 1 0.13 0.03 0.73
N/P 1.85 2.45 2.50 2.30 2 . 2 2
Table 14. Coepariaon of the 39°C-induced M protein reduction in 
ta Ni and ta'*' revertant R2/3.
Protein Peak Area ratio 39°/33° Comparative ratio
A. R2/3 B. ts Na A/B
M 0.16 0.05 3.20
P 0.89 1.08 0.82
N 1.04 1 . 1 0 0.94
F 1 0.86 0.87 0.98
Table 15. Immunoprécipitation of M protein at 33°C.
Anti-M MAb Relative Yield*
ts N^/wt** ts N^revertant Revertant/wt
Mi 31.7 29.2 108.6
m 2 23.6 23.2 1 0 1 . 8
C781 31.6 35.8 88.3
8085 29.2 36.3 80.9
Relative yield = (ratio of M protein areas) x 100
*
wt = wild-type RSN-2
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hour-chase incubation at 39°C. Nevertheless, comparison of the final 
chase sample at 39°C with the control incubation at 33°C shows that 
the revertant M protein is also eventually decreased at 39°C, 
indicating that this revertant still exhibits some degree of 
temperature-instability. The relative accumulation (39°/33° ratio) 
of intracellular viral proteins at the end of the chase (samples of 3 
hours) in the revertant and ts Nj is shown in Table 14. Taken 
together, the pulse-chase/shift experiments suggest that the ts Nj^  M 
protein becomes metabolically unstable soon after its synthesis at 
39°C. In the absence of any major post-translational M modifications 
(Cash et al., 1979) the rapid temperature-induced destabilization, 
even on M protein presynthesized at 33°C, implies that the protein 
may be inherently thermolabile, possibly due to a conformational 
alteration. The fact that the ts Nj M protein, synthesized at 33°C, 
disappeared from the 39°C-profile at similar times to M protein 
synthesized at 39°C (between 20-40 minutes incubation at 39°C by 
pulse-chase and between 25-50 minutes incubation at 39°C by shift-up; 
Figure 34 and 36, respectively) would be surprising if a wild-type- 
like, normally stable configuration at 33°C is assumed.
Alternatively, it may indicate partial expression of the defect even 
at the permissive temperature.
Immunoprécipitation with anti-M MAbs. Immunoprécipitation by anti-M 
MAbs of 33°C-maintained wild-type -, mutant- and revertant-infected 
cells also suggested partial instability of the mutant M protein at 
33°C (Figure 37). It should be mentioned that these anti-M MAbs did 
not react with denatured M protein on Western blots and would thus be 
likely to recognize conformational-rather than linear-epitopes. The , 
four anti-M MAbs included in Figure 37 bind to different M-protein 
epitopes by competitive ELISA tests (Orvell et al., 1987). With all
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four MAbs the profiles were similar in that a reduced amount of ts Nx 
M protein was reactive with these antibodies compared to the wild- 
type and revertant M proteins (Table 15). Comparison in Figure 37B 
of the total M protein obtained from the ts Nj sample 
(immunoprécipitation with polyclonal anti-RS serum) with the amount 
of M protein immunoprecipitated with the two anti-M MAbs shows that 
only a proportion of ts M protein reacts with the MAbs. The 
corresponding densitometer tracings are shown in Figure 38A.
Although the presence of a very faint M protein band in the ts
tracks of Figure 37B could be due to "leaking" from the adjoining,
/
strongly labelled revertant M band, the te N  ^M protein reacted 
positively with one of the two MAbs (anti-M C781) by immuno­
précipitation of in vitro translated ts Nj M protein (Figure 38B). 
Thus, the decreased efficiency of immunoprécipitation of the ts Nj M 
protein in vivo is probably due to quantitative, rather than 
qualitative (i.e. absence of the C781 epitope), differences. Since 
the polyclonal antiserum and the anti-M MAb recognize the wild-type M 
protein with similar efficiencies (Figure 38A), the quantitative 
difference in the corresponding profiles of the mutant ts may 
reflect the existence of aberrantly folded (or unfolded) M protein 
molecules, which do not possess the denaturation-sensitive (i.e., 
conformation-dependent) epitope to, at least, this monoclonal 
antibody.
In addition to the M protein, the two anti-M MAbs in Figure 37A 
immunoprecipitate a low Mr band (ca 14.5K), which appears to 
comigrate with the 1C/1B band of the polyclonal profile. The 
assignment of the latter band to the 1C/1B non-structural RS virus 
proteins is tentative, in the absence of MAbs specific for these 
polypeptides. However it has been possible to resolve the low Mr
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Figure 37. Immunoprécipitation of the M protein with anti-M MAbs. 
Cells infected with the wild-type RSN-2 (lanes W), the mutant ts N]^  
(lanes N) or the ts+ revertant R2/3 (lanes R) were incubated at 33°C 
and labelled with [35S¡methionine. Samples were immunoprecipitated 
with polyclonal anti-RS virus serum (anti-RSV) or with four different 
anti-M MAbs, and analyzed on a 6-15% linear gradient gel (A) or by 
10% SDS-PAGE (B). MAb C781 has been raised against the virion M 
protein of the subgroup A/Long strain, whereas the other three MAbs 
have been raised against a subgroup B strain-virion M protein (Orvell 
et al., 1987). Pbrk is a ca 22K breakdown fragment of the P protein, 
which is not well resolved from the 2 1K F2 band (probably due to the 
diffuse migration of the Fj glycopolypeptide). The designation of 
the low Mr band, seen by polyclonal anti-RSV immunoprécipitation in 
panel A, as the 1C/1B non-structural RS virus proteins is shown 
between parentheses to indicate the fact that this is a tentative 
assignment (as explained in the text).
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■ (A) Efficiency of. immunoprécipitation of the ts Nj M protein with
polyclonal and monoclonal anti-M antibodies. This figure shows 
densitometer tracings of the M protein bands present in the 
fluorogram of Figure 37B. Densitométrie data were fed into a 
compatible computer programme, which enabled manipulation of 
graphic outputs in order to obtain direct comparison of M 
protein band densities (peak areas). M protein peaks from 
different tracings were superimposed on the same graph, which 
is plotted as M protein band intensity (in absorbance units) 
against M protein peak position (in millimetres).
(B) Immunoprécipitation of in vitro translated RS virus proteins. 
Aliquots of total cytoplasmic RNA, extracted from cells 
infected with the wild-type RSN-2 (lanes W), the mutant ts 
or mutant ts N^g, were used to programme in vitro protein 
synthesis in the rabbit reticulocyte lysate system.
Translation products were immunoprecipitated with anti-P MAb 
8268 or anti-M MAb C781 and analyzed by 15% SDS-PAGE. The 
mobility difference between the ts Nj and RSN-2 (or ts N^g) P 
proteins is indicated by the double bar. A smaller mobility 
difference between the M proteins of ts N^ and RSN-2 (or ts 
N^g) is similarly indicated (see Figure 41). The faint band 
between the circles in all tracks is an internal reticulocyte 
lysate polypeptide (detected as an in vitro translation product 
in the absence of exogenous mRNA). The three bands marked x 
are of cellular (BS-C-1) origin (detectable in in vitro 
translations of RNA extracted from infected and mock-infected 
cells; see also Figure 41 and Figure 63).
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band of the polyclonal profile into two separate bands by using a 
polyacylamide-sucrose gel system. This type of gel is an effective 
resolving system for polypeptides of low molecular weight 
(Dr. P. Chambers, personal communication). The two bands are 
indicated in Figure 39 and the relative quantities and apparent 
mobilities are in agreement with those previously observed for the IB 
and 1C proteins. Although the reported molecular weights for the in 
vitro translated 1C and IB proteins are 14K and 11K, respectively, 
the 1C protein undergoes proteolytic processing in vivo to a 12.5K 
polypeptide (Huang et ai., 1985), which might explain the close 
migration of the two bands shown in Figure 39. The slower apparent 
mobility of the (putative) 1C/1B band in 6-15% gradient gels at ca 
14.5K (Figure 37A) is consistent with that reported by Dubovi (1982) 
and Elango et al. (1985). The relative apparent mobilities of the 
two non-structural proteins have been observed to be sensitive to 
differences in the conditions of gel electrophoresis such as gel pH 
and concentration of bisacrylamide (Collins and Hertz, 1985b). 
Therefore, the difference in 1C/1B apparent mobility betweeen the 
gradient and sucrose-polyacrylamide gels could be a consequence of 
the different concentrations of the cross-linking agent in the two 
gel systems (see Materials, Section 2A.2). Incidentally, a band 
migrating slightly ahead of the P protein in the RSS-2 and RSN-2 
tracks (indicated by asterisks in Figure 39) appears to exhibit the 
characteristic mobility difference of the P protein between these two 
virus strains and could thus be P-related. Whether this situation is 
equivalent to the appearance of a P doublet band in strain A2 is not 
known, since the phenomenon was not further investigated. i
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Figure 39. Analysis of RS virus proteins by a sucrose-polyacrylamide 
gel system. BS-C-1 cells were infected with the wild-types A2, RSS-2 
or RSN-2, incubated at 33°C and labelled with [ 35SJmethionine.
Lysates of infected cells were immunoprecipitated with polyclonal 
anti-RSV serum and analyzed by SDS-sucrose-PAGE, which enables 
resolution of low Mr polypeptides (Dr. P. Chambers, personal 
communication). The two closely migrating low Mr bands in the 
profiles are provisionally assigned to the two non-structural RS 
virus proteins 1C and IB. The two bands migrating just ahead of the 
P proteins of RSS-2 and RSN-2, which show the characteristic P 
mobility difference between the two strains, are indicated by 
asterisks.
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Since the (putative) IB protein ie more etable/abundant of the 
two low Mr polypeptides resolved in Figure 39, it appears that the 
low Mr band in polyclonal anti-RS profiles corresponds mostly to this 
protein. Thus the presence of this band in anti-M MAb profiles could 
be due to coprecipitation of the M and IB proteins. However, both 
proteins are predicted to have similar net positive charges at 
neutral pH (Satake and Venkatesan, 1984; Collins and Wertz, 1985b) 
and migrate at Bimilar positions towards the basic end of two- 
dimensional (NEPHGE/SDS-PAGE) gels (Dubovi, 1982), such that a 
possible interaction between them, leading to coprecipitation, does 
not seem likely. It is also possible that the two anti-M MAbs in 
Figure 37A fortuitously cross-react with the IB protein, perhaps due 
to the presence of similar epitopes on both proteins. Alternatively, 
the variable appearance of the 14.5K band in anti-M MAb profiles, in 
amounts directly related to the concurrently abundant presence of M 
protein in the profile, could be the result of a small degree of 
proteolytic breakdown during preparation of the samples (despite the 
use of the protease inhibitor PMSF).
The anti-M MAbs were also used for immunoprécipitation of 
virion-aesociated M protein. Similarly to infected-cell lysates, 
PEG-precipitated supernatants of ts N^-infected monolayers contained 
reduced amounts of virus-specific polypeptides compared to the wild- 
type and ts+ revertant samples (Figure 40A). Quantification of the 
respective profiles (Table 16) shows that there is also a two-fold 
deficiency of M protein in ts virions relative to that observed 
for the other two major structural polypeptides, N and Fj. This 
phenomenon, which has been noted previously in Figure 33, becomes 
more obvious by comparison of the relative abundance of the three 
proteins in Table 17. Comparison of the profiles obtained by
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Figure 40. Immunoprécipitation of soluble extracts from PEG- 
precipitated virions with anti-M MAbs. BS-C-1 cells were infected 
with the wild-type RSN-2 (wt), the ts mutant or its ts+ revertant 
R2/3 (R) and incubated at 33°C. Following labelling with 
[^ 5S]methionine, released virus particles in the supernatant media of 
infected cultures were collected by PEG-precipitation, lysed and 
immunoprecipitated with polyclonal anti-RS virus serum (Pol) or two 
different anti-M MAbs (Mlf M2 ). Virus polypeptides were resolved on 
a 6—15% linear gradient gel which was fluorographed and exposed to X- 
ray film (panel A). Densitometer scanning of the fluorogram was 
carried out to quantitate the M-protein bands in the profiles. With 
the aid of a compatible software programme the densitometer tracings 
for the M protein in different tracks were superimposed and are 
presented in panel B. The M protein peak areas are plotted as 
absorbance units (A.U.) against millimetres (mm), as described in the 
legend of Figure 38A.
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Tabi« 16 Comparison of wild-typa, mutant and rovortant virion 
proteins at 33°C.
Protein Relative Yield*
ts N^/wt ts N^/revertant Wt/revertant
M 1 1 10 95
N 28 22 80
ri 34 28 82
* Relative yield = (protein area ratio) x 100
Table 17. Comparison of virion polypeptide ratios at 33°C.
Protein area 
ratio
Wild-type
RSN-2
Revertant 
ts+ R2/3
Mutant
ts
M/N 2.07 1.73 0.85
M/Fi 1.49 1.28 0.50
N/Fx 0.72 0.74 0.59
Table 18. Comparison of virion N protein immunoprecipitated 
by anti-RS serum or anti-M MAbs.
Antibody M protein
peak area (A.U. x mm)
% Relative yield of 
M protein
Wt R2/3 ts Nj ts Nx/ ts Nx/ Wt/
wt R2/3 R2/3
Pol. anti-RSV 10.65 1 1 .2 2 1 .2 2 1 1 10 95
MAb H] 10 .0 1 12.30 1.31 13 1 1 82
MAb M2 10.30 11.37 1.25 12 1 1 91
* A.U. x mm « absorbance units (peak height) x millimetres (peak width).
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inmunoprecipitation with polyclonal and monoclonal anti-M antibodies 
shows however that, despite this apparent M protein deficiency, the 
total amount of virion-associated ts M protein is efficiently 
recognized by the anti-M MAbs (Table 18 and Figure 40B). This 
observation suggests that, in contrast to ts N^-infected cells, ts 
virus particles contain only properly folded M protein molecules. In 
conjunction with the pulse/shift-up experiment of Figure 36A, these 
data also suggest that mutant ts Nj is partially restricted at the 
permissive temperature, possibly due to altered conformation of a 
proportion of M protein molecules (inferred by the decreased 
reactivity with the anti-M MAbs) which affects virus spread and/or 
the efficiency of virion production.
M protein mobility. A further observation consistent with a ts 
lesion in the M protein of ts Nj was made during in vitro translation 
experiments. As shown in Figure 41A, the M protein of both mutant 
and revertant viruses (lanes 2 and 3, respectively) appeared to 
migrate marginally, but reproducibly, more slowly than the 
wild-type-, ts+ N^g-revertant- and ts N^g-M proteins (lanes 1,4,5, 
respectively). This mobility difference had not been previously 
detected in the in vivo labelled M proteins, possibly because of the 
usual intense labelling of the abundant M protein, which results in 
its migration as a diffuse, "expanded" band (where such a small 
difference would not be easily detected). Occasionally, however, 
when labelling conditions were such that the M protein migrated as a 
discrete band (i.e., small amount of label used) a slightly retarded 
apparent M mobility could be observed for the mutant and revertant 
proteins (Figure 41B). The fact that the mutant M,protein mobility 
was retained in the ts+ revertant R2/3 indicates that this virus is a 
pseudorevertant and possibly explains the partial temperature-
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Figure 41
, (A) In vitro translation of viral polypeptides. Total cytoplasmic 
RNA, isolated from cells infected with the wild-type RSN-2 
(lanes 1), the ts+ revertant [of ts NjJ R2/3 (lanes 2), the 
mutant ts N^ (lane 3), the ts+ revertant [of ts N^g] R3/6 (lane 
4) or the ts mutant N^g (lane 5), was used for rabbit 
reticulocyte lysate in vitro protein synthesis. The 
translation products were immunoprecipitated with polyclonal 
anti-RS virus serum (panels II and III) or the anti-P MAb 3-5 
(panel I). Samples were boiled in 3x reducing buffer and 
analyzed by 15% SDS-PAGE. The P and M mobility differences 
between the R2/3 and ts N^ proteins, and the other RSN-2 strain 
viruses are indicated by double bars and double arrows, 
respectively. The two bands migrating above and below the M 
protein appear to be P-specific by comparison with panel I.
The low Mr bands in all three panels (marked x) have been found 
to be of host cell (BS-C-1) origin by comparison with in vitro 
translations of mock-infected cell RNA (not shown).
(B) Immunoprécipitation of viral polypeptides with polyclonal anti- 
RS virus serum. BS-C-1 monolayers infected with the wild-types 
RSS-2 (lanes S) or RSN-2 (lanes W), the ts+ revertant R2/3 
(lanes R) or the mutant ts Nj (lanes N) and incubated at 33°C, 
were labelled with [35S]methionine. Intracellular viral 
polypeptides were immunoprecipitated from the lysed cell 
monolayers (panel II) and virion-associated proteins from lysed 
PEG-precipitated particles released in the supernatant media of 
the same cultures (panel I). Samples were analyzed on 6-15% 
linear gradient gels. Lanes M contain the Mr protein markers 
(sizes indicated in kilodaltons).
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sensitivity of its M protein at 39°C (pulse/shift-up experiment in 
Figure 36B) . This observation prompted analysis of other available 
ts+ revertant clones. In Figure 42, the M proteins of two other ts+ 
clones are shown after immunoprécipitation with polyclonal anti-RS 
serum and an anti-M MAb. ' The mobility of the respective M proteins 
appears to be the same as that of clone R2/3, with all three 
migrating more slowly than the wild-type M protein, suggesting that 
these revertant clones are second-site revertants as well. 
Intracellular RNA synthesis. In an effort to examine the effects of 
the intracellular M protein instability at 39°C, analysis of mRNA 
synthesis in ts Nj-infected cells was undertaken. The rationale of 
this approach was based on previous studies of tsM-protein mutants of 
VSV which exhibited the phenomenon of hypertranscription at the 
restrictive temperature. In Figure 43A, dot-blots of total 
cytoplasmic infected-cell RNA, hybridized to nick—translated cDNA 
clones of the RS virus (A2 strain) N, P and M genes, and washed under 
semi-stringent conditions (see legend) are shown. Visual inspection 
of the autoradiograms does not reveal excess RNA synthesis in ts N^- 
infected cells at 39°C. If background hybridization to uninfected- 
cell RNA (which is stronger in the 39°C samples) is taken into 
account, the nearly equivalent radioactivity between viral samples of 
33°C and 39°C actually imply reduced RNA levels at 39°C for all 
virus-infected samples. This is probably a consequence of increased 
host metabolism at 39°C and the fact that equal sample volumes were 
used (spectrophotometric quantitation of RNA samples was not a 
reliable measure of RS virus-specific RNA, since RS virus does not 
inhibit host cell RNA synthesis). Although these dot-blots were 
hybridized to denatured double-stranded cDNA probes, the majority of 
bound radioactivity is more likely to reflect hybridization to viral
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Figure 42. Immunoprécipitation of M protein. PEG-precipitated 
supernatant media from virus-infected cultures (labelled with 
(^5SJmethionine) were immunoprecipitated with polyclonal antiserum or 
an anti-M MAb (M2). Lanes 1 : wild-type A2-infected cells, lanes 2 : 
wild-type RSN-2, lanes 3 : ts+ revertant clone R2/3, lanes 4 : ts+ 
revertant clone R2/4, lanes 5 : ts+ revertant clone R2/5. Samples 
were analyzed by 12.5% SDS-PAGE. Lane M contains the Mr protein 
markers.
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Figure 43. Dot-blots of RS virus RNA hybridized to different DNA
probes.
*
(A) Total cytoplasmic RNA samples, extracted from mock-infected 
cells (UI) and from cells infected with the wild-type RSN-2 
(wt), the mutant tn or the ts+ revertant R2/3 (R), at two 
days post-infection at 33°C and 39°C, were applied on a 
nitrocellulose filter. Replicate strips of the filter were 
hybridized to denatured double-stranded DNA probes, prepared by 
nick-translation of the A2 strain N, P and M cDNAs, for 16 
hours at 42°C in buffer containing 50% formamide. The filters 
were then washed twice in 2x SSC at room temperature, followed 
by two washes in O.lx SSC at 42°C (for the N and P probes) or 
in 0.5x SSC at room temperature (for the M probe), and exposure 
to X-ray film.
(B ) Total cytoplasmic RNA samples extracted from mock-infected 
cells (UI), or from cells infected with the wild-type RSN-2 at 
different times post-infection at 33°C (indicated in the 
figure), were applied in duplicate on a nitrocellulose filter 
and hybridized to single-stranded (ss) DNA probes prepared from 
recombinant pTZ18/19 plasmids containing an A2-P cDNA insert. 
The strand-specificity of hybridization of the two probes (for 
viral mRNA or for genomic negative-strand RNA) is indicated in 
parentheses. [Details of the construction and [ P)-labelling 
of the recombinant pTZ plasmids are given in section 3.4A and 
Figure 70). Panel II shows a longer exposure to X-ray film of 
the hybridized dot-blots of panel I. The parentheses in the 4 
hour-sample of mock-infected cells indicates that no samples 
have been applied at that position (as seen more clearly in
panel II).
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mRNA species since the amount of genomic RNA was repeatedly found to 
comprise < 10% of the total RNA under the employed extraction method 
(isotonic lysis) by use of strand-specific DNA probes (Figure 43B).
The less efficient hybridization of the P probe to the ts Nj and ts+ 
revertant samples in Figure 43A is probably due to the variable 
amounts of viral RNA present in the samples since this was not 
observed in Northern blots hybridized with a single-stranded DNA 
probe containing the same cDNA insert (Figure 44A). Figure 44A also 
shows a significant reduction of mRNA levels in ts N^-infected 
cultures at 39°C at two days post-infection (although the mRNA levels 
in all the samples again appear to be variable). Similarly, in vitro 
translation of total cytoplasmic RNA isolated at two days post­
infection from cells infected with the wild-type RSN-2, the ts+ 
revertant R2/3 or ts N^ suggested a markedly decreased synthesis of 
virus-specific mRNAa in ts N^-infected cells at 39°C (Figure 44B).
However, due to the low virus yields obtained in the initial 
stages of RS virus infection, it was not possible to monitor mRNA 
synthesis at times immediately post-infection by the dot-blot assay.
As shown in Figure 43B, wild-type viral mRNA synthesis could not be 
quantitatively assayed before 16 hours post-infection. Attempts to 
increase the virus-specific signal by using high specific activity 
single-stranded RNA probes did not improve the sensitivity of 
detection, as this resulted in higher background levels as well 
(observed by Northern blotting to be due to non-specific 
hybridization to the 28S and 18S cellular rRNAs). Equally, attempts 
to reduce background hybridization by alternative hybridization 
buffers and/or more stringent washing conditions resulted in loss of • 
bound radioactivity from virus-infected samples as well, probably due 
to the fact that the P probe which was used was derived from the A2
2 0 0
Figure 44.
(A) Northern blot of RS virus (+)sense transcripts. Duplicate cell 
monolayers were infected with the wild-type RSN-2, ts N^ -j, the 
mutant ts N! and its ts+ revertant R2/3, or the mutant ts N^g 
and its ts+ revertant R3/6, and incubated at 33°C (lanes 3) and 
39°C (lanes 9). At two days post-infection cytoplasmic RNA was 
isolated from the infected and mock-infected (UI) cultures. 
Equal sample volumes were loaded on a 1.5% agarose-2M 
formaldehyde gel, which was blotted onto nitrocellulose. The 
filter was incubated with a single-stranded, [^ P)-labelled DNA 
probe (pTZ18/P), which is specific for plus-strand P gene- 
transcripts, for 16 hours at 42°C in the presence of 50% 
formamide. The filter was then washed successively in 2x SSC 
at room temperature and O.lx SSC at 42°C, and exposed to X-ray 
film. The autoradiogram shows probe hybridization to P mRNA 
and to a P-readthrough transcript (N-P or P-M bicistronic RNA) .
(B) In vitro translation of RS virus mRNAs. Aliquots of 
cytoplasmic RNA, isolated at two days post-infection from cells 
infected with the wild-type RSN-2 (Wt), the ts+ revertant R2/3 
(R), ts N^ or from mock-infected cells (UI) and incubated at 
33° and 39°C, were used for cell-free protein synthesis in the 
rabbit reticulocyte lysate system. Translation products were 
immunoprecipitated with polyclonal anti-RS virus serum and 
analyzed by 10% SDS-PAGE. Lane M contains the Mr protein 
markers.
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strain. [The P genes of the two subgroups have recently been shown 
to share only 80% nucleotide identity; Johnson and Collins, 1990J.
Sussarr. The M protein of ts Nj was found to be metabolically 
unstable soon after its synthesis at 39°C. The M protein was stable 
in three ts+ revertants at 39°C, suggesting that the ts phenotype was 
related to M-protein instability. The M protein of ts Nj and the ts+ 
revertants also migrated more slowly than the wild-type M protein on 
SDS—PAGE. Partial M-protein instability was also observed in ts Nj^ - 
infected cultures at 33°C.
ADDENDUM: Observation of protein cosiplexes by use of different MAbs.
The observation of a specific M-protein deficiency in ts virions, 
released at 33°C, was interesting because it implied that virus 
particles can be formed with significantly less than wild-type levels 
of M protein. This is inconsistent with the central role assigned to 
this protein during virus assembly, i.e. the simultaneous protein- 
protein interactions with viral envelope and nucleocapsid core 
proteins. The availability of several MAbs with different epitopic 
and protein specificities provided an opportunity to examine protein 
interactions in RS virus-infected cells and particles, on the basis 
of the principle of coprecipitation.
Under the experimental conditions used for immunoprécipitation, 
protein interactions (leading to coprecipitation) were observed for 
the nucleocapsid-a8sociated N and P proteins, in accord with previous 
findings (Gimenez et al., 1984; Mufson et al., 1985; Nôrrby et al., 
1986a; Orvell et al., 1987). Thus all the anti-P MAbs coprecipitated 
a proportion of N protein from infected-cell cytoplasm and from 
released virus (a representative experiment is shown in Figure 45; 
see also Figure 6). The reverse coprecipitation- of the P protein by
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Figure 45. Immunoprécipitation with anti-P MAbs. Cells infected 
with the wild-type RSN-2 (lanes 1), the ts+ revertant (of ts N^g) 
R3/6 (lanes 2), ts Njg (lanes 3), the ts+ revertant (of ts f^) R2/3 
(lanes 4) or ts (lanes 5), were incubated at 33°C and labelled 
with [35S¡methionine. Labelled cultures were lysed and 
immunoprecipitated with polyclonal anti-RS virus serum or with two 
different anti-P MAbs. Samples were analyzed by 10% SDS-PAGE. Pbrk 
is a breakdown fragment of the P protein.
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anti-N MAbs - was also observed, however the amount of coprecipitated 
p protein was variable (Figure 46), perhaps due to the existence of 
more than one type of N-P protein complexes. It is noteworthy that 
two types of complexes between the nucleocapsid protein and 
phosphoprotein have been identified in the rhabdovirus VSV (see 
Sections 1A.1 and 1A.2) and a detergent-sensitive NP-P complex 
(obtained - by anti-P MAb immunoprécipitation - in the presence of 
NP40 but unstable in the presence of also 0.1% SDS) has been observed 
by Randall et al. (1987) for the paramyxovirus SV5. The latter 
appears to be the case with the N-P complex recognized in infected­
cell extracts by the majority of the anti-N MAbs shown in Figure 46, 
which is not observed in similarly immunoprecipitated extracts from 
virions which were solubilized in the presence of 0.1% SDS (in 
addition to the non-ionic detergents used for both cells and PEG- 
precipitates).
As already shown in Figure 37, 40 and 42, the anti-M MAbs 
immunoprecipitated only the M protein (and the unidentified low Mr 
band) from lysates of infected cells and virus particles. This is 
also observed in Figure 47, when immunoprecipitates from lysed 
virions have been washed with the low-salt buffer used for lysis (RIP 
buffer; 0.15M NaCl) instead of the high-salt (0.5M LiCl) buffer 
routinely used for washing. This observation contrasts with the 
situation in VSV where the M protein remains in contact with 
nucleocapsid cores under low ionic strength conditions of virion 
solubilization (Emerson, 1987). This difference could be due to the 
considerably less basic nature of the RS virus M protein and/or 
changes in the nature of its association with nucleocapsids caused by 
MAb-binding. [Such changes have been inferred in VSV on the basis of 
altered transcription-inhibition activities of the core-bound M
‘ Figura 46. Immunoprécipitation with anti-N MAbs. Replicate BS-C-1 
monolayers, infected with the wild-type RSN-2 and maintained at 33°C, 
were labelled with [35S¡methionine for 16 hours. Cellular material 
was separated from supernatant medium by centrifugation at 10,000g 
for one minute and lysed with NP40 detergent in PBS (containing 1 mM 
PMSF) on ice (panels A). Supernatants were mixed with 1/5 volume 36% 
PEG, incubated at +4°C overnight, and PEG-precipitates were collected 
by centrifugation and lysed in RIP buffer on ice (panels B). Both 
kinds of lysates were immunoprecipitated with polyclonal anti-RS 
virus serum (lanes P) or with a panel of anti-N MAbs 
(Nl, 2,3,4,5,7,8,9,11). Samples were boiled in 3x reducing sample 
buffer and analyzed by 10% SDS-PAGE. Immunoprecipitated, (35S] — 
labelled polypeptides were visualised by fluorography.
Anti-N MAbs 4 and 7 immunoprecipitate only the N protein, 
whereas the remaining MAbs coprecipitate variable amounts of P 
protein. MAbs 2,3,5,8 and 9, which seem to react with an N-P complex 
in the infected-cell cytoplasm, immunoprecipitate only virion- 
associated N protein (from particles released into the culture 
medium) . [This difference may be due to the different conditions of 
detergent-solubilization used for immunoprécipitations from infected 
cells or from virus particles, as explained in the text). In 
contrast, MAbs 1 and 11 coprecipitate N and P proteins from both 
types of soluble extracts (lysates of infected cells or of PEG- 
precipitated particles). Pbrk is a breakdown fragment of the P 
protein.
205
Figure 47. Immunoprécipitation of virion-asaociated proteins
(A) Cells infected with the wild-type RSN-2, the ts mutant N^g or
its ts+ revertant R3/6, were incubated at 33°C and labelled 
with [35S]methionine. PEG-precipitated particles in the 
supernatant media of these cultures were collected and 
immunoprecipitated with polyclonal anti-RS virus serum (lanes 
POL), the anti-N MAb (lanes N), the anti-M MAb C781 (lanes
M) or the anti-22K MAb 5H5 (lanes 22). Samples were analyzed 
by 12.5% SDS—PAGE. Lane (M) contains the Mr protein markers, 
whose molecular weights are indicated in kilodaltons.
(B) Cells infected with the wild-type RSN-2 (lanes W) or the ts+ 
revertant R3/6 (lanes R) were incubated at 33°C and labelled 
with (35SJmethionine. PEG-precipitated particles were lysed 
and immunoprecipitated with polyclonal anti-RSV serum (POL), 
the anti-22K MAb C3142 or two anti-N MAbs (Nj^, Ng), and 
analyzed by 10% SDS-PAGE.
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protein upon binding of anti-M MAbs to different M-epitopes (Pal et 
al., 1985b;Ye et al., 1985)]. However, under the same, low ionic 
strength conditions (during immunoprécipitation and subseguent 
washing steps), the anti-22K MAb 5H5 coprecipitates a proportion of 
the virion-associated N and P proteins, together with the 22K (Figure 
47), suggesting an association between these structural polypeptides 
in the virus particle.
This coprecipitation of N, P and 22K proteins seems to be 
specific (and possibly related to the 22K epitope recognized by MAb 
5H5), since it was not observed with a different anti-22K MAb (C3142; 
Figure 47B). The profiles of infected-cell lysates,
immunoprecipitated with either anti-22K MAb (Figure 48A) contain some 
N protein (and that of MAb 5H5 also a faint P band). The presence of 
the N protein in the profile of MAb C3142 however, appears to be non­
specific, since preincubation with an anti-N MAb completely removes 
the N protein from the profile without detectably affecting the 
amount of 22K protein present (Figure 48A, compare lanes 4 and 5 in 
panel II). [Indeed, a variable amount of N protein was detected in 
all MAb immunoprécipitations since the protein is very abundant and 
extensive washing is required for its effective removal]. Therefore, 
in order to investigate the specificity of coprecipitation of N 
protein (and of a smaller amount of P protein) by anti-22K MAb 5H5 
(Figure 48A, panel I), the infected-cell lysates were pretreated with 
this MAb, or with one of the anti-M MAbs (which do not coprecipitate 
N or P protein) as a control, before incubation with an anti-P MAb 
(which coprecipitates N protein). As shown in Figure 48B, prior 
incubation with the anti-M MAb (lanes 4) does not appear to remove 
the N and P proteins from the soluble extract (as compared to the 
anti-N and anti-P immunoprécipitations), whereas preincubation with
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rjoure 48. Immunoprécipitation with anti-22K MAbs.
(A) Cells infected with the wild-type RSN-2 or the ts+ revertant 
R3/6 were incubated at 33°C and labelled with [35SJmethionine. 
Samples in panel I were immunoprecipitated with anti-N MAb N10  
(lanes 1), anti-P MAb M189 (lanes 2), anti-P M189 and anti-22K 
MAb 5H5 (lanes 3) or anti-22K MAb 5H5 alone (lanes 4). Samples 
in panel II were immunoprecipitated with polyclonal anti-RS 
virus serum (lanes 1), anti-N MAb Ng (lanes 2), anti-N MAb N jj 
(lanes 3) or anti-22K MAb C3142 (lanes 5). Lanes 4 contain 
samples immunoprecipitated with anti-22K MAb C3142 following 
incubation of infected-cell lysates with anti-N MAb Nji (which 
coprecipitates N and P proteins as shown in lanes 3).
(B ) Cells infected with the wild-type RSN-2 or the ts+ revertant 
R2/3 were incubated at 33°C and labelled with [35SJmethionine. 
Samples were immunoprecipitated with anti-P MAb 8268 after 
incubation of cell lysates with anti-P MAb 9178 (lanes 1), 
anti-22K MAb 5H5 (lanes 2), anti-N MAb NX1 (lanes 3) or anti-M 
MAb Ml (lanes 4) and removal of viral polypeptides bound to 
these MAbs from the soluble infected-cell fraction by addition 
of protein A-bearing, fixed Staph, aureus cells
("immunoprecipitin").
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MAb 5H5 results in similarly efficient removal of the N protein as 
that observed for the anti-N and anti-P MAb8.
It thus seems unlikely that the majority of N protein present 
in the MAb 5H5 profiles is due to non-specific precipitation or 
inefficient washing of the immunoprecipitates since such a phenomenon 
is not observed with the.anti-M MAb. The observation of a faint P- 
protein band by MAb 5H5-immunoprecipitation of infected-cell lysates 
is in agreement with the corresponding profiles from virion-lysates 
(Figure 47A) and could be due to the presence of cell-associated 
virus particles in extracts of infected cells. Taken together, the 
reactivity patterns of the two anti-22K MAb8 suggest that the 22K 
protein exists both in a free form (recognized by MAb C3142) and in a 
form associated with what appears to be an N-P protein complex 
(recognized by MAb 5H5) in the cytoplasm of infected cells. This is 
consistent with the immunofluorescence pattern obtained by staining 
infected cells with MAb 5H5 (Routledge et al., 1987a) which is 
discussed in the following Section.
3.3B DISCUSSION
M protein deficiency. In agreement with a previous study of ts Nlf 
which suggested that this mutant possessed a maturation defect, the 
ts Ni polypeptide profile at 39°C revealed a significant and specific 
decrease of intracellular M protein (Figure 30), the protein which 
mediates virion assembly. Furthermore, the ts P protein was 
observed to migrate with an aberrant mobility as previously reported , 
(Pringle et al., 1981). This P protein alteration was also exhibited
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by spontaneous ts+ reversants both in the intact protein and in 
enzymatically-produced P fragments.
The temperature-induced instability of the ts Nj M protein 
observed by pulse-chase/shift-up experiments (Figure 34, 36) could be 
due to a higher rate of intracellular degradation, as a result of an 
altered conformation. However no distinct M-breakdown products were 
identified during pulse-chase experiments. It is possible that such 
fragments may have been too small to be retained in the gel or that 
they might have lost their antigenicity. Alternatively, the protein 
may be absent from the soluble fraction of infected-cell lysates 
(which was used for immunoprécipitations) due to abnormal 
accumulation into insoluble aggregates. Both phenomena have been 
described for tsM-protein mutants of VSV (Knipe et al., 1977a; Ono et 
al., 1987). It would be possible to distinguish between these two 
alternatives by immunofluorescence and/or temperature shift-down 
experiments, where reversibility would be predicted only in the 
absence of M protein degradation.
N protein mobility. The ts M protein was observed to be an 
electrophoretic variant, migrating slightly more slowly than the 
wild-type M protein (Figure 41). M mobility differences have also 
been noticed in tsM-protein mutants of NDV (Peeples and Bratt, 1984) 
and of VSV (Knipe et al., 1977a; Kennedy-Morrow and Lesnaw, 1984; Pal 
et al., 1985b). Although electrophoretic migration differences may 
not be thought consistent with single missense mutations (which have 
been shown to underly many temperature-sensitive phenotypes), such a 
correlation has in fact been demonstrated in the case of VSV tsM-
protein mutants. Site-directed mutagenesis of M cDNA clones and >/
conformational energy analysis of M-oligopeptides have shown that 
certain amino acid changes which alter the charge and/or the
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predicted local secondary structure can cause apparent mobility 
variation (Brandt-Rauf et al., 1987; Li et al., 1988; Shipley et al. ,
1988). The fact that the three ts+ revertants examined possessed the 
ts M protein mobility could be due to the screening of only a 
small number of revertants and/or the possibility of independent 
isolation of the same ts+ clone more than once. This observation, 
taken together with the demonstration of some degree of M protein 
instability at 37°C in one revertant (Figure 36B), suggests that 
these clones are pseudorevertants, containing a second compensatory 
mutation at another site within the M gene or in a different gene.
Isolation of pseudorevertants appears to be a common phenomenon 
in tsM-protein mutants of VSV which have a remarkably high rate of 
reversion (10-3), attributable to many secondary mutations in the M 
gene (Morita et al. , 1987). Similarly, 7 out of 10 revertants 
isolated at a frequency of 10-4-10-5  from tsM-protein mutants of NDV 
were pseudorevertants (Peeples and Bratt, 1984). The high frequency
X  __Aof isolation of ts revertants from ts (approximately 10 ) is
consistent with pseudoreversion which, in the case of VSV, is 
considered to indicate that M-protein conformation is a major 
determinant of its function (Gopalakrishna and Lenard, 1985; Ogden et 
al., 1986). However, as both the P and M proteins of the ts+ 
revertants exhibit the altered mobility of their parent mutant, 
further experiments will be necessary in order to rule out 
conclusively any potential contribution of the P protein alteration 
to the ts Nj phenotype. For instance, it would be possible to take 
advantage of the mobility differences in order to study the 
intracellular stability of the ts M protein at 39°C in the 
presence of the wild-type P protein in doubly-infected cells, as well 
as the possibility of formation of phenotypically-mixed virions
Incontaining the ts Nj P and wild-type M proteins (and vice versa). 
addition, sequencing of the M and P genes from ts and the ts+ 
revertants would provide molecular characterization of the ts Nj 
lesion and the secondary mutations by which it is compensated. To 
initiate this approach, the sequence of a P cDNA clone from ts Nj was 
determined and is discussed in the following section (3.4A) . 
Immunoprécipitation of N protein. The ts Nj M protein was found to 
be partially affected by incubation even at the permissive 
temperature by pulse/shift-up (Figure 36A) and immunoprécipitation 
experiments (Figure 37, 38). Mutant ts N^ was also consistently 
observed to grow more slowly in culture at 33°C compared to the wild- 
type and other ts viruses, indicating that partial instability of its 
M protein at 33°C was affecting the spread of infection throughout 
the monolayer. The important role assigned to the matrix protein 
during virus maturation was underlined by the fact that all virion- 
associated ts M protein molecules seemed to possess the proper 
conformation (equally recognized by polyclonal antiserum and the 
conformation-dependent anti-M MAbs), presumably because this is the 
functional conformation compatible with the protein interactions 
required during virion assembly. In contrast, a proportion of 
intracellular ts N^ M protein did not appear to have this 
conformation, which probably explains the reduced growth of ts at 
the permissive temperature. A similar observation has been reported 
for a tsM-protein mutant of VSV New Jer~ey serotype (Kennedy-Morrow 
and Lesnaw, 1984).
In addition to the M protein, a band of approximately 14.5K was 
present in two anti-M MAb profiles (Figure 37A), which comigrated 
with the (tentatively assigned) IB non-Btructural protein. Since 
both proteins are similarly basic (Dubovi, 1982), it is possible that
the two M-protein epitopes recognized by the two anti-M MAbs are also 
present in the IB protein. Such cross-reaction has been noticed 
previously with an anti-measles-HN MAb, which immunoprecipitated the 
RS virus N protein in separate reactions (Nôrrby et al., 1986b). A 
"geminiepitopic" anti-F MAb has also been described, which recognizes 
the same epitope on both RS virus F^ and Fj subunits on Western blots 
(Samson et al., 1986). Since these anti-M MAbs did not react with 
denatured M protein, it was not possible to differentiate between 
coprecipitation and cross-reaction.
Interestingly, a similar situation has been observed in the 
absence of any immunoprécipitation. Venkatesan et al. (1983) found 
that some plasmid clones containing an M cDNA insert hybrid-selected 
RS virus mRNA, which in cell-free translations produced the M protein 
and a smaller protein of approximately 15K. This band comigrated 
with the hybrid-selected translation product of the IB mRNA.
However, since not all of the M-clones exhibited this phenomenon and 
the reverse hybrid-selection of M mRNA by IB cDNA clones was not 
observed, the possibility of cross-hybridization was ruled out 
(Venkatesan et al., 1984). Satake and Venkatesan (1984) suggested 
that this 15K protein may arise from translation of a second small 
ORF present in the M mRNA. However, such a protein would be in a 
different reading frame from that of the M protein and would thus not 
be expected to share antigenic sites with the M, whereas the small 
protein described here was observed by anti-M MAb
immunoprécipitation. On the other hand, the inconsistent presence of 
the low Mr band in hybrid-selected translations of M mRNA and the 
occasional detection of this small protein in anti-M MAb profiles ■
from virions (Figure 40A) suggest that this polypeptide may be a 
breakdown product of the M protein (the IB non-structural protein
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would not be detected in the partially purified virions examined in 
this study). Comparison of anti-M MAb immunoprecipitates of IB cDNA— 
hybrid-selected and hybrid-arrested RNA samples could be used to 
resolve the origin of this low Mr band.
RNA synthesis. Inhibition of transcription in vitro as a consequence 
of electrostatic interactions between the highly basic M protein and 
RNP cores in both VSV (see Introduction, Section 1A.3) and Sendai 
virus (Marx et al., 1974) is indicative of the strength of M protein- 
RNP interactions. The decreased intracellular stability of M protein 
in tsM-protein mutants of VSV has been correlated with significantly 
enhanced mRNA synthesis (“hypertranscription") at the restrictive 
temperature. In this study, reduced — rather than increased - mRNA 
levels were observed in ts N^-infected cells at 39°C (Figure 44). 
However, as RNA samples were prepared at two days post-infection, 
this result could well be due to the growth restriction of ts Nj at 
39°C. (The discrepancy between the levels of viral mRNA at two days 
post-infection at 39°C, detected (indirectly) by protein-labelling of 
ts N^-infected cells (where a decreased level of viral protein 
synthesis can be observed; Figure 34A) and by Northern blotting or in 
vitro translation of total cytoplasmic ts N^-infected cell RNA (which 
suggest absence of virus-specific mRNAs; Figure 44) is probably 
artifactual, due to loss of some RNA during the extraction procedure 
and/or the fact that only a fraction of the total RNA extracted from 
one monolayer culture was used for RNA analyses]. Study of mRNA 
synthesis at earlier tims post-infection was precluded by the low 
yields of virus-specific mRNAs at such times, which required at least 
one growth-cycle (i.e. 12 hours) in culture before,they could be 
reliably detected (at 16 hours p.i.). This problem may have been 
compounded by the fact that a non-homologous cDNA probe was used.
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Homologous probes (from RSN-2, rather than A2, cDNAs) might allow 
more stringent hybridization conditions to be used, thereby 
increasing the sensitivity of detection. Alternatively, the 
multiplicity-related difficulties encountered in vivo may be 
circumvented in vitro through amplification of a target mRNA 
population (isolated at different times p.i. at 39°C) by the recently 
described quantitative PCR assay (Hayashi et el., 1989; Wang et ai.,
1989).
Virion-associated ts proteins. In view of the importance of the 
matrix protein for virus assembly, the observation of an M protein 
deficiency in ts Nj virions at 33°C (Figures 33, 40 and Table 16) was 
surprising. This M protein reduction could be due to an alteration 
of its association with the envelope and/or the envelope 
glycoproteins. Similar phenomena have been observed with ts M- 
protein mutants of VSV (Mancarella and Lenard, 1981; Reidler et el., 
1981). However, this seems unlikely in view of the efficient 
recognition of the ts virion M protein by the conformation- 
dependent anti-M MAbs, as previously discussed. Furthermore, the 
N/Fj ratio in ts Nj virions did not differ significantly from that in 
wild-type and revertant virions (Table 17). In contrast, tsM-protein 
mutants of NDV were found to incorporate approximately half as much F 
protein in virions as compared to wild-type and ts+ revertants 
(Peeples and Bratt, 1984). Thus the largely unaffected N/Fj ratio in 
ts Nj-virions is at variance with the observed deficiency in M 
protein, which is presumed to link nucleocapsids (reflected by N 
protein) to the viral envelope (reflected by F protein). It is 
possible that the decrease of immunoprecipitated virion M protein is ■ 
an artifact of the disruption process, e.g. self-aggregation, which 
could result in depletion of soluble M protein from the
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inmiunoprecipitated fraction. Alternatively, these results may 
indicate involvement of a second RS virus protein in virion assembly.
The matrix proteins of enveloped negative-stranded RNA viruses 
have a central role in virus assembly by linking the intracellular 
progeny nucleocapsids to those parts of the membrane that have been 
modified through insertion of the viral glycoproteins. Recent data 
have shown that, although this function is conserved, there can be 
variation in the structural features of the M protein. In the 
rhabdovirus VSV, the peripheral matrix protein is associated with the 
lipid bilayer and with the RNP cores primarily through ionic 
interactions (Ogden et al., 1986; Pal and Wagner, 1987). In 
contrast, the matrix (M^) protein of influenza virus appears to be 
inserted into the lipid bilayer (Ye et al., 1987) and also contains a 
"zinc-finger" motif which enables it to bind directly to viral RNA 
(Ye et al., 1989; Wakefield and Brownlee, 1989). The paramyxovirus M 
protein resembles the rhabdovirus M protein in attaching to RNP cores 
through electrostatic interactions with nucleocapsid-associated 
proteins and in being peripherally associated with the envelope. The 
nature of the latter association, however, appears to be hydrophobic 
rather than ionic (Bellini et al., 1986; Galinski et al., 1987;
Faaberg and Peeples, 1988). RS virus is the only paramyxovirus that 
contains a second non-glycosylated, membrane-associated protein, the 
22K protein. The similarity of the properties of this protein to the 
paramyxovirus M protein (peripheral membrane association, basic 
charge) has, in the past, implied at least an auxiliary role for the 
22K protein in virus maturation and assembly (Collins and Wertz,
1985c; Elango et al., 1985; Huang et al., 1985). In addition, ■
Routledge et al. (1987a) observed similar immunofluorescent staining 
patterns with anti-N, anti-P or anti-22K MAbs in acetone-fixed
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infected cells, suggesting that a proportion of all three proteins 
may be associated with the same intracellular structures. The 
existence of a similar association in virus particles was suggested 
during this study by the ability of an anti-22K MAb to coprecipitate 
a proportion of N and P proteins together with the 22K protein 
(Figure 47A). The observation of an M protein deficiency in ts 
virions without a corresponding effect in either the internal or 
envelope virion components may thus be due to separate interactions 
of these components with the two different peripheral membrane RS 
virus proteins. However, in view of the limitations of the PEG- 
precipitation method (discussed in Section 3.2A) it is possible that 
the PEG-precipitated material (considered here as "virions") contains 
some N and/or Fj protein released from disrupted cells, thus 
affecting the observed N/Fj ratio. Quantitation of the structural 
polypeptides in gradient-purified ts virions will be necessary to 
accurately determine their relative abundance. Further studies (such 
as chemical cross-linking) would be useful in defining the 
relationships between the membrane-associated and nucleocapsid- 
associated proteins in RS virus particles.
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3.4 T» MUTANT M m
3.4A RESULTS
Viral protein synthesis. Mutant ts Nig (RSN-2 strain) was previously 
found to be negative for both intracellular- and surface- 
immunofluorescent staining (Pringle et al., 1981), suggesting that 
the ts Nig defect was exhibited early in infection. This result was 
confirmed here by immunoprécipitation and SDS-PAGE (Fig. 49), where 
no intracellular or virion-associated polypeptides could be detected 
at 39°C in ts Nlg-infected cultures (panels A and B, respectively).
In contrast, ts+ revertants isolated from ts N^g (also shown in Fig. 
49) exhibited efficient viral protein synthesis at 39°C and their 
profiles were indistinguishable from that of the wild-type RSN-2.
Mutant ts N^g possessed a P protein which did not react with 
anti-P MAb 3-5 at 33°C (Fig. 50). This negative reaction has also 
been observed by Western blotting and by immunofluorescence (Dr. B. 
Gimenez, personal communication). The ts N^g P protein was found to 
be positive to all other anti-P MAbs tested (two of which are shown 
in Fig. 50). The P protein of revertant clone R3/6 (Fig. 50) and of 
all the other revertants (not shown) is efficiently recognized by 
anti-P MAb 3-5. The simultaneous reversion of the temperature- 
sensitive phenotype and of the P-reactivity with MAb 3-5 in the ts+ 
revertants suggests that the P protein of mutant ts N^g is the site 
of its ts lesion.
Since viral polypeptide synthesis could not be detected by 
labelling of ts Njg-infected cells at 39°C, the intracellular 
stability of the ts Nlg P protein was examined by pulse/shift-up 
experiments. Figure 51A shows the negative profile of ts Nig-
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Figure 49. Viral polypeptide synthesis by ts N^g and its ts+ 
revertants. BS-C-1 cells were infected with the wild-type RSN-2, 
mutant ts Njg or three different ts+ revertant clones (R3/l,4,6) and 
incubated at 33°C (lanes 3) and 39°C (lanes 9). Infected and mock- 
infected (MI) monolayers were labelled with (35SJmethionine, lysed 
and immunoprecipitated with polyclonal anti-RS virus serum (A).
Virus particles in the supernatants of these cultures were collected 
by PEG-precipitation and similarly immunoprecipitated (B). Virus- 
specific polypeptides were resolved by 6-15% linear gradient gels.
In panel A, the three bands indicated by circles, which are present 
in the ts N 19 profile of 39°C, could be cellular polypeptides and/or 
due to "leaking" from the adjacent, strongly labelled profile (which 
can be observed to occur also in panel B).
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Figure 50. Immunoprécipitation of the ts P protein with anti-P
MAbs. Cells infected with the wild-type RSN-2, the mutant ts Nlg or 
the ts+ revertant R3/6, were incubated at 33°C and labelled with 
[^S] methionine. Released virus particles in the supernatant media 
were collected by precipitation with 36% PEG, lysed and 
immunoprecipitated with polyclonal anti-RSV serum (lanes 1) and the 
anti-P MAbs 8268 (lanes 2), 9178 (lanes 3) or 3-5 (lanes 4). 
Immunoprecipitates were analyzed by reducing 10% SDS-PAGE. Lane M 
contains the Mr protein markers.
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infected cultures incubated at 39°C immediately post-infection (lane 
P39). However, when ts N19-infected cells that had been maintained 
and labelled at 33°C were chased at 39°C for up to two hours, no 
progressive decrease of the P protein band was observed, suggesting 
that the ts N19 P protein is not thermolabile. Thus the negative 
polypeptide profile of ts N19 at the restrictive temperature is 
probably not due to P-protein instability. As the paramyxovirus P 
protein is known to be involved in mRNA synthesis (see section IB.3), 
the coordinate effect on overall ts N19-protein synthesis implies 
that the ts defect may affect the function and/or the interactions of 
the ts N^g P protein in the RNA polymerase complex. Ts N19-infected 
cells did not exhibit viral mRNA synthesis at 2 days post-infection 
at 39°C (Fig. BIB). However, the technical difficulties discussed in 
section 3.3A did not permit analysis of ts N19-mRNA synthesis at the 
initial stages of infection.
Production of P cDNA clones. In order to identify the site of the ts 
N j9 P lesion at the nucleotide level, cDNA clones of the P mRNA were 
prepared by reverse transcription and amplification by the polymerase 
chain reaction (PCR). For both of these reactions, which were 
performed sequentially in the same reaction mixture (according to a 
modified procedure devised by Dr. M. A. McCrae, as described in 
section 2B.4.1), P gene-specific primers were used such that only P- 
specific clones would be generated from the total cytoplasmic 
infected-cell RNA samples, which were used as templates. The 
sequences of these primers are shown in Fig. 52A, together with the 
end regions of the P mRNA to which they were designed to hybridize 
(i.e., the 3 'end-primer directly to P mRNA and the,5'end-primer to 
the 3'end-primed complementary DNA strand). Terminal restriction 
Bites were added to the P-specific oligonucleotides in order to
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Figure 51.
, (A) Intracellular stability of the ts N^g P protein. Replicate BS­
C-1 monolayers were infected with mutant ts N^g, incubated at 
33° and 39°C for 48 hours, and labelled for 10 minutes with 
[35S]methionine. One culture from each temperature was lysed 
and immunoprecipitated with polyclonal anti—RS virus serum 
immediately after the removal of label (lanes P). The 
remaining cultures were similarly treated after further 
incubation in medium containing non-radioactive methionine, for 
the times indicated in the figure. One set of infected 
cultures, that had been maintained and labelled at 33°C, was 
thus treated following incubation at 39°C, after removal of the 
label (chase + shift-up). Two control cultures were further 
incubated at the temperature at which labelling had been 
carried out, for the 2 hour-duration of the chase (lanes 2h).
(B) Synthesis of P gene-transcripts in RS virus-infected cells.
Cytoplasmic RNA from cells infected with the wild-type RSN-2 
(wt), the mutant ts N^g or its ts+ revertant R3/6 (R^g), or 
from mock-infected cells (UI), was isolated at two days post­
infection from cultures incubated at 33° and 39°C. Four-pl 
aliquots of the RNA samples were treated with a formamide- 
formaldehyde mix at 60°C for 10 minutes and analyzed by gel 
electrophoresis in a 1.5% agarose-formaldehyde gel. Following 
Northern transfer to nitrocellulose, P-specific RS virus 
transcripts were detected by hybridization with a gel-purified, 
nick-translated PstI fragment of the A2 strain - P cDNA (see 
Figure 69B) and autoradiography. The positions of the P mRNA 
and of a less abundant bicistronic (readthrough) transcript 
containing the P-gene sequence are indicated.
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figure 52. Production of P cDNA clones by reverse transcription and 
PCR amplification. Panel A shows the sequences of the 
oligonucleotide primers, used for obtaining P-specific cDNA from a 
population of RS virus mRNA molecules, and the sequence of the 
relevant regions of the P mRNA (from RS virus strain 18537; Johnson 
and Collins, 1990). The nucleotides contained in the box represent 
the conserved RS virus mRNA-start signal. The nucleotides added to 
the 5' ends of the primers in order to create terminal restriction 
sites on the P cDNA are shown in bold letters. Panel B shows 
ethidium bromide-stained 1% agarose gels, on which PCR products were 
analyzed after completion of thermal cycling. The arrows indicate 
the position of the P cDNAs derived from the wild-type RSN-2, the ts+ 
revertant R3/6 or the mutants ts N19 and ts Nj. Lanes L contain the 
ladder of DNA fragments of known size (indicated on the right, in 
base pairs).
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facilitate subsequent cloning. The P gene-specific parts of the 
primers were selected on the basis of the P mRNA sequence of a 
different subgroup B virus, the 18537 strain (Johnson and Collins, 
1990; kindly communicated by Dr. P. Collins before publication).
As shown in Fig. 52A, most of the 5'end-specific primer 
consists of non-coding nucleotides, since this sequence (containing 
the RS virus consensus mRNA start signal) was almost exactly 
conserved between the two RS virus subgroups (Johnson and Collins,
1990) and was thus anticipated to be highly specific for the RSN-2 P 
mRNA. In contrast, the 3' non-coding mRNA region has been shown to 
be variable between the subgroups as well as between different 
strains of the same subgroup (Lambden, 1985; L6pez et al., 1988; 
Johnson and Collins, 1990). Consequently, the 3 'end-specific primer 
was designed to be complementary to the more highly conserved 3' 
terminal coding sequence (the codons for the C-terminal 7 amino 
acids) in order to increase the specificity of primer hybridization 
to the RSN-2 P mRNA. Figure 52B shows electrophoresed aliquots of 
the PCR reaction mixtures (after forty thermal cycles), where the 
major DNA product appears to be the P cDNA on the basis of its size 
(approximately 800 bp, close to the estimated 750 bp).
The P-specificity of the PCR products was further assessed by 
restriction mapping of recombinant plasmid DNA. The PCR products 
were gel-purified and inserted into the multiple cloning site (MCS) 
of the Bluescribe vector, both by blunt-end ligation into the SmaI 
site and after restriction of the 5'end with BamHl. It was however 
found that the Klenow polymerase treatment did not extend the PCR 
products completely to their end sequences, such that the primer
restriction sites could not be identified in all the clones
Therefore, in subsequent cloning experiments only blunt-end ligations 
into the Bluescribe plasmid were carried out. Consequently, the cDNA 
products were capable of insertion in either of the two opposite 
orientations with respect to the MCS restriction sites, so both the 
orientation and the authenticity of the PCR-generated clones were 
determined by restriction mapping. A series of double digestions 
that were predicted to produce asymmetric restriction fragments, 
according to orientation, was performed. Two of these are shown in 
Fig. 53 and 54, in comparison to the predicted digest patterns.
The clones selected for further analysis are shown in Fig. 55. 
Two different clones from each type of viral mRNA (i.e. wild-type, 
ts+ revertant and ts N 19), representing the two opposite 
orientations, and one clone from the ts Nj P mRNA were used for 
nucleotide sequencing.
Sequence determination. The P cDNAs were excised from the 
recombinant Bluescribe plasmids and ligated into the pair of M13 
vectors, mplB and mpl9. These contain the multiple cloning site in 
opposite orientation with respect to the site of hybridization of the 
17mer universal sequencing primer and to the direction of the lacZ 
gene-transcription (Fig. 56A). Thus insertion of the same fragment 
into the two vectors (by forced cloning) enabled sequencing from both 
ends, but from opposite strands. Since the "extended DNA sequencing" 
protocol was used (see section 2B.5.3), the insert terminal sequences 
could not be determined by use of the universal primer due to its 
proximity to the site of insertion. For sequencing of these regions 
a more distally annealing primer ("LAC") was used, which hybridized 
to a site approximately 120 bp downstream from the'MCS, within the 
lacZ gene. The direction of DNA synthesis (extension) from the "LAC"
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Figure 53. Restriction mapping of recombinant Bluescribe/RS virus P 
plasmids (1). The drawing in panel I is a graphic representation of 
the restriction fragments produced by digestion with PvuII or by 
double digestion with PvuII/EcoRI. The P cDNAs, possessing terminal
fiamHI and PvuII restriction sites, were inserted into the Smal site
2 2 6 a
(Figure 53 - continued)
of the multiple cloning site (MCS) of the BlueBcribe plasmid by 
blunt-end ligation, allowing insertion in either orientation (A or B) 
with respect to the sites of MCS. The multiple cloning site is 
contained within a region between two PvuII sites present in the 
Bluescribe vector at positions 764 and 1142 (only this region from 
the plasmid is shown here). Digestion with PvuII produces two 
fragments from clones in either the A or B orientation (designated as 
p a /b 1, P A/b 2) which, however, have different sizes (the 
approximate fragment sizes are indicated in base pairs between 
parentheses), thereby allowing determination of insert orientation in 
the recombinant plasmids. The EcoRI and BamHI sites on the fragments 
are indicated as E and B, respectively. Subsequent digestion of the 
PvuII fragments with EcoRI (or simultaneous double digestion) also 
produces an equal number of fragments (three) of the P cDNA. The 
third small fragment (approximately 20 bp) produced by PvuII/EcoRI 
digestion of clones with the B orientation is not included in the 
drawing, as this fragment is too small to be retained in the agarose 
mini-gels of panel II, which were used to resolve the products of 
PvuII or PvuII/EcoRI digestion. The gels were stained with ethidium 
bromide, and DNA fragments were visualized and photographed using a 
UV-transilluminator (as described in Methods, section 2B.4.6). The 
positions of the fragments drawn in panel I are indicated on the gels 
by arrows. Lanes L contain the ladder of DNA fragments of standard 
size, which were co-electrophoresed in order to estimate the sizes of 
the restriction fragments produced from the recombinant plasmids.
(The sizes of the DNA standards are given in base pairs).
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Flour« 54. Restriction mapping of recombinant Bluescribe/RS virus P 
plasmids (2). The top half of the figure is a graphic representation 
of the restriction fragments produced by AvalZ/Pstl double digestion 
of the recombinant plasmids, according to the orientation of 
insertion of the P cDNA clones with respect to the unique sites of 
the multiple cloning site (MCS) of the vector. The Avail site is an 
internal restriction site of the P cDNA at position 492. The clones 
possess terminal BajnHI (B) and PvuII (P) sites at positions 1 and 
750, respectively. Thus double digestion with Avail and PstI 
produces a fragment of approximately 280 bp (AA1) from clones in 
orientation A, or a fragment of approximately 520 bp (AB1) from 
clones in orientation B. The bottom half shows ethidium bromide- 
stained agarose minigels in which the Avall/PstI digestion products 
were resolved. Clones 2,4,6,7 and 14 contain P cDNA derived from 
wild-type RSN-2 mRNA, and clones 19 and 23 contain P cDNA from mutant 
ta Nlg mRNA. Lane BS contains the restriction fragments of the 
Bluescribe vector alone (i.e. having no insert). Fragment X 
represents an Avail fragment of the vector, which is derived from the 
gene specifying ampicillin-resistance. Lanes L contain the ladder of 
DNA size markers (the numbers given indicate their sizes in base 
pairs).
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Figure 55. Orientation of insertion of the PCR-derived P cDNA 
clones. The PCR products were inserted by blunt-end ligation into 
the unique Smal site of the multiple cloning site (MCS) of the 
Bluescribe vector. The MCS (the sequence between the £coRI and 
Hind III restriction sites) is contained within a PvuII fragment of 
the Bluescribe plasmid, which is shown here as the black line. The 
Smal site of insertion is indicated between parentheses (to denote 
loss of this site following insertion). The P cDNA inserts are shown 
in green and the positions of characteristic terminal and internal 
restriction sites, which were used for restriction mapping, are 
indicated. The blue arrows show the 5' -* 3' direction of P mRNA 
synthesis. The red arrows indicate the direction of in vitro 
transcription from the adjacent T3 and T7 bacteriophage RNA 
polymerase promoters. P mRNA-sense transcripts are produced in vitro 
by T7 transcription for clones in orientation A (W7, R34, N23) or by 
T3 transcription for clones in orientation B (W6, R29, N19, C15).
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Panel A shows the site of hybridization (illustrated by the dashed
lines) of the 17mer universal sequencing primer to single-stranded
M13 mpl8/19 DNA templates, and the 5 1 -* 3• direction of DNA synthesis
during dideoxy-sequencing reactions. M13 vectors mpl8 and mpl9
contain the multiple cloning site (MCS) in opposite orientation with
respect to the site of primer hybridization. Thus, insertion of the
P cDNAs into these vectors by forced cloning (i.e., by generating
presented in panel B. The arrowheads indicate the 5' -»3* direction
of sequencing DNA synthesis, by extension from the 17mer primer or
from the "LAC" primer (which hybridizes to a position further
downstream from the MCS within the lacZ gene, as explained in the
text). The double arrow corresponding to the internal HincII-Avall P
fragment indicates the fact that the sequence of this region was
determined from both strands (this fragment was Bubcloned by blunt
end ligation into both mpl8 and mpl9, as described in Methods
M
C
S
primer was the same as that from the universal primer. The overall 
sequencing strategy is outlined in Fig. 56B.
Since the upper limit of efficient resolution was approximately 
300 nucleotides downstream of the primer region, an internal P cDNA 
fragment covering the middle portion of the 750 bp-clone (WincIIi44- 
AvaII492, Fig. 56B) was also subcloned into the mpl8/19 pair of 
vectors and its sequence was determined from both strands. This was 
necessary because of the existence of several runs of (C)4 residues 
in this region. As shown in Fig. 57A, this resulted in sequence 
ambiguities (i.e. band compression and/or presence of all four 
nucleotides in the same position) when primer extension on the full- 
size clone produced the P mRNA-sense sequence. However, these 
ambiguities were clearly resolved by primer extension on the 
subcloned fragment and sequence determination of either the plus- or 
minus-strand (Fig. 57).
P mRNA sequence comparisons. By compilation of the sequences 
obtained from the seven different clones shown in Fig. 55, a 
consensus sequence was established for the RSN-2 strain P cDNA, which 
is presented as the 5' -* 3' mRNA sequence in Fig. 58, together with 
the deduced amino acid sequence of the P protein. The sequence 
reveals the existence of a novel HindIII site in the RSN-2 strain P 
cDNA, which is not present in the A2 or 18537 P cDNAs. The existence 
of this site had already been indicated by restriction mapping 
experiments (Fig. 59). The nucleotide substitutions creating the 
HindIII site give rise to one of the overall three amino acid 
differences between the deduced RSN-2 and 18537 P protein sequences 
(Fig. 60). This very high level of amino acid identity between the t 
two subgroup B strains is consistent with that found between the 
subgroup A/Long, A2 and Edinburgh strains (which are the only other P
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Figure 57. Sequencing of PCR-derived clones by subcloning into
single-stranded M13 vectors. Part A shows representative 
autoradiograms of sequencing gels, where the 5' -»3' direction of 
sequencing DNA synthesis coincided with the 5' -» 3* direction of the 
P mRNA (plus-strand). The four tracks from each sample, containing 
the respective dideoxynucleotide-termination mix are indicated as 
C,T,A,G. Panels 1 and 2 show the P sequence between nucleotides 150- 
310, derived from the wild-type clone W6 and mutant clone N19, 
respectively, by primer extension of the full-length cDNA clone. The 
three areas <<a,b,c», which are pointed out by arrows in panel 2, 
show the sequence ambiguities mentioned in the text, i.e. the 
compression of successive C residues and the presence of all four 
nucleotides at the same sequence position. Panel 3 shows the 
sequence containing these areas (in the wild-type clone W6) produced 
by sequencing extension on a shorter, subcloned fragment (H i n d i - 
Avail) of the full-length P clone, where these ambiguities were 
resolved. The sequences of the two areas « a »  and <<b>> are written 
in the 5' -* 3' direction of sequencing DNA synthesis and the arrows 
indicate the 5' -»3' direction of the P mRNA. The nucleotide 
substitution identified in clone N19 (A -» G) at position 297 (see 
Table 20) is marked by asterisks. In part B, the sequence of the 
« a »  and <<b>> regions is shown in the anti-mRNA sense, produced by 
primer extension on the subcloned HincII-Avall fragment in the 
direction of the opposite (minus) strand, which also enabled 
resolution of the ambiguous regions of the P sequence.
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Flour« 58. Nucleotide sequence of the RSN-2 P mRNA and deduced amino
acid sequence of the RSN-2 P protein. The P mRNA sequence was 
compiled on the basis of sequencing data obtained for seven different 
P cDNA clones, derived from RSN-2 strain-virus mRNA. The clones did 
not contain the sequence of the 3' non-coding mRNA region (except for 
the translation termination codon UGA which is not shown), thus only 
the sequence corresponding to the coding region of the RSN-2 P mRNA 
was determined in the present study. The 5' and 3' terminal 
sequences which are underlined by the dashed lines represent the 
parts of the P sequence contained in the oligonucleotide primers (see 
Figure 52), which were constructed on the basis of the strain 18537 P 
mRNA sequence. The underlined sequence between nucleotides 272-277 
corresponds to a unique Hind III restriction site (AAGCTT) of the RSN- 
2 P cDNA. The cDNA sequence was numbered and converted into RNA and 
amino acid sequences using the Microgenie computer program (Beckman), 
originally described by Queen and Korn (1984).
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figure 59. Existence of an internal HindZII site in the RSN-2 strain 
P cONA. The top part of the figure is a schematic representation of 
the restriction fragments produced by HindIII digestion of 
recombinant Bluescribe/RSN-2 strain P plasmids. Only the multiple 
cloning site of the vector is shown, containing the P cDNA insert 
(drawn in green) into the SmaI site, in the two opposite orientations 
A and B. The BamHZ and PvuII terminal restriction sites of the 
insert are indicated as B and P, respectively. The position of the 
Hindlll site in the P cDNA insert is between nucleotides 272-277.
Thus Hindlll digestion produces a fragment of approximately 500 base 
pairs (bp) from clones in orientation A (HA1) or a fragment of 
approximately 300 bp from clones in orientation B (HB1) . The bottom 
part of the figure shows ethidium bromide-stained agarose mini-gels 
in which the HindIII digests were resolved. The positions of the HA1 
and HB1 fragments are indicated by arrows. Lanes L contain the 
ladder of DNA fragments of standard size (given in base pairs). The 
restriction fragments shown were produced by Hindlll digestion of 
clones W6 (lane 6), R29 and R34 (lanes 29, 34), N19 and N23 (lanes 
19, 23).
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Figure 60. Comparison of P mRNA sequences of two RS virus subgroup B 
strains. The sequence of the RSN-2 P mRNA (deduced from P cDNA- 
sequencing in the present study) is shown on the top line and the 
corresponding region from the strain 18537 P mRNA (Johnson and 
Collins, 1990) is shown on the bottom line. The positions where 
nucleotide differences lead to amino acid changes are indicated. 
Additional silent nucleotide differences are pointed out by 
asterisks. Also shown are the positions of the initiating methionine 
of the P ORF [Met(l)) and of the methionine residue used for internal 
initiation of translation in the P ORF [Met(148)] during cell-free P 
protein synthesis. The underlined sequence corresponds to the 
Hind III site present only in the RSN-2 P cDNA. The alignment of the 
two sequences was performed using the Microgenie computer programme.
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Met(1) Glu
1 GGGGCAAAUAAGUCAACAUOGAGAAGUUUGCACCUGAAUUUCAUGGAGAAGAAGCAAAUA
1 GGGGCAAAUAAGUCAACAUOGAGAAGUUUGCACCUGAAUUUCAUGGAGAAGAUGCAAACA
Asp *
61 ACAAAGCUACCAAAUUCCUAGAAUCAAUAAAGGGCAAGUUCGCAUCAUCCAAAGAUCCUA
61 ACAAAGCUACCAAAUUCCUAGAAUCAAUAAAGGGCAAGUUUGCAUCAUCCAAAGAUCCUA
121 AGAAGAAAGAUAGCAUAAUAUCUGUUAACUCAAUAGAUAUAGAAGUAACUAAAG AGAGCC 
121 AGAAGAAAGAUAGCAUAAUAUCUGUUAACUCAAUAGAUAUAGAAGUAACUAAAGAGAGCC
181 CGAUAACAUCUGGCACCAACAUCAUCAAUCCAAUAAGUGAAGCUGAUAGUACCCCAGAAG 
181 CGAUAACAUCUGGCACCAACAUCAUCAAUCCAAUAAGUGAAGCUGAUAGUACCCCAGAAG
Val
241 CCAAAGCCAACUACCCAAGAAAACCCCUAGUAAGCUUCAAAGAAGAUCUCACCCCAAGUG 
241 CU AAAGCCAACUACCCAAGAAAACCCCUAGAUAGCUUCAAAGAAG AUCUCACCCCAAGUG
* Asp
301 ACAACCCCUUUUCUAAGUUGUACAAAGAAACAAUAGAAACAUUUGAUAACAAUGAAGAAG 
301 ACAACCCCUUUUCUAAGUUGUACAAAGAAACAAUAGAAACAUUUGAUAACAAUGAAGAAG
361 AAUCUAGCUACUCAUAUGAAGAAAUAAAUGAUCAAACAAAUGACAACAUUACAGCAAGAC 
361 AAUCUAGCUACUCAUAUGAAGAAAUAAAUGAUCAAACAAAUGACAACAUUACAGCAAGAC
Met(148)
421 UAGAUAGAAUUG AUG AAAAAUUAAGUGAAAUAUUAGGAAUGCUCCAUACAUUAGUAGUUG
421 UAGAUAGAAUUGAUGAAAAAUUAAGUGAAAUAUUAGG AAUQCUCCAU ACAUUAGUAGUUG
481 CAAGUGCAGGACCCACUUCAGCUCGCGAUGGAAUAAGAGAUGCUAUGGUUGGUCUAAGAG 
481 CAAGUGCAGGACCCACCUCAGCUCGCGAUGGAAUAAGAGAUGCUAUGGUUGGUCUAAGAG
541 AAGAAAUG AUAGAAAAAAUAAGAGCGGAAGCAUUAAUGACCAAUGAUAGGUUAGAGGCUA
541 AAG AAAUGAUAGAAAAAAUAAGAGCGGAAGCAUUAAUGACCAAUGAUAGGUUAGAGGCUA
601 UGGCAAGACUUAGGAAUGAGGAAAGCGAAAAAAUGGCAAAAGACACCUCAGAUGAAGUGU 
601 UGGCAAGACUUAGGAAUGAGGAAAGCGAAAAAAUGGCAAAAGACACCUCAGAUGAAGUGU
Asp
661 CUCUUAAUCCAACUUCCAAAAAAUUGAGUGACUUGUUGGAAG ACAACGAUAGUG ACAAUG
661 CUCUUAAUCCAACUUCCAAAAAAUUGAGUAAUUUGUUGG AAG ACAACGAUAGUG ACAAUG
Asn
721 AUCUAUCACUUGAUGAUUUU 740
721 AUCUAUCACUUGAUGAUUUU 740
RSN-2
18537
RSN-2
18537
RSN-2
18537
RSN-2
18537
RSN-2
18537
RSN-2
18537
RSN-2
18537
RSN-2
18537
RSN-2
18537
RSN-2
18537
RSN-2
18537
RSN-2
18537
RSN-2
18537
sequences available). Comparison of the identity levels between the 
five RS virus strains (Table 19) shows that the P protein sequences 
are also highly conserved between the subgroups, whereas there is 
relatively more inter-subgroup variation at the nucleotide level.
The nucleotide differences observed in each of the seven P cDNA 
clones are shown in Table 20. Different kinds of substitutions 
(relative to the consensus RSN-2 nucleotide) were found in each pair 
of clones that were derived from the same type of mRNA (wild-type, 
revertant, ts N19). Thus one wild-type clone (W6) had a substitution 
leading to an amino acid change (Asp -» Gly) whereas the second clone 
(W7) had the consensus RSN-2 sequence but lacked the 5 'terminal 46 
nucleotides of the P sequence, probably due to incomplete extension 
of the PCR product (Fig. 61). The two revertant clones had one 
substitution each but only in one of them (R34) did this lead to an 
amino acid change (lie -» Val). The one clone from the ts Nj mRNA had 
a single nucleotide difference causing a single amino acid change 
(Asn -* Asp; Fig. 61). Three or four nucleotide substitutions were 
identified in the two clones from the mutant ts N19. However, only 
one of these - causing a Gly -* Ser change (amino acid 172) - was 
common to the clones (Fig. 62), suggesting that this difference is 
associated with the ts Nlg P mRNA.
Since the procedure used for generation of cDNA clones 
consisted of two error-prone reactions (reverse transcription and PCR 
amplification), it is possible that some of the nucleotide 
differences seen in individual clones are artifacts of the in vitro 
synthetic process. Alternatively (or additionally) the observed 
silent nucleotide substitutions could be due to variation in the ,
original mRNA samples. The high error rate of the viral RNA 
polymerase (which lacks a proofreading activity; Holland et al.,
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Table 19. Comparison of P sRNA and probain sequences between 
subgroup A and B strains of RS virus.
Subgroup Strains Nucleotide
Differences
% Identity Mean
A/A Long/Edinburgh** 19 97.4
A/A Long/A2** 17 97.8 97.6
A/A A2/Edinburgh* * 18 97.5
B/B 18537/RSN-2 9 98.8 98.8
A/B A2/18537*** 107 85.5
A/B A2/RSN-2 109 85.3 85.1
A/B Long/18537 111 85.0
A/B Long/RSN-2 113 84.7
Amino Acid 
Differences
A/A Long/Edinburgh** 4 98.3
A/A Long/A2** 4 98.3 98.6
A/A A2/Edinburgh* * 2 99.2
B/B 18537/RSN-2 3 98.8 98.8
A/B A2/18537*** 23 90.4
A/B A2/RSN-2 24 90.0 89.8
A/B Long/18537 25 89.6
A/B Long/RSN-2 26 89.2
exclusive of differences in the non-coding mRNA regions.
** strain A2 sequence : Satake et el. (1984); strain Edinburgh : Lambden 
(1985); strain Long and comparison of the three subgroup A sequences' I
from : López et al. (1988).
*** strain 18537 sequence and comparison with the A2 sequence 
from : Johnson and Collins (1990).
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figure 61. Nucleotide differences in clones W6 and C15, and absence 
of a 5' terminal region from clone W7. In the upper half of the 
picture the 3 ’ proximal P sequence is shown in the anti-message
sense. Clone R29 was derived from ts+ revertant R3/6 P mRNA and has 
the consensus RSN-2 sequence in this region. The asterisks mark the 
T -* C substitutions found in clones W6 and C15, which correspond to 
A -* G substitutions in the respective P mRNA-sense strands. In the 
lower half, the 5' proximal P sequences of two different 1413- 
recombinant s, containing the W7 P cDNA insert, are shown in the mRNA- 
sense (+ strand). Clone N23 was derived from ts Njg P mRNA. The 
region between the tails of the arrows in clone N23 (P nucleotides 1- 
46) is absent from clone W7, where the sequence AGAA (nucleotides 47- 
50) immediately follows the trinucleotide CCC of the SmaI site. (In 
the case of W7, the sequence CCC and the preceding sequence of the 
multiple cloning site were part of the BamHI-EcoRI fragment subcloned 
from the recombinant Bluescribe/W7 plasmid into vector mpl9).
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Figure 62. Nucleotide substitutions in two different P cDNA clones 
derived from the mutant ts N^g P mRNA. The relevant regions of the 
3' proximal P sequence in clones N19 (from the mutant ts N^g) and W6 
(from the wild-type RSN-2) are shown in the anti-message sense. The 
two nucleotide differences found in clone N19, C -* T at position 531 
and A -» G at position 592 (corresponding to G -» A and U -» C 
substitutions in the P mRNA, respectively) are marked by asterisks 
and indicated on the autoradiograms by arrows. The second mutant 
clone N23 has only the C -*T substitution at position 531, which is 
indicated in the lower half of the picture by comparison with the 
wild-type-derived clone W7.
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1982) is known to give rise to mRNA variability, such that naturally 
occurring viable variants are often detected in any mRNA population 
(Collins et al., 1984b; Olmsted et al., 1986). This would seem to be 
the case for the T -» C substitution at position 318 of clone Nlg 
(Table 20), which does not lead to an amino acid change although it 
occurs at a first codon position [TTG(Leu) -» CTG(Leu)].
Interestingly, the sequence of the A2 P mRNA also has a C at 
nucleotide 318, supporting the assumption that this is a naturally 
variable site. Since the T -* C substitution was not found in the 
second ts Nig clone (which had different silent substitutions), it 
appears likely that the two clones were generated from different mRNA 
molecules. Thus the common G -* A substitution (nucleotide 531), 
which causes the only predicted amino acid change in clone N23, is 
probably the site of the ts mutation in ts Nig.
In vitro synthesis of the P protein. In order to confirm that the 
Gly -» Ser change (predicted from the sequence of the two mutant 
clones) correlated with the loss of the epitope to anti-P MAb 3-5, 
the P cDNA clones were transcribed in vitro from the appropriate 
bacteriophage promoter (see Fig. 55) and the P mRNA-sense transcripts 
were used to programme protein synthesis in the rabbit reticulocyte 
lysate system.
Figure 63 (panel I) shows the translation products of the two 
ts Nj9 clones after immunoprécipitation with an anti-P MAb. Both 
clones produce a P-specific protein which comigrates with the in 
vitro translated ts Nig P protein (lane 3). The existence of a 
number of faster migrating bands in the profiles is probably due to 
proteolytic breakdown of the P protein. A similar ,pattern of bands 
was often observed by anti-P MAb immunoprécipitation of in vitro 
translations programmed with total cytoplasmic RNA from virus-
2 4 0
figure 63. In vitro translation of RS virus RNA from infected cells 
and of P-transcripts synthesized in vitro. Translation products were 
immunoprecipitated with anti-P MAb 8268 (panel I and lane 1 of panel 
II), polyclonal anti-RS virus serum (panel II, lane 2) or with anti-P 
MAb 3-5 (panel III) and analyzed by SDS-PAGE. In panel I, the 
profiles are from in vitro translated P transcripts of the two ts 
N19-derived cDNA clones N23 (lane 1) and N19 (lane 2), and from RNA 
isolated from ts Njg-infected cells (lane 3); lane M contains the Mr 
protein markers; Pint is the internally initiated product by 
translation from AUG148 in the P ORF. In panel II, both tracks 
contain in vitro translated RS virus proteins from ts N^-infected 
cells. Similar translation products from wild-type RSN-2- or ts Nj- 
infected cell RNA are shown in panel III (lanes 1 and 2, 
respectively). The bars between the panels indicate the presence of 
equivalent bands in profiles from in vivo and in vitro-synthesized 
RNA, which are possibly due to proteolytic breakdown of the P 
protein. [The difference in the relative migration of these bands 
between panels I and II is probably a consequence of the different 
percentage polyacrylamide gels used for electrophoretic analysis].
The three low Mr bands, indicated by X, are primary translation (or 
secondary breakdown) products of BS-C-1 cell RNA, which is present in 
RNA preparations from infected-cell cytoplasm.
241
infected cells <Fig. 63, panels II and III). However, the low Mr 
band designated Pint has been found to arise from internal initiation 
of translation in the P ORF, as will be explained below.
The P proteins expressed from the revertant clone R34 (lie -* 
Val) and the mutant clone N23 (Gly -» Ser) are efficiently recognized 
by polyclonal antiserum and the anti-P MAb 8268 (Fig. 64A). However, 
in contrast to the R34 P protein, the N23 P protein - which contains 
the single Gly -* Ser change - does not appear to react with anti-P 
MAb 3-5, similarly to the ts Nlg P protein translated in vitro from 
ts Nig-infected cell RNA. A longer exposure of the same gel (Fig. 
64B) shows only a very faint P band in the N23 sample 
immunoprecipitated with MAb 3-5. A similarly faint P band can be 
observed by immunoprécipitation of a duplicate N23 sample with an 
unrelated anti-N MAb. It should be noted that this anti-N MAb (N7) 
does not coprecipitate any detectable amounts of P protein in vivo 
(Fig. 46). This suggests that the presence of the faint N23 P band 
in both the anti-P MAb 3-5 and anti-N MAb N7 profiles is non- 
specific, probably due to residual protein in the immunoprecipitate. 
Therefore the Gly -* Ser change in the P protein of clone N23 appears 
to be solely responsible for the negative reaction to anti-P MAb 3-5. 
Since this is the biochemical phenotype of the ts Nlg P protein in 
vivo, and recovery of the 3-5 epitope is coordinate with restoration 
of the tB phenotype in the ts+ revertants, the Gly -* ser change at 
amino acid position 172 of the P protein is most likely the site of 
the temperature-sensitive lesion in mutant ts Nig.
Mutations affecting the apparent mobility of the P protein. As 
already mentioned in section 3.3, the P protein of ts Nj (and its ts+ 
revertants) has a slower apparent mobility in SDS-PAGE than the wild- 
type P protein both in vivo and in vitro (for example, see Fig. 30
2 4 2
Figure 64. Immunoprécipitation of in vitro translation products with 
polyclonal and different monoclonal antibodies. In panel A, in vitro 
synthesized P transcripts from cDNA clone R34 (derived from the ts+ 
revertant R3/6) and from clone N23 (derived from the ts mutant N^g) 
were translated in vitro and immunoprecipitated with polyclonal anti- 
RS virus serum and anti-P MAbs 8268 and 3-5. The lanes indicated as 
ts N^g contain in vitro translation products from ts Njg-infected 
cell RNA, immunoprecipitated with anti-P MAb 3-5 or anti-N MAb N7.
In vitro translation products of N23-P transcripts were also 
immunoprecipitated with the anti-N MAb, in order to obtain a negative 
control (i.e. assess the degree of non-specific inclusion of protein 
in the immunoprecipitates). The difference between the positive and 
negative reactions is more clearly demonstrated in panel B, which is 
a longer exposure of the fluorogram shown in panel A.
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Iand 41). The P cDNA clone (C15) produced from ts Nj mRNA contained 
only one nucleotide difference from the RSN-2 consensus sequence, 
which predicted a single Asn -* Asp change in the P protein sequence 
(Table 20). In Figure 65A, it can be seen that the P polypeptide 
translated in vitro from C15-P RNA transcripts comigrates with the in 
vitro translated ts N^ P protein, with both exhibiting the 
characteristic mobility difference from the RSN-2 strain P protein 
(represented in Fig. 65A by the in vitro translated P protein of 
clone N23). This observation correlates the Asn -* Asp change with 
the slower apparent mobility of the ts N! P protein.
A similar amino acid change (i.e. involving an acidic residue) 
was also deduced from the sequence of one wild-type clone (W6; Table 
20), which caused a loss, rather than addition, of an Asp residue. 
This single Asp -* Gly change of clone W6 was also observed to affect 
the apparent mobility of the respective P protein, but in this case 
the protein migrated faster than the in vitro synthesized RSN-2 P 
protein (Fig. 65B). Since the Asp -* Gly change in a clone derived 
from RSN-2 P mRNA results in aberrant P electrophoretic mobility, the 
corresponding nucleotide substitution is most likely an artifact of 
the cloning procedure. Nonetheless this change provided a second 
example of altered P mobility due to a single amino acid change.
The relative migration of the C15 and W6 P proteins (with 
respect to the RSN-2 P protein) suggests that the negative charge of 
the Asp residue (involved in both cases) may be important for the 
mobility differences, since addition of an Asp (in place of uncharged 
Asn in clone CIS) retards the migration of the P protein, whereas 
replacement of Asp by an uncharged residue (Gly in clone H6) 
increases the SDS-PAGE mobility of the P protein. These effects may
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Figure 65. In vitro translation of the P protein from in vitro 
synthesized RNA transcripts of P cDNA clones. In panel A, 
translation products were immunoprecipitated with polyclonal anti-RS 
virus serum. Lane ts N^ contains in vitro translated polypeptides 
from cytoplasmic RNA isolated from ts N^-infected BS-C-1 cells. In 
panel B, translation products were immunoprecipitated with anti-P MAb 
8268. The Pint bands, which exhibit the characteristic mobility 
shifts of the respective P proteins are the internally initiated 
translation products from AUGj^g in the P ORF.
2 4 5
be due to alteration of detergent-binding properties and/or 
modification of local protein structure.
Effects of point nutations on the predicted secondary structure of 
the P protein. The predicted secondary structures of the RSN-2 P 
protein and of the relevant regions of the W6 and C15 P proteins, 
using the algorithm of Chou and Fasman (1978), are compared in Fig.
66. These predictions are based only on the primary amino acid 
sequence and do not consider the effects of phosphorylation on 
protein structure. The position of the Asn -* Asp change in clone C15 
is indicated by the loss of a potential glycosylation site (three 
such sites are pointed out in the structure plot as explained in the 
legend), since the wild-type Asn-Pro-Thr becomes Asp-Pro-Thr in C15. 
This change falls into a region of random coil and does not appear to 
produce any alteration in secondary structure. On the other hand, 
the region where the Asp -* Gly change of clone W6 occurs is predicted 
to form successive /9-turns, interspersed by short regions of random 
coil. The introduction of glycine appears to cause a shift in the 
position of the second /9-turn in this region, which resultB in loss 
of a downstream turn and reversal in the direction of the extreme C— 
terminal region. The shift in the position of the /9-turn and in the 
residues involved in subsequent /)-turns or areas of random coil can 
also be deduced from the different distribution of the hydrophilicity 
symbols (according to the algorithm of Kyte and Doolittle, 1982) in 
this region.
Using the alternative prediction method of Gamier et al.
(1978), a similar profile is obtained for the W6 P protein (Fig. 67). 
Thus the presence of the Gly residue favours formation of a /J-turn at i 
that position and slightly increases the coil structure between the 
turns. The Gamier prediction of the CIS P protein structure (Fig.
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' Figure 66. Predicted secondary structure of the P protein. The 
predicted structure of the entire wild-type RSN-2 P protein is shown, 
together with the C-terminal regions of the C15 (ts Nj) and W6 P 
proteins, where amino acid changes affecting the P apparent SDS-PAGE 
mobility are located. Secondary structure predictions used the 
method of Chou and Fasman (1978), which is based solely on the 
primary amino acid sequence and does note take into account the 
effects of post-translational modifications of the protein, such as 
phosphorylation. However, the computer programme used for 
graphically displaying the predicted structures, indicates the 
position of target sites for potential glycosylation (i.e., the 
tripeptide Asn-X-Ser/Thr). Although these sites are not used in vivo 
for glycosylation of the P protein their indication on the structure 
plots enables identification of the sites of the C15 and H6 amino 
acid changes, as explained in the text. Computer manipulation of the 
data was kindly performed by Dr. M. McCrae. Explanations of the 
symbols used to depict regions of random coil or a-helical structure, 
and the hydropathy index according to the method of Kyte and 
Doolittle (1982; indicated as KD) are given in the box on the left. 
The two regions where a /3-sheet structure is predicted are indicated 
on the structure plot. Polypeptide-chain reversals represent 
formation of /3-turns. The number of predicted ^-turns in the extreme 
C-terminal region of the RSN-2 and W6 P proteins, downstream of the 
site of the W6 amino acid change, is also indicated (5 and 4, 
respectively).
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figure 67. Predicted secondary structure of the RSN-2, W6 and C15 P 
proteins according to the algorithm of Gamier et ai. (1978).
Computation of the data and the graphic output of predicted 
structures were obtained with the Microgenie computer programme. The 
relative probabilities of the four secondary structures occurring 
along each protein (a-helix : Alph, /9-sheet : Beta, ^-turn and random 
coil) are shown in four separate graphs, one above the other. Values 
above the horizontal axes are considered as positive. Especially 
high values in a graph ("peaks") indicate that there is a greater 
(predicted) probability of that structure being formed. In any given 
region, the protein is most likely to have the type of secondary 
structure which corresponds to the graph with the highest positive 
value at that position. The arrows indicate the differences in 
predicted structure due to amino acid changes. The four graphs for 
the wild-type RSN-2 P protein are shown in the middle. The white 
arrows point out the increased probability of a turn being formed 
at the position of the Asp -» Gly change in clone W6 and the increased 
random coil structure between the turns, in accordance with the 
prediction based on the algorithm of Chou and Fasman (see Figure 66). 
The black arrows indicate differences in the graphs for the predicted 
a-helix and random coil structures due to the Asn -* Asp change in 
the P protein of clone C15 (ts N^).
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67) is somewhat different from the Chou and Fasman prediction. The 
Asn -* Asp change is predicted to cause a small increase in the cr- 
helical content of the corresponding wild-type region and 
simultaneously reduce the random coil structure at this site.
However, these changes are small and, in view of the variance of the 
two prediction methods, probably not significant.
Interestingly, two substantial changes in the predicted 
structure of the P protein of clone N^g (which contains two 
additional amino acid differences to the Gly -* Ser ts mutation at 
position 172; Table 20) were detected. As shown in Fig. 68, the ts 
mutation itself does not alter the predicted secondary structure of 
the N23 P protein, which contains only the Gly -» Ser amino acid 
change. The structure alterations predicted for the P protein of 
clone N^g are : loss of a ^-turn and replacement by random coil 
structure due to the Ser -* Gly change at position 94, and formation 
of additional ^-turns between two a-helical regions due to the Leu -* 
Ser change at position 192. This second change falls within the C- 
terminal P domain that can be independently translated in vitro from 
methionine residue 148 (Pint product; see below). However neither 
the in vitro expressed P protein from clone Njg, nor the respective 
Pint polypeptide, exhibit altered electrophoretic mobility compared 
to the corresponding N23 translation products (Fig. 63). Therefore, 
significant alterations in the predicted secondary structure of the P 
protein cannot be conclusively correlated with changes in P apparent 
mobility.
Internal initiation of translation in the P ORF. Among the in vitro 
translation products of RNA transcripts produced from the P cDNA 
clones, a low Mr band of approximately 15-16K was invariably 
detected. Although additional (fainter) bands in the profiles could
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Figure 68. Predicted secondary structure of the RSN-2, N23 (ts N^g) 
and N19 P proteins according to the algorithm of Chou and Fasman 
(1978). Computer manipulation of the data was kindly performed by 
Dr. M. McCrae. A key to the symbols used in the graphic display of 
predicted structures is given in the box (for detailed explanations, 
see legend of Figure 66). The predicted secondary structure of the 
wild-type RSN-2 P protein is shown in the middle. The predicted 
structure of the P protein of clone N23, containing only the Gly -* 
Ser change at position 172, appears to be identical to that of the 
RSN-2 P protein. [Since the Gly -* Ser mutation at amino acid 172
•
does not alter the predicted secondary structure of the protein, its 
position on the structure plot is indicated approximately in the 
middle of the region between residues 150-200). The P protein of 
clone N19 contains additional amino acid changes (see Table 20), at 
amino acid (aa) positions 94 and 192, which are predicted to alter 
the secondary structure of the P protein as indicated by the arrows.
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be correlated with similar bands present in in vitro translations of 
P mRNA from infected cells (probably reflecting some proteolytic 
degradation), only trace amounts of this low Mr band could be 
detected by in vitro translation of P mRNA synthesized in vivo (Fig. 
63). This small polypeptide was also translated from RNA produced by 
T7-in vitro transcription of a truncated A2-strain P cDNA insert in a 
different vector (pTZ19; Fig. 69A). This cDNA clone (obtained from 
Dr. G. Wertz) contained the full 3' non-coding P mRNA region, but was 
lacking the first 231 nucleotides of the P mRNA, including the coding 
sequence for the N-terminal 72 amino acids (Fig. 69B) . This clone 
had been inserted into the pTZ18/19 pair of vectors in order to 
provide the single-Btranded DNA and RNA probes mentioned in section 
3.3A.
As shown in Fig. 70, the pTZ plasmids contain the multiple 
cloning site (from the pUC18/19 vectors) in opposite orientation with 
respect to the adjacent T7 promoter and the site of hybridization of 
the M13 reverse sequencing primer. The pTZ vectors can be replicated 
as double-stranded DNA (from the pBR322 origin of replication) and 
used as linearized templates for in vitro T7 transcription of cDNA 
inserts in the MCS, producing strand-specific RNA probes. The 
vectors also contain the origin of replication of the fl DNA 
bacteriophage, from which single-stranded DNA can be synthesized upon 
superinfection with the helper phage M13K07, according to published 
protocols (Dotto et al., 1983; Dente et al., 1985; Vieira and 
Messing, 1987). The single-stranded DNA of the recombinant pTZ/A2-P 
plasmids can then be used as template for primer extension from the 
reverse primer, producing strand-specific DNA probes. [The strand- 
specificity of both kinds of probes was predicted by the orientation 
of insertion of the A2 P cDNA (assessed by restriction mapping) and
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‘ Figure 69. In vitifo translation of a 5' deleted clone of the A2 P 
cDNA. Panel A shows the in vitro translation products (after 
immunoprécipitation with polyclonal anti-RS virus serum) of RNA 
isolated from mock-infected cells (UI) or from A2-infected cells, and 
of RNA synthesized in vitro by T7 transcription of an A2-P cDNA 
insert in plasmid pTZ. Transcription of recombinant plasmid pTZ18/P 
produced anti-mRNA sense transcripts (- strand) whereas transcription 
of plasmid pTZ19/P produced P mRNA-sense transcripts ( + strand), 
which could be translated in vitro. Panel B shows the map of the 5' 
deleted A2-P clone, which was inserted into vectors pTZ18/19, in 
comparison with the full-length A2-P cDNA (redrawn from Satake et 
al., 1984). The truncated clone (obtained from Dr. G. Wertz,
Alabama, U.S.A.) possessed two terminal Pst I sites and was thus 
inserted into the PstI site of the multiple cloning site of the pTZ 
plasmids (see Figure 70). The 5' Pst I site is an internal site of 
the P cDNA and the 3' PstI site was derived from plasmid pBR322, 
where the cDNA was inserted during the original cloning procedure 
after homopolymer tailing (the "tail" is indicated by the wavy line). 
The white arrow indicates the position of the AUG148 (nucleotide 462) 
from which internal initiation of in vitro translation in the P ORF 
produces the low Mr band pointed out by the arrow in panel A. The 
position of the Bell restriction site, which was used to separate the 
AUG14g codon from an upstream initiation codon (from which the 
sequence of the 5' deleted clone was translated into RS virus P- 
specific polypeptides, see also Figure 71) is also indicated.
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Figur» 70. Construction of pTZ/A2-P recombinants. The S' terminally
truncated A2-P clone shown in Figure 69B was inserted into the Pat I 
, site of the multiple cloning site (MCS) of vectors pTZ18/19. These 
plasmids contain the MCS in opposite orientation with respect to the 
position of the adjacent T7 promoter (shown as the blue rectangle) 
and to the site of hybridization of the M13 reverse primer (shown as 
the red rectangle), within the lacZ gene. The P insert is shown in 
green and the position of the unique internal Avail site is indicated 
(at nucleotides 492-497 of the full-length P sequence). The green 
arrow indicates the 5' -» 3' P mRNA sense; the blue arrow indicates 
the direction of in vitro transcription from the T7 promoter; the red 
dotted arrow indicates the direction of primer extension from the 
reverse primer; the black arrow indicates the direction of
Dtranscription of the gene coding for ampicillin-resistance (Amp ); 
the red arrow indicates the direction of transcription of the lacZ 
gene (the portion encoding the a-peptide of 0-galactosidase). The 
black rectangles mark the positions of the origins of plasmid 
replication as double-stranded DNA (from the origin of plasmid 
pBR322), and as single-stranded DNA (from the origin of bacteriophage 
fl) upon superinfection of bacteria containing the pTZ plasmids with 
a helper phage (M13K07; Vieira and Messing, 1987). Plasmid pTZ18/A2- 
P provides anti-P-sense RNA transcripts by T7-transcription, or 
templates for synthesis of anti-sense DNA strands, which can be used
as strand-specific probes for RS virus P mRNA (and P-bicistronic
32transcripts) after synthesis in the presence of [ PJUTP or
32( P]dCTP, respectively (as shown in Figure 43 and 44A). Plasmid 
pTZ19/A2—P provides P mRNA-sense transcripts by T7 transcription 
(which can be translated in vitro due to the in-frame ligation shown
in Figure 71A), or templates for synthesis of P mRNA-sense single-
32stranded DNA, which can be used as (P)-labelled probes for genomic
RS virus RNA (as shown in Figure 43).
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confirmed by hybridization to total cytoplasmic RNA and oligo(dT)- 
selected mRNA from virus-infected cells].
The pT219/A2—P clones which produced P mRNA-sense transcripts 
from the T7 promoter could also be translated in vitro into the 
products shown in Pig. 69A, despite the absence of the authentic P 
start codon. This is because ligation of the 5' PstI site of the 
insert with the Pstl site in the MCS brings the truncated P coding 
region in-frame with an immediately upstream AUG codon, which is part 
of the SphX restriction site (Fig. 71A). The resulting polypeptide 
is 171 amino acid-long (predicted Mr of ca 19.3 Kd) and contains two 
amino acid differences from the authentic P protein as shown in Fig. 
71A. Interestingly, two major P-specific bands (recognized by 
polyclonal anti-RSV serum and anti-P MAb 3-5; Fig. 71B), with an 
apparent mobility of ca 21K and 23K, are observed, which probably 
represent the N-terminally truncated forms of the P doublet band of 
the wild-type A2. This suggests that the residue)s) responsible for 
this phenomenon is (are) not contained in the N-terminal 72 amino 
acids of the A2 P protein. Two faster migrating, fainter bands 
(possibly proteolytic fragments) are also present in both the 
polyclonal and anti-P MAb profiles (indicated by arrows), however the 
abundant low Mr polypeptide is not immunoprecipitated by anti-P MAb 
3-5. A fainter band of similar mobility to the low Mr abundant 
product can be observed also in the A2 profile, suggesting that this 
product is not an artifact of the in vitro expression of the P 
protein from cloned cDNA. The P-specificity of this product was also 
supported by the ability to immunoprecipitate it with anti-P MAb 8268 
(Fig. 72A) . It is noteworthy that Venkatesan et al. (1984) alBO ■
observed a similar (ca 16K) band by in vitro translation of P cDNA-
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1 Figure 7 X. In vitr'o synthesis of an N-terminally truncated form of 
the A2 P protein. Panel A shows the sequence around the in-frame 
ligation of the PstI A2-P clone (see Figure 69 and 70) with the PstI 
site of the multiple cloning site of plasmid pTZ19. In vitro 
transcription of the recombinant pTZ19/P plasmid from the adjacent T7 
promoter produces P mRNA-sense transcripts (having the same sequence 
that is shown here as DNA). The initiating methionine codon is 
provided by the sequence of the immediately upstream SphI restriction 
site. Due to this ligation the first and second amino acids (Met and 
Pro) of the N-terminally truncated P protein are different from the 
ones found in the A2-P sequence (Asp and Thr; shown in parentheses). 
Subsequent residues are the same as in the authentic P protein and 
their positions in the amino acid sequence of the intact P 
polypeptide are given in parentheses. Panel B shows the in vitro 
translation products of cytoplasmic RNA synthesized in mock-infected 
cells (01) or in A2-infected cells and of the T7 transcripts 
synthesized in vitro from recombinant vectors pTZ18/P (having the 
sequence of the minus P RNA strand) and pTZ19/P (having the sequence 
of the plus, P mRNA-sense, strand as explained above). The 
translation products were immunoprecipitated with polyclonal anti-RS 
virus Berum or anti-P MAb 3-5. The N-terminally truncated form of 
the A2 P doublet band is indicated [(A5')PJ. Pint is the internally 
initiated product of the P ORF (from Met148). The two faint bands 
pointed out by arrows probably represent the respective breakdown 
fragments of the two (A5') P bands.
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hybrid-selected mRNA from infected cells (which also translated the P 
protein).
Since the low Mr band translated from the in vitro transcripts 
was not recognized by anti-P MAb 3-5 (Fig. 71B), it was important to 
determine the mechanism of its production, as this would be useful in 
mapping the 3-5 epitope which i B  absent from the ts N19 P protein.
The size and relative abundance of this product suggested either that 
significant proteolytic cleavage occurred at a specific site of the P 
protein in the absence of other viral proteins, or that independent 
translation from an internal start codon occurred in the same ORF as 
that of the P protein (since this product reacted with anti-P MAb 
8268; Fig. 63 and 72A). The latter phenomenon has been previously 
identified in reticulocyte lysate in vitro translations (Kozak,
1986a; Dasso and Jackson, 1989).
The first AUG codon in the P protein sequence (downstream of 
the initiating methionine, in both the A2 and RSN-2 P proteins) is 
located at position 148 and surrounded by the sequence GGAAUGC (see 
Fig. 58), which contains a purine (G) at the -3 position (i.e. 3 
nucleotides upstream of the AUG). Presence of a purine in this 
position is thought to have a dominant favourable "context" effect on 
translational initiation (Kozak, 1986b; 1989a). To test the 
possibility of internal initiation at this site, a 5'BclI-Pstl 3' 
fragment of the A2 P clone (which contained only the AUG14q as the 
first start codon) was subcloned into the transcription vector pGEMl 
(which had been subjected to BamHI-Pstl double digestion, since 
restriction with BamHI provides compatible cohesive ends for ligation 
with the BelI-generated termini; Maniatis et al., 1982). The •
construction of this recombinant is graphically presented in Fig.
72B. Figure 72C shows that the translation product of T7 RNA
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Figure 72. Internal initiation of in vitro translation in the P ORF
(A) In vitro translation products of total cytoplasmic RNA extracted from
A2-infected cells (lanes 2), or of in vitro synthesized RNA transcripts 
‘ of the A2-P cDNA clone shown in Figure 69 (lanes l),were immuno- 
precipitated with polyclonal anti-RS virus serum (POL),the anti-P MAbs 
3-5, 8268, 9516, or the anti-N MAb N2,and analyzed by 12.5* SDS-PAGE.
The arrow indicates the position of the low Mr polypeptide, synthesized 
from in vitro transcripts,which does not react with MAb 3-5 but is 
efficiently recognized by MAb 8268. (B) A 5' BclI-Patl 3* fragment
from the A2-P cDNA clone, which contained an AUG codon at approximately 
80 bp from its 5' end (corresponding to amino acid position 148 of the 
intact P protein) was subcloned into the multiple cloning site of vector 
pGEMl,which is flanked by the promoters for the RNA polymerases of 
bacteriophages SP6 and T7 (only this region of the plasmid is shown 
here). The promoters are shown as black rectangles and the arrows 
indicate the direction of in vitro transcription by the respective 
polymerases. The MCS region between the PstI and BamHI sites,which is 
replaced by the cDNA insert in the recombinant plasmid,is represented by 
the dashed line. The BamHI and Bell sites are indicated between 
parentheses to denote loss of these sites following ligation of their 
compatible cohesive ends. The position of the internal AUG is marked by 
the arrowhead on the P mRNA-sense transcript produced by T7 
transcription. (C) In vitro translation products of P mRNA-sense 
transcripts produced from recombinant plasmid pTZ19/A2-P (shown in 
Figure 70) and of transcripts produced from plasmid pGEMl/P(BcI) , shown 
in (B),by T7-transcription (P mRNA-sense or + transcripts) and by SP6- 
transcription (anti-sense or - transcripts)»were immunoprecipitated by 
polyclonal anti-RS virus serum and analyzed by 15* SDS-PAGE. The arrow 
indicates the polypeptide translated from the internal AUG in the 
pGEMl/P(Bel) transcripts, which is also translated from the pTZ19/P 
transcripts that contain an upstream AUG as shown in Figure 71A. Lanes M 
in (A) and (C) contain the Mr protein markers.
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transcripts from the subcloned P fragment comigrates with the 
previously observed abundant low Mr protein product of RNAs from the 
larger A2 P clone. This suggests that the presence of this 
polypeptide is indeed due to internal initiation of translation in 
the P ORF rather than to proleolytic breakdown of the P protein. 
Suasary. Viral protein synthesis in mutant ts was found to be
completely restricted at 39°C. The ts Nlg P protein did not react 
with anti-P MAb 3-5, in contrast to the wild-type and ts+ revertants 
P proteins, suggesting that the ts Nig lesion was located in the P 
gene.
Sequence determination and in vitro expression of cDNA clones, 
derived from wild-type, ts N^g and ts+ revertant P mRNAs, showed that 
the negative reaction to MAb 3-5 was due to a Gly -* Ser amino acid 
change at position 172 of the ts Nig P protein. Similar experiments 
with a cDNA clone derived from ts Nj P mRNA suggested that the 
aberrant (slower) ts Nj P mobility is caused by a single Asn -* Asp 
change at position 217. Loss of an Asp residue from an adjacent site 
(position 233), and its replacement by uncharged Gly in a different 
clone, resulted in a shift in P electrophoretic mobility in the 
opposite direction (faster migration than the RSN-2 P).
A P-specific, low Mr polypeptide, observed by in vitro 
translation, was found to be a primary translation product of P mRNA- 
sense transcripts, due to internal initiation in the P ORF. This 
polypeptide represented the C-terminal 93 amino acids of the P 
protein.
* •
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3.4B DISCUSSION
P protein defect. Growth restriction of ts N19 at an early stage of 
infection at 39°C was correlated with a P protein alteration (loss of 
a MAb-epitope) on the basis of coordinate reversion of the two 
phenotypes in several ts+ revertants. Since the ts N^g mutation 
affecting the MAb 3-5 epitope did not induce detectable instability/ 
degradation of the P protein at 39°C, it seems likely that the 
negative phenotype at the restrictive temperature is not due to 
absence of the P protein, but to absence of a functional P protein.
The paramyxovirus P and rhabdovirus NS phosphoproteins are 
known to be essential components of the RNA polymerase complex. 
Consequently, temperature-sensitive lesions in these proteins have 
profound effects on viral mRNA synthesis at the restrictive 
temperature (see section 1A.2 and IB.3). Thus the absence of ts N^g- 
protein synthesis at 39°C may result from absence of synthesis of the 
corresponding mRNA species. Due to inability to perform kinetic 
studies of early mRNA synthesis, it was not possible to determine if 
a ts defect was exhibited at the level of primary and/or post-primary 
transcription (by studying ts N^g-mRNA synthesis at 39°C immediately 
post-infection). It is possible that use of an homologous probe for 
an abundant viral transcript (e.g. the 1C mRNA) may enable such 
analysis to be carried out.
The loss of the 3-5 epitope from the ts N19 P protein was 
attributed to a Gly -* Ser change at amino acid position 172, on the 
basis of sequencing and in vitro transcription-translation data.
This change did not affect the predicted secondary structure of the 
ts Nlg P protein. However, in the case of the phosphoprotein P,
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1structure predictions based solely on amino acid sequence would not 
have the same degree of accuracy as for other globular proteins (ca 
70%; Chou and Fasman, 1978), since they do not take into account the 
effects of addition of the negatively charged, hydrophilic phosphate 
groups. The observation of reversion to the wild-type residue, at 
the original site of the mutation in revertant R3/6, suggests that 
presence of glycine in this position may be important for the 
structural/functional integrity of the P protein. Sequence analysis 
of several more ts+ revertants will be required to confirm this 
hypothesis.
Preliminary mapping of the 3-5 epitope. The inability to 
immunoprecipitate with MAb 3-5 the C-terminal P protein region which 
is translated in vitro by internal initiation at Met148 (Pint 
product), implied that the 3-5 epitope was not linear (i.e. dependent 
only on the amino acid sequence) since the amino acid change 
responsible for its loss was located within this region, at residue 
172. On the other hand, the positive reaction with MAb 3-5 of N- 
terminally truncated forms of the P protein (A5'-A2) suggests that 
the aminoterminal 72 amino acids are not involved in binding of this 
anti-P MAb. Taken together, these observations indicate that 
residues in both the middle and C-terminal thirds of the protein 
participate in formation of the 3-5 epitope. Alternatively, the 
residues of the 3-5 epitope may be contained solely in the Pint 
product, but the folding status of this region could be somewhat 
different in the absence of long-range cooperative interactions with 
the middle P region. For example, the Pint product may adopt a 
relatively more extended conformation than the equivalent region in < 
the whole protein (which has been found to be the case with most 
subdomain protein fragments; Kim and Baldwin, 1982) or the 3-5
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epitope may become internalized by the independent folding of this 
region. The second possibility however does not appear likely, given 
that antibodies are thought to initially bind to solvent-exposed 
(i.e. hydrophilic) sites (although the subsequent "induced fit" may 
allow binding of previously buried hydrophobic residues; Hopp and 
Hoods, 1981; Geysen et al., 1987; Getzoff et al., 1987). Thus both 
alternative explanations for the absence of binding of MAb 3-5 by the 
Pint product suggest that MAb-binding depends on correct folding of 
the carboxyterminal two-thirds of the P protein and, consequently, 
that the 3-5 epitope may be discontinuous.
Most monoclonal antibodies raised against native, "assembled" 
proteins (as was MAb 3-5) have been found to recognize conformational 
(discontinuous) epitopes (Berzofsky, 1985; Van Regenmortel, 1987).
The ability of MAb 3-5 to react with P protein on Western blots, a 
property often associated with recognition of denaturation-resistant 
(i.e. conformation-independent) antigenic determinants (reviewed by 
Lenstra et al., 1990), is therefore unexpected. However the P 
protein is thought to bind poorly to SDS, due to electrostatic 
repulsion by its acidic and phosphate groups. It is thus possible 
that binding of MAb 3-5 to P protein on Western blots is due to the 
inability of SDS to effectively disrupt the conformation of the 
protein and/or the ability of partially denatured P protein to refold 
after boiling in SDS and transfer to nitrocellulose in the absence of 
the detergent (Dunn, 1986). This hypothesis might explain the 
observation that not only the Pint product, but also the N-terminally 
truncated A2 P doublet band failed to be recognized by MAb 3-5 on 
Western blots (data not shown), in contrast to their positive 
reaction by immunoprécipitation, and despite the ability of MAb 3-5 
to recognize intact, full-length P protein on Western blots. This
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would suggest that, although the N-terminal domain is not directly 
involved in MAb-binding in solution, its presence becomes important 
for MAb-binding after SDS-treatment (by contributing to resistance to 
denaturation and/or by favouring refolding of the protein).
It is interesting to note that two amino acid differences 
located close in the linear sequence to Gly17 2 (which is required for 
3-5 binding), in the wild-type A2 P protein (Val -» lie at position 
171) and in the R34 P protein (lie -* Val at position 166), do not 
abolish binding by MAb 3-5. Both isoleucine and valine have similar 
properties (hydrophobic, with non-polar aliphatic side—chains) and 
their reciprocal replacement would not be expected to affect the 
folding of the protein. (However, this does not necessarily indicate 
a discontinuous epitope, because not all the residues within a 
continuous (linear) antigenic determinant have to be in contact with 
the antibody (Benjamin et al., 1984; Van Regenmortal, 1987)J.
Construction of synthetic oligopeptides from the sequence 
surrounding the Gly172 residue and studies of their ability to bind 
to MAb 3-5 will be necessary to distinguish between a linear or an 
"assembled", conformational 3-5 epitope. If, as suggested here, the 
MAb epitope is indeed formed by residues not contiguous in the linear 
sequence, identification of the residues involved could be achieved 
by in vitro expression of a P clone lacking only the middle region 
(residues 72-148) and of clones progressively deleted from their 3' 
end (corresponding to C-terminal residues 148-241).
P mobility differences. The slower electrophoretic migration of the 
ts Nj P protein could be attributed to a single amino acid 
difference, which involved replacement of the wild-type uncharged Asn • 
residue by an acidic Asp residue, since the in vitro expressed P 
protein (from a ts N^-derived P cDNA clone) containing this change
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comigrated with the ts Ni P protein (Fig. 65A). The reverse effect 
on mobility (i.e. faster migration than the RSN-2 P) was observed in 
a P protein (W6) where an acidic Asp residue was replaced by an 
uncharged Gly (Fig. 65B).
Interestingly, the same "ladder" of mobility shifts was 
detected also for the respective Pint product, which itself exhibits 
anomalous SDS-PAGE mobility. The predicted molecular weight of the 
Pint polypeptide is approximately 10.SK (10,455 daltons for RSN-2 and 
10,483 for A2), yet its apparent mobility is that of a 15-16K 
polypeptide. This discrepancy cannot be accounted for by addition of 
phosphate groups alone, since there are only 14 potential 
phosphorylation sites (Ser, Thr) within the Pint sequence. On the 
other hand, the Pint product has a high content of acidic residues 
(22% compared to 12% basic). Thus the slower than predicted 
electrophoretic mobility of the Pint product can be attributed to the 
same factors that cause the aberrant mobility of the entire P 
protein, i.e. its acidic nature (which is enhanced by 
phosphorylation). It is conceivable that small changes in the 
intrinsic charge of the acidic C-terminal domain can affect the 
apparent P mobility by increasing/reducing the level of SDS binding 
(in the W6 and C15 P proteins, respectively). The observation that 
single amino acid changes within the C-terminal 24 residues can 
affect the apparent mobility of the Pint product and of the whole P 
protein in a similar manner suggests that this C-terminal region is 
exposed at the surface of the P protein and is at least partially 
responsible for its aberrant migration in SDS-PAGE.
Alterations in electrophoretic mobility due to single amino i
acid differences have been reported previously for bovine and rat a- 
crystallin A chains (De Jong et al., 1978), for a mutant baculovirus
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polyhedrin (Caretens et al., 1986), for the M protein of a tsM mutant 
of VSV (Li et al., 1988) and for the NS proteins of VSV tsNS mutants 
(Rae and Elliott, 1986b). In the latter case, two different point 
mutations, both involving loss of an acidic residue, were identified 
within the acidic N-terminal domain of the NS protein. Replacement 
of the wild-type Glu residue by Lys in tsEj resulted in faster 
migration of the respective NS protein whereas a Glu -* Gly change (in 
a nearby position) in tsE3 also produced a more rapidly (than wild- 
type) migrating NS protein, although not as rapidly as the tsE3 NS 
protein (where the acidic residue was replaced by a basic one). 
However, both changes also caused alterations in the predicted 
secondary structure of the NS protein, which could equally have 
contributed to the observed mobility differences.
The composite effect of changes in both the charge and the 
predicted structure of the protein was demonstrated in the case of 
the VSV tsM-protein mutant ts023, where the slower migration of the 
mutant M protein was attributed to a Gly -* Glu change (Li et a l . , 
1988). The negative charge of the acidic residue was found to 
contribute to the M mobility difference, since replacement of the 
wild-type Gly by Ala (which was predicted to cause the same change in 
structure as Glu in that position) resulted in intermediate M 
mobility between the wild-type (Gly) and the mutant (Glu) M proteins.
Radical changes in the predicted secondary structure did not 
appear to be involved in the mobility differences observed in this 
study, given that significant alterations were predicted for the P 
protein of clone N^g (Fig. 68) which exhibits the normal RSN-2 P 
mobility (Fig. 63A), whereas virtually no change could be predicted 
for the ts Nj^ClB) P protein which exhibits altered mobility (Fig. 
66). In the case of the W6 P protein, where a change in the position
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and number of predicted £-turns was observed, it is possible that 
both this and the loss of the Asp residue affect its electrophoretic 
mobility. This could be investigated by replacement of the wild-type 
Asp with a neutral amino acid which would not affect the predicted 
wild—type secondary structure (e.g. Gin) by in vitro site-directed 
mutagenesis. Similarly, the effect of the Asp addition in the ts 
(C15) P protein could be determined by replacing the wild-type Asn 
for a basic residue.
Potential role of phosphorylation in eobility shifts. Since both the 
W6 and ts Nj (C15) changes are found in the vicinity of potential 
phosphorylation sites (Ser, Thr), the possibility that their P 
mobility differences are also due to effects of changes in 
phosphorylation should be considered. Several Ser/Thr protein 
kinases are known to exist in reticulocyte lysates and to be able to 
use exogenous proteins as substrates (Edelman et al., 1987; Smith et 
al., 1989). The NDV P and VSV NS proteins have been found to be 
phosphorylated during in vitro translation to similar extents as in 
vivo (Hightower et al., 1984; Chattopahdhay and Banerjee, 1987b).
This is probably the case with the in vitro translated RS virus P 
protein, since this apparent mobilities of the in vitro and in vivo 
synthesized RSN-2 P proteins are the same and the A2 P doublet band 
is faithfully reproduced in vitro.
Among the protein kinases of the rabbit reticulocyte lysate 
system, casein kinases I and II, which show a broad substrate 
specificity and are also found in a wide variety of eukaryotic cells, 
would be likely to recognize acceptor sites in the RS virus P protein 
both in vivo and in vitro, since they show preference for Ser/Thr t
flanked by acidic residues (Leader and Katan, 1988). As shown in 
Fig. 73, the sequence produced by the C15 amino acid change does not
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Figure 73. Site-specificity of three Ser/Thr protein kinases and 
potential target sites within the C-terminal sequence of the P 
protein. Panel A shows the sequence-specificity of the target sites 
for phosphorylation by protein kinase C and casein kinases I and II, 
in the order N-terminus -* C-terminus (a). The target hydroxyl-amino 
acid Ser (which can be replaced by Thr as phosphate acceptor) is 
marked by asterisks. Glutamate (Glu) residues in the target 
sequences of the acidic residue-specific casein kinases can be 
substituted by aspartate or phosphoserine (b ) . The (Glun, X,„) 
sequence indicates that the position of Glu (or Asp or phosphoserine) 
and X residues are not specified within a group of n + m residues 
(c). [The information presented in panel A was adapted from Leader 
and Katan, 1988). Panel B shows the C-terminal sequence of the P 
protein (residues 212-241), which contains the two amino acid changes 
causing apparent mobility differences. The askerisks denote the 
presence of potential phosphorylation sites on the basis of the
sequence-specificities listed in panel A : for casein kinase I (Asp-
* * Glu-Val-Ser ) , n = 2 and m=l; for protein kinase C (Lys-Lys-Leu-Ser )
* * or (Thr-Ser-Lys-Lys), n=2 and m=l or (Ser-Lys-Lys), n=2 and m=0.
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resemble the site-specificity of either kinase (although potential 
target sites do exist nearby), whereas the wild-type Asp which is 
replaced by Gly in W6 is not part of either target sequence.
Therefore the amino acid changes that cause mobility alterations do 
not seem to create/eliminate sites of phosphate addition by these 
acidic residue-specLfic kinases. Furthermore, previous data have 
shown that minor differences in phosphorylation of acidic proteins 
are not normally detected as mobility differences by standard SDS- 
PAGE (Chambers and Samson, 1980; Hsu and Kingsbury, 1982; Marnell and 
Summers, 1984; Masters and Banerjee, 1986). It is possible, however, 
that changes in protein structure due to phosphorylation of sites 
adjacent to the two amino acid changes (shown in Fig. 73), which 
would not be predicted by the methods discussed in section 3.4A 
(which are based only on amino acid sequence) and/or the effect pf 
the negatively charged phosphates on SDS-binding, are also involved 
in the observed mobility differences. This might explain the ability 
to detect single charge variants by one-dimensional SDS-PAGE (which 
normally require two-dimensional isoelectric focusing for their 
resolution; Samson et al., 1981). Thus, in order to evaluate the 
potential contribution of phosphorylation to the P mobility 
differences, it will be necessary to compare the mobilities of the 
unmodified forms of the RSN-2, W6 and C15 P proteins (e.g. by in 
vitro phosphatase treatment and/or expression in bacterial cells).
In vitro translational initiation from an internal P AUG codon.
Internal initiation of in vitro translation in the rabbit
reticulocyte lysate system is not an uncommon phenomenon (reviewed by
+ 2 +Kozak, 1989b). Factors such as the concentration of K , Mg and •
spermidine in the reaction mixtures and degradation of mRNA 
molecules, have been found to influence the frequency of
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translational Initiation in vitro at internal AUG codons (Gupta and 
Kingsbury, 1985b; Curran et al., 1986; Dasso and Jackson, 1989;
Kozak, 1986a; 1989a).
The internal initiation product (Pint) identified here appeared 
to be translated more efficiently in the absence of an upstream AUG 
or in the presence pf a preceding AUG in an unfavourable context for 
initiation (Fig. 72) and less efficiently in the presence of the 
authentic P mRNA start codon (Fig. 63, 71), which lies in the optimal 
context for initiation according to the roles of Kozak (1986a,b). 
These observations are consistent with the "leaky scanning" model of 
translational initiation, which states that a suboptimal context 
around a 5' proximal AUG triplet will allow some ribosomes to 
continue scanning beyond this site and initiate at an internal 
downstream AUG (Kozak, 1986a, 1989a,b). Presence of the 5 1 cap is 
thought to favour binding of the small (40S) ribosomal subunit to the 
5'end of an mRNA molecule, although the relative contribution of the 
cap structure to the fidelity of in vitro translation is not clear 
since cap-independent internal initiation events have been observed 
(Dorner et al., 1984; Herman, 1987; Wong et al., 1987; Dasso and 
Jackson, 1989). This category includes cases of translational 
initiation on fragments of degraded mRNA molecules, since 
reticulocyte lysate ribosomes are able to bind to 5'terminal RNA 
regions in the absence of a 5'cap (Lodish and Rose, 1977; Kozak, 
1989a,b). This property was reflected here by the ability to
translate the in vitro synthesized P RNA transcripts which were
32uncapped. Although [ PJUTP-labelled P transcripts were found to be 
intact (by gel electrophoresis) after the in vitro,transcription 
reactions (and subsequent DNase treatment), it is possible that some 
RNA degradation may have occurred during the in vitro translation
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reactions (despite the inclusion of an RNase inhibitor) and may have 
contributed to the relative abundance of the Pint product.
Since the in vitro synthesized P transcripts and P mRNA 
molecules isolated from infected cells both contain the same, optimal 
P start codon, the observed difference in efficiency of internal 
initiation between the two kinds of transcripts (Fig. 63) could be a 
consequence of their different structures. Although, as discussed 
above, reticulocyte lysate ribosomes exhibit relatively cap- 
independent binding to 5'RNA termini, the simultaneous presence of 
the 5'cap and of the optimal 5'proximal AUG codon in the P mRNA 
molecules synthesized in vivo would be expected to increase the 
efficiency of initiation at this first AUG triplet (Kozak, 1980; 
Hassin et ml., 1986; Dasso and Jackson, 1989). Alternatively (or 
additionally) the absence of the 170 nucleotides-long 3 'mRNA non­
coding region from the in vitro P transcripts and/or the presence of 
upstream 5' extraneous sequences (from the multiple cloning site) 
could affect the P RNA secondary structure, a factor known to 
contribute to the selection of translational initiation sites 
(Pelletier and Sonenberg, 1985; Kozak, 1986c, 1989a,c; see also 
section IB.2). These possibilities could be investigated by 
construction of a full-length P cDNA clone and in vitro translation 
of the corresponding capped and uncapped transcripts.
Unlike the P genes of the other paramyxoviruses, which encode 
additional non-structural proteins, the P gene of RS virus is thought 
to be structurally and functionally monocistronic (see section IB.2). 
The existence of separate genes coding for the non-structural RS 
virus polypeptides has been considered as an explanation for this 
difference in P gene expression (Satake et ml., 1984; Elango et ml., 
1985; Collins et ml., 1984a, 1986). However the Sendai virus P mRNA,
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which encodes the P and C / C  proteins from different ORFs by leaky 
scanning of 5' proximal AUG codons, also encodes a small protein 
called X by internal initiation in the P ORF (Curran and Kolakofsky, 
1987, 1988a,b; Vidal et al., 1988).
The X protein, which has been identified both in vivo and in 
vitro, represents the C-terminal 95 residues of the P protein and is 
thought to be translated by a cap-dependent but scanning-independent 
mechanism, i.e. by direct binding of the 40S ribosomal subunit at an 
internal, 3' proximal AUG (Curran and Kolakofsky, 1988b). A similar 
mechanism (i.e. independent initiation) has been proposed to explain 
synthesis of the VSV 7K protein from a 3' proximal AUG codon in the 
NS mRNA, although in this case initiation was found to be cap- 
independent as well (Herman 1986, 1987). The 7K protein represents 
the C-terminal 65 residues of the NS protein and is detected in small 
amounts in vivo. The possible independent functions of these C- 
terminal regions of the two phosphoproteins, when translated as 
individual polypeptides, are currently unknown.
The small amounts of Sendai virus X and VSV 7K proteins, which 
35are detected by ( SJmethionine-labelling in infected cells, have 
been attributed to relative lack of methionine residues as well as 
relative molar abundance (with respect to the intact P or NS 
proteins). Since the Pint product contains 7 out of the total 8 
methionines of the RS virus P protein, the inability to detect this 
product in vivo (by immunoprécipitation with MAb 8268 or during 
pulse-chase experiments with polyclonal anti-RSV serum) may be due to 
a very low frequency of internal translational initiation in vivo. 
This is supported by the observation of very small amounts of Pint 
product during in vitro translations of intact, capped P mRNA (as 
discussed above). It is also possible that this product is less
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stable in infected cells or/and rapidly associated with another viral 
protein (e.g. N or 22K). Immunoprécipitation of samples, after 
pulse-chase labelling, with MAb 8268 (which reacts with the Pint 
polypeptide) and different anti-N (or anti-22K) MAbs, in the presence 
of more potent protease inhibitors than PMSF, could enable 
identification of the Pint product in RS virus-infected cells. 
Presently however, in the absence of such evidence, the event of 
internal initiation of translation in the P ORF in RS virus should be 
viewed with caution, given the ability of the in vitro system to 
fortuitously utilize internal AUG codons under certain conditions (as 
mentioned above).
3.5 GENERAL DISCUSSION AMD CONCLUSIONS
Temperature-sensitive mutants of viruses have often been used 
as tool8 for the investigation of viral protein functions (e.g. in 
VSV) and temperature-sensitive derivatives of wild-type virulent 
strains have also been used as live attenuated vaccines [e.g. the 
Sabin type 3 vaccine strain of poliovirus (derived from the virulent 
strain Leon)]. The first series of RS virus ts mutants was produced 
by Chanock and his colleagues from the A2 strain in order to evaluate 
their suitability as live RS virus vaccines. However mutant ts Aj 
was found to be genetically unstable in seronegative children and 
mutant ts A2 was poorly infectious when administered under permissive 
conditions, as mentioned previously (Section 1C.3).
The over-attenuation of ts A2 is probably the consequence of a 
non-ts cleavage defect of the F0 protein whereas the ts defect in 
this mutant appears to be the delayed maturation of the G-precursor 
species p50 into fully glycosylated G protein (Section 3.2). The
271
results obtained from analysis of ts A1 (Section 3.1) suggest the 
existence of a mutation in the fusion protein. However, 
characterization of ts+ revertants did not allow unambiguous 
assignment of the ts A1 lesion to the F gene, since restoration of 
rl,2 mobility was not correlated with complete reversion of the ts 
phenotype. In mutant ts Nj, absence of the M protein at 39°C was 
observed, in addition to the previously reported aberrant mobility of 
its P protein. Ts* revertant analysis suggested that restoration of 
the ts phenotype was due to M-protein stability in the infected-cell 
cytoplasm at the restrictive temperature (Section 3.3). Mutant ts 
N^g, which exhibited a ts defect early in infection at 39°C, 
possessed an antigenically altered P protein. A single Gly -* Ser 
mutation at position 172 of the ts N^g P protein was found to abolish 
binding of anti-P MAb 3-5. The P protein of a series of ts+ 
revertants reacted positively with this MAb and in the one revertant 
sequenced this correlated with existence of the wild-type glycine at 
position 172 (Section 3.4). Table 21 summarizes the supporting data 
for the proposed gene assignments for the three complementation 
groups B, D, E (and a tentative assignment for group A) on the basis 
of results obtained with the aforementioned representative mutants ts 
A2, ts N^, ts Njg (ts A^).
Representative mutants of the other four complementation groups 
(shown in Table 5) were also studied by immunoprécipitation and SDS- 
PAGE but no differences in their protein profiles were detected. 
However several RS virus proteins cannot be observed simultaneously 
by a single labelling procedure and/or the same conditions of gel 
electrophoresis (e.g. 1A, IB, 1C, G). Furthermore,- the trace amounts 
of L protein synthesized in vivo (due to the additional site-specific 
attenuation of L-gene transcription described in Section 1C.1) are
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not easily detectable by such analysis. It is possible that 
production of an L-specific antiserum raised against a synthetic L- 
oligopeptide (constructed on the basis of recently obtained sequence 
information; Dr. P. Collins, personal communication) will facilitate 
the gene assignment of mutant ts N17 (complementation group B ’) which 
is assumed to possess an L-protein lesion (see Section 1C.3).
However, as only a minority of amino acid changes will give rise to 
electrophoretic mobility differences, an alternative approach for 
obtaining assignments for the remaining groups would be the In vivo 
complementation of ts mutants by co-infecting vaccinia-RS virus 
recombinants, expressing individual wild-type RS virus proteins (this 
approach has been so far successful in the case of the already 
assigned mutant ts N^g; C. R. Pringle, personal communication).
During the course of this work several interesting 
observations, not directly related to analysis of ts phenotypes, 
emerged. For example, the inability to detect synthesis of the RSN-2 
G protein in the absence of N-linked glycosylation is at variance 
with the previously observed ability of the A2 G protein to undergo 
Ji-linked-independent O-glycosylation and surface expression, and may 
be relevant for the understanding of the requirements for vectorial 
transport of this N-terminally anchored glycoprotein. A similar 
observation for the G protein of VSV (differences in the efficiency 
of surface expression of unglycosylated G protein between two wild- 
type strains; see Section 1A.4) enabled delineation of the 
requirement for W-linked carbohydrates for intracellular transport 
and, in conjunction with analysis of the tsG-protein mutant ts045, 
allowed determination of the role of protein folding for migration to 
the cell surface of this C-terminally anchored glycoprotein. 
Identification of the site of the mutation responsible for the
temperature-sensitive maturation of the ts A2 G protein and further 
analysis of its effects on G protein-processing/transport (e.g. by 
expression of the ts A2 G protein in the ldlD cell system as 
described by Hertz et al., 1989) may be useful for definition of the 
structural features involved in selection of sites for O- 
glycosylation and in intracellular transport.
Other observations deserving further examination are the 
different N-P protein complexes coprecipitated by anti-N and anti-P 
MAbs, and the N-P-22K complex immunoprecipitated by an anti-22K MAb 
mainly from (partially purified) virus particles. The latter 
observation may indicate involvement of the 22K protein in maturation 
and virion formation in RS virus. Investigation of the effects of 
the ts Ni M-protein defect on viral mRNA synthesis at 39°C would be a 
useful approach for probing the nucleocapsid-envelope protein 
associations in RS virus, given that the RNP-M protein interaction 
during maturation in the rhabdovirus VSV and the paramyxovirus Sendai 
virus entails inhibition of transcription by progeny nucleocapsids 
and absence of this interaction leads to over-production of viral 
mRNA in tsM-protein mutants of VSV at the restrictive temperature.
Finally, the observation of internal initiation of in vitro 
translation in the P ORF is noteworthy, since internal initiation 
from a 3' proximal AUG in the phosphoprotein reading frame has also 
been observed (albeit in vivo as well as in vitro) for the VSV NS 
mRNA and the Sendai virus P mRNA. At present, the possibility that 
the in vitro synthesis of the RS virus Pint product is artifactual 
(due to the particular (K ) and [Mg ) concentrations used and/or to 
fragmentation of some mRNA molecules, which could render the 
"internal" initiation site proximal to the 5' RNA terminus) cannot be 
discounted. This could be investigated by electrophoretic analysis
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of [32P]-labelled transcripts following incubation with reticulocyte 
lysate to detect any mRNA degradation by endogenous RNases, by 
temporally monitoring the in vitro synthesis of the Pint product, and 
by assessing the efficiency of internal initiation under different 
experimental conditions. The availability of an anti-P MAb which 
efficiently reacts with the Pint product (MAb 8268) may assist 
detection of this polypeptide in RS virus-infected cells if internal 
initiation of P mRNA translation does take place in vivo.
Use of the recently developed PCR-mediated amplification of 
cDNA, synthesized by reverse transcription of viral mRNA, proved to 
be a rapid and convenient method for obtaining clones of specific 
viral mRNAs whose protein products have been predicted to possess a 
temperature-sensitive defect on the basis of in vivo studies. This 
approach enabled identification of the ts N19 lesion at the 
nucleotide level, which is the ultimate proof required to confirm 
gene assignments based on examination of in vivo ts phenotypes. 
Although the combination of reverse transcription and PCR 
amplification produced clones possessing several nucleotide 
differences which might have obscured recognition of the authentic ts 
mutation, expression of the cDNA clones in vitro substantiated the 
sequencing data by allowing verification of the effects of individual 
coding changes on the properties of the respective polypeptides. In 
addition, the in vitro generation of random polymerase copying errors 
in individual clones offered the opportunity to obtain variously 
mutated forms of the P protein by in vitro transcription-translation, 
which contributed to the interpretation of the effects of amino acid 
changes on the characteristics (mobility, antigenioity) of the 
protein.
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A by-product of this analysis was the derivation of a consensus 
sequence for the P protein of a second subgroup B strain (RSN-2) of 
RS virus. The number of P amino acid differences (3) observed 
between the RSN-2 and 18537 strains is similar to that observed 
between the three subgroup A strains (Table 19) and supports the 
classification of strain RSN-2 in subgroup B, made previously on the 
basis of anti-P MAb reactivity (Gimenez et al., 1986). RS virus 
strains in subgroup B have been found to exhibit substantial mobility 
and epitopic variation in their G proteins, on account of which 
subgroup B has been further divided into subgroups B^ and B2 
(Akerlind et al., 1988). Strain 18537 has been assigned to subgroup 
Bj which is characterized by faster migrating G proteins. The 
electrophoretic mobility of the RSN-2 G protein (see Section 3.2A) 
suggests classification of this strain to subgroup B^ as well and 
this has been confirmed by the pattern of reactivity of the RSN-2 G 
protein with the B1/B2-discriminating anti-G MAba (C. R. Pringle, 
unpublished data).
Although the levels of intrasubgroup variation in P protein 
sequence are similar between the A and B strains, it should be 
mentioned that the amino acid and nucleotide differences observed 
between the RSN-2 and 18537 P sequences (Figure 60) reflect the 
minimum potential variation since the regions of the RSN-2 sequence 
corresponding to the primer-oligonucleotides were derived from the 
18537 sequence (as explained in 3.4A). Nonetheless, the almost exact 
sequence conservation in these terminal regions between the A2 and 
18537 strains (only one nucleotide difference in each), the efficient 
amplification of the RSN-2 P mRNA by use of these primers and the 
comigration of the in vitro expressed RSN-2 (and ts Nj) P proteins 
(containing these terminal 18537 residues) with the proteins
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translated from authentic strain RSN-2 (and ts Nj) P mRNA, do not 
suggest existence of substantial sequence variation In these regions. 
However, It would now be possible to obtain the full nucleotide 
sequence of the RSN-2 P mRNA, using reverse transcription and PCR 
amplification, by construction of Internal RSN-2 P-specific primers 
(based on the sequence determined here) and their use In conjunction 
with an oligo(dT)-based primer (in order to obtain the sequence of 
the C-terminal 7 amino acids and of the 3' non-coding region) or an 
N-gene-specific primer (for obtaining the 5' proximal P mRNA sequence 
from an N-P bicistronic transcript as a template).
Of the three amino acid differences detected between the two 
subgroup B strains, one (Asp -» Glu at position 12) is a conservative 
replacement (acidic residue maintained) and the second (Asp -* Val at 
position 85) falls within the highly divergent region of the P 
protein identified by Johnson and Collins (1990). As shown in Figure 
74A, this region also contains the two, three and one out of the 
overall four, four and two amino acid differences between the 
subgroup A strains Long/A2, Long/Edinburgh and A2/Edinburgh, 
respectively. This organization of the RS virus P protein (existence 
of a short, variable "spacer" region approximately in the middle of 
the protein) has been suggested to reflect existence of two separate 
functional domains at the more highly conserved N- and C-termini 
(Johnson and Collins, 1990), perhaps similarly to the VSV NS protein, 
where the N-terminal domain I and the C-terminal domains II and III 
can functionally complement each other in trans during VSV in vitro 
transcription (Chattopadhay and Banerjee, 1987b). The positive 
reaction of the N-terminally truncated A2-P doublet band with anti-P , 
MAbs 3-5, 8268, 9516 (Figure 72A) and M189 (not shown) suggests that 
the carboxyterminal two-thirds of the P protein are exposed at the
2 7 8
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\surface of nucleocapsids (and available as immunogens, and probably 
also for protein interactions), consistent with their high content of 
acidic residues and of potential phosphorylation sites (Satake et 
al., 1984). This structure of the RS virus P protein differs from 
the organization of the paramyxovirus P protein, where the N-terminal 
region (the one exposed at the surface of RNP particles) is 
predominantly acidic and contains the majority of phosphorylated 
residues (see Section IB.3). This observation can perhaps be 
correlated with several other, already mentioned, differences 
concerning P gene expression between RS virus and the other 
paramyxoviruses (namely the much smaller size of the RS virus P 
protein, the expression of RS virus non-structural polypeptides from 
separate genes, the absence of a cysteine-rich "V"-protein ORF in the 
RS virus P gene). Furthermore, the high level of sequence 
conservation between the subgroup A and B P proteins contrasts with 
the observation of the highest sequence divergence in the P proteins 
of the paramyxovirus and morbillivirus genera (see Section IB.4).
Interestingly, the third amino acid difference between strains 
RSN-2 and 18537 is contained within a short region of intersubgroup 
sequence variation, which corresponds to the C-terminal P domain 
where single amino acid changes affecting the P apparent mobility 
were located (Figure 74B). It is also noteworthy that this 
difference (Asn -» Asp at position 225) is the Bame as the one found 
in the ts N^ clone (Asn -* Asp at position 217) which causes the 
slower mobility of the ts N! P protein. Small differences in P 
apparent mobility have been observed within the Bj and B2 subgroups 
with the earliest isolates (one of which is strain,18537) possessing , 
the fastest migrating P proteins (31-32K), later isolates having P 
proteins of intermediate Mr (33-34K, for instance the RSN-2 P
2 8 0
protein) and the subgroup B2 strains having P proteins of slow 
mobility (similar to those of subgroup A strains; Morgan et al.,
1987; Akerlind et al., 1988). On the basis of the already mentioned 
effects on P mobility of the ts Nj amino acid change, it is 
conceivable that similar single-residue differences (perhaps within 
this relatively variable C-terminal domain) may be responsible for 
this heterogeneity in P protein SDS-PAGE mobility among subgroup B 
strains.
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